data_2n52_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n52 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.415 -2.188 0 CA-C-O 123.4 1.572 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 2.7 t-20 -111.06 96.29 29.18 Favored Pre-proline 0 C--N 1.253 -3.629 0 CA-C-N 112.252 -2.249 . . . . 0.0 108.369 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.3 Cg_exo -68.6 154.96 70.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.914 1.743 . . . . 0.0 112.578 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -148.94 128.26 12.96 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' O ' HD13 ' A' ' 51' ' ' LEU . 34.0 t -104.02 103.46 13.28 Favored 'General case' 0 C--N 1.254 -3.584 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.18 160.24 52.33 Favored Glycine 0 N--CA 1.4 -3.711 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.057 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.2 m -66.93 -4.73 10.21 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 120.701 0.286 . . . . 0.0 110.666 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -7.77 53.03 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.17 1.462 . . . . 0.0 107.749 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA2' ' HZ2' ' A' ' 52' ' ' LYS . . . 102.25 -34.37 5.77 Favored Glycine 0 N--CA 1.397 -3.941 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.321 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.16 155.12 30.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.52 HG22 ' CB ' ' A' ' 56' ' ' LYS . 88.4 m -110.92 131.22 55.23 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.053 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -120.77 138.24 54.11 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.542 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.83 -34.72 65.62 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 114.874 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.8 p30 -147.28 178.26 8.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -74.54 -30.07 61.62 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-O 122.148 0.975 . . . . 0.0 111.217 -174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -39.13 86.62 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.128 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.774 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.57 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 27.5 t80 -81.17 -15.65 55.16 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.66 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.704 ' O ' HG23 ' A' ' 43' ' ' VAL . 40.9 m -58.17 -52.77 64.18 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 112.766 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.79 -25.2 62.77 Favored 'General case' 0 CA--C 1.462 -2.433 0 CA-C-O 123.413 1.578 . . . . 0.0 111.048 -176.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -75.81 -25.8 56.67 Favored 'General case' 1 C--N 1.206 -5.664 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.927 175.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.557 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 20.5 mt -73.16 -41.37 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.049 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 39' ' ' CYS . 84.3 t -57.9 -29.89 36.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 110.85 -2.886 . . . . 0.0 110.516 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.74 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -48.38 -43.63 34.02 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 178.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.428 ' CB ' HD13 ' A' ' 49' ' ' ILE . 5.6 m -134.39 61.67 1.67 Allowed 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 122.169 0.985 . . . . 0.0 111.669 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.5 0.33 89.94 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 118.561 2.184 . . . . 0.0 118.561 167.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.557 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 88.76 -19.31 38.09 Favored Glycine 0 C--N 1.27 -3.123 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.525 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 30.9 mmtm -78.0 -10.65 59.7 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.746 1.219 . . . . 0.0 113.72 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.428 HD13 ' CB ' ' A' ' 45' ' ' SER . 59.2 mt -62.26 148.98 9.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.9 m -125.6 -179.35 4.6 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 25' ' ' CYS . 35.8 tp -99.29 141.36 32.16 Favored 'General case' 1 N--CA 1.331 -6.382 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 23.7 mttp -87.02 -55.48 3.81 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.385 1.088 . . . . 0.0 108.839 167.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -131.07 133.2 24.42 Favored Pre-proline 0 C--N 1.288 -2.096 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.637 -166.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.08 109.33 2.81 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 N-CA-C 104.987 -2.736 . . . . 0.0 104.987 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.69 -175.24 15.76 Favored Glycine 0 C--N 1.281 -2.476 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.52 ' CB ' HG22 ' A' ' 31' ' ' THR . 14.6 pttp -80.65 174.35 11.7 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 121.766 0.793 . . . . 0.0 111.138 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 165.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 122.982 1.372 . . . . 0.0 107.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.35 110.65 13.09 Favored Pre-proline 0 C--N 1.263 -3.182 0 CA-C-N 112.112 -2.313 . . . . 0.0 111.408 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 149.84 84.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.682 2.255 . . . . 0.0 111.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.68 131.35 12.32 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.64 0.776 . . . . 0.0 109.546 -172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 42.0 t -100.69 108.88 20.86 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.644 ' O ' ' HE3' ' A' ' 52' ' ' LYS . . . -74.41 151.24 43.1 Favored Glycine 1 N--CA 1.395 -4.071 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.695 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 p -59.31 -25.86 64.5 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 124.031 0.932 . . . . 0.0 109.826 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' CB ' HG12 ' A' ' 49' ' ' ILE . 14.6 t70 -74.52 3.42 7.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 126.384 1.874 . . . . 0.0 109.872 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.95 -29.85 8.2 Favored Glycine 0 CA--C 1.468 -2.856 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.956 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' ASP . 49.9 mt-30 -74.19 128.68 36.16 Favored 'General case' 0 CA--C 1.45 -2.867 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -173.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 56' ' ' LYS . 87.7 m -107.7 132.54 53.23 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.32 -1.764 . . . . 0.0 108.843 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.96 143.41 48.03 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.92 -32.21 55.78 Favored Glycine 0 C--O 1.219 -0.792 0 O-C-N 124.671 1.232 . . . . 0.0 113.969 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 31.0 p30 -155.1 174.64 14.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 38' ' ' PHE . 18.5 tptm -66.53 -32.92 74.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.141 0.972 . . . . 0.0 111.102 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 3.7 t -50.6 -53.63 29.1 Favored 'General case' 1 C--N 1.236 -4.344 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.861 171.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.28 -40.42 74.34 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.852 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' O ' HG13 ' A' ' 42' ' ' ILE . 65.1 t80 -68.02 -46.55 70.9 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.119 -1.4 . . . . 0.0 113.529 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG21 ' A' ' 43' ' ' VAL . 21.9 t -70.17 -36.76 74.91 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.789 -171.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.567 ' C ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -85.78 -7.81 58.52 Favored 'General case' 0 N--CA 1.392 -3.329 0 CA-C-O 122.102 0.953 . . . . 0.0 110.581 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 38' ' ' PHE . . . -88.07 -28.02 21.6 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.654 -2.066 . . . . 0.0 110.629 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.61 HD11 ' HA ' ' A' ' 39' ' ' CYS . 68.8 mt -60.47 -45.42 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.904 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.769 HG21 ' O ' ' A' ' 39' ' ' CYS . 46.8 t -52.7 -32.29 17.17 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 110.491 -3.05 . . . . 0.0 111.013 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.8 mmpm? -86.45 -42.41 13.63 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.647 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 35.7 t -74.47 -15.98 60.87 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 123.787 0.679 . . . . 0.0 110.894 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.42 18.6 7.03 Favored Glycine 0 N--CA 1.401 -3.647 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.963 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.97 -5.59 61.85 Favored Glycine 0 C--N 1.295 -1.704 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.354 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.647 ' HD3' ' O ' ' A' ' 45' ' ' SER . 3.8 mtpm? -60.49 -25.06 65.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.517 HG12 ' CB ' ' A' ' 28' ' ' ASP . 9.5 mt -85.05 132.71 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.489 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.0 m -128.39 -179.37 4.99 Favored 'General case' 0 C--N 1.267 -3.022 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 170.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 25' ' ' CYS . 27.7 tp -98.66 140.99 32.04 Favored 'General case' 1 N--CA 1.333 -6.314 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.644 ' HE3' ' O ' ' A' ' 26' ' ' GLY . 77.4 mttt -88.05 -56.89 3.14 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 122.55 1.167 . . . . 0.0 107.858 165.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -153.88 140.13 12.63 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.218 -167.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.06 110.28 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.085 1.857 . . . . 0.0 108.848 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 161.05 11.31 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 31' ' ' THR . 8.9 mtpm? -57.94 165.65 1.75 Allowed 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 C--N 1.274 -2.715 0 N-CA-C 101.522 -3.51 . . . . 0.0 101.522 159.72 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.421 -1.907 0 CA-C-O 122.988 1.375 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.26 94.93 19.77 Favored Pre-proline 0 C--N 1.257 -3.449 0 CA-C-N 112.218 -2.264 . . . . 0.0 107.343 175.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.3 132.35 14.94 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.799 1.666 . . . . 0.0 112.241 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' THR . 80.7 m80 -141.97 127.71 19.23 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.3 t -102.11 107.58 18.72 Favored 'General case' 0 C--N 1.249 -3.771 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 169.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' A' ' 52' ' ' LYS . . . -71.14 165.26 53.37 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.685 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -51.76 -28.77 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.444 0.698 . . . . 0.0 110.481 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 8.9 t70 -60.5 -37.32 80.74 Favored 'General case' 0 CA--C 1.48 -1.729 0 C-N-CA 126.374 1.87 . . . . 0.0 110.085 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.07 -20.08 14.65 Favored Glycine 0 CA--C 1.459 -3.451 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.479 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 46.1 mt-30 -72.2 131.97 43.47 Favored 'General case' 0 CA--C 1.468 -2.184 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.538 HG21 ' CB ' ' A' ' 56' ' ' LYS . 95.4 m -102.31 131.32 48.98 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.234 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 65.4 m-85 -123.21 143.12 50.24 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.986 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.22 95.75 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.439 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 36.9 p30 -133.15 177.14 7.9 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 117.651 0.726 . . . . 0.0 109.413 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 83.6 tttt -67.97 -35.28 78.1 Favored 'General case' 0 C--O 1.189 -2.128 0 CA-C-O 121.336 0.589 . . . . 0.0 111.35 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -38.57 88.34 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.421 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -63.09 -39.44 94.72 Favored 'General case' 0 C--N 1.26 -3.32 0 CA-C-N 112.977 -1.919 . . . . 0.0 109.821 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 22.6 t80 -88.91 -27.55 20.9 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.153 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.78 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.9 t -57.9 -40.88 81.4 Favored 'General case' 0 CA--C 1.481 -1.71 0 C-N-CA 124.612 1.165 . . . . 0.0 110.938 -173.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -73.86 -24.08 59.69 Favored 'General case' 0 N--CA 1.409 -2.494 0 CA-C-O 122.853 1.311 . . . . 0.0 110.485 -170.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -79.7 -29.27 40.69 Favored 'General case' 0 C--N 1.265 -3.078 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.703 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.5 mt -67.08 -42.91 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 39' ' ' CYS . 10.3 t -62.56 -27.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.943 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.33 -39.5 74.69 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.8 -0.562 . . . . 0.0 112.275 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.404 ' HB2' HG13 ' A' ' 49' ' ' ILE . 31.2 m -105.82 22.62 15.28 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.51 14.8 75.29 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 170.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 85.29 0.74 88.45 Favored Glycine 0 C--N 1.274 -2.88 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 3.0 mmmp? -68.55 -28.71 67.21 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 45' ' ' SER . 40.5 mt -76.69 145.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.004 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -130.24 -175.34 3.6 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 25' ' ' CYS . 31.4 tp -86.18 141.37 29.39 Favored 'General case' 1 N--CA 1.326 -6.663 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 21.0 ttmm -91.75 -52.15 4.89 Favored 'General case' 0 N--CA 1.38 -3.936 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.514 172.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -145.21 137.27 13.16 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.856 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.04 110.38 3.06 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 107.137 -1.909 . . . . 0.0 107.137 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.79 179.47 17.8 Favored Glycine 0 C--N 1.288 -2.09 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.538 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.0 pttp -78.73 170.43 16.67 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-O 121.433 0.635 . . . . 0.0 110.617 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.482 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 32.4 m . . . . . 0 C--N 1.273 -2.742 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.4 m . . . . . 0 N--CA 1.428 -1.554 0 CA-C-O 122.212 1.006 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 27.9 t-20 -111.66 94.33 23.25 Favored Pre-proline 0 C--N 1.268 -2.974 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.085 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.45 123.9 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.105 1.203 . . . . 0.0 109.584 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 48.7 p-80 -153.63 133.57 13.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.579 ' O ' HD12 ' A' ' 51' ' ' LEU . 44.1 t -92.74 114.19 26.68 Favored 'General case' 0 C--N 1.264 -3.143 0 CA-C-N 113.877 -1.51 . . . . 0.0 106.993 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.23 147.53 50.1 Favored Glycine 1 N--CA 1.393 -4.172 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.561 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 p -45.69 -41.27 10.26 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 124.826 1.251 . . . . 0.0 110.757 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.91 3.35 5.39 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.136 0.974 . . . . 0.0 112.81 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.43 54.59 Favored Glycine 0 CA--C 1.46 -3.358 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -73.2 122.77 22.44 Favored 'General case' 0 CA--C 1.45 -2.877 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.595 HG21 ' HA ' ' A' ' 56' ' ' LYS . 94.7 m -116.95 127.7 54.48 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.676 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 31.6 m-85 -134.61 161.11 36.03 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.315 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.51 -31.7 52.2 Favored Glycine 0 C--N 1.298 -1.539 0 CA-C-N 113.182 -1.826 . . . . 0.0 114.563 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.8 p30 -162.7 -175.57 4.51 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 117.467 0.633 . . . . 0.0 109.549 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -68.1 -42.57 80.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.418 0.628 . . . . 0.0 111.862 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -32.6 74.08 Favored 'General case' 0 C--N 1.247 -3.879 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.586 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -53.61 -43.21 68.46 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.681 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -133.1 26.01 4.23 Favored 'General case' 0 C--O 1.195 -1.787 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.864 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.715 ' O ' HG23 ' A' ' 43' ' ' VAL . 49.8 t -54.5 -45.56 73.28 Favored 'General case' 0 C--O 1.202 -1.406 0 C-N-CA 122.924 0.49 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.619 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -69.0 -25.91 64.75 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 125.69 1.596 . . . . 0.0 114.489 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 38' ' ' PHE . . . -82.16 -25.93 33.88 Favored 'General case' 1 C--N 1.203 -5.78 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.016 174.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 39' ' ' CYS . 12.8 mt -65.45 -42.54 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 39' ' ' CYS . 80.6 t -49.5 -44.56 18.88 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.354 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.54 -31.05 29.31 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.297 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.4 m -80.89 8.4 8.38 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.358 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 2.31 58.01 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.99 -6.11 68.21 Favored Glycine 0 C--N 1.29 -2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.2 mtpm? -61.03 -25.77 67.15 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 124.627 1.171 . . . . 0.0 113.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.442 HD11 ' HA ' ' A' ' 42' ' ' ILE . 14.4 mt -66.42 125.86 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 CA-C-O 123.02 1.39 . . . . 0.0 112.406 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -131.31 -175.33 3.66 Favored 'General case' 0 C--N 1.261 -3.258 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 35.6 tp -94.98 141.21 28.92 Favored 'General case' 1 N--CA 1.328 -6.556 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 24.4 mmtm -77.46 -65.44 0.96 Allowed 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -167.5 151.19 6.11 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 112.208 -2.269 . . . . 0.0 108.098 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.61 138.56 80.75 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.136 1.89 . . . . 0.0 110.664 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.52 163.98 29.37 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.1 mtpm? -63.77 162.84 12.68 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 176.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 98.5 m . . . . . 0 C--N 1.271 -2.824 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 158.428 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.797 0.808 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.814 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 5.5 m-20 -56.91 102.51 0.31 Allowed Pre-proline 0 C--N 1.273 -2.74 0 CA-C-N 113.363 -1.744 . . . . 0.0 113.153 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.18 151.84 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.846 1.697 . . . . 0.0 111.48 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.477 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 88.2 m-70 -148.49 129.05 14.03 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 110.482 -173.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 34.7 t -103.38 101.54 11.45 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 169.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -77.39 170.08 54.97 Favored Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.251 -171.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' CG ' ' A' ' 52' ' ' LYS . 31.0 m -68.37 -4.47 14.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.679 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' GLN . 9.9 t70 -78.77 -8.09 58.41 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.668 1.187 . . . . 0.0 107.886 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.02 -29.53 8.61 Favored Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.857 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' ASP . 48.9 mt-30 -74.26 145.06 44.33 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.529 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.2 m -108.92 131.6 54.88 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.307 -1.77 . . . . 0.0 109.249 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 95.0 m-85 -129.28 151.34 50.05 Favored 'General case' 0 N--CA 1.398 -3.035 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.257 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.49 -26.09 59.02 Favored Glycine 0 C--O 1.208 -1.508 0 CA-C-N 114.5 -1.227 . . . . 0.0 115.469 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.814 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 7.8 p30 -164.5 173.59 11.89 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.661 0.731 . . . . 0.0 109.277 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -62.44 -32.58 73.46 Favored 'General case' 0 C--O 1.182 -2.448 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.659 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 61.7 m -57.13 -39.94 76.14 Favored 'General case' 0 C--N 1.255 -3.519 0 CA-C-O 122.351 1.072 . . . . 0.0 111.829 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.16 -38.31 56.82 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.738 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 21.4 t80 -81.43 -6.09 58.58 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.759 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -63.89 -41.99 97.57 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.591 -0.693 . . . . 0.0 111.396 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -71.41 -17.56 62.39 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 125.244 1.418 . . . . 0.0 113.856 -176.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -87.22 -26.7 23.39 Favored 'General case' 1 C--N 1.208 -5.575 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.593 173.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 39' ' ' CYS . 22.9 mt -72.02 -36.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 39' ' ' CYS . 93.8 t -54.07 -33.13 24.01 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 CA-C-N 110.611 -2.995 . . . . 0.0 111.246 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 3.0 mmmm -48.11 -43.01 30.56 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.2 m -124.36 29.65 6.28 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.46 26.34 28.06 Favored Glycine 0 N--CA 1.4 -3.721 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.565 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 80.72 -8.87 54.26 Favored Glycine 0 C--N 1.277 -2.738 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.618 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -72.8 -19.89 61.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -69.68 150.76 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.351 0.596 . . . . 0.0 110.989 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -125.46 -176.38 3.58 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 41.6 tp -97.56 140.94 31.23 Favored 'General case' 1 N--CA 1.329 -6.512 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.487 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 7.2 mtmp? -93.42 -50.71 5.32 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.698 0.761 . . . . 0.0 110.583 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 18.0 m170 -126.34 130.24 23.97 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.907 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.64 109.68 2.8 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 163.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.78 -179.23 20.07 Favored Glycine 0 C--N 1.285 -2.267 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -169.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.529 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.0 pttp -78.4 174.07 11.67 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-O 122.188 0.994 . . . . 0.0 111.911 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.28 -2.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.208 165.327 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.416 -2.17 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 46.4 t-20 -111.11 105.59 57.11 Favored Pre-proline 0 C--N 1.277 -2.544 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.53 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.08 148.69 63.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.791 1.661 . . . . 0.0 112.183 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' THR . 69.7 m-70 -148.07 130.81 16.01 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' HD13 ' A' ' 51' ' ' LEU . 43.8 t -106.69 102.6 11.96 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 169.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -68.98 160.16 52.53 Favored Glycine 0 N--CA 1.405 -3.397 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.0 m -60.8 -21.17 62.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -73.36 -16.34 61.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 125.54 1.536 . . . . 0.0 110.894 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.43 ' HA2' ' HZ3' ' A' ' 52' ' ' LYS . . . 108.19 -20.68 30.33 Favored Glycine 1 CA--C 1.448 -4.14 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.456 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.92 130.37 40.84 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 96.8 m -115.85 127.86 55.36 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.368 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 60.4 m-85 -132.88 155.28 49.32 Favored 'General case' 0 N--CA 1.388 -3.569 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.624 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.2 -22.86 72.94 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 113.232 -1.804 . . . . 0.0 114.483 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 33.2 p30 -156.79 169.33 24.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.458 0.629 . . . . 0.0 110.403 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -61.24 -33.71 73.95 Favored 'General case' 0 C--O 1.196 -1.724 0 CA-C-O 121.286 0.565 . . . . 0.0 111.922 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.518 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 97.3 m -57.44 -41.17 79.99 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.142 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -77.04 -40.78 45.12 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.157 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.502 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 33.7 t80 -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.963 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.788 ' O ' HG22 ' A' ' 43' ' ' VAL . 52.4 t -59.49 -40.98 88.76 Favored 'General case' 0 C--O 1.192 -1.942 0 C-N-CA 123.224 0.61 . . . . 0.0 111.556 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.09 -20.84 61.59 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-O 122.732 1.253 . . . . 0.0 112.05 -170.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -74.22 -39.2 63.25 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 112.793 -2.003 . . . . 0.0 107.847 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.8 mt -71.15 -49.34 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.087 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 39' ' ' CYS . 59.5 t -50.34 -53.69 11.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.177 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -71.74 -33.95 69.13 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.522 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 m -83.48 0.99 43.94 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.425 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 93.78 14.3 52.9 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -6.77 58.05 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 46' ' ' GLY . 2.1 mtpm? -67.21 -16.01 64.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.6 mt -78.77 147.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.27 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.6 m -121.69 176.78 5.54 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 38.9 tp -99.31 141.44 32.09 Favored 'General case' 1 N--CA 1.329 -6.484 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.45 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 34.2 mttp -88.42 -57.14 3.03 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 122.449 1.118 . . . . 0.0 108.81 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -130.92 138.96 34.16 Favored Pre-proline 0 C--N 1.285 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 113.282 -165.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.81 109.47 2.61 Favored 'Trans proline' 0 N--CA 1.435 -1.946 0 N-CA-C 104.537 -2.909 . . . . 0.0 104.537 161.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.23 178.33 18.66 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -168.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.523 ' CB ' HG22 ' A' ' 31' ' ' THR . 14.7 pttp -78.05 175.65 9.91 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 122.031 0.92 . . . . 0.0 111.403 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 165.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 122.826 1.298 . . . . 0.0 108.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.8 m-20 -69.36 116.82 46.4 Favored Pre-proline 0 C--N 1.272 -2.777 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.933 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.96 148.46 70.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.838 2.359 . . . . 0.0 112.239 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -152.5 127.12 9.43 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 124.08 0.952 . . . . 0.0 108.757 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 14.0 t -100.05 99.11 9.8 Favored 'General case' 0 C--N 1.254 -3.562 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 28' ' ' ASP . . . -80.14 170.96 54.12 Favored Glycine 0 CA--C 1.46 -3.401 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.372 -168.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 m -73.82 5.17 4.32 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.848 0.833 . . . . 0.0 109.398 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 26' ' ' GLY . 8.8 t70 -68.69 -19.84 64.39 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.529 2.332 . . . . 0.0 105.839 169.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 -36.04 4.52 Favored Glycine 1 N--CA 1.394 -4.143 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -85.54 155.59 21.12 Favored 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.7 m -96.21 124.75 40.33 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.678 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 56.8 m-85 -113.21 142.74 45.44 Favored 'General case' 1 N--CA 1.377 -4.121 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.67 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.35 -35.82 80.7 Favored Glycine 0 CA--C 1.49 -1.509 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.691 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.3 p-10 -149.69 168.71 22.85 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.349 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -59.03 -29.99 67.69 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.513 1.125 . . . . 0.0 111.982 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.517 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 0.7 OUTLIER -55.53 -50.79 69.06 Favored 'General case' 0 C--N 1.249 -3.788 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.73 174.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 40' ' ' LYS . . . -69.44 -33.95 73.7 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.893 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -83.14 -16.71 45.66 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.588 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.785 ' O ' HG21 ' A' ' 43' ' ' VAL . 42.5 t -68.09 -31.65 71.42 Favored 'General case' 0 CA--C 1.47 -2.126 0 O-C-N 122.034 -0.416 . . . . 0.0 110.373 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -66.62 -29.52 69.57 Favored 'General case' 0 CA--C 1.454 -2.722 0 CA-C-O 122.33 1.062 . . . . 0.0 112.471 -169.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.722 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.0 -35.14 66.78 Favored 'General case' 1 C--N 1.224 -4.886 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.268 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 39' ' ' CYS . 25.4 mt -68.32 -42.13 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.081 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.785 HG21 ' O ' ' A' ' 39' ' ' CYS . 58.6 t -58.56 -33.02 47.29 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.392 0 CA-C-N 111.107 -2.769 . . . . 0.0 111.387 174.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 7.7 mmpt? -81.11 -37.4 28.98 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.708 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.1 t -84.51 -20.57 31.41 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.667 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 103.87 31.99 4.58 Favored Glycine 0 N--CA 1.4 -3.756 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.32 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.81 -13.19 57.36 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' GLY . 2.3 mtpm? -67.36 -24.81 65.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 41' ' ' ALA . 70.0 mt -80.74 146.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.203 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -134.71 -176.62 4.29 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 37.3 tp -93.11 141.13 28.75 Favored 'General case' 1 N--CA 1.34 -5.973 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.457 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 23.0 mtmm -88.77 -49.7 6.67 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.141 168.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -146.1 132.22 9.57 Favored Pre-proline 0 C--N 1.283 -2.311 0 C-N-CA 118.507 -1.277 . . . . 0.0 112.075 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.26 109.91 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.89 1.727 . . . . 0.0 108.33 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.46 -167.46 13.78 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.585 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 12.6 pttp -86.98 169.4 12.47 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-O 121.439 0.638 . . . . 0.0 110.831 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.273 -2.727 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.035 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.413 -2.312 0 CA-C-O 122.599 1.19 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.6 m120 -111.01 97.06 32.89 Favored Pre-proline 0 C--N 1.258 -3.396 0 CA-C-N 113.065 -1.879 . . . . 0.0 108.628 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 57.1 Cg_endo -73.91 133.8 18.87 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.047 1.165 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' THR . 62.1 m-70 -141.67 128.34 20.33 Favored 'General case' 0 CA--C 1.464 -2.349 0 CA-C-O 121.491 0.662 . . . . 0.0 109.842 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.9 t -101.95 108.77 20.33 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 167.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.21 162.8 52.75 Favored Glycine 1 N--CA 1.393 -4.209 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -60.06 -22.17 62.36 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.875 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.86 6.17 16.58 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.683 1.23 . . . . 0.0 110.106 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.01 -27.17 9.38 Favored Glycine 0 CA--C 1.467 -2.917 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.564 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.51 145.97 47.14 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 56' ' ' LYS . 94.2 m -119.18 134.02 55.44 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.569 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 36.3 m-85 -133.62 152.54 51.91 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 121.222 0.534 . . . . 0.0 111.946 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -37.01 93.75 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 113.903 -1.498 . . . . 0.0 115.132 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 31.2 p30 -141.92 175.82 9.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -67.77 -36.87 81.27 Favored 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.348 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.22 -37.66 86.21 Favored 'General case' 0 C--N 1.252 -3.643 0 CA-C-O 122.422 1.106 . . . . 0.0 110.801 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 34' ' ' ASN . . . -63.41 -36.46 83.81 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.987 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.525 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -92.24 -25.32 18.69 Favored 'General case' 0 C--O 1.195 -1.792 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.706 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.762 ' O ' HG23 ' A' ' 43' ' ' VAL . 12.9 t -51.68 -50.55 60.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.887 1.275 . . . . 0.0 111.68 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.19 -29.38 67.35 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-O 122.186 0.993 . . . . 0.0 113.626 -176.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 38' ' ' PHE . . . -78.52 -28.08 46.17 Favored 'General case' 1 C--N 1.224 -4.851 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.546 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 39' ' ' CYS . 35.3 mt -64.43 -43.31 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.614 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.2 t -56.96 -36.84 51.74 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 111.443 -2.617 . . . . 0.0 111.351 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 38.5 mmtm -82.44 -38.69 23.63 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.144 0.497 . . . . 0.0 112.301 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 49' ' ' ILE . 9.5 t -81.88 -14.85 55.65 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.367 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.59 0.2 6.23 Favored Glycine 0 N--CA 1.401 -3.663 0 N-CA-C 117.002 1.561 . . . . 0.0 117.002 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.11 84.21 Favored Glycine 0 C--N 1.283 -2.382 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.807 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.293 44.1 mttt -56.89 -36.52 70.23 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 122.029 0.919 . . . . 0.0 109.812 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.5 ' HB ' HG12 ' A' ' 42' ' ' ILE . 1.2 mp -59.69 132.05 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.683 -166.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.2 m -138.22 178.47 7.11 Favored 'General case' 0 C--N 1.26 -3.313 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 171.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 22.0 tp -91.9 140.37 29.74 Favored 'General case' 1 N--CA 1.321 -6.918 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.4 ttmt -96.17 -52.78 3.88 Favored 'General case' 1 N--CA 1.343 -5.777 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.093 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -141.11 139.21 18.84 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.659 -173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.13 110.13 2.82 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 106.766 -2.052 . . . . 0.0 106.766 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.6 173.77 17.04 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -171.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.559 ' CB ' HG23 ' A' ' 31' ' ' THR . 13.4 pttp -75.93 172.23 13.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 121.665 0.745 . . . . 0.0 110.646 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 27.9 m . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 166.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 122.397 1.094 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.23 111.21 12.72 Favored Pre-proline 0 C--N 1.267 -3.0 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.995 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 39.3 Cg_exo -60.0 143.03 99.61 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 123.775 2.983 . . . . 0.0 112.673 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.5 130.58 11.87 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 123.729 0.811 . . . . 0.0 110.039 -170.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 30.9 t -103.35 105.44 15.71 Favored 'General case' 0 C--N 1.258 -3.396 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.676 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -86.16 177.04 49.03 Favored Glycine 0 CA--C 1.464 -3.144 0 C-N-CA 119.284 -1.436 . . . . 0.0 113.798 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 m -76.03 4.08 9.09 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-O 121.827 0.822 . . . . 0.0 109.094 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' GLN . 9.2 t70 -66.59 -18.28 65.28 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.603 2.361 . . . . 0.0 105.746 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -32.91 6.46 Favored Glycine 0 N--CA 1.399 -3.793 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.662 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' ASP . 45.7 mt-30 -91.71 156.14 17.79 Favored 'General case' 0 CA--C 1.47 -2.116 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -172.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 56' ' ' LYS . 75.8 m -96.48 128.76 43.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.109 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 91.8 m-85 -116.02 147.88 40.75 Favored 'General case' 0 N--CA 1.38 -3.955 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.7 -27.44 61.52 Favored Glycine 0 C--N 1.299 -1.509 0 O-C-N 124.873 1.358 . . . . 0.0 113.011 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 27.0 p30 -159.66 171.17 20.07 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 41.0 ttmt -63.17 -32.78 74.26 Favored 'General case' 0 C--O 1.182 -2.467 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.573 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 2.7 t -49.11 -53.86 18.75 Favored 'General case' 1 C--N 1.242 -4.082 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.572 173.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -66.0 -41.9 90.42 Favored 'General case' 0 C--N 1.264 -3.124 0 C-N-CA 125.566 1.547 . . . . 0.0 111.03 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.676 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 19.2 t80 -85.53 -17.41 36.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.822 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.1 t -61.78 -31.09 71.27 Favored 'General case' 0 C--O 1.181 -2.516 0 O-C-N 121.707 -0.621 . . . . 0.0 110.501 -172.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.779 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.7 -32.2 73.77 Favored 'General case' 0 CA--C 1.461 -2.48 0 CA-C-O 122.398 1.094 . . . . 0.0 112.454 -171.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.779 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -66.28 -40.56 90.17 Favored 'General case' 1 C--N 1.234 -4.455 0 CA-C-N 111.971 -2.377 . . . . 0.0 108.014 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.601 HD13 ' CE2' ' A' ' 38' ' ' PHE . 53.5 mt -71.22 -50.63 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.37 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 39' ' ' CYS . 18.3 t -53.85 -52.1 38.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.196 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.84 -30.61 68.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.436 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.5 m -90.44 12.27 19.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.491 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.64 6.03 68.31 Favored Glycine 0 N--CA 1.408 -3.219 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.516 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 93.4 -4.37 73.37 Favored Glycine 1 C--N 1.248 -4.345 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 10.0 mptt -68.48 -29.78 68.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.7 mt -75.93 149.07 6.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.048 173.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -132.16 -177.48 4.47 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.8 tp -87.2 140.79 29.19 Favored 'General case' 1 N--CA 1.331 -6.401 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.6 ttmt -85.44 -56.32 3.58 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.299 170.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -140.33 136.48 16.86 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.589 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.3 110.19 3.06 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 N-CA-C 106.643 -2.099 . . . . 0.0 106.643 167.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 109.4 -173.93 17.57 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 31' ' ' THR . 9.0 mtpm? -67.05 170.22 7.19 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.5 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 66.3 m . . . . . 0 C--N 1.275 -2.655 0 CA-C-N 109.956 -3.293 . . . . 0.0 103.055 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.412 -2.343 0 CA-C-O 122.919 1.342 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.0 m120 -111.14 92.43 15.43 Favored Pre-proline 0 C--N 1.264 -3.141 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.731 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -63.79 125.33 15.21 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.961 1.774 . . . . 0.0 110.445 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-70 -141.7 125.07 16.56 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-O 122.187 0.994 . . . . 0.0 110.915 -172.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 43.0 t -100.05 106.79 18.58 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.22 159.27 53.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.412 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 45.7 m -53.46 -22.1 7.33 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 123.575 0.75 . . . . 0.0 112.072 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.1 m-20 -83.9 11.6 7.44 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.773 0.797 . . . . 0.0 110.521 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.55 -27.34 5.29 Favored Glycine 0 CA--C 1.479 -2.185 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.571 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 28' ' ' ASP . 25.8 mt-30 -73.84 129.89 38.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 56' ' ' LYS . 84.6 m -107.8 134.7 50.38 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 112.575 -2.102 . . . . 0.0 112.208 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 11.3 m-85 -132.01 165.73 23.31 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.711 169.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.87 97.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.991 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.4 p30 -141.78 177.49 8.14 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 117.783 0.791 . . . . 0.0 109.408 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 32.8 ttpt -66.25 -39.33 89.43 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-O 121.432 0.634 . . . . 0.0 112.498 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -60.57 -38.22 83.88 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.283 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' ASN . . . -59.44 -40.82 88.01 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.567 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 11.4 t80 -102.65 -2.06 29.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 43' ' ' VAL . 10.6 t -58.42 -40.95 83.88 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 123.536 0.735 . . . . 0.0 112.156 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -75.48 -26.24 58.03 Favored 'General case' 0 CA--C 1.472 -2.056 0 CA-C-O 123.036 1.398 . . . . 0.0 109.637 -171.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.705 ' N ' ' HG2' ' A' ' 40' ' ' LYS . . . -80.36 -27.24 38.28 Favored 'General case' 1 C--N 1.229 -4.635 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.999 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 39' ' ' CYS . 37.6 mt -67.59 -41.31 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 39' ' ' CYS . 46.4 t -56.05 -39.12 56.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.672 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 68.1 mmtt -84.59 -36.91 21.75 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.255 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.534 ' HB2' HD12 ' A' ' 49' ' ' ILE . 75.7 m -88.77 20.51 3.46 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.26 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.45 63.67 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 118.19 2.036 . . . . 0.0 118.19 166.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.77 0.46 49.85 Favored Glycine 0 C--N 1.283 -2.368 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.563 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 45' ' ' SER . 1.3 mtpm? -55.64 -26.46 44.51 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 123.286 0.634 . . . . 0.0 111.084 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 45' ' ' SER . 1.3 mp -64.99 133.24 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 123.072 1.415 . . . . 0.0 111.633 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -137.94 -176.03 4.29 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 25' ' ' CYS . 16.2 tp -89.73 139.47 30.53 Favored 'General case' 1 N--CA 1.316 -7.138 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 11.7 tptp -99.01 -39.08 8.71 Favored 'General case' 0 N--CA 1.384 -3.735 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.26 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -164.38 136.29 3.62 Favored Pre-proline 0 C--N 1.28 -2.428 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.588 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.24 109.65 2.72 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.54 168.82 21.86 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 31' ' ' THR . 2.3 mmmp? -48.37 154.55 0.6 Allowed 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 118.666 2.839 . . . . 0.0 118.666 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.459 ' C ' ' HZ2' ' A' ' 56' ' ' LYS . 98.5 m . . . . . 0 C--N 1.253 -3.6 0 CA-C-N 108.914 -3.767 . . . . 0.0 102.922 165.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.423 -1.824 0 CA-C-O 121.715 0.769 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.15 92.74 16.12 Favored Pre-proline 0 C--N 1.275 -2.659 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.341 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 72.3 Cg_endo -88.37 124.98 1.75 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.705 1.603 . . . . 0.0 112.839 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.532 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 60.8 m-70 -152.14 128.98 10.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 C-N-CA 125.161 1.384 . . . . 0.0 108.596 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.7 t -96.14 110.53 22.78 Favored 'General case' 0 C--N 1.261 -3.252 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.7 164.48 54.75 Favored Glycine 0 N--CA 1.4 -3.761 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.003 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.7 p -62.42 -8.48 6.17 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 123.264 0.626 . . . . 0.0 110.58 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.96 -23.02 59.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 126.362 1.865 . . . . 0.0 108.578 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -27.4 20.45 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -76.86 141.8 40.47 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.518 HG22 ' CB ' ' A' ' 56' ' ' LYS . 87.7 m -107.09 126.31 52.19 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.699 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.524 ' HB3' ' CE2' ' A' ' 38' ' ' PHE . 29.8 p90 -102.17 134.46 45.39 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.293 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -34.07 67.65 Favored Glycine 0 CA--C 1.503 -0.682 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.926 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -143.7 167.7 21.65 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 172.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -72.61 -33.35 66.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.667 0.746 . . . . 0.0 110.219 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -52.4 -36.16 53.47 Favored 'General case' 0 C--N 1.254 -3.581 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.427 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.95 -49.39 30.49 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 125.408 1.693 . . . . 0.0 111.115 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 32' ' ' TYR 0.407 44.1 p90 -145.58 42.24 1.25 Allowed 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 118.007 -1.477 . . . . 0.0 114.869 174.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.758 ' O ' HG22 ' A' ' 43' ' ' VAL . 37.5 t -60.8 -38.17 84.44 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.538 175.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.625 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.05 -29.3 64.01 Favored 'General case' 0 CA--C 1.458 -2.59 0 CA-C-O 123.201 1.476 . . . . 0.0 107.948 -171.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 38' ' ' PHE . . . -73.06 -29.84 63.26 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.195 178.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 39' ' ' CYS . 17.1 mt -70.83 -41.5 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.598 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 39' ' ' CYS . 25.6 t -60.06 -31.8 48.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.874 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.415 172.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.35 -41.92 75.95 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.986 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 44.5 t -70.2 -44.18 69.2 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.278 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.77 2.91 Favored Glycine 1 N--CA 1.388 -4.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.939 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.37 0.25 89.98 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 45' ' ' SER . 55.9 mttt -65.8 -23.18 66.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 30.3 mt -71.19 128.18 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.537 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m -109.5 -178.56 3.58 Favored 'General case' 0 C--N 1.26 -3.305 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.532 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 29.7 tp -95.51 140.67 30.02 Favored 'General case' 1 N--CA 1.317 -7.075 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 54.3 tttm -99.73 -43.22 6.53 Favored 'General case' 1 N--CA 1.351 -5.399 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.606 172.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 22.8 m170 -139.18 133.83 16.38 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.365 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.5 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 164.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.01 -171.98 19.42 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -169.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.518 ' CB ' HG22 ' A' ' 31' ' ' THR . 14.4 pttp -79.45 173.28 12.74 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 122.042 0.925 . . . . 0.0 111.834 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.284 -2.263 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.598 166.107 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.636 ' O ' ' HD3' ' A' ' 23' ' ' PRO 0.278 14.8 m . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 87.4 m-20 -94.0 91.8 0.65 Allowed Pre-proline 0 C--N 1.269 -2.926 0 C-N-CA 124.357 1.063 . . . . 0.0 111.836 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 21' ' ' SER . 6.2 Cg_exo -78.68 157.36 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.174 1.916 . . . . 0.0 110.999 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -145.34 126.27 14.49 Favored 'General case' 0 CA--C 1.465 -2.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.793 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 44.8 t -103.26 110.86 23.0 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 171.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 163.44 54.68 Favored Glycine 0 N--CA 1.409 -3.157 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 p -64.33 -9.5 18.18 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.518 0.675 . . . . 0.0 110.325 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.23 -29.31 66.1 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 126.2 1.8 . . . . 0.0 109.097 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.26 -23.31 23.2 Favored Glycine 0 N--CA 1.403 -3.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.699 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.56 138.04 46.61 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 56' ' ' LYS . 99.4 m -107.36 128.33 54.37 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.567 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.444 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 38.2 m-85 -124.63 152.06 44.09 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.931 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.91 -38.87 38.83 Favored Glycine 0 C--N 1.31 -0.916 0 O-C-N 125.144 1.527 . . . . 0.0 114.702 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.1 p30 -155.12 -179.87 8.49 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 23.1 tptm -58.44 -46.96 85.48 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.4 m -52.15 -36.22 50.86 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.574 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -63.54 -45.62 89.7 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.703 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' HB2' ' CG ' ' A' ' 32' ' ' TYR . 35.6 t80 -112.73 -2.04 14.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.77 ' O ' HG23 ' A' ' 43' ' ' VAL . 44.7 t -57.05 -46.78 82.18 Favored 'General case' 0 CA--C 1.46 -2.492 0 C-N-CA 124.091 0.956 . . . . 0.0 111.085 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.734 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.99 -33.04 73.59 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.994 1.317 . . . . 0.0 114.213 -172.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.63 -31.88 57.67 Favored 'General case' 1 C--N 1.222 -4.959 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.302 178.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 39' ' ' CYS . 25.3 mt -65.54 -40.91 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 39' ' ' CYS . 22.1 t -57.82 -35.44 51.38 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.042 -2.344 . . . . 0.0 110.922 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 31.3 mmtm -79.08 -33.0 44.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.685 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.8 m -89.94 21.25 3.72 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.594 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.87 82.3 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.73 6.73 85.44 Favored Glycine 0 C--N 1.272 -2.991 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -68.78 -25.81 64.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.217 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.31 133.99 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -120.63 -177.37 3.45 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 25' ' ' CYS . 33.1 tp -88.35 141.03 28.88 Favored 'General case' 1 N--CA 1.321 -6.887 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.793 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 44.5 tttt -86.22 -45.92 10.85 Favored 'General case' 1 N--CA 1.366 -4.627 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.437 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.9 p80 -179.72 154.86 0.72 Allowed Pre-proline 0 C--N 1.31 -1.135 0 O-C-N 124.489 1.118 . . . . 0.0 111.681 174.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.47 149.16 74.45 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.163 1.909 . . . . 0.0 109.848 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.23 161.28 37.14 Favored Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.487 ' HA ' HG23 ' A' ' 31' ' ' THR . 13.6 ptmm? -69.38 155.66 40.09 Favored 'General case' 0 N--CA 1.406 -2.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.125 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.25 -3.728 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.698 178.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.304 2.0 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -70.59 106.77 1.91 Allowed Pre-proline 0 C--N 1.264 -3.129 0 C-N-CA 123.505 0.722 . . . . 0.0 111.796 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.55 142.04 10.22 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.32 2.013 . . . . 0.0 111.851 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 73.2 m80 -150.44 127.4 11.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-O 121.745 0.783 . . . . 0.0 109.695 -172.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -96.22 97.96 9.93 Favored 'General case' 0 C--N 1.245 -3.949 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 28' ' ' ASP . . . -84.16 167.79 43.93 Favored Glycine 0 CA--C 1.461 -3.338 0 C-N-CA 119.149 -1.501 . . . . 0.0 112.213 -167.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -76.51 5.45 7.31 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.207 1.004 . . . . 0.0 108.661 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 26' ' ' GLY . 11.7 t70 -69.53 -14.07 62.67 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 128.339 2.656 . . . . 0.0 106.169 171.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.46 -35.62 4.39 Favored Glycine 0 N--CA 1.403 -3.545 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 28' ' ' ASP . 20.3 mt-30 -91.76 155.4 18.29 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.521 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.5 m -96.93 130.01 44.3 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.048 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 50.7 m-85 -118.44 139.8 50.84 Favored 'General case' 0 N--CA 1.387 -3.617 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.855 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 -30.96 61.73 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.501 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -141.56 176.22 9.06 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.019 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -61.84 -40.22 94.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.573 0.701 . . . . 0.0 111.746 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 48.4 t -57.56 -43.69 84.66 Favored 'General case' 0 C--N 1.254 -3.579 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.492 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -67.95 -41.02 83.11 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.899 -173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE2' HD12 ' A' ' 42' ' ' ILE . 38.3 t80 -85.03 -11.9 54.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.85 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.782 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -61.98 -46.05 90.96 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.554 0.742 . . . . 0.0 111.029 -178.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.778 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.24 -29.1 67.84 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-O 122.435 1.112 . . . . 0.0 112.006 -166.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.778 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -61.18 -41.79 97.42 Favored 'General case' 1 C--N 1.236 -4.348 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.594 178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.515 HD12 ' CE2' ' A' ' 38' ' ' PHE . 42.2 mt -75.93 -54.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.202 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 t -57.74 -33.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 112.716 -2.038 . . . . 0.0 112.953 -174.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -92.39 -31.88 15.16 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 32.4 t -70.5 -38.73 74.35 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.133 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 26.89 2.05 Favored Glycine 1 N--CA 1.379 -5.126 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.856 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.39 -5.1 64.94 Favored Glycine 0 C--N 1.305 -1.152 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 45' ' ' SER . 50.3 mttt -65.21 -27.03 68.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 41' ' ' ALA . 71.5 mt -85.28 141.15 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.416 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -126.17 -178.09 4.19 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.216 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 43.9 tp -98.89 140.9 32.36 Favored 'General case' 1 N--CA 1.328 -6.545 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 31.3 mttp -80.84 -57.55 3.5 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 122.419 1.104 . . . . 0.0 108.202 167.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -145.09 139.69 15.37 Favored Pre-proline 0 C--N 1.294 -1.819 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.587 -168.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.51 110.17 3.0 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.36 171.39 14.5 Favored Glycine 0 C--N 1.289 -2.051 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.521 ' CB ' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -76.13 175.13 9.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 122.748 1.261 . . . . 0.0 113.665 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' C ' ' HZ1' ' A' ' 56' ' ' LYS . 68.8 m . . . . . 0 C--N 1.269 -2.909 0 CA-C-N 112.024 -2.353 . . . . 0.0 104.958 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 17.2 m . . . . . 0 N--CA 1.419 -2.019 0 CA-C-O 122.942 1.354 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 13.4 m120 -111.28 103.28 54.77 Favored Pre-proline 0 C--N 1.258 -3.405 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.501 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.57 136.79 31.68 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.469 1.446 . . . . 0.0 111.125 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 79.2 m-70 -143.88 127.61 17.18 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.924 0.869 . . . . 0.0 109.977 -175.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' HD12 ' A' ' 51' ' ' LEU . 26.1 t -93.7 103.25 15.41 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.26 161.03 45.49 Favored Glycine 0 N--CA 1.41 -3.071 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.888 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.6 p -54.03 -28.38 38.12 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 123.895 0.878 . . . . 0.0 110.398 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.0 t70 -60.85 -46.37 90.84 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.687 1.232 . . . . 0.0 109.085 173.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.35 -16.63 7.09 Favored Glycine 1 CA--C 1.445 -4.294 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.5 mt-30 -72.23 135.57 46.1 Favored 'General case' 0 CA--C 1.455 -2.691 0 CA-C-N 114.002 -1.099 . . . . 0.0 113.704 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.517 HG22 ' HG2' ' A' ' 56' ' ' LYS . 90.0 m -102.34 121.38 42.18 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.873 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HD2' ' O ' ' A' ' 34' ' ' ASN . 5.3 p90 -111.64 135.48 52.18 Favored 'General case' 1 N--CA 1.377 -4.082 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.447 177.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.08 -39.95 92.84 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.386 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 28.9 p30 -140.55 170.22 16.19 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.59 -36.33 80.68 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.542 0.687 . . . . 0.0 112.397 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -33.57 75.07 Favored 'General case' 0 C--N 1.246 -3.897 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.891 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.542 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -50.58 -43.54 56.5 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.35 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 48.4 t80 -118.37 -1.75 11.22 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.301 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.724 ' O ' HG23 ' A' ' 43' ' ' VAL . 52.1 t -52.17 -50.94 60.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.81 1.244 . . . . 0.0 111.644 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -66.6 -26.19 66.97 Favored 'General case' 0 N--CA 1.408 -2.532 0 C-N-CA 124.942 1.297 . . . . 0.0 114.001 -175.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -84.12 -27.19 28.35 Favored 'General case' 1 C--N 1.218 -5.115 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.732 176.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 39' ' ' CYS . 28.2 mt -66.03 -41.16 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.789 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.1 t -53.21 -44.18 51.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.4 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 42.4 mmtm -69.87 -34.84 74.12 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.733 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.7 m -81.76 -9.07 59.73 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.512 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.11 -19.5 5.44 Favored Glycine 1 N--CA 1.396 -4.024 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 97.56 -0.42 59.66 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -173.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -61.68 -32.31 72.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.165 -1.018 . . . . 0.0 112.898 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' HB ' HG12 ' A' ' 42' ' ' ILE . 3.4 mp -70.61 136.81 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 122.017 0.913 . . . . 0.0 109.724 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -131.07 -178.55 4.88 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 37.9 tp -96.8 141.52 29.92 Favored 'General case' 1 N--CA 1.326 -6.67 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 42.5 mttp -89.95 -58.35 2.54 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 122.468 1.128 . . . . 0.0 109.169 165.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -138.01 143.99 41.89 Favored Pre-proline 0 C--N 1.28 -2.426 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.655 -165.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.67 109.91 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 165.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.48 165.47 12.32 Favored Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 31' ' ' THR . 12.8 mtpp -56.59 161.96 2.47 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.283 -2.308 0 CA-C-N 109.585 -3.461 . . . . 0.0 102.553 159.259 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 122.289 1.042 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.82 97.05 36.15 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.993 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 58.5 Cg_endo -74.65 123.93 8.42 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.618 0.878 . . . . 0.0 110.191 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.552 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 49.6 p-80 -153.06 138.29 17.44 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 46.0 t -108.69 109.77 21.02 Favored 'General case' 0 C--N 1.249 -3.761 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.17 162.91 52.86 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 19.9 m -54.91 -18.83 5.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.721 0.808 . . . . 0.0 111.64 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.3 t70 -64.92 -30.59 71.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.494 1.14 . . . . 0.0 109.081 174.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.01 -16.6 35.94 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.1 mt-30 -73.24 136.03 44.58 Favored 'General case' 0 CA--C 1.465 -2.327 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.482 HG22 ' CB ' ' A' ' 56' ' ' LYS . 99.0 m -111.13 130.21 55.69 Favored 'General case' 0 C--N 1.263 -3.189 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.101 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 54.2 m-85 -135.25 156.83 48.3 Favored 'General case' 0 N--CA 1.396 -3.143 0 CA-C-O 122.136 0.97 . . . . 0.0 112.251 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.16 -20.98 78.4 Favored Glycine 0 C--N 1.287 -2.176 0 CA-C-N 112.669 -2.06 . . . . 0.0 114.796 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 p30 -162.95 172.16 15.49 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 118.342 1.071 . . . . 0.0 108.787 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -63.86 -38.82 92.51 Favored 'General case' 0 C--O 1.197 -1.692 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -53.05 -43.93 67.03 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.931 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -63.7 -40.78 97.63 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.945 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 30' ' ' GLN . 44.6 t80 -104.03 5.2 35.19 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.807 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.3 t -61.43 -41.01 96.51 Favored 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 122.362 0.265 . . . . 0.0 110.361 -171.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -63.86 -30.01 71.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 125.618 1.567 . . . . 0.0 114.181 -174.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.55 -36.12 65.59 Favored 'General case' 1 C--N 1.209 -5.515 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.67 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 39' ' ' CYS . 40.3 mt -72.56 -44.44 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.954 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 39' ' ' CYS . 48.9 t -51.9 -50.97 31.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -66.93 -37.72 84.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.263 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m -87.06 13.25 9.63 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.865 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.85 79.99 Favored Glycine 0 N--CA 1.401 -3.636 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.05 2.72 87.52 Favored Glycine 0 C--N 1.279 -2.616 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.99 -21.98 62.23 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.1 mt -71.12 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.262 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 m -124.0 -173.45 2.76 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 32.6 tp -88.59 141.14 28.77 Favored 'General case' 1 N--CA 1.329 -6.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 52.0 tttm -99.88 -42.23 6.89 Favored 'General case' 1 N--CA 1.361 -4.882 0 C-N-CA 124.585 1.154 . . . . 0.0 111.152 174.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 28.3 m170 -138.26 132.65 16.87 Favored Pre-proline 0 C--N 1.284 -2.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.669 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.05 109.49 2.89 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 N-CA-C 105.067 -2.705 . . . . 0.0 105.067 163.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 107.58 176.52 22.48 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -169.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.482 ' CB ' HG22 ' A' ' 31' ' ' THR . 13.2 ptmm? -70.29 169.24 14.2 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.449 1.119 . . . . 0.0 113.322 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.479 ' C ' ' HZ2' ' A' ' 56' ' ' LYS . 27.4 m . . . . . 0 C--N 1.286 -2.174 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.672 166.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.424 -1.743 0 CA-C-O 122.907 1.336 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 49.4 t-20 -111.16 95.65 26.42 Favored Pre-proline 0 C--N 1.25 -3.75 0 CA-C-N 112.073 -2.331 . . . . 0.0 106.577 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.08 150.06 59.53 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.581 1.521 . . . . 0.0 111.434 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.531 ' O ' ' HA ' ' A' ' 31' ' ' THR . 18.9 m80 -138.94 122.52 17.38 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.46 ' O ' HD13 ' A' ' 51' ' ' LEU . 50.2 t -98.0 100.35 11.68 Favored 'General case' 0 C--N 1.254 -3.554 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.72 166.81 54.66 Favored Glycine 0 N--CA 1.407 -3.242 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.993 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' CG ' ' A' ' 52' ' ' LYS . 66.5 m -65.86 -6.52 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.796 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 30' ' ' GLN . 15.0 t70 -81.82 -7.97 59.65 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.908 1.283 . . . . 0.0 108.424 175.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.95 -27.15 10.51 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 28' ' ' ASP . 46.9 mt-30 -73.79 136.2 43.56 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 98.3 m -106.33 128.95 54.38 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.228 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -123.66 147.05 47.76 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.575 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.56 -38.63 82.05 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.834 1.334 . . . . 0.0 115.289 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.8 p30 -143.67 174.77 10.5 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -67.9 -31.43 71.2 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.613 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -38.98 90.1 Favored 'General case' 0 C--N 1.25 -3.723 0 CA-C-O 122.905 1.336 . . . . 0.0 110.074 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -70.79 -32.47 69.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 112.609 -2.087 . . . . 0.0 108.659 177.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.623 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 30.3 t80 -85.11 -10.61 56.62 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.482 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.765 ' O ' HG23 ' A' ' 43' ' ' VAL . 31.2 m -58.84 -52.43 65.76 Favored 'General case' 0 C--O 1.188 -2.164 0 O-C-N 121.366 -0.834 . . . . 0.0 112.765 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.614 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -65.39 -32.41 74.03 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 123.339 1.542 . . . . 0.0 111.27 -177.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.659 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -66.49 -26.49 67.2 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.465 176.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.662 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 33.3 mt -81.47 -44.24 20.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.252 1.501 . . . . 0.0 108.344 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 39' ' ' CYS . 96.0 t -54.31 -36.69 34.36 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.976 0 CA-C-N 111.495 -2.593 . . . . 0.0 112.21 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.1 ptmm? -56.96 -26.09 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.551 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 49' ' ' ILE . 17.6 m -134.26 57.47 1.81 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 122.185 0.993 . . . . 0.0 112.463 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.32 -0.17 69.48 Favored Glycine 0 N--CA 1.41 -3.064 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 168.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.662 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 80.6 -0.94 84.58 Favored Glycine 0 N--CA 1.411 -3.018 0 C-N-CA 120.285 -0.959 . . . . 0.0 111.917 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.1 -14.94 58.12 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 45' ' ' SER . 68.2 mt -62.22 149.92 8.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.636 0.732 . . . . 0.0 110.423 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -125.74 178.4 5.72 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 25' ' ' CYS . 29.8 tp -94.43 141.87 28.08 Favored 'General case' 1 N--CA 1.336 -6.155 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 178.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.32 -51.62 5.47 Favored 'General case' 0 CA--C 1.453 -2.763 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.609 166.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -149.21 132.34 8.24 Favored Pre-proline 0 C--N 1.258 -3.407 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.39 109.83 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 N-CA-C 107.211 -1.88 . . . . 0.0 107.211 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.75 165.12 12.87 Favored Glycine 0 C--N 1.279 -2.622 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.0 mtpm? -60.1 164.41 4.08 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 C--N 1.269 -2.903 0 N-CA-C 102.082 -3.303 . . . . 0.0 102.082 158.763 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.218 -0.557 0 CA-C-O 122.168 0.985 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.7 m-20 -62.28 112.8 7.06 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.34 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.01 148.11 34.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.558 2.172 . . . . 0.0 112.007 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 94.1 m-70 -152.06 128.07 10.37 Favored 'General case' 0 CA--C 1.476 -1.876 0 CA-C-O 121.964 0.887 . . . . 0.0 110.901 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 42.2 t -94.42 98.79 11.12 Favored 'General case' 0 C--N 1.256 -3.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 170.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.89 166.3 44.66 Favored Glycine 0 CA--C 1.463 -3.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.417 -168.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -77.36 4.75 10.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.01 -18.11 65.22 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 127.515 2.326 . . . . 0.0 106.539 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.42 -35.3 5.15 Favored Glycine 1 N--CA 1.391 -4.363 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 75.1 mt-30 -91.6 156.28 17.74 Favored 'General case' 0 CA--C 1.457 -2.602 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 56' ' ' LYS . 95.3 m -96.21 124.63 40.28 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 112.847 -1.979 . . . . 0.0 108.106 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 30' ' ' GLN . 93.6 m-85 -110.98 145.2 38.85 Favored 'General case' 0 N--CA 1.381 -3.887 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.564 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.22 85.66 Favored Glycine 0 C--N 1.3 -1.42 0 O-C-N 125.114 1.509 . . . . 0.0 112.522 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.4 p-10 -156.47 173.35 17.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.187 0.518 . . . . 0.0 111.097 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -28.38 66.48 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 125.71 1.604 . . . . 0.0 110.558 -176.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 0.7 OUTLIER -57.0 -49.23 76.42 Favored 'General case' 1 C--N 1.241 -4.116 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.476 175.172 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.7 -35.18 58.03 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.811 -175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.454 ' CZ ' HD12 ' A' ' 42' ' ' ILE . 29.2 t80 -86.76 -24.61 25.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.775 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.7 t -67.56 -28.5 67.84 Favored 'General case' 0 C--O 1.188 -2.137 0 CA-C-N 119.55 1.068 . . . . 0.0 110.686 -172.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.796 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.83 -31.8 73.2 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.817 1.294 . . . . 0.0 111.468 -170.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.796 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -64.59 -40.23 95.15 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 111.569 -2.559 . . . . 0.0 108.648 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 39' ' ' CYS . 46.3 mt -73.31 -46.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.822 -175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 39' ' ' CYS . 26.4 t -56.6 -35.18 44.06 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.655 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.9 mmpm? -84.53 -35.91 22.53 Favored 'General case' 0 C--N 1.281 -2.382 0 O-C-N 121.692 -0.63 . . . . 0.0 112.59 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.41 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.9 t -74.92 -23.49 58.35 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.843 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.89 7.96 Favored Glycine 0 N--CA 1.401 -3.661 0 C-N-CA 121.073 -0.585 . . . . 0.0 113.383 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 -8.49 79.71 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.0 mtpm? -65.92 -28.26 68.8 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 41' ' ' ALA . 74.3 mt -82.93 147.94 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.911 173.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.1 m -137.99 179.98 6.11 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 46.6 tp -88.92 141.46 28.47 Favored 'General case' 1 N--CA 1.339 -6.002 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.404 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 31.2 mttp -81.1 -59.22 2.73 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.105 166.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -143.59 142.05 20.16 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.784 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.08 110.34 2.87 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.861 1.708 . . . . 0.0 107.983 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.71 175.3 17.6 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 31' ' ' THR . 8.6 mtpm? -64.3 162.04 15.58 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--N 1.267 -2.997 1 N-CA-C 99.58 -4.23 . . . . 0.0 99.58 158.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.602 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 t . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.2 m120 -106.61 92.92 7.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 C-N-CA 117.904 -1.519 . . . . 0.0 114.29 -173.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 21' ' ' SER . 4.0 Cg_endo -83.19 153.6 14.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.126 1.884 . . . . 0.0 110.53 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -150.63 128.41 11.66 Favored 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.3 t -99.46 95.77 7.23 Favored 'General case' 1 C--N 1.242 -4.069 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 168.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.563 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -84.8 165.17 39.89 Favored Glycine 0 CA--C 1.451 -3.909 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.863 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 49' ' ' ILE . 41.4 m -67.93 4.85 1.03 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 117.912 0.856 . . . . 0.0 111.441 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.2 -24.35 66.26 Favored 'General case' 0 C--N 1.364 1.225 0 C-N-CA 127.189 2.196 . . . . 0.0 105.757 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.11 -31.04 8.99 Favored Glycine 0 N--CA 1.396 -3.98 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.236 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.04 155.99 19.13 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.565 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 97.6 m -97.72 124.32 42.01 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.239 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.511 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 60.1 m-85 -117.58 142.51 47.12 Favored 'General case' 0 N--CA 1.383 -3.789 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.435 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -36.19 82.24 Favored Glycine 0 C--N 1.309 -0.97 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.199 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.706 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.3 p30 -145.72 -178.29 6.02 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 117.258 0.529 . . . . 0.0 109.602 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -67.59 -37.35 82.44 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.121 0.486 . . . . 0.0 112.175 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.79 -38.39 87.89 Favored 'General case' 0 C--N 1.25 -3.728 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.702 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -63.04 -37.44 87.19 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.141 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.563 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 13.5 t80 -94.55 -8.75 37.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.832 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG23 ' A' ' 43' ' ' VAL . 16.1 t -62.51 -37.59 86.64 Favored 'General case' 0 CA--C 1.472 -2.024 0 C-N-CA 123.088 0.555 . . . . 0.0 110.455 -171.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.714 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -65.27 -33.39 75.86 Favored 'General case' 0 CA--C 1.454 -2.723 0 C-N-CA 124.362 1.065 . . . . 0.0 113.103 -172.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.714 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.33 -34.85 59.0 Favored 'General case' 1 C--N 1.218 -5.114 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.815 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.2 mt -63.04 -43.42 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.444 -3.127 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' CYS . 41.2 t -55.03 -41.9 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.641 0 CA-C-N 111.518 -2.583 . . . . 0.0 111.053 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 24.7 mmtm -65.21 -37.69 88.11 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HG13 ' A' ' 49' ' ' ILE . 24.7 m -104.08 28.59 6.62 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.984 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 20.61 59.1 Favored Glycine 0 N--CA 1.4 -3.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 77.64 0.55 74.08 Favored Glycine 0 C--N 1.275 -2.847 0 CA-C-N 117.896 0.848 . . . . 0.0 111.226 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -80.4 -21.4 42.3 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 41' ' ' ALA . 75.1 mt -62.98 152.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 121.053 0.454 . . . . 0.0 110.271 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -127.68 -176.28 3.72 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 25' ' ' CYS . 37.5 tp -97.0 140.75 31.05 Favored 'General case' 1 N--CA 1.332 -6.365 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.469 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 36.1 mtpt -81.63 -50.2 9.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 121.965 0.888 . . . . 0.0 108.611 170.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -154.89 133.17 6.87 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.057 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.13 110.7 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.264 1.976 . . . . 0.0 108.481 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.27 -170.25 13.28 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.565 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.0 ptmm? -80.49 166.8 20.86 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.769 0.795 . . . . 0.0 112.415 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.5 ' C ' ' HZ2' ' A' ' 56' ' ' LYS . 53.4 m . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 165.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.5 0.667 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 18.6 t-20 -70.95 110.61 7.54 Favored Pre-proline 0 C--N 1.271 -2.843 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.8 Cg_exo -71.44 159.62 50.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.578 2.185 . . . . 0.0 112.459 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -151.75 130.64 12.5 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 123.289 0.636 . . . . 0.0 109.698 -172.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.456 ' O ' HD11 ' A' ' 51' ' ' LEU . 50.4 t -108.43 104.37 13.7 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.618 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -69.63 169.25 45.04 Favored Glycine 0 N--CA 1.414 -2.793 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.268 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -65.21 -19.39 65.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.554 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.7 t70 -61.26 -36.86 81.15 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 125.272 1.429 . . . . 0.0 108.953 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.73 -18.66 14.76 Favored Glycine 0 N--CA 1.398 -3.887 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.554 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.1 mt-30 -71.66 135.3 46.82 Favored 'General case' 0 CA--C 1.452 -2.822 0 CA-C-O 122.375 1.083 . . . . 0.0 113.795 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.4 m -117.86 133.17 56.2 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.019 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 66.4 m-85 -131.26 162.33 30.27 Favored 'General case' 0 N--CA 1.38 -3.928 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.398 172.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 -25.11 63.62 Favored Glycine 0 C--N 1.294 -1.773 0 CA-C-N 113.386 -1.733 . . . . 0.0 113.362 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.7 p30 -158.99 168.21 27.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.07 -35.62 73.67 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.647 0.737 . . . . 0.0 111.571 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -50.07 -52.67 32.67 Favored 'General case' 0 C--N 1.256 -3.499 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.335 174.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -66.33 -33.74 76.41 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.258 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CZ ' ' HA3' ' A' ' 26' ' ' GLY . 48.2 t80 -95.0 -2.11 51.04 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.127 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.825 ' O ' HG22 ' A' ' 43' ' ' VAL . 14.5 p -61.38 -43.85 98.16 Favored 'General case' 0 CA--C 1.439 -3.296 0 O-C-N 121.908 -0.495 . . . . 0.0 111.149 -172.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -57.26 -35.57 69.9 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 126.152 1.781 . . . . 0.0 114.496 -172.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -68.59 -39.49 80.9 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.665 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 39' ' ' CYS . 34.9 mt -69.19 -48.12 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.001 -177.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 39' ' ' CYS . 37.1 t -50.75 -50.63 22.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 112.009 -2.359 . . . . 0.0 111.832 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -78.73 -32.59 46.82 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.87 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.509 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 16.3 m -80.55 4.21 19.2 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.017 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' HZ1' ' A' ' 48' ' ' LYS . . . 90.45 19.05 46.7 Favored Glycine 1 N--CA 1.385 -4.706 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 171.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 -0.47 62.63 Favored Glycine 0 C--N 1.29 -2.012 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 45' ' ' SER . 38.7 mttp -71.77 -19.39 62.02 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -79.83 140.99 15.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.645 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 m -121.08 -179.71 4.12 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 25' ' ' CYS . 35.9 tp -90.16 141.06 29.07 Favored 'General case' 1 N--CA 1.324 -6.765 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.648 ' HD2' ' SG ' ' A' ' 57' ' ' CYS . 2.2 ttmp? -90.02 -54.59 3.97 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.842 170.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -139.38 137.16 18.55 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.083 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.62 109.83 2.93 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 N-CA-C 105.796 -2.424 . . . . 0.0 105.796 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.84 -177.22 16.96 Favored Glycine 0 C--N 1.284 -2.341 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -169.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.2 pttp -79.21 173.35 12.67 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-O 121.901 0.857 . . . . 0.0 111.327 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.648 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 24.8 m . . . . . 0 C--N 1.281 -2.409 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 165.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' A' ' 34' ' ' ASN . 27.3 m . . . . . 0 N--CA 1.414 -2.257 0 CA-C-O 122.12 0.962 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -110.75 100.44 45.88 Favored Pre-proline 0 C--N 1.276 -2.625 0 CA-C-N 113.161 -1.836 . . . . 0.0 109.554 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.59 125.19 8.77 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.426 2.084 . . . . 0.0 111.267 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -151.53 129.32 11.62 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 125.236 1.415 . . . . 0.0 108.845 -174.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.496 ' O ' HD12 ' A' ' 51' ' ' LEU . 42.2 t -92.61 106.73 18.66 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 160.35 53.54 Favored Glycine 0 N--CA 1.401 -3.657 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.349 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' CG ' ' A' ' 52' ' ' LYS . 50.3 m -64.61 -7.37 10.23 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.854 0.835 . . . . 0.0 110.468 173.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 30' ' ' GLN . 25.3 t70 -81.36 -10.48 59.53 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.763 2.025 . . . . 0.0 108.374 176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.49 -31.6 6.32 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 28' ' ' ASP 0.266 26.1 mt-30 -74.72 130.08 38.85 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -177.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 56' ' ' LYS . 89.9 m -98.81 126.04 44.35 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.695 -2.048 . . . . 0.0 110.092 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HB2' ' HB1' ' A' ' 37' ' ' ALA . 30.1 p90 -106.99 133.03 52.24 Favored 'General case' 0 N--CA 1.39 -3.45 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.745 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.75 -42.51 61.55 Favored Glycine 0 CA--C 1.499 -0.912 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.807 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' CB ' ' HA ' ' A' ' 21' ' ' SER . 32.6 p30 -128.72 168.78 15.34 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 173.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -71.58 -35.47 70.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.733 0.777 . . . . 0.0 110.141 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -48.26 -44.9 33.85 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.755 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 32' ' ' TYR . . . -50.76 -42.99 58.21 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.431 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.539 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 8.8 t80 -127.53 -1.36 6.18 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 117.492 -1.683 . . . . 0.0 114.186 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.719 ' O ' HG22 ' A' ' 43' ' ' VAL . 31.7 p -51.45 -55.35 19.25 Favored 'General case' 0 C--O 1.194 -1.861 0 C-N-CA 123.471 0.708 . . . . 0.0 111.38 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.548 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -65.12 -24.38 67.4 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 127.045 2.138 . . . . 0.0 114.586 -177.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 38' ' ' PHE . . . -82.04 -28.73 32.32 Favored 'General case' 1 C--N 1.202 -5.816 0 CA-C-N 113.179 -1.828 . . . . 0.0 110.718 173.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 39' ' ' CYS . 22.0 mt -66.99 -43.14 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.78 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 39' ' ' CYS . 46.7 t -50.34 -41.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 110.619 -2.991 . . . . 0.0 110.995 171.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -86.0 -29.46 23.48 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.464 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.472 ' HB3' ' HD3' ' A' ' 48' ' ' LYS . 64.3 m -86.85 12.96 9.77 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.43 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.36 3.48 72.15 Favored Glycine 0 N--CA 1.413 -2.895 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.68 14.12 82.83 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 4.5 pttm -64.74 -25.0 67.74 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-O 121.94 0.876 . . . . 0.0 109.671 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 42' ' ' ILE . 4.1 mp -79.02 131.51 34.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.688 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 p -130.84 -177.82 4.53 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 27.8 tp -95.16 141.48 28.72 Favored 'General case' 1 N--CA 1.343 -5.806 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.608 ' NZ ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.23 -54.95 3.72 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.458 164.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -149.72 135.09 9.79 Favored Pre-proline 0 C--N 1.262 -3.219 0 CA-C-N 113.575 -1.648 . . . . 0.0 112.175 -167.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.8 110.3 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.965 1.776 . . . . 0.0 108.453 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.92 168.74 15.35 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.532 ' HA ' HG21 ' A' ' 31' ' ' THR . 12.3 mtpp -56.03 162.51 1.88 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.413 -2.289 0 CA-C-N 109.435 -3.53 . . . . 0.0 101.817 158.292 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 C--O 1.219 -0.542 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.76 43.0 0.47 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 148.39 51.04 0.02 OUTLIER Glycine 0 CA--C 1.482 -2.013 0 CA-C-O 122.467 1.037 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.654 ' HG2' ' N ' ' A' ' 5' ' ' VAL . 6.8 tt0 -151.4 179.21 8.54 Favored 'General case' 1 N--CA 1.351 -5.386 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.654 ' N ' ' HG2' ' A' ' 4' ' ' GLN . 10.8 p -71.4 47.72 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 CA-C-O 122.655 1.217 . . . . 0.0 108.353 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -65.89 96.55 0.3 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.454 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 80.1 m -49.43 100.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.584 168.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.55 8.48 0.5 Allowed Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.557 1.075 . . . . 0.0 115.651 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.52 ' OE2' ' HB3' ' A' ' 40' ' ' LYS . 39.4 mt-10 -78.03 -45.05 24.73 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.9 t80 42.19 47.09 3.96 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 127.406 2.282 . . . . 0.0 114.871 159.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.502 ' HG3' HG11 ' A' ' 43' ' ' VAL . 88.2 mm-40 -69.35 -12.52 61.73 Favored 'General case' 1 C--N 1.238 -4.268 0 CA-C-O 123.235 1.493 . . . . 0.0 112.185 174.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.517 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 3.4 t70 -143.04 -176.08 4.77 Favored 'General case' 1 N--CA 1.364 -4.771 0 CA-C-N 112.779 -2.009 . . . . 0.0 106.329 177.165 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 t -100.04 -27.51 13.52 Favored 'General case' 0 C--N 1.257 -3.444 0 CA-C-O 121.484 0.659 . . . . 0.0 110.762 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.517 ' HG2' ' OD2' ' A' ' 12' ' ' ASP . 23.8 pttm -84.69 18.6 2.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.913 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 7' ' ' CYS . 3.4 t -92.7 86.11 2.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.445 0.641 . . . . 0.0 109.848 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -133.61 148.74 51.59 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.752 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 9.1 p -115.99 178.77 4.19 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.2 p -96.12 152.26 18.71 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 113.752 -1.567 . . . . 0.0 113.563 -178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -12.6 25.9 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -105.18 174.56 5.82 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.438 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -98.04 89.62 4.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 123.4 1.572 . . . . 0.0 111.046 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 2.7 t-20 -111.06 96.29 29.18 Favored Pre-proline 0 C--N 1.253 -3.629 0 CA-C-N 112.252 -2.249 . . . . 0.0 108.369 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.414 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.3 Cg_exo -68.6 154.96 70.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.914 1.743 . . . . 0.0 112.578 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -148.94 128.26 12.96 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' O ' HD13 ' A' ' 51' ' ' LEU . 34.0 t -104.02 103.46 13.28 Favored 'General case' 0 C--N 1.254 -3.584 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.18 160.24 52.33 Favored Glycine 0 N--CA 1.4 -3.711 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.057 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.2 m -66.93 -4.73 10.21 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 120.701 0.286 . . . . 0.0 110.666 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -7.77 53.03 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.17 1.462 . . . . 0.0 107.749 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.408 ' HA2' ' HZ2' ' A' ' 52' ' ' LYS . . . 102.25 -34.37 5.77 Favored Glycine 0 N--CA 1.397 -3.941 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.321 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.16 155.12 30.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.52 HG22 ' CB ' ' A' ' 56' ' ' LYS . 88.4 m -110.92 131.22 55.23 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.053 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -120.77 138.24 54.11 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.542 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.83 -34.72 65.62 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 114.874 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.8 p30 -147.28 178.26 8.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -74.54 -30.07 61.62 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-O 122.148 0.975 . . . . 0.0 111.217 -174.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.752 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -60.5 -39.13 86.62 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.128 173.898 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.774 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.57 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 27.5 t80 -81.17 -15.65 55.16 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.66 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.704 ' O ' HG23 ' A' ' 43' ' ' VAL . 40.9 m -58.17 -52.77 64.18 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 112.766 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.612 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.79 -25.2 62.77 Favored 'General case' 0 CA--C 1.462 -2.433 0 CA-C-O 123.413 1.578 . . . . 0.0 111.048 -176.498 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.74 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -75.81 -25.8 56.67 Favored 'General case' 1 C--N 1.206 -5.664 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.927 175.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.557 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 20.5 mt -73.16 -41.37 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.049 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 39' ' ' CYS . 84.3 t -57.9 -29.89 36.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 110.85 -2.886 . . . . 0.0 110.516 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.74 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -48.38 -43.63 34.02 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 178.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.428 ' CB ' HD13 ' A' ' 49' ' ' ILE . 5.6 m -134.39 61.67 1.67 Allowed 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 122.169 0.985 . . . . 0.0 111.669 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.5 0.33 89.94 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 118.561 2.184 . . . . 0.0 118.561 167.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.557 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 88.76 -19.31 38.09 Favored Glycine 0 C--N 1.27 -3.123 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.525 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 30.9 mmtm -78.0 -10.65 59.7 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.746 1.219 . . . . 0.0 113.72 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.428 HD13 ' CB ' ' A' ' 45' ' ' SER . 59.2 mt -62.26 148.98 9.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.9 m -125.6 -179.35 4.6 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 25' ' ' CYS . 35.8 tp -99.29 141.36 32.16 Favored 'General case' 1 N--CA 1.331 -6.382 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.169 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.434 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 23.7 mttp -87.02 -55.48 3.81 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.385 1.088 . . . . 0.0 108.839 167.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -131.07 133.2 24.42 Favored Pre-proline 0 C--N 1.288 -2.096 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.637 -166.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.08 109.33 2.81 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 N-CA-C 104.987 -2.736 . . . . 0.0 104.987 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.69 -175.24 15.76 Favored Glycine 0 C--N 1.281 -2.476 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.52 ' CB ' HG22 ' A' ' 31' ' ' THR . 14.6 pttp -80.65 174.35 11.7 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 121.766 0.793 . . . . 0.0 111.138 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 165.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.44 106.2 3.08 Favored Glycine 0 C--O 1.243 0.664 0 N-CA-C 115.65 1.02 . . . . 0.0 115.65 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.94 -94.1 1.95 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 113.791 0.276 . . . . 0.0 113.791 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -73.39 173.64 9.28 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.146 0.578 . . . . 0.0 110.254 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.24 77.86 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 122.554 1.169 . . . . 0.0 108.951 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.516 ' OD2' ' HA ' ' A' ' 18' ' ' THR . 2.4 t70 -128.8 82.38 2.08 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HA ' HG13 ' A' ' 15' ' ' VAL 0.254 17.8 p 36.53 85.67 0.01 OUTLIER 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -175.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.45 -35.47 4.11 Favored Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.4 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' C ' ' H ' ' A' ' 11' ' ' GLN . 3.4 mp0 -79.68 -41.66 26.37 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.487 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 53.1 t80 66.7 -4.96 0.68 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.87 1.668 . . . . 0.0 115.232 169.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.416 ' H ' ' C ' ' A' ' 9' ' ' GLU . 38.4 mt-30 -134.74 -0.51 2.85 Favored 'General case' 0 C--N 1.256 -3.482 0 C-N-CA 124.054 0.942 . . . . 0.0 110.273 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.616 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 11.6 t70 -78.26 -150.74 0.05 OUTLIER 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.625 -175.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.537 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 12.5 t -137.54 -39.27 0.58 Allowed 'General case' 1 C--N 1.217 -5.152 0 O-C-N 121.653 -0.654 . . . . 0.0 111.898 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.436 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 20.1 pttm -79.27 0.12 30.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.919 0.888 . . . . 0.0 110.719 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' CG2' ' HB3' ' A' ' 12' ' ' ASP . 46.4 t -53.56 116.4 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.111 0 C-N-CA 125.307 1.443 . . . . 0.0 113.086 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -75.57 174.19 10.04 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 112.719 -2.037 . . . . 0.0 108.975 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 11.2 p -99.43 179.95 4.41 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.578 ' H ' ' HA ' ' A' ' 36' ' ' CYS . 53.8 p -78.6 175.35 10.46 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 123.077 1.418 . . . . 0.0 114.737 -174.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -85.36 -5.58 59.29 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 110.842 -2.89 . . . . 0.0 109.274 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.43 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 41.3 mt-10 -99.21 141.79 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -108.98 20.24 18.64 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.982 1.372 . . . . 0.0 107.382 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.35 110.65 13.09 Favored Pre-proline 0 C--N 1.263 -3.182 0 CA-C-N 112.112 -2.313 . . . . 0.0 111.408 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 149.84 84.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.682 2.255 . . . . 0.0 111.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.68 131.35 12.32 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.64 0.776 . . . . 0.0 109.546 -172.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.58 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 42.0 t -100.69 108.88 20.86 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.644 ' O ' ' HE3' ' A' ' 52' ' ' LYS . . . -74.41 151.24 43.1 Favored Glycine 1 N--CA 1.395 -4.071 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.695 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 p -59.31 -25.86 64.5 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 124.031 0.932 . . . . 0.0 109.826 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' CB ' HG12 ' A' ' 49' ' ' ILE . 14.6 t70 -74.52 3.42 7.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 126.384 1.874 . . . . 0.0 109.872 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.95 -29.85 8.2 Favored Glycine 0 CA--C 1.468 -2.856 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.956 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' H ' ' C ' ' A' ' 28' ' ' ASP . 49.9 mt-30 -74.19 128.68 36.16 Favored 'General case' 0 CA--C 1.45 -2.867 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -173.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.564 HG23 ' HA ' ' A' ' 56' ' ' LYS . 87.7 m -107.7 132.54 53.23 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.32 -1.764 . . . . 0.0 108.843 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -119.96 143.41 48.03 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.92 -32.21 55.78 Favored Glycine 0 C--O 1.219 -0.792 0 O-C-N 124.671 1.232 . . . . 0.0 113.969 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.556 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 31.0 p30 -155.1 174.64 14.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HA ' ' HB3' ' A' ' 38' ' ' PHE . 18.5 tptm -66.53 -32.92 74.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.141 0.972 . . . . 0.0 111.102 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.578 ' HA ' ' H ' ' A' ' 18' ' ' THR . 3.7 t -50.6 -53.63 29.1 Favored 'General case' 1 C--N 1.236 -4.344 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.861 171.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.28 -40.42 74.34 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.852 -178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' O ' HG13 ' A' ' 42' ' ' ILE . 65.1 t80 -68.02 -46.55 70.9 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.119 -1.4 . . . . 0.0 113.529 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG21 ' A' ' 43' ' ' VAL . 21.9 t -70.17 -36.76 74.91 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.789 -171.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.567 ' C ' ' HD3' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -85.78 -7.81 58.52 Favored 'General case' 0 N--CA 1.392 -3.329 0 CA-C-O 122.102 0.953 . . . . 0.0 110.581 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 38' ' ' PHE . . . -88.07 -28.02 21.6 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.654 -2.066 . . . . 0.0 110.629 171.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.61 HD11 ' HA ' ' A' ' 39' ' ' CYS . 68.8 mt -60.47 -45.42 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.904 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.769 HG21 ' O ' ' A' ' 39' ' ' CYS . 46.8 t -52.7 -32.29 17.17 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 110.491 -3.05 . . . . 0.0 111.013 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.588 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.8 mmpm? -86.45 -42.41 13.63 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.647 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 35.7 t -74.47 -15.98 60.87 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 123.787 0.679 . . . . 0.0 110.894 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.42 18.6 7.03 Favored Glycine 0 N--CA 1.401 -3.647 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.963 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.97 -5.59 61.85 Favored Glycine 0 C--N 1.295 -1.704 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.354 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.647 ' HD3' ' O ' ' A' ' 45' ' ' SER . 3.8 mtpm? -60.49 -25.06 65.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.517 HG12 ' CB ' ' A' ' 28' ' ' ASP . 9.5 mt -85.05 132.71 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.489 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.0 m -128.39 -179.37 4.99 Favored 'General case' 0 C--N 1.267 -3.022 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 170.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.502 HD13 ' O ' ' A' ' 25' ' ' CYS . 27.7 tp -98.66 140.99 32.04 Favored 'General case' 1 N--CA 1.333 -6.314 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.644 ' HE3' ' O ' ' A' ' 26' ' ' GLY . 77.4 mttt -88.05 -56.89 3.14 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 122.55 1.167 . . . . 0.0 107.858 165.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -153.88 140.13 12.63 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.218 -167.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -72.06 110.28 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.085 1.857 . . . . 0.0 108.848 170.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 161.05 11.31 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.564 ' HA ' HG23 ' A' ' 31' ' ' THR . 8.9 mtpm? -57.94 165.65 1.75 Allowed 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 C--N 1.274 -2.715 0 N-CA-C 101.522 -3.51 . . . . 0.0 101.522 159.72 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 117.78 140.87 6.65 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.49 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.38 -69.92 0.26 Allowed Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' ASP . 4.3 pm0 -73.02 -176.25 2.04 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 123.699 0.8 . . . . 0.0 110.193 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 p -70.89 4.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.291 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -72.95 105.33 4.4 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 122.93 1.348 . . . . 0.0 111.704 -171.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 47.2 t -78.04 6.0 8.78 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.907 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.32 -67.68 3.44 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.538 ' CD ' ' HZ1' ' A' ' 44' ' ' LYS . 37.0 mt-10 -94.72 -30.3 14.35 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.505 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HA ' ' HB3' ' A' ' 7' ' ' CYS . 60.3 t80 62.9 84.12 0.15 Allowed 'General case' 0 C--N 1.364 1.236 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.552 ' OE1' ' HA ' ' A' ' 43' ' ' VAL . 6.6 mm100 -54.27 -66.18 0.44 Allowed 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.958 166.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.605 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 21.6 t0 -149.16 173.34 13.53 Favored 'General case' 0 N--CA 1.386 -3.626 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.088 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -65.22 -16.79 63.91 Favored 'General case' 0 C--N 1.257 -3.428 0 C-N-CA 128.111 2.564 . . . . 0.0 113.767 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.605 ' HG2' ' OD2' ' A' ' 12' ' ' ASP . 34.7 mmtm -88.62 -16.87 31.34 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.813 1.292 . . . . 0.0 107.788 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.6 t -103.21 101.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.31 -173.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -136.43 156.38 48.7 Favored 'General case' 0 C--O 1.261 1.658 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.708 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 14.9 p -109.6 178.42 4.44 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.981 0.896 . . . . 0.0 112.637 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 t -135.09 166.53 22.85 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.053 175.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -94.36 -38.26 11.07 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -55.74 139.67 44.36 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 111.309 -2.678 . . . . 0.0 109.999 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 99.25 1.87 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 122.988 1.375 . . . . 0.0 112.811 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.26 94.93 19.77 Favored Pre-proline 0 C--N 1.257 -3.449 0 CA-C-N 112.218 -2.264 . . . . 0.0 107.343 175.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.3 132.35 14.94 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.799 1.666 . . . . 0.0 112.241 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' THR . 80.7 m80 -141.97 127.71 19.23 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.52 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.3 t -102.11 107.58 18.72 Favored 'General case' 0 C--N 1.249 -3.771 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 169.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.533 ' O ' ' HE2' ' A' ' 52' ' ' LYS . . . -71.14 165.26 53.37 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.685 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -51.76 -28.77 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.444 0.698 . . . . 0.0 110.481 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 8.9 t70 -60.5 -37.32 80.74 Favored 'General case' 0 CA--C 1.48 -1.729 0 C-N-CA 126.374 1.87 . . . . 0.0 110.085 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.07 -20.08 14.65 Favored Glycine 0 CA--C 1.459 -3.451 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.479 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 46.1 mt-30 -72.2 131.97 43.47 Favored 'General case' 0 CA--C 1.468 -2.184 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.538 HG21 ' CB ' ' A' ' 56' ' ' LYS . 95.4 m -102.31 131.32 48.98 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.234 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 65.4 m-85 -123.21 143.12 50.24 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.986 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.22 95.75 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.439 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' O ' ' HB2' ' A' ' 37' ' ' ALA . 36.9 p30 -133.15 177.14 7.9 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 117.651 0.726 . . . . 0.0 109.413 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 83.6 tttt -67.97 -35.28 78.1 Favored 'General case' 0 C--O 1.189 -2.128 0 CA-C-O 121.336 0.589 . . . . 0.0 111.35 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.708 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -61.7 -38.57 88.34 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.421 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.453 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -63.09 -39.44 94.72 Favored 'General case' 0 C--N 1.26 -3.32 0 CA-C-N 112.977 -1.919 . . . . 0.0 109.821 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 41' ' ' ALA . 22.6 t80 -88.91 -27.55 20.9 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.153 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.78 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.9 t -57.9 -40.88 81.4 Favored 'General case' 0 CA--C 1.481 -1.71 0 C-N-CA 124.612 1.165 . . . . 0.0 110.938 -173.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.605 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -73.86 -24.08 59.69 Favored 'General case' 0 N--CA 1.409 -2.494 0 CA-C-O 122.853 1.311 . . . . 0.0 110.485 -170.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.605 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -79.7 -29.27 40.69 Favored 'General case' 0 C--N 1.265 -3.078 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.703 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.5 mt -67.08 -42.91 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.78 HG23 ' O ' ' A' ' 39' ' ' CYS . 10.3 t -62.56 -27.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.943 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.538 ' HZ1' ' CD ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -70.33 -39.5 74.69 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.8 -0.562 . . . . 0.0 112.275 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.404 ' HB2' HG13 ' A' ' 49' ' ' ILE . 31.2 m -105.82 22.62 15.28 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.51 14.8 75.29 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 170.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 85.29 0.74 88.45 Favored Glycine 0 C--N 1.274 -2.88 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.553 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 3.0 mmmp? -68.55 -28.71 67.21 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 45' ' ' SER . 40.5 mt -76.69 145.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.004 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -130.24 -175.34 3.6 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 25' ' ' CYS . 31.4 tp -86.18 141.37 29.39 Favored 'General case' 1 N--CA 1.326 -6.663 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.533 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 21.0 ttmm -91.75 -52.15 4.89 Favored 'General case' 0 N--CA 1.38 -3.936 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.514 172.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -145.21 137.27 13.16 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.856 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.04 110.38 3.06 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 107.137 -1.909 . . . . 0.0 107.137 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.79 179.47 17.8 Favored Glycine 0 C--N 1.288 -2.09 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -171.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.538 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.0 pttp -78.73 170.43 16.67 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-O 121.433 0.635 . . . . 0.0 110.617 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.482 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 32.4 m . . . . . 0 C--N 1.273 -2.742 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.86 54.5 14.28 Favored Glycine 0 C--O 1.219 -0.835 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.87 -51.51 0.75 Allowed Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -64.35 125.74 25.58 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.912 -1.144 . . . . 0.0 108.917 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.498 HG21 ' NH2' ' A' ' 19' ' ' ARG . 39.3 t -59.37 -14.9 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 126.218 1.807 . . . . 0.0 114.939 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.09 81.39 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -167.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' CB ' HG13 ' A' ' 15' ' ' VAL . 71.7 m -87.43 79.67 8.35 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 164.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.95 -17.97 59.27 Favored Glycine 0 CA--C 1.496 -1.121 0 CA-C-N 113.447 -1.706 . . . . 0.0 114.147 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -67.17 -47.11 71.96 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.8 t80 45.33 32.75 1.08 Allowed 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 125.201 1.4 . . . . 0.0 113.577 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -58.63 -24.26 60.72 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-O 122.686 1.232 . . . . 0.0 113.924 -177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.544 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 7.5 t70 -131.11 152.8 50.03 Favored 'General case' 2 C--N 1.24 -4.184 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.472 175.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -65.3 -28.82 69.59 Favored 'General case' 0 C--N 1.249 -3.782 0 C-N-CA 125.174 1.39 . . . . 0.0 113.435 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.544 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 7.7 ptpp? -85.73 5.19 33.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.296 0.57 . . . . 0.0 110.869 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.486 HG13 ' CB ' ' A' ' 7' ' ' CYS . 89.8 t -86.37 79.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.684 1.23 . . . . 0.0 113.847 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -138.09 151.66 48.02 Favored 'General case' 0 C--O 1.271 2.237 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.778 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 6.3 p -111.71 176.13 5.15 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.3 p -101.4 174.3 6.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 126.263 1.825 . . . . 0.0 113.763 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.498 ' NH2' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -126.23 -8.07 6.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.161 -1.836 . . . . 0.0 107.663 168.078 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -93.04 148.02 22.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.4 m -86.66 101.11 12.96 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 122.212 1.006 . . . . 0.0 110.651 176.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 27.9 t-20 -111.66 94.33 23.25 Favored Pre-proline 0 C--N 1.268 -2.974 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.085 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.45 123.9 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.105 1.203 . . . . 0.0 109.584 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.592 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 48.7 p-80 -153.63 133.57 13.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' O ' HD12 ' A' ' 51' ' ' LEU . 44.1 t -92.74 114.19 26.68 Favored 'General case' 0 C--N 1.264 -3.143 0 CA-C-N 113.877 -1.51 . . . . 0.0 106.993 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.23 147.53 50.1 Favored Glycine 1 N--CA 1.393 -4.172 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.561 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 p -45.69 -41.27 10.26 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 124.826 1.251 . . . . 0.0 110.757 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.91 3.35 5.39 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.136 0.974 . . . . 0.0 112.81 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.43 54.59 Favored Glycine 0 CA--C 1.46 -3.358 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -73.2 122.77 22.44 Favored 'General case' 0 CA--C 1.45 -2.877 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.595 HG21 ' HA ' ' A' ' 56' ' ' LYS . 94.7 m -116.95 127.7 54.48 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.676 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 31.6 m-85 -134.61 161.11 36.03 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.315 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.51 -31.7 52.2 Favored Glycine 0 C--N 1.298 -1.539 0 CA-C-N 113.182 -1.826 . . . . 0.0 114.563 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.8 p30 -162.7 -175.57 4.51 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 117.467 0.633 . . . . 0.0 109.549 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -68.1 -42.57 80.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.418 0.628 . . . . 0.0 111.862 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.778 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.0 OUTLIER -63.39 -32.6 74.08 Favored 'General case' 0 C--N 1.247 -3.879 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.586 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -53.61 -43.21 68.46 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.681 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.549 ' CD1' ' HB2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -133.1 26.01 4.23 Favored 'General case' 0 C--O 1.195 -1.787 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.864 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.715 ' O ' HG23 ' A' ' 43' ' ' VAL . 49.8 t -54.5 -45.56 73.28 Favored 'General case' 0 C--O 1.202 -1.406 0 C-N-CA 122.924 0.49 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.619 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -69.0 -25.91 64.75 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 125.69 1.596 . . . . 0.0 114.489 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.516 ' HB1' ' O ' ' A' ' 38' ' ' PHE . . . -82.16 -25.93 33.88 Favored 'General case' 1 C--N 1.203 -5.78 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.016 174.023 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.545 HD13 ' HA ' ' A' ' 39' ' ' CYS . 12.8 mt -65.45 -42.54 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 39' ' ' CYS . 80.6 t -49.5 -44.56 18.88 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.354 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.54 -31.05 29.31 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.297 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.457 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.4 m -80.89 8.4 8.38 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.358 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 2.31 58.01 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.99 -6.11 68.21 Favored Glycine 0 C--N 1.29 -2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.457 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.2 mtpm? -61.03 -25.77 67.15 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 124.627 1.171 . . . . 0.0 113.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.442 HD11 ' HA ' ' A' ' 42' ' ' ILE . 14.4 mt -66.42 125.86 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 CA-C-O 123.02 1.39 . . . . 0.0 112.406 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -131.31 -175.33 3.66 Favored 'General case' 0 C--N 1.261 -3.258 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.592 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 35.6 tp -94.98 141.21 28.92 Favored 'General case' 1 N--CA 1.328 -6.556 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.49 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 24.4 mmtm -77.46 -65.44 0.96 Allowed 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 55.6 t-80 -167.5 151.19 6.11 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 112.208 -2.269 . . . . 0.0 108.098 -171.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.61 138.56 80.75 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.136 1.89 . . . . 0.0 110.664 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.52 163.98 29.37 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.595 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.1 mtpm? -63.77 162.84 12.68 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 176.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 98.5 m . . . . . 0 C--N 1.271 -2.824 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 158.428 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.41 -36.34 0.27 Allowed Glycine 0 C--O 1.22 -0.773 0 C-N-CA 119.72 -1.229 . . . . 0.0 113.154 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.63 35.72 3.46 Favored Glycine 0 CA--C 1.487 -1.705 0 CA-C-O 123.256 1.476 . . . . 0.0 109.547 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -121.53 -162.32 0.97 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 111.864 -2.168 . . . . 0.0 105.405 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -73.38 84.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-O 122.503 1.144 . . . . 0.0 108.537 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -93.46 99.59 12.05 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.394 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' CB ' HG11 ' A' ' 15' ' ' VAL . 46.6 m -30.73 119.71 0.19 Allowed 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 126.915 2.086 . . . . 0.0 113.789 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.69 -12.16 81.94 Favored Glycine 0 N--CA 1.424 -2.165 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.018 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -68.81 -49.71 56.23 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.9 t80 49.94 33.28 6.44 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.636 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.506 ' CG ' HG12 ' A' ' 43' ' ' VAL . 16.0 mm100 -46.08 -35.25 4.74 Favored 'General case' 0 C--N 1.272 -2.763 0 C-N-CA 125.256 1.422 . . . . 0.0 114.557 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.621 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 10.6 t70 -141.98 176.48 8.91 Favored 'General case' 2 N--CA 1.372 -4.369 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -88.02 -2.06 58.38 Favored 'General case' 0 C--N 1.244 -3.988 0 C-N-CA 124.793 1.237 . . . . 0.0 112.233 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.621 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 38.3 mmtm -92.61 -8.16 44.98 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG11 ' CB ' ' A' ' 7' ' ' CYS . 21.3 t -85.97 73.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.934 -175.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -137.11 146.0 44.55 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.623 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 16.7 p -110.89 -172.34 2.01 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -174.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.2 p -79.38 173.17 12.85 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 113.402 -1.727 . . . . 0.0 114.686 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' HD3' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -124.7 -11.01 7.29 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 112.918 -1.946 . . . . 0.0 107.381 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -88.33 -172.48 3.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 126.247 1.819 . . . . 0.0 109.794 178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -116.48 23.12 12.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.797 0.808 . . . . 0.0 109.445 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.814 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 5.5 m-20 -56.91 102.51 0.31 Allowed Pre-proline 0 C--N 1.273 -2.74 0 CA-C-N 113.363 -1.744 . . . . 0.0 113.153 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -76.18 151.84 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.846 1.697 . . . . 0.0 111.48 -177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.477 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 88.2 m-70 -148.49 129.05 14.03 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 110.482 -173.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 34.7 t -103.38 101.54 11.45 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 169.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.569 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -77.39 170.08 54.97 Favored Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.251 -171.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.4 ' HA ' ' CG ' ' A' ' 52' ' ' LYS . 31.0 m -68.37 -4.47 14.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.679 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 30' ' ' GLN . 9.9 t70 -78.77 -8.09 58.41 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.668 1.187 . . . . 0.0 107.886 174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.02 -29.53 8.61 Favored Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.857 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.402 ' H ' ' C ' ' A' ' 28' ' ' ASP . 48.9 mt-30 -74.26 145.06 44.33 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.529 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.2 m -108.92 131.6 54.88 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.307 -1.77 . . . . 0.0 109.249 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 95.0 m-85 -129.28 151.34 50.05 Favored 'General case' 0 N--CA 1.398 -3.035 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.257 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.49 -26.09 59.02 Favored Glycine 0 C--O 1.208 -1.508 0 CA-C-N 114.5 -1.227 . . . . 0.0 115.469 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.814 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 7.8 p30 -164.5 173.59 11.89 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.661 0.731 . . . . 0.0 109.277 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -62.44 -32.58 73.46 Favored 'General case' 0 C--O 1.182 -2.448 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.659 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 61.7 m -57.13 -39.94 76.14 Favored 'General case' 0 C--N 1.255 -3.519 0 CA-C-O 122.351 1.072 . . . . 0.0 111.829 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.421 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.16 -38.31 56.82 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.738 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.569 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 21.4 t80 -81.43 -6.09 58.58 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.759 ' O ' HG22 ' A' ' 43' ' ' VAL . 3.0 t -63.89 -41.99 97.57 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.591 -0.693 . . . . 0.0 111.396 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.564 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -71.41 -17.56 62.39 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 125.244 1.418 . . . . 0.0 113.856 -176.749 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.686 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -87.22 -26.7 23.39 Favored 'General case' 1 C--N 1.208 -5.575 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.593 173.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.583 HD11 ' HA ' ' A' ' 39' ' ' CYS . 22.9 mt -72.02 -36.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.759 HG22 ' O ' ' A' ' 39' ' ' CYS . 93.8 t -54.07 -33.13 24.01 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 CA-C-N 110.611 -2.995 . . . . 0.0 111.246 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.686 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 3.0 mmmm -48.11 -43.01 30.56 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.2 m -124.36 29.65 6.28 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.46 26.34 28.06 Favored Glycine 0 N--CA 1.4 -3.721 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.565 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 80.72 -8.87 54.26 Favored Glycine 0 C--N 1.277 -2.738 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.618 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -72.8 -19.89 61.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -69.68 150.76 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.351 0.596 . . . . 0.0 110.989 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -125.46 -176.38 3.58 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.487 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 41.6 tp -97.56 140.94 31.23 Favored 'General case' 1 N--CA 1.329 -6.512 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.487 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 7.2 mtmp? -93.42 -50.71 5.32 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.698 0.761 . . . . 0.0 110.583 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 18.0 m170 -126.34 130.24 23.97 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.907 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.64 109.68 2.8 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 163.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 110.78 -179.23 20.07 Favored Glycine 0 C--N 1.285 -2.267 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -169.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.529 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.0 pttp -78.4 174.07 11.67 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-O 122.188 0.994 . . . . 0.0 111.911 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.28 -2.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.208 165.327 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.509 ' H ' ' CG ' ' A' ' 6' ' ' ASP . 28.2 pt20 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 119.967 -0.063 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.38 -96.39 2.38 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.53 99.46 1.47 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -45.91 36.75 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 120.635 3.569 . . . . 0.0 120.635 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 5' ' ' VAL . 47.7 t -111.1 -20.27 6.37 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.972 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 1' ' ' GLN . 25.1 p-10 -81.85 66.17 7.31 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.718 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 16.8 m 29.56 102.68 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.404 0 C-N-CA 126.638 1.975 . . . . 0.0 115.757 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.43 -23.19 60.0 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.166 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.471 ' HB3' HG11 ' A' ' 43' ' ' VAL . 14.2 mm-40 -68.26 -54.37 18.13 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 124.429 1.092 . . . . 0.0 109.381 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.484 51.2 p90 48.4 84.39 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.457 ' OE1' HG23 ' A' ' 42' ' ' ILE . 12.1 pt20 -62.26 -43.3 99.15 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.205 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -140.85 151.58 44.44 Favored 'General case' 1 N--CA 1.364 -4.728 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.474 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.9 p -51.38 -47.65 62.8 Favored 'General case' 1 C--N 1.239 -4.229 0 C-N-CA 128.667 2.787 . . . . 0.0 116.417 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.535 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -93.05 11.58 27.09 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.584 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 48.4 t -85.78 105.2 14.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.332 0.587 . . . . 0.0 109.666 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 40.2 p90 -111.46 149.84 30.73 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.426 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' HB2' ' N ' ' A' ' 36' ' ' CYS . 25.9 p -96.15 -165.27 1.26 Allowed 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.56 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.557 ' HB ' ' O ' ' A' ' 20' ' ' GLU . 1.1 p -77.76 145.46 36.45 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -95.83 -30.22 13.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.557 ' O ' ' HB ' ' A' ' 18' ' ' THR . 34.6 mp0 -90.88 -166.03 1.49 Allowed 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 111.615 -2.538 . . . . 0.0 107.172 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -128.13 105.41 8.36 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 46.4 t-20 -111.11 105.59 57.11 Favored Pre-proline 0 C--N 1.277 -2.544 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.53 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.08 148.69 63.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.791 1.661 . . . . 0.0 112.183 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 31' ' ' THR . 69.7 m-70 -148.07 130.81 16.01 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.422 ' O ' HD13 ' A' ' 51' ' ' LEU . 43.8 t -106.69 102.6 11.96 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 169.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -68.98 160.16 52.53 Favored Glycine 0 N--CA 1.405 -3.397 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.0 m -60.8 -21.17 62.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -73.36 -16.34 61.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 125.54 1.536 . . . . 0.0 110.894 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.43 ' HA2' ' HZ3' ' A' ' 52' ' ' LYS . . . 108.19 -20.68 30.33 Favored Glycine 1 CA--C 1.448 -4.14 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.456 177.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.92 130.37 40.84 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 96.8 m -115.85 127.86 55.36 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.368 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 60.4 m-85 -132.88 155.28 49.32 Favored 'General case' 0 N--CA 1.388 -3.569 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.624 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.2 -22.86 72.94 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 113.232 -1.804 . . . . 0.0 114.483 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.644 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 33.2 p30 -156.79 169.33 24.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.458 0.629 . . . . 0.0 110.403 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 79.3 tttt -61.24 -33.71 73.95 Favored 'General case' 0 C--O 1.196 -1.724 0 CA-C-O 121.286 0.565 . . . . 0.0 111.922 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.621 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 97.3 m -57.44 -41.17 79.99 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.142 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -77.04 -40.78 45.12 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.157 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.502 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 33.7 t80 -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.963 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.788 ' O ' HG22 ' A' ' 43' ' ' VAL . 52.4 t -59.49 -40.98 88.76 Favored 'General case' 0 C--O 1.192 -1.942 0 C-N-CA 123.224 0.61 . . . . 0.0 111.556 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.579 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.09 -20.84 61.59 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-O 122.732 1.253 . . . . 0.0 112.05 -170.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.579 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -74.22 -39.2 63.25 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 112.793 -2.003 . . . . 0.0 107.847 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.55 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.8 mt -71.15 -49.34 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.087 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.788 HG22 ' O ' ' A' ' 39' ' ' CYS . 59.5 t -50.34 -53.69 11.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.177 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -71.74 -33.95 69.13 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.522 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 m -83.48 0.99 43.94 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.425 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 93.78 14.3 52.9 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 173.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -6.77 58.05 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.431 ' H ' ' C ' ' A' ' 46' ' ' GLY . 2.1 mtpm? -67.21 -16.01 64.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.6 mt -78.77 147.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.27 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.6 m -121.69 176.78 5.54 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 38.9 tp -99.31 141.44 32.09 Favored 'General case' 1 N--CA 1.329 -6.484 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.45 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 34.2 mttp -88.42 -57.14 3.03 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 122.449 1.118 . . . . 0.0 108.81 167.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -130.92 138.96 34.16 Favored Pre-proline 0 C--N 1.285 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 113.282 -165.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.81 109.47 2.61 Favored 'Trans proline' 0 N--CA 1.435 -1.946 0 N-CA-C 104.537 -2.909 . . . . 0.0 104.537 161.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.23 178.33 18.66 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -168.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.523 ' CB ' HG22 ' A' ' 31' ' ' THR . 14.7 pttp -78.05 175.65 9.91 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 122.031 0.92 . . . . 0.0 111.403 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 165.893 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 . . . . . 0 C--O 1.221 -0.433 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.68 87.05 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.415 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.1 -71.98 0.9 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -91.07 130.06 37.01 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.25 60.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.689 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -131.53 91.51 3.02 Favored 'General case' 0 C--N 1.258 -3.404 0 CA-C-N 113.51 -1.677 . . . . 0.0 107.082 166.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' HA ' ' CD1' ' A' ' 10' ' ' PHE 0.386 2.4 p 38.08 -103.04 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.57 -83.76 0.2 Allowed Glycine 0 N--CA 1.437 -1.273 0 O-C-N 124.089 0.868 . . . . 0.0 112.926 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.83 -5.03 56.75 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 125.204 1.402 . . . . 0.0 113.49 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.603 ' C ' ' H ' ' A' ' 12' ' ' ASP . 8.2 m-85 -53.87 -46.11 71.22 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' N ' HG13 ' A' ' 43' ' ' VAL . 54.8 mt-30 62.19 -17.83 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 126.828 2.051 . . . . 0.0 114.007 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 4.8 t70 -75.02 -152.07 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.076 0 C-N-CA 127.696 2.399 . . . . 0.0 111.797 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.473 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 20.4 p -126.47 -12.75 6.12 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 129.957 3.303 . . . . 0.0 111.037 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.633 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -78.9 3.02 18.15 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-O 122.987 1.375 . . . . 0.0 108.587 176.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 7' ' ' CYS . 73.8 t -52.22 107.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.255 -3.524 0 C-N-CA 128.767 2.827 . . . . 0.0 113.438 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -96.57 127.3 42.43 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.29 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.628 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 22.6 p -89.6 -172.52 3.61 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 124.345 1.028 . . . . 0.0 111.098 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.456 ' HB ' ' OE1' ' A' ' 20' ' ' GLU . 63.7 p -77.92 174.97 10.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 122.79 1.281 . . . . 0.0 114.277 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.57 -10.64 16.14 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 112.246 -2.252 . . . . 0.0 109.115 171.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.456 ' OE1' ' HB ' ' A' ' 18' ' ' THR . 2.1 mp0 -63.24 140.62 58.89 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.871 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -107.03 13.11 27.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.826 1.298 . . . . 0.0 108.163 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.8 m-20 -69.36 116.82 46.4 Favored Pre-proline 0 C--N 1.272 -2.777 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.933 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.96 148.46 70.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.838 2.359 . . . . 0.0 112.239 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -152.5 127.12 9.43 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 124.08 0.952 . . . . 0.0 108.757 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 14.0 t -100.05 99.11 9.8 Favored 'General case' 0 C--N 1.254 -3.562 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 28' ' ' ASP . . . -80.14 170.96 54.12 Favored Glycine 0 CA--C 1.46 -3.401 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.372 -168.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 m -73.82 5.17 4.32 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.848 0.833 . . . . 0.0 109.398 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.408 ' H ' ' C ' ' A' ' 26' ' ' GLY . 8.8 t70 -68.69 -19.84 64.39 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.529 2.332 . . . . 0.0 105.839 169.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 -36.04 4.52 Favored Glycine 1 N--CA 1.394 -4.143 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -85.54 155.59 21.12 Favored 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.7 m -96.21 124.75 40.33 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.678 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.447 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 56.8 m-85 -113.21 142.74 45.44 Favored 'General case' 1 N--CA 1.377 -4.121 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.67 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.35 -35.82 80.7 Favored Glycine 0 CA--C 1.49 -1.509 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.691 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.579 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.3 p-10 -149.69 168.71 22.85 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.349 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -59.03 -29.99 67.69 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.513 1.125 . . . . 0.0 111.982 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.628 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -55.53 -50.79 69.06 Favored 'General case' 0 C--N 1.249 -3.788 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.73 174.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 40' ' ' LYS . . . -69.44 -33.95 73.7 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.893 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.5 t80 -83.14 -16.71 45.66 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.588 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.785 ' O ' HG21 ' A' ' 43' ' ' VAL . 42.5 t -68.09 -31.65 71.42 Favored 'General case' 0 CA--C 1.47 -2.126 0 O-C-N 122.034 -0.416 . . . . 0.0 110.373 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.722 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -66.62 -29.52 69.57 Favored 'General case' 0 CA--C 1.454 -2.722 0 CA-C-O 122.33 1.062 . . . . 0.0 112.471 -169.891 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.722 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.0 -35.14 66.78 Favored 'General case' 1 C--N 1.224 -4.886 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.268 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 39' ' ' CYS . 25.4 mt -68.32 -42.13 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.081 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.785 HG21 ' O ' ' A' ' 39' ' ' CYS . 58.6 t -58.56 -33.02 47.29 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.392 0 CA-C-N 111.107 -2.769 . . . . 0.0 111.387 174.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.592 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 7.7 mmpt? -81.11 -37.4 28.98 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.708 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.1 t -84.51 -20.57 31.41 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.667 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 103.87 31.99 4.58 Favored Glycine 0 N--CA 1.4 -3.756 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.32 -179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.81 -13.19 57.36 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' GLY . 2.3 mtpm? -67.36 -24.81 65.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.441 HD13 ' O ' ' A' ' 41' ' ' ALA . 70.0 mt -80.74 146.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.203 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -134.71 -176.62 4.29 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 37.3 tp -93.11 141.13 28.75 Favored 'General case' 1 N--CA 1.34 -5.973 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.457 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 23.0 mtmm -88.77 -49.7 6.67 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.141 168.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -146.1 132.22 9.57 Favored Pre-proline 0 C--N 1.283 -2.311 0 C-N-CA 118.507 -1.277 . . . . 0.0 112.075 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.26 109.91 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.89 1.727 . . . . 0.0 108.33 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.46 -167.46 13.78 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.585 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 12.6 pttp -86.98 169.4 12.47 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-O 121.439 0.638 . . . . 0.0 110.831 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.273 -2.727 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.035 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.594 ' H ' ' NE2' ' A' ' 1' ' ' GLN . 1.5 mp0 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.7 -82.24 1.32 Allowed Glycine 0 CA--C 1.506 -0.493 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.93 121.25 11.65 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -70.47 92.44 0.82 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.91 0.386 . . . . 0.0 111.965 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.57 -1.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.49 68.32 0.06 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -165.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.487 ' HB3' ' CG1' ' A' ' 15' ' ' VAL . 68.7 m -104.3 79.34 1.58 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.187 0.994 . . . . 0.0 108.867 168.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -4.46 90.25 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.553 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -73.8 -48.53 30.78 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.8 t80 50.32 30.93 4.82 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.609 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 122.657 1.218 . . . . 0.0 112.99 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.537 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t0 -129.75 150.31 51.11 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.623 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -74.29 -19.3 60.53 Favored 'General case' 0 C--N 1.247 -3.868 0 C-N-CA 124.899 1.28 . . . . 0.0 112.752 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -86.46 -10.39 54.29 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.779 0.8 . . . . 0.0 109.145 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.571 HG13 ' SG ' ' A' ' 39' ' ' CYS . 78.5 t -75.41 73.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -172.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.46 143.2 37.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 162.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.689 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 16.1 p -109.31 -176.57 3.06 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.141 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 t -134.37 170.44 15.73 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.999 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -99.45 -21.57 15.9 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 113.367 -1.742 . . . . 0.0 107.287 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -69.66 140.2 53.6 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.075 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 p -79.87 100.5 8.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 122.599 1.19 . . . . 0.0 111.829 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.6 m120 -111.01 97.06 32.89 Favored Pre-proline 0 C--N 1.258 -3.396 0 CA-C-N 113.065 -1.879 . . . . 0.0 108.628 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 57.1 Cg_endo -73.91 133.8 18.87 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.047 1.165 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' THR . 62.1 m-70 -141.67 128.34 20.33 Favored 'General case' 0 CA--C 1.464 -2.349 0 CA-C-O 121.491 0.662 . . . . 0.0 109.842 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.581 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.9 t -101.95 108.77 20.33 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 167.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.21 162.8 52.75 Favored Glycine 1 N--CA 1.393 -4.209 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -60.06 -22.17 62.36 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.875 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -81.86 6.17 16.58 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.683 1.23 . . . . 0.0 110.106 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.01 -27.17 9.38 Favored Glycine 0 CA--C 1.467 -2.917 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.564 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.51 145.97 47.14 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.559 HG23 ' CB ' ' A' ' 56' ' ' LYS . 94.2 m -119.18 134.02 55.44 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.569 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 36.3 m-85 -133.62 152.54 51.91 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 121.222 0.534 . . . . 0.0 111.946 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -37.01 93.75 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 113.903 -1.498 . . . . 0.0 115.132 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HB1' ' A' ' 37' ' ' ALA . 31.2 p30 -141.92 175.82 9.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -67.77 -36.87 81.27 Favored 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.348 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.689 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.3 t -62.22 -37.66 86.21 Favored 'General case' 0 C--N 1.252 -3.643 0 CA-C-O 122.422 1.106 . . . . 0.0 110.801 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 34' ' ' ASN . . . -63.41 -36.46 83.81 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.987 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.525 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -92.24 -25.32 18.69 Favored 'General case' 0 C--O 1.195 -1.792 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.706 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.762 ' O ' HG23 ' A' ' 43' ' ' VAL . 12.9 t -51.68 -50.55 60.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.887 1.275 . . . . 0.0 111.68 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.677 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.19 -29.38 67.35 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-O 122.186 0.993 . . . . 0.0 113.626 -176.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' HB1' ' O ' ' A' ' 38' ' ' PHE . . . -78.52 -28.08 46.17 Favored 'General case' 1 C--N 1.224 -4.851 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.546 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 39' ' ' CYS . 35.3 mt -64.43 -43.31 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.614 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.2 t -56.96 -36.84 51.74 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 111.443 -2.617 . . . . 0.0 111.351 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.677 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 38.5 mmtm -82.44 -38.69 23.63 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.144 0.497 . . . . 0.0 112.301 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.461 ' HB3' HD13 ' A' ' 49' ' ' ILE . 9.5 t -81.88 -14.85 55.65 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.367 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.59 0.2 6.23 Favored Glycine 0 N--CA 1.401 -3.663 0 N-CA-C 117.002 1.561 . . . . 0.0 117.002 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.11 84.21 Favored Glycine 0 C--N 1.283 -2.382 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.807 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.293 44.1 mttt -56.89 -36.52 70.23 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 122.029 0.919 . . . . 0.0 109.812 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.5 ' HB ' HG12 ' A' ' 42' ' ' ILE . 1.2 mp -59.69 132.05 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.683 -166.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.2 m -138.22 178.47 7.11 Favored 'General case' 0 C--N 1.26 -3.313 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 171.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 22.0 tp -91.9 140.37 29.74 Favored 'General case' 1 N--CA 1.321 -6.918 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.4 ttmt -96.17 -52.78 3.88 Favored 'General case' 1 N--CA 1.343 -5.777 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.093 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -141.11 139.21 18.84 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.659 -173.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.13 110.13 2.82 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 106.766 -2.052 . . . . 0.0 106.766 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.6 173.77 17.04 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -171.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.559 ' CB ' HG23 ' A' ' 31' ' ' THR . 13.4 pttp -75.93 172.23 13.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 121.665 0.745 . . . . 0.0 110.646 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.421 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 27.9 m . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 166.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.2 -73.05 2.23 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 150.71 19.7 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -83.41 45.72 1.07 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.231 1.015 . . . . 0.0 111.803 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.44 134.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.259 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.564 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 12.9 t70 -129.4 126.2 38.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 16' ' ' TYR . 83.6 m -22.83 -48.03 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.31 1.844 . . . . 0.0 115.029 169.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.31 -79.09 0.01 OUTLIER Glycine 0 N--CA 1.467 0.758 0 O-C-N 124.061 0.85 . . . . 0.0 114.985 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 6.6 tm-20 -70.81 -40.57 72.42 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.731 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 65.3 t80 77.84 5.73 2.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.57 165.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.458 ' HB2' ' OE1' ' A' ' 9' ' ' GLU . 32.8 mt-30 -127.17 -8.34 5.9 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 110.068 171.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -95.55 121.38 37.18 Favored 'General case' 0 N--CA 1.386 -3.655 0 CA-C-O 123.141 1.448 . . . . 0.0 111.59 -176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -43.44 -20.36 0.02 OUTLIER 'General case' 1 C--N 1.237 -4.298 0 C-N-CA 129.861 3.264 . . . . 0.0 116.233 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -93.32 -32.44 14.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.921 0.867 . . . . 0.0 110.998 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.616 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -98.91 93.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.336 -170.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.709 ' HA ' ' SG ' ' A' ' 7' ' ' CYS . 50.4 p90 -138.22 174.12 10.9 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 6' ' ' ASP 0.35 0.3 OUTLIER 65.64 165.79 0.18 Allowed 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.45 -166.163 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 t -147.35 176.02 10.33 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.802 0.811 . . . . 0.0 111.459 -171.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.495 ' H ' ' HD3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -70.12 -19.49 63.23 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.56 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.517 ' CD ' ' HZ3' ' A' ' 35' ' ' LYS . 49.2 mt-10 -81.48 122.82 28.02 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 m -96.78 17.36 16.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.141 1.776 . . . . 0.0 109.756 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.23 111.21 12.72 Favored Pre-proline 0 C--N 1.267 -3.0 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.995 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 39.3 Cg_exo -60.0 143.03 99.61 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 123.775 2.983 . . . . 0.0 112.673 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.5 130.58 11.87 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 123.729 0.811 . . . . 0.0 110.039 -170.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 30.9 t -103.35 105.44 15.71 Favored 'General case' 0 C--N 1.258 -3.396 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.676 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -86.16 177.04 49.03 Favored Glycine 0 CA--C 1.464 -3.144 0 C-N-CA 119.284 -1.436 . . . . 0.0 113.798 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.8 m -76.03 4.08 9.09 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-O 121.827 0.822 . . . . 0.0 109.094 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 30' ' ' GLN . 9.2 t70 -66.59 -18.28 65.28 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.603 2.361 . . . . 0.0 105.746 169.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -32.91 6.46 Favored Glycine 0 N--CA 1.399 -3.793 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.662 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 28' ' ' ASP . 45.7 mt-30 -91.71 156.14 17.79 Favored 'General case' 0 CA--C 1.47 -2.116 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -172.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 56' ' ' LYS . 75.8 m -96.48 128.76 43.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.109 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 91.8 m-85 -116.02 147.88 40.75 Favored 'General case' 0 N--CA 1.38 -3.955 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.7 -27.44 61.52 Favored Glycine 0 C--N 1.299 -1.509 0 O-C-N 124.873 1.358 . . . . 0.0 113.011 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.573 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 27.0 p30 -159.66 171.17 20.07 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HZ3' ' CD ' ' A' ' 20' ' ' GLU . 41.0 ttmt -63.17 -32.78 74.26 Favored 'General case' 0 C--O 1.182 -2.467 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.573 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 2.7 t -49.11 -53.86 18.75 Favored 'General case' 1 C--N 1.242 -4.082 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.572 173.237 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -66.0 -41.9 90.42 Favored 'General case' 0 C--N 1.264 -3.124 0 C-N-CA 125.566 1.547 . . . . 0.0 111.03 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.676 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 19.2 t80 -85.53 -17.41 36.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.822 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.1 t -61.78 -31.09 71.27 Favored 'General case' 0 C--O 1.181 -2.516 0 O-C-N 121.707 -0.621 . . . . 0.0 110.501 -172.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.779 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.7 -32.2 73.77 Favored 'General case' 0 CA--C 1.461 -2.48 0 CA-C-O 122.398 1.094 . . . . 0.0 112.454 -171.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.779 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -66.28 -40.56 90.17 Favored 'General case' 1 C--N 1.234 -4.455 0 CA-C-N 111.971 -2.377 . . . . 0.0 108.014 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.601 HD13 ' CE2' ' A' ' 38' ' ' PHE . 53.5 mt -71.22 -50.63 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.37 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.822 HG23 ' O ' ' A' ' 39' ' ' CYS . 18.3 t -53.85 -52.1 38.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.196 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.84 -30.61 68.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.436 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.5 m -90.44 12.27 19.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.491 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.64 6.03 68.31 Favored Glycine 0 N--CA 1.408 -3.219 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.516 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 93.4 -4.37 73.37 Favored Glycine 1 C--N 1.248 -4.345 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 10.0 mptt -68.48 -29.78 68.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.46 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.7 mt -75.93 149.07 6.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.048 173.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -132.16 -177.48 4.47 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.488 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.8 tp -87.2 140.79 29.19 Favored 'General case' 1 N--CA 1.331 -6.401 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.6 ttmt -85.44 -56.32 3.58 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.299 170.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 63.7 m170 -140.33 136.48 16.86 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.589 -174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.3 110.19 3.06 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 N-CA-C 106.643 -2.099 . . . . 0.0 106.643 167.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 109.4 -173.93 17.57 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.547 ' HA ' HG23 ' A' ' 31' ' ' THR . 9.0 mtpm? -67.05 170.22 7.19 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.5 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 66.3 m . . . . . 0 C--N 1.275 -2.655 0 CA-C-N 109.956 -3.293 . . . . 0.0 103.055 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.67 -24.29 2.88 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.151 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.9 -64.23 0.03 OUTLIER Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.29 -179.51 6.3 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -83.99 72.57 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.184 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.446 ' HB2' ' CD1' ' A' ' 10' ' ' PHE . 9.0 p-10 -87.1 91.46 8.72 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . 0.41 72.0 m -25.76 77.84 0.0 OUTLIER 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 120.746 3.61 . . . . 0.0 120.746 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.9 -76.63 0.01 OUTLIER Glycine 0 C--N 1.36 1.9 0 O-C-N 126.084 2.115 . . . . 0.0 112.136 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.486 ' CD ' ' HZ2' ' A' ' 44' ' ' LYS . 21.7 mt-10 -88.38 -33.71 17.83 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 113.432 -1.384 . . . . 0.0 109.801 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 25.8 t80 49.27 41.51 20.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 123.047 1.403 . . . . 0.0 109.951 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -48.84 -35.62 15.01 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 112.943 -1.935 . . . . 0.0 113.9 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -127.48 157.57 39.72 Favored 'General case' 2 N--CA 1.367 -4.62 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.211 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.9 p -49.06 -52.78 23.53 Favored 'General case' 0 C--N 1.245 -3.975 0 C-N-CA 130.091 3.356 . . . . 0.0 117.033 -173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.37 6.6 48.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 121.218 -0.927 . . . . 0.0 111.0 -170.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.484 HG12 ' SG ' ' A' ' 39' ' ' CYS . 2.7 t -87.56 74.39 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-O 122.017 0.913 . . . . 0.0 113.201 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -127.33 149.65 49.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.704 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 3.3 p -113.97 179.36 3.98 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.644 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -137.35 171.77 13.97 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.567 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -15.58 19.27 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.293 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.55 163.57 27.59 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.5 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -97.0 102.5 14.29 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-O 122.919 1.342 . . . . 0.0 111.972 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.0 m120 -111.14 92.43 15.43 Favored Pre-proline 0 C--N 1.264 -3.141 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.731 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -63.79 125.33 15.21 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.961 1.774 . . . . 0.0 110.445 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.41 ' O ' ' HA ' ' A' ' 31' ' ' THR . 5.2 m-70 -141.7 125.07 16.56 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-O 122.187 0.994 . . . . 0.0 110.915 -172.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.613 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 43.0 t -100.05 106.79 18.58 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.22 159.27 53.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.412 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.437 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 45.7 m -53.46 -22.1 7.33 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 123.575 0.75 . . . . 0.0 112.072 173.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' C ' ' H ' ' A' ' 30' ' ' GLN . 1.1 m-20 -83.9 11.6 7.44 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.773 0.797 . . . . 0.0 110.521 175.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.55 -27.34 5.29 Favored Glycine 0 CA--C 1.479 -2.185 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.571 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.48 ' H ' ' C ' ' A' ' 28' ' ' ASP . 25.8 mt-30 -73.84 129.89 38.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.56 HG22 ' HA ' ' A' ' 56' ' ' LYS . 84.6 m -107.8 134.7 50.38 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 112.575 -2.102 . . . . 0.0 112.208 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.499 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 11.3 m-85 -132.01 165.73 23.31 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.711 169.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.87 97.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.991 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.4 p30 -141.78 177.49 8.14 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 117.783 0.791 . . . . 0.0 109.408 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 32.8 ttpt -66.25 -39.33 89.43 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-O 121.432 0.634 . . . . 0.0 112.498 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.704 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 2.0 t -60.57 -38.22 83.88 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 34' ' ' ASN . . . -59.44 -40.82 88.01 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.567 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.499 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 11.4 t80 -102.65 -2.06 29.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.744 ' O ' HG22 ' A' ' 43' ' ' VAL . 10.6 t -58.42 -40.95 83.88 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 123.536 0.735 . . . . 0.0 112.156 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.705 ' HG2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -75.48 -26.24 58.03 Favored 'General case' 0 CA--C 1.472 -2.056 0 CA-C-O 123.036 1.398 . . . . 0.0 109.637 -171.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.705 ' N ' ' HG2' ' A' ' 40' ' ' LYS . . . -80.36 -27.24 38.28 Favored 'General case' 1 C--N 1.229 -4.635 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.999 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.586 HD12 ' HA ' ' A' ' 39' ' ' CYS . 37.6 mt -67.59 -41.31 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 39' ' ' CYS . 46.4 t -56.05 -39.12 56.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.672 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 68.1 mmtt -84.59 -36.91 21.75 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.255 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.534 ' HB2' HD12 ' A' ' 49' ' ' ILE . 75.7 m -88.77 20.51 3.46 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.26 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.45 63.67 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 118.19 2.036 . . . . 0.0 118.19 166.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.77 0.46 49.85 Favored Glycine 0 C--N 1.283 -2.368 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.563 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.516 ' HD3' ' O ' ' A' ' 45' ' ' SER . 1.3 mtpm? -55.64 -26.46 44.51 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 123.286 0.634 . . . . 0.0 111.084 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 45' ' ' SER . 1.3 mp -64.99 133.24 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 123.072 1.415 . . . . 0.0 111.633 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -137.94 -176.03 4.29 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 25' ' ' CYS . 16.2 tp -89.73 139.47 30.53 Favored 'General case' 1 N--CA 1.316 -7.138 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.433 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 11.7 tptp -99.01 -39.08 8.71 Favored 'General case' 0 N--CA 1.384 -3.735 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.26 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -164.38 136.29 3.62 Favored Pre-proline 0 C--N 1.28 -2.428 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.588 -176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.24 109.65 2.72 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 170.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.54 168.82 21.86 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' HA ' HG22 ' A' ' 31' ' ' THR . 2.3 mmmp? -48.37 154.55 0.6 Allowed 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 118.666 2.839 . . . . 0.0 118.666 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.459 ' C ' ' HZ2' ' A' ' 56' ' ' LYS . 98.5 m . . . . . 0 C--N 1.253 -3.6 0 CA-C-N 108.914 -3.767 . . . . 0.0 102.922 165.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.411 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 14.9 mm-40 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.8 -158.97 53.76 Favored Glycine 0 C--N 1.333 0.381 0 O-C-N 123.947 0.78 . . . . 0.0 113.28 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.37 69.56 3.25 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -86.21 178.34 7.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.074 0.94 . . . . 0.0 112.732 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 17' ' ' CYS . 80.4 t -76.74 157.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.977 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' N ' HG13 ' A' ' 5' ' ' VAL 0.431 26.5 t70 -67.7 74.33 0.18 Allowed 'General case' 0 C--N 1.353 0.726 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 -169.482 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.9 m -120.16 46.47 1.96 Allowed 'General case' 1 C--N 1.242 -4.097 0 CA-C-N 111.918 -2.401 . . . . 0.0 104.524 150.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -16.93 58.73 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 113.625 -1.625 . . . . 0.0 114.263 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.496 ' CD ' ' HZ1' ' A' ' 44' ' ' LYS . 28.0 mt-10 -72.29 -21.3 61.37 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 117.225 0.512 . . . . 0.0 110.672 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 13' ' ' THR . 27.8 t80 63.03 63.92 0.9 Allowed 'General case' 0 C--N 1.352 0.682 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 161.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' HG3' ' N ' ' A' ' 12' ' ' ASP . 3.9 pt20 -53.33 -51.46 62.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.704 1.24 . . . . 0.0 112.728 170.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.417 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 64.5 t0 -132.34 164.19 27.02 Favored 'General case' 2 N--CA 1.375 -4.185 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 6.9 t -71.77 -35.77 70.17 Favored 'General case' 1 C--N 1.243 -4.064 0 C-N-CA 125.997 1.719 . . . . 0.0 114.84 -167.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.494 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.62 8.63 44.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -174.21 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 12' ' ' ASP . 37.4 t -91.83 114.5 29.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 0.0 111.731 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.436 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 43.8 p90 -132.98 150.42 52.16 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.731 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 22.8 p -78.16 168.37 19.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.21 -0.996 . . . . 0.0 113.597 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -79.24 151.46 31.16 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.243 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -111.13 -9.56 14.35 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.195 170.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 30.2 mp0 -94.9 176.19 6.35 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.375 176.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -98.16 110.99 23.48 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.715 0.769 . . . . 0.0 109.154 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -111.15 92.74 16.12 Favored Pre-proline 0 C--N 1.275 -2.659 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.341 -178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.424 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 72.3 Cg_endo -88.37 124.98 1.75 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.705 1.603 . . . . 0.0 112.839 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.532 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 60.8 m-70 -152.14 128.98 10.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 C-N-CA 125.161 1.384 . . . . 0.0 108.596 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.494 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.7 t -96.14 110.53 22.78 Favored 'General case' 0 C--N 1.261 -3.252 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.7 164.48 54.75 Favored Glycine 0 N--CA 1.4 -3.761 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.003 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.7 p -62.42 -8.48 6.17 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 123.264 0.626 . . . . 0.0 110.58 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.96 -23.02 59.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 126.362 1.865 . . . . 0.0 108.578 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -27.4 20.45 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -76.86 141.8 40.47 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.518 HG22 ' CB ' ' A' ' 56' ' ' LYS . 87.7 m -107.09 126.31 52.19 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.699 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.524 ' HB3' ' CE2' ' A' ' 38' ' ' PHE . 29.8 p90 -102.17 134.46 45.39 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.293 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -34.07 67.65 Favored Glycine 0 CA--C 1.503 -0.682 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.926 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 p30 -143.7 167.7 21.65 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 172.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -72.61 -33.35 66.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.667 0.746 . . . . 0.0 110.219 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.731 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 4.6 t -52.4 -36.16 53.47 Favored 'General case' 0 C--N 1.254 -3.581 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.427 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -47.95 -49.39 30.49 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 125.408 1.693 . . . . 0.0 111.115 -179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.524 ' CE2' ' HB3' ' A' ' 32' ' ' TYR 0.407 44.1 p90 -145.58 42.24 1.25 Allowed 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 118.007 -1.477 . . . . 0.0 114.869 174.279 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.758 ' O ' HG22 ' A' ' 43' ' ' VAL . 37.5 t -60.8 -38.17 84.44 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.538 175.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.625 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.05 -29.3 64.01 Favored 'General case' 0 CA--C 1.458 -2.59 0 CA-C-O 123.201 1.476 . . . . 0.0 107.948 -171.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 38' ' ' PHE . . . -73.06 -29.84 63.26 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.195 178.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 39' ' ' CYS . 17.1 mt -70.83 -41.5 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.598 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.758 HG22 ' O ' ' A' ' 39' ' ' CYS . 25.6 t -60.06 -31.8 48.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.874 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.415 172.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 9' ' ' GLU . 0.0 OUTLIER -69.35 -41.92 75.95 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.986 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.465 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 44.5 t -70.2 -44.18 69.2 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.278 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.77 2.91 Favored Glycine 1 N--CA 1.388 -4.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.939 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.37 0.25 89.98 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.465 ' HD2' ' O ' ' A' ' 45' ' ' SER . 55.9 mttt -65.8 -23.18 66.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' A' ' 42' ' ' ILE . 30.3 mt -71.19 128.18 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.537 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m -109.5 -178.56 3.58 Favored 'General case' 0 C--N 1.26 -3.305 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.532 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 29.7 tp -95.51 140.67 30.02 Favored 'General case' 1 N--CA 1.317 -7.075 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 54.3 tttm -99.73 -43.22 6.53 Favored 'General case' 1 N--CA 1.351 -5.399 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.606 172.386 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 22.8 m170 -139.18 133.83 16.38 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.365 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.5 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 164.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 105.01 -171.98 19.42 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -169.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.518 ' CB ' HG22 ' A' ' 31' ' ' THR . 14.4 pttp -79.45 173.28 12.74 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 122.042 0.925 . . . . 0.0 111.834 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.284 -2.263 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.598 166.107 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.87 -150.91 1.36 Allowed Glycine 0 CA--C 1.525 0.657 0 O-C-N 123.82 0.7 . . . . 0.0 114.099 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 100.84 84.12 1.78 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -69.06 102.92 1.74 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.353 1.061 . . . . 0.0 112.152 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.91 134.55 50.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.051 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.595 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.8 t0 -93.43 111.96 23.76 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 172.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 19.7 m -78.64 78.52 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -167.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -113.87 19.92 17.88 Favored Glycine 1 N--CA 1.375 -5.393 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 171.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.51 -53.07 3.56 Favored 'General case' 1 N--CA 1.319 -6.997 0 C-N-CA 122.778 0.431 . . . . 0.0 111.547 -176.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.327 78.9 m-85 -132.8 -24.52 1.93 Allowed 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 120.348 3.462 . . . . 0.0 120.348 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.522 ' HG2' HG21 ' A' ' 43' ' ' VAL . 13.4 mm-40 -58.55 -45.05 89.76 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 124.465 2.078 . . . . 0.0 108.993 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.596 ' OD1' ' HG2' ' A' ' 14' ' ' LYS 0.29 11.9 t70 -177.82 -166.08 0.11 Allowed 'General case' 1 N--CA 1.379 -4.023 1 N-CA-C 99.596 -4.224 . . . . 0.0 99.596 -177.204 . . . . . . . . 5 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 t -99.85 -23.68 14.89 Favored 'General case' 1 C--N 1.242 -4.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.596 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 21.5 pttm -96.68 10.51 38.44 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' A' ' 12' ' ' ASP . 5.5 t -97.56 73.24 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 118.834 -1.146 . . . . 0.0 109.926 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -76.77 173.53 11.56 Favored 'General case' 0 C--O 1.273 2.305 0 CA-C-O 123.063 1.411 . . . . 0.0 113.374 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.605 ' HB2' ' N ' ' A' ' 36' ' ' CYS . 29.7 p -109.43 -172.7 2.1 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.343 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.516 ' H ' ' HB3' ' A' ' 35' ' ' LYS . 2.7 t -134.31 147.92 50.67 Favored 'General case' 0 CA--C 1.443 -3.161 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.617 ' HG2' ' OE2' ' A' ' 20' ' ' GLU . 3.3 ptp180 -124.97 3.73 8.02 Favored 'General case' 1 C--N 1.224 -4.876 0 O-C-N 125.939 2.024 . . . . 0.0 109.924 -167.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.617 ' OE2' ' HG2' ' A' ' 19' ' ' ARG . 1.8 mp0 -82.59 -168.78 2.15 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.413 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.636 ' O ' ' HD3' ' A' ' 23' ' ' PRO 0.278 14.8 m -76.07 31.18 0.12 Allowed 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 125.318 1.447 . . . . 0.0 112.444 -177.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.751 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 87.4 m-20 -94.0 91.8 0.65 Allowed Pre-proline 0 C--N 1.269 -2.926 0 C-N-CA 124.357 1.063 . . . . 0.0 111.836 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.636 ' HD3' ' O ' ' A' ' 21' ' ' SER . 6.2 Cg_exo -78.68 157.36 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.174 1.916 . . . . 0.0 110.999 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -145.34 126.27 14.49 Favored 'General case' 0 CA--C 1.465 -2.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.793 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 44.8 t -103.26 110.86 23.0 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 171.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 163.44 54.68 Favored Glycine 0 N--CA 1.409 -3.157 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 p -64.33 -9.5 18.18 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.518 0.675 . . . . 0.0 110.325 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.23 -29.31 66.1 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 126.2 1.8 . . . . 0.0 109.097 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.26 -23.31 23.2 Favored Glycine 0 N--CA 1.403 -3.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.699 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.56 138.04 46.61 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.487 HG23 ' HA ' ' A' ' 56' ' ' LYS . 99.4 m -107.36 128.33 54.37 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.567 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.444 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 38.2 m-85 -124.63 152.06 44.09 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.931 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.91 -38.87 38.83 Favored Glycine 0 C--N 1.31 -0.916 0 O-C-N 125.144 1.527 . . . . 0.0 114.702 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.751 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.1 p30 -155.12 -179.87 8.49 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HB3' ' H ' ' A' ' 18' ' ' THR . 23.1 tptm -58.44 -46.96 85.48 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.605 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 69.4 m -52.15 -36.22 50.86 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.574 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -63.54 -45.62 89.7 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.703 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' HB2' ' CG ' ' A' ' 32' ' ' TYR . 35.6 t80 -112.73 -2.04 14.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.77 ' O ' HG23 ' A' ' 43' ' ' VAL . 44.7 t -57.05 -46.78 82.18 Favored 'General case' 0 CA--C 1.46 -2.492 0 C-N-CA 124.091 0.956 . . . . 0.0 111.085 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.734 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.99 -33.04 73.59 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.994 1.317 . . . . 0.0 114.213 -172.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.63 -31.88 57.67 Favored 'General case' 1 C--N 1.222 -4.959 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.302 178.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 39' ' ' CYS . 25.3 mt -65.54 -40.91 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.77 HG23 ' O ' ' A' ' 39' ' ' CYS . 22.1 t -57.82 -35.44 51.38 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.042 -2.344 . . . . 0.0 110.922 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.734 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 31.3 mmtm -79.08 -33.0 44.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.685 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.8 m -89.94 21.25 3.72 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.594 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.87 82.3 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.73 6.73 85.44 Favored Glycine 0 C--N 1.272 -2.991 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -68.78 -25.81 64.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.217 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.31 133.99 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -120.63 -177.37 3.45 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 25' ' ' CYS . 33.1 tp -88.35 141.03 28.88 Favored 'General case' 1 N--CA 1.321 -6.887 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.793 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 44.5 tttt -86.22 -45.92 10.85 Favored 'General case' 1 N--CA 1.366 -4.627 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.252 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.437 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.9 p80 -179.72 154.86 0.72 Allowed Pre-proline 0 C--N 1.31 -1.135 0 O-C-N 124.489 1.118 . . . . 0.0 111.681 174.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.47 149.16 74.45 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.163 1.909 . . . . 0.0 109.848 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.23 161.28 37.14 Favored Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.487 ' HA ' HG23 ' A' ' 31' ' ' THR . 13.6 ptmm? -69.38 155.66 40.09 Favored 'General case' 0 N--CA 1.406 -2.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.125 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.25 -3.728 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.698 178.992 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.36 -33.79 72.29 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.78 -119.71 1.32 Allowed Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.29 -175.3 2.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.58 114.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.473 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 22.4 t70 -130.45 124.2 31.52 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 170.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.662 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 6.6 p -49.93 -88.0 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 169.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.16 -83.96 0.02 OUTLIER Glycine 0 C--O 1.207 -1.554 0 CA-C-O 121.787 0.66 . . . . 0.0 112.94 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -99.92 -3.03 33.24 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 126.357 1.863 . . . . 0.0 108.95 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 12' ' ' ASP . 84.6 m-85 -104.25 83.19 2.04 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-O 124.518 2.104 . . . . 0.0 110.362 -173.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.498 ' CA ' HG12 ' A' ' 43' ' ' VAL . 71.8 mm-40 -37.42 -22.19 0.01 OUTLIER 'General case' 1 C--N 1.22 -5.058 2 C-N-CA 134.649 5.18 . . . . 0.0 114.434 172.223 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.426 ' CG ' ' HZ3' ' A' ' 14' ' ' LYS . 14.4 t0 -80.44 122.61 27.2 Favored 'General case' 0 N--CA 1.384 -3.752 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -73.05 -15.14 61.52 Favored 'General case' 1 C--N 1.214 -5.306 0 CA-C-N 112.609 -2.087 . . . . 0.0 113.475 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.426 ' HZ3' ' CG ' ' A' ' 12' ' ' ASP . 22.9 pttm -90.9 5.87 46.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.337 0.589 . . . . 0.0 111.377 176.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.662 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 16.0 t -96.62 123.15 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' ASP . 47.0 p90 -115.09 160.18 19.97 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 19.3 p -74.04 166.44 23.39 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 125.91 2.006 . . . . 0.0 115.238 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 9.7 t -89.49 173.98 8.04 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.242 171.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -15.99 25.28 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.387 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.693 ' O ' ' HB2' ' A' ' 34' ' ' ASN 0.445 18.5 mm-40 -48.1 131.81 15.8 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 118.55 2.796 . . . . 0.0 118.55 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.304 2.0 m -68.89 23.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 131.146 3.778 . . . . 0.0 114.196 -169.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.458 ' H ' ' C ' ' A' ' 20' ' ' GLU . 11.8 m120 -70.59 106.77 1.91 Allowed Pre-proline 0 C--N 1.264 -3.129 0 C-N-CA 123.505 0.722 . . . . 0.0 111.796 -176.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.55 142.04 10.22 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.32 2.013 . . . . 0.0 111.851 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.436 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 73.2 m80 -150.44 127.4 11.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-O 121.745 0.783 . . . . 0.0 109.695 -172.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 51.6 t -96.22 97.96 9.93 Favored 'General case' 0 C--N 1.245 -3.949 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 170.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' C ' ' H ' ' A' ' 28' ' ' ASP . . . -84.16 167.79 43.93 Favored Glycine 0 CA--C 1.461 -3.338 0 C-N-CA 119.149 -1.501 . . . . 0.0 112.213 -167.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -76.51 5.45 7.31 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.207 1.004 . . . . 0.0 108.661 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 26' ' ' GLY . 11.7 t70 -69.53 -14.07 62.67 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 128.339 2.656 . . . . 0.0 106.169 171.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.46 -35.62 4.39 Favored Glycine 0 N--CA 1.403 -3.545 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 28' ' ' ASP . 20.3 mt-30 -91.76 155.4 18.29 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.521 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.5 m -96.93 130.01 44.3 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.048 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 50.7 m-85 -118.44 139.8 50.84 Favored 'General case' 0 N--CA 1.387 -3.617 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.855 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 -30.96 61.73 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.501 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.693 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 12.3 p-10 -141.56 176.22 9.06 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.019 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -61.84 -40.22 94.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.573 0.701 . . . . 0.0 111.746 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.482 ' HA ' ' CB ' ' A' ' 17' ' ' CYS . 48.4 t -57.56 -43.69 84.66 Favored 'General case' 0 C--N 1.254 -3.579 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.492 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -67.95 -41.02 83.11 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.899 -173.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.515 ' CE2' HD12 ' A' ' 42' ' ' ILE . 38.3 t80 -85.03 -11.9 54.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.85 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.782 ' O ' HG22 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -61.98 -46.05 90.96 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.554 0.742 . . . . 0.0 111.029 -178.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.778 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.24 -29.1 67.84 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-O 122.435 1.112 . . . . 0.0 112.006 -166.304 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.778 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -61.18 -41.79 97.42 Favored 'General case' 1 C--N 1.236 -4.348 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.594 178.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.515 HD12 ' CE2' ' A' ' 38' ' ' PHE . 42.2 mt -75.93 -54.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.202 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.782 HG22 ' O ' ' A' ' 39' ' ' CYS . 11.2 t -57.74 -33.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 112.716 -2.038 . . . . 0.0 112.953 -174.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -92.39 -31.88 15.16 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.453 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 32.4 t -70.5 -38.73 74.35 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.133 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 26.89 2.05 Favored Glycine 1 N--CA 1.379 -5.126 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.856 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.39 -5.1 64.94 Favored Glycine 0 C--N 1.305 -1.152 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.453 ' HD2' ' O ' ' A' ' 45' ' ' SER . 50.3 mttt -65.21 -27.03 68.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.574 HD12 ' O ' ' A' ' 41' ' ' ALA . 71.5 mt -85.28 141.15 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.416 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -126.17 -178.09 4.19 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.216 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 43.9 tp -98.89 140.9 32.36 Favored 'General case' 1 N--CA 1.328 -6.545 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 31.3 mttp -80.84 -57.55 3.5 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 122.419 1.104 . . . . 0.0 108.202 167.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -145.09 139.69 15.37 Favored Pre-proline 0 C--N 1.294 -1.819 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.587 -168.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.51 110.17 3.0 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.36 171.39 14.5 Favored Glycine 0 C--N 1.289 -2.051 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.521 ' CB ' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -76.13 175.13 9.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 122.748 1.261 . . . . 0.0 113.665 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' C ' ' HZ1' ' A' ' 56' ' ' LYS . 68.8 m . . . . . 0 C--N 1.269 -2.909 0 CA-C-N 112.024 -2.353 . . . . 0.0 104.958 175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 12.4 mm-40 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.56 81.05 0.23 Allowed Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.85 -68.52 3.52 Favored Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -91.51 169.6 10.63 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.87 136.33 22.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.337 0.589 . . . . 0.0 110.588 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -129.21 133.31 47.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 168.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -73.82 74.73 1.61 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.794 0.807 . . . . 0.0 110.409 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.0 -7.02 65.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.97 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.23 -45.02 82.15 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 172.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.0 t80 46.96 43.73 13.98 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.407 1.483 . . . . 0.0 112.956 166.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -42.72 -46.47 5.12 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.065 176.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.562 ' OD1' ' HD2' ' A' ' 14' ' ' LYS . 7.5 t0 -129.03 149.91 50.65 Favored 'General case' 2 N--CA 1.37 -4.455 0 CA-C-N 111.82 -2.445 . . . . 0.0 106.135 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 p -55.99 -27.59 53.5 Favored 'General case' 1 C--N 1.231 -4.579 0 C-N-CA 127.963 2.505 . . . . 0.0 115.474 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.562 ' HD2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -87.47 -5.75 58.68 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.976 -1.077 . . . . 0.0 109.755 -175.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.83 79.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -167.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -136.84 144.12 43.46 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.683 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 15.5 p -108.07 -179.8 4.0 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.987 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.41 HG21 ' OD1' ' A' ' 22' ' ' ASN . 6.2 t -131.39 169.38 16.11 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.549 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -97.28 -21.61 17.15 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 109.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.02 152.18 25.5 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.461 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.421 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 17.2 m -83.94 97.65 9.36 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.942 1.354 . . . . 0.0 112.42 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 13.4 m120 -111.28 103.28 54.77 Favored Pre-proline 0 C--N 1.258 -3.405 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.501 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.57 136.79 31.68 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.469 1.446 . . . . 0.0 111.125 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.559 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 79.2 m-70 -143.88 127.61 17.18 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.924 0.869 . . . . 0.0 109.977 -175.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' O ' HD12 ' A' ' 51' ' ' LEU . 26.1 t -93.7 103.25 15.41 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 172.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.26 161.03 45.49 Favored Glycine 0 N--CA 1.41 -3.071 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.888 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.6 p -54.03 -28.38 38.12 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 123.895 0.878 . . . . 0.0 110.398 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.0 t70 -60.85 -46.37 90.84 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.687 1.232 . . . . 0.0 109.085 173.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.35 -16.63 7.09 Favored Glycine 1 CA--C 1.445 -4.294 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.587 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.5 mt-30 -72.23 135.57 46.1 Favored 'General case' 0 CA--C 1.455 -2.691 0 CA-C-N 114.002 -1.099 . . . . 0.0 113.704 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.517 HG22 ' HG2' ' A' ' 56' ' ' LYS . 90.0 m -102.34 121.38 42.18 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.873 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.423 ' HD2' ' O ' ' A' ' 34' ' ' ASN . 5.3 p90 -111.64 135.48 52.18 Favored 'General case' 1 N--CA 1.377 -4.082 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.447 177.617 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.08 -39.95 92.84 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.386 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 28.9 p30 -140.55 170.22 16.19 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.59 -36.33 80.68 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.542 0.687 . . . . 0.0 112.397 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.683 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -62.43 -33.57 75.07 Favored 'General case' 0 C--N 1.246 -3.897 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.891 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.542 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -50.58 -43.54 56.5 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.35 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 48.4 t80 -118.37 -1.75 11.22 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.301 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.724 ' O ' HG23 ' A' ' 43' ' ' VAL . 52.1 t -52.17 -50.94 60.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.81 1.244 . . . . 0.0 111.644 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.7 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -66.6 -26.19 66.97 Favored 'General case' 0 N--CA 1.408 -2.532 0 C-N-CA 124.942 1.297 . . . . 0.0 114.001 -175.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -84.12 -27.19 28.35 Favored 'General case' 1 C--N 1.218 -5.115 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.732 176.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.559 HD12 ' HA ' ' A' ' 39' ' ' CYS . 28.2 mt -66.03 -41.16 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.789 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.1 t -53.21 -44.18 51.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.4 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 42.4 mmtm -69.87 -34.84 74.12 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.733 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.7 m -81.76 -9.07 59.73 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.512 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.11 -19.5 5.44 Favored Glycine 1 N--CA 1.396 -4.024 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.425 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 97.56 -0.42 59.66 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -173.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -61.68 -32.31 72.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.165 -1.018 . . . . 0.0 112.898 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' HB ' HG12 ' A' ' 42' ' ' ILE . 3.4 mp -70.61 136.81 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 122.017 0.913 . . . . 0.0 109.724 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -131.07 -178.55 4.88 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.559 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 37.9 tp -96.8 141.52 29.92 Favored 'General case' 1 N--CA 1.326 -6.67 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.488 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 42.5 mttp -89.95 -58.35 2.54 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 122.468 1.128 . . . . 0.0 109.169 165.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -138.01 143.99 41.89 Favored Pre-proline 0 C--N 1.28 -2.426 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.655 -165.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.67 109.91 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 165.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.48 165.47 12.32 Favored Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.517 ' HG2' HG22 ' A' ' 31' ' ' THR . 12.8 mtpp -56.59 161.96 2.47 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.283 -2.308 0 CA-C-N 109.585 -3.461 . . . . 0.0 102.553 159.259 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.506 ' CD ' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.506 ' H ' ' CD ' ' A' ' 1' ' ' GLN . . . -125.64 126.08 5.77 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 119.176 0.898 . . . . 0.0 111.216 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.98 53.61 29.39 Favored Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.537 HE21 ' HB2' ' A' ' 6' ' ' ASP . 3.8 pm0 -137.23 173.33 11.8 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 114.313 -0.943 . . . . 0.0 113.082 -169.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 17' ' ' CYS . 89.5 t -101.3 125.95 55.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 161.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.537 ' HB2' HE21 ' A' ' 4' ' ' GLN 0.251 1.6 t0 -105.18 89.18 3.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 119.244 3.053 . . . . 0.0 119.244 -162.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 m -116.06 40.64 2.77 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 153.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -0.76 63.86 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.036 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.3 -22.03 62.88 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 171.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.0 t80 73.05 76.78 0.14 Allowed 'General case' 0 C--N 1.362 1.148 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 163.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.55 ' OE1' HG11 ' A' ' 15' ' ' VAL . 3.2 pt20 -72.0 -50.51 28.06 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.605 167.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.503 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 7.8 t0 -142.56 155.71 45.03 Favored 'General case' 1 C--N 1.241 -4.111 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 172.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 t -71.75 -29.56 64.64 Favored 'General case' 0 C--N 1.258 -3.397 0 C-N-CA 124.865 1.266 . . . . 0.0 112.82 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 7.9 ptpp? -84.54 3.98 34.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.182 0.515 . . . . 0.0 111.524 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.55 HG11 ' OE1' ' A' ' 11' ' ' GLN . 28.2 t -101.58 119.82 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-O 121.897 0.856 . . . . 0.0 112.078 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -122.32 165.31 16.46 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.7 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 30.7 p -92.68 178.27 5.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 122.101 0.953 . . . . 0.0 113.02 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 p -82.76 154.79 24.59 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.216 -1.356 . . . . 0.0 114.079 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -112.41 -9.28 13.85 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.319 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -95.07 155.77 16.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -91.85 107.1 18.97 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.289 1.042 . . . . 0.0 110.63 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.82 97.05 36.15 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.993 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.406 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 58.5 Cg_endo -74.65 123.93 8.42 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.618 0.878 . . . . 0.0 110.191 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.552 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 49.6 p-80 -153.06 138.29 17.44 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 46.0 t -108.69 109.77 21.02 Favored 'General case' 0 C--N 1.249 -3.761 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.17 162.91 52.86 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.511 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 19.9 m -54.91 -18.83 5.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.721 0.808 . . . . 0.0 111.64 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.3 t70 -64.92 -30.59 71.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.494 1.14 . . . . 0.0 109.081 174.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.01 -16.6 35.94 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.517 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.1 mt-30 -73.24 136.03 44.58 Favored 'General case' 0 CA--C 1.465 -2.327 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.482 HG22 ' CB ' ' A' ' 56' ' ' LYS . 99.0 m -111.13 130.21 55.69 Favored 'General case' 0 C--N 1.263 -3.189 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.101 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 54.2 m-85 -135.25 156.83 48.3 Favored 'General case' 0 N--CA 1.396 -3.143 0 CA-C-O 122.136 0.97 . . . . 0.0 112.251 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.16 -20.98 78.4 Favored Glycine 0 C--N 1.287 -2.176 0 CA-C-N 112.669 -2.06 . . . . 0.0 114.796 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 p30 -162.95 172.16 15.49 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 118.342 1.071 . . . . 0.0 108.787 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -63.86 -38.82 92.51 Favored 'General case' 0 C--O 1.197 -1.692 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.7 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.9 t -53.05 -43.93 67.03 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.931 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -63.7 -40.78 97.63 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.945 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE1' ' HB2' ' A' ' 30' ' ' GLN . 44.6 t80 -104.03 5.2 35.19 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.807 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.3 t -61.43 -41.01 96.51 Favored 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 122.362 0.265 . . . . 0.0 110.361 -171.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HE3' ' O ' ' A' ' 37' ' ' ALA . 0.0 OUTLIER -63.86 -30.01 71.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 125.618 1.567 . . . . 0.0 114.181 -174.084 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.55 -36.12 65.59 Favored 'General case' 1 C--N 1.209 -5.515 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.67 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 39' ' ' CYS . 40.3 mt -72.56 -44.44 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.954 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 39' ' ' CYS . 48.9 t -51.9 -50.97 31.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -66.93 -37.72 84.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.263 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m -87.06 13.25 9.63 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.865 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.85 79.99 Favored Glycine 0 N--CA 1.401 -3.636 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.05 2.72 87.52 Favored Glycine 0 C--N 1.279 -2.616 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.99 -21.98 62.23 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.1 mt -71.12 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.262 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 m -124.0 -173.45 2.76 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.552 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 32.6 tp -88.59 141.14 28.77 Favored 'General case' 1 N--CA 1.329 -6.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 52.0 tttm -99.88 -42.23 6.89 Favored 'General case' 1 N--CA 1.361 -4.882 0 C-N-CA 124.585 1.154 . . . . 0.0 111.152 174.599 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 28.3 m170 -138.26 132.65 16.87 Favored Pre-proline 0 C--N 1.284 -2.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.669 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.05 109.49 2.89 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 N-CA-C 105.067 -2.705 . . . . 0.0 105.067 163.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.406 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 107.58 176.52 22.48 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -169.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.482 ' CB ' HG22 ' A' ' 31' ' ' THR . 13.2 ptmm? -70.29 169.24 14.2 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.449 1.119 . . . . 0.0 113.322 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.479 ' C ' ' HZ2' ' A' ' 56' ' ' LYS . 27.4 m . . . . . 0 C--N 1.286 -2.174 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.672 166.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.74 -64.86 0.04 OUTLIER Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 106.181 -2.768 . . . . 0.0 106.181 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.7 139.09 17.62 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 106.862 -2.495 . . . . 0.0 106.862 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -83.74 105.84 14.96 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 16' ' ' TYR . 48.0 t -103.1 146.49 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 166.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . 0.284 6.0 t70 -92.78 79.27 4.74 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.945 -2.302 . . . . 0.0 116.75 -170.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 83.8 m -110.25 67.34 0.64 Allowed 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.11 -3.24 16.69 Favored Glycine 0 C--N 1.359 1.817 0 CA-C-N 113.096 -1.865 . . . . 0.0 112.576 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.518 ' OE2' ' HB3' ' A' ' 40' ' ' LYS . 44.9 mt-10 -62.98 -45.37 92.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.0 t80 46.04 34.66 2.11 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 126.391 1.877 . . . . 0.0 115.153 159.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.496 ' CG ' HG12 ' A' ' 43' ' ' VAL . 87.7 mm-40 -58.02 -20.73 41.0 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-O 123.132 1.444 . . . . 0.0 113.895 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 15.3 t70 -145.5 164.95 30.04 Favored 'General case' 2 N--CA 1.355 -5.204 0 CA-C-N 112.946 -1.934 . . . . 0.0 106.609 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -72.42 -34.06 67.57 Favored 'General case' 0 C--N 1.259 -3.369 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.237 -173.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.572 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 23.3 pttm -80.63 9.44 6.13 Favored 'General case' 0 C--O 1.26 1.642 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.473 HG11 ' CB ' ' A' ' 7' ' ' CYS . 13.6 t -92.31 83.79 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.071 0.938 . . . . 0.0 110.595 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.454 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 52.6 p90 -137.68 152.73 49.58 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.705 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 16.5 p -115.57 -175.27 2.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 t -129.17 165.22 21.74 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.386 -1.734 . . . . 0.0 106.567 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.604 ' HG2' ' OE1' ' A' ' 20' ' ' GLU . 24.9 ptt-85 -110.09 -17.82 13.48 Favored 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.07 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.604 ' OE1' ' HG2' ' A' ' 19' ' ' ARG . 4.8 mp0 -74.75 146.82 41.86 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-N 113.859 -1.518 . . . . 0.0 107.047 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -81.44 90.35 6.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.907 1.336 . . . . 0.0 112.353 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.549 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 49.4 t-20 -111.16 95.65 26.42 Favored Pre-proline 0 C--N 1.25 -3.75 0 CA-C-N 112.073 -2.331 . . . . 0.0 106.577 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -71.08 150.06 59.53 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.581 1.521 . . . . 0.0 111.434 -177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.531 ' O ' ' HA ' ' A' ' 31' ' ' THR . 18.9 m80 -138.94 122.52 17.38 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.46 ' O ' HD13 ' A' ' 51' ' ' LEU . 50.2 t -98.0 100.35 11.68 Favored 'General case' 0 C--N 1.254 -3.554 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 171.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.72 166.81 54.66 Favored Glycine 0 N--CA 1.407 -3.242 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.993 -172.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.407 ' HA ' ' CG ' ' A' ' 52' ' ' LYS . 66.5 m -65.86 -6.52 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.796 175.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 30' ' ' GLN . 15.0 t70 -81.82 -7.97 59.65 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.908 1.283 . . . . 0.0 108.424 175.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.95 -27.15 10.51 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 28' ' ' ASP . 46.9 mt-30 -73.79 136.2 43.56 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 98.3 m -106.33 128.95 54.38 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.228 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -123.66 147.05 47.76 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.575 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.56 -38.63 82.05 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.834 1.334 . . . . 0.0 115.289 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.549 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.8 p30 -143.67 174.77 10.5 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -67.9 -31.43 71.2 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.613 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.632 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.4 OUTLIER -61.79 -38.98 90.1 Favored 'General case' 0 C--N 1.25 -3.723 0 CA-C-O 122.905 1.336 . . . . 0.0 110.074 178.603 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -70.79 -32.47 69.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 112.609 -2.087 . . . . 0.0 108.659 177.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.623 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 30.3 t80 -85.11 -10.61 56.62 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.482 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.765 ' O ' HG23 ' A' ' 43' ' ' VAL . 31.2 m -58.84 -52.43 65.76 Favored 'General case' 0 C--O 1.188 -2.164 0 O-C-N 121.366 -0.834 . . . . 0.0 112.765 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.614 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -65.39 -32.41 74.03 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 123.339 1.542 . . . . 0.0 111.27 -177.075 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.659 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -66.49 -26.49 67.2 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.465 176.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.662 ' CG2' ' HA2' ' A' ' 47' ' ' GLY . 33.3 mt -81.47 -44.24 20.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.252 1.501 . . . . 0.0 108.344 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 39' ' ' CYS . 96.0 t -54.31 -36.69 34.36 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.976 0 CA-C-N 111.495 -2.593 . . . . 0.0 112.21 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.659 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.1 ptmm? -56.96 -26.09 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.551 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.403 ' HB2' HD12 ' A' ' 49' ' ' ILE . 17.6 m -134.26 57.47 1.81 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 122.185 0.993 . . . . 0.0 112.463 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.32 -0.17 69.48 Favored Glycine 0 N--CA 1.41 -3.064 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 168.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.662 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 80.6 -0.94 84.58 Favored Glycine 0 N--CA 1.411 -3.018 0 C-N-CA 120.285 -0.959 . . . . 0.0 111.917 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.1 -14.94 58.12 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.403 HD12 ' HB2' ' A' ' 45' ' ' SER . 68.2 mt -62.22 149.92 8.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.636 0.732 . . . . 0.0 110.423 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -125.74 178.4 5.72 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 25' ' ' CYS . 29.8 tp -94.43 141.87 28.08 Favored 'General case' 1 N--CA 1.336 -6.155 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 178.366 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.433 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -89.32 -51.62 5.47 Favored 'General case' 0 CA--C 1.453 -2.763 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.609 166.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 -149.21 132.34 8.24 Favored Pre-proline 0 C--N 1.258 -3.407 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.909 -169.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.39 109.83 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 N-CA-C 107.211 -1.88 . . . . 0.0 107.211 168.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.75 165.12 12.87 Favored Glycine 0 C--N 1.279 -2.622 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.0 mtpm? -60.1 164.41 4.08 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 C--N 1.269 -2.903 0 N-CA-C 102.082 -3.303 . . . . 0.0 102.082 158.763 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.73 75.16 Favored Glycine 0 C--O 1.214 -1.103 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.6 159.94 11.16 Favored Glycine 0 N--CA 1.417 -2.611 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 144.28 37.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 118.601 1.2 . . . . 0.0 111.154 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.571 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 14.1 p -144.08 151.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.504 ' HB2' HG22 ' A' ' 18' ' ' THR . 7.5 p-10 -88.62 104.6 17.0 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.446 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' HA ' HG11 ' A' ' 15' ' ' VAL 0.743 3.3 p 62.64 -33.87 0.11 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 50.77 -88.99 0.01 OUTLIER Glycine 0 N--CA 1.463 0.489 0 O-C-N 124.21 0.944 . . . . 0.0 115.318 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 35.1 mp0 -70.41 -30.2 67.02 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 123.382 0.673 . . . . 0.0 110.35 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.767 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.6 t80 73.16 -0.78 3.26 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 124.216 1.006 . . . . 0.0 113.598 164.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -133.13 -3.99 3.1 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.425 1.107 . . . . 0.0 109.248 172.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.548 ' CG ' ' HZ1' ' A' ' 14' ' ' LYS . 7.1 t70 -78.58 -158.44 0.14 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.208 -1.814 . . . . 0.0 112.463 -169.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.543 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 9.4 t -138.34 -22.47 1.02 Allowed 'General case' 0 C--N 1.252 -3.65 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.777 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.548 ' HZ1' ' CG ' ' A' ' 12' ' ' ASP . 9.0 ptpp? -83.49 9.74 10.54 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.358 1.075 . . . . 0.0 109.378 177.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 7' ' ' CYS . 26.8 t -55.43 120.57 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 127.556 2.343 . . . . 0.0 113.959 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 15.0 m-85 -97.1 147.97 23.5 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.63 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 12.1 p -85.51 -178.45 6.69 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.578 ' HB ' ' H ' ' A' ' 20' ' ' GLU . 73.8 p -78.29 169.53 18.11 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -169.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.1 ptt85 -100.28 1.36 41.62 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 109.282 -3.599 . . . . 0.0 106.684 174.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.578 ' H ' ' HB ' ' A' ' 18' ' ' THR . 59.3 mt-10 -104.06 140.66 37.45 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.328 -174.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -105.69 14.27 28.58 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.554 1.141 . . . . 0.0 109.907 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.656 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.7 m-20 -62.28 112.8 7.06 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.34 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.01 148.11 34.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.558 2.172 . . . . 0.0 112.007 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.474 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 94.1 m-70 -152.06 128.07 10.37 Favored 'General case' 0 CA--C 1.476 -1.876 0 CA-C-O 121.964 0.887 . . . . 0.0 110.901 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 42.2 t -94.42 98.79 11.12 Favored 'General case' 0 C--N 1.256 -3.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 170.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -82.89 166.3 44.66 Favored Glycine 0 CA--C 1.463 -3.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.417 -168.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -77.36 4.75 10.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.01 -18.11 65.22 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 127.515 2.326 . . . . 0.0 106.539 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.42 -35.3 5.15 Favored Glycine 1 N--CA 1.391 -4.363 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 75.1 mt-30 -91.6 156.28 17.74 Favored 'General case' 0 CA--C 1.457 -2.602 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.539 HG23 ' HG2' ' A' ' 56' ' ' LYS . 95.3 m -96.21 124.63 40.28 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 112.847 -1.979 . . . . 0.0 108.106 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 30' ' ' GLN . 93.6 m-85 -110.98 145.2 38.85 Favored 'General case' 0 N--CA 1.381 -3.887 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.564 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.22 85.66 Favored Glycine 0 C--N 1.3 -1.42 0 O-C-N 125.114 1.509 . . . . 0.0 112.522 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.656 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.4 p-10 -156.47 173.35 17.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.187 0.518 . . . . 0.0 111.097 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 0.3 OUTLIER -59.11 -28.38 66.48 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 125.71 1.604 . . . . 0.0 110.558 -176.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.63 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -57.0 -49.23 76.42 Favored 'General case' 1 C--N 1.241 -4.116 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.476 175.172 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.417 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.7 -35.18 58.03 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.811 -175.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.454 ' CZ ' HD12 ' A' ' 42' ' ' ILE . 29.2 t80 -86.76 -24.61 25.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.775 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.7 t -67.56 -28.5 67.84 Favored 'General case' 0 C--O 1.188 -2.137 0 CA-C-N 119.55 1.068 . . . . 0.0 110.686 -172.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.796 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.83 -31.8 73.2 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.817 1.294 . . . . 0.0 111.468 -170.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.796 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -64.59 -40.23 95.15 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 111.569 -2.559 . . . . 0.0 108.648 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.562 HD11 ' HA ' ' A' ' 39' ' ' CYS . 46.3 mt -73.31 -46.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.822 -175.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 39' ' ' CYS . 26.4 t -56.6 -35.18 44.06 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.655 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.9 mmpm? -84.53 -35.91 22.53 Favored 'General case' 0 C--N 1.281 -2.382 0 O-C-N 121.692 -0.63 . . . . 0.0 112.59 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.41 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.9 t -74.92 -23.49 58.35 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.843 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.89 7.96 Favored Glycine 0 N--CA 1.401 -3.661 0 C-N-CA 121.073 -0.585 . . . . 0.0 113.383 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 -8.49 79.71 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.0 mtpm? -65.92 -28.26 68.8 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 HD12 ' O ' ' A' ' 41' ' ' ALA . 74.3 mt -82.93 147.94 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.911 173.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.1 m -137.99 179.98 6.11 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 46.6 tp -88.92 141.46 28.47 Favored 'General case' 1 N--CA 1.339 -6.002 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.404 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 31.2 mttp -81.1 -59.22 2.73 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.105 166.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -143.59 142.05 20.16 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.784 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.08 110.34 2.87 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.861 1.708 . . . . 0.0 107.983 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.71 175.3 17.6 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.539 ' HG2' HG23 ' A' ' 31' ' ' THR . 8.6 mtpm? -64.3 162.04 15.58 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--N 1.267 -2.997 1 N-CA-C 99.58 -4.23 . . . . 0.0 99.58 158.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.49 -1.337 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.52 -68.95 3.44 Favored Glycine 0 C--O 1.215 -1.07 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 -171.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.7 170.55 13.35 Favored Glycine 0 C--O 1.271 2.463 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -77.52 132.43 38.37 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.93 0.395 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.78 155.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.05 111.28 12.34 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.489 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 88.0 m -114.59 63.58 0.67 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 156.038 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.47 -5.07 34.47 Favored Glycine 0 CA--C 1.49 -1.49 0 CA-C-N 112.589 -2.096 . . . . 0.0 114.212 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' CB ' HG11 ' A' ' 43' ' ' VAL . 45.9 mt-10 -64.3 -40.83 96.71 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 170.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 t80 49.04 31.9 3.64 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 125.009 1.443 . . . . 0.0 113.361 165.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.06 -13.86 30.46 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-O 122.792 1.282 . . . . 0.0 114.025 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.638 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 15.0 t70 -139.67 143.96 37.39 Favored 'General case' 0 C--N 1.248 -3.812 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -65.67 -34.47 78.28 Favored 'General case' 0 C--N 1.248 -3.814 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.638 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 24.1 pttm -86.82 12.79 10.13 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -176.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.488 ' CG2' ' HB3' ' A' ' 12' ' ' ASP . 21.2 t -94.86 100.3 10.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.952 0.882 . . . . 0.0 112.728 -174.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -137.13 155.05 50.07 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.695 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 23.6 p -113.94 -175.06 2.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.154 0.978 . . . . 0.0 112.883 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 5.7 t -146.23 163.44 35.46 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.423 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 7.3 ptm180 -115.31 -18.58 11.03 Favored 'General case' 1 C--N 1.235 -4.373 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.703 -176.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.27 126.31 49.23 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -170.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.602 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 t 62.84 -4.58 0.24 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 163.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.706 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.2 m120 -106.61 92.92 7.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 C-N-CA 117.904 -1.519 . . . . 0.0 114.29 -173.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.602 ' HD3' ' O ' ' A' ' 21' ' ' SER . 4.0 Cg_endo -83.19 153.6 14.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.126 1.884 . . . . 0.0 110.53 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -150.63 128.41 11.66 Favored 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.3 t -99.46 95.77 7.23 Favored 'General case' 1 C--N 1.242 -4.069 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 168.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.563 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -84.8 165.17 39.89 Favored Glycine 0 CA--C 1.451 -3.909 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.863 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.405 ' HB2' HG23 ' A' ' 49' ' ' ILE . 41.4 m -67.93 4.85 1.03 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 117.912 0.856 . . . . 0.0 111.441 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.2 -24.35 66.26 Favored 'General case' 0 C--N 1.364 1.225 0 C-N-CA 127.189 2.196 . . . . 0.0 105.757 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.11 -31.04 8.99 Favored Glycine 0 N--CA 1.396 -3.98 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.236 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.04 155.99 19.13 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.565 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 97.6 m -97.72 124.32 42.01 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.239 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.511 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 60.1 m-85 -117.58 142.51 47.12 Favored 'General case' 0 N--CA 1.383 -3.789 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.435 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -36.19 82.24 Favored Glycine 0 C--N 1.309 -0.97 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.199 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.706 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.3 p30 -145.72 -178.29 6.02 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 117.258 0.529 . . . . 0.0 109.602 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -67.59 -37.35 82.44 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.121 0.486 . . . . 0.0 112.175 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.695 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -61.79 -38.39 87.89 Favored 'General case' 0 C--N 1.25 -3.728 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.702 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -63.04 -37.44 87.19 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.141 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.563 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 13.5 t80 -94.55 -8.75 37.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.832 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG23 ' A' ' 43' ' ' VAL . 16.1 t -62.51 -37.59 86.64 Favored 'General case' 0 CA--C 1.472 -2.024 0 C-N-CA 123.088 0.555 . . . . 0.0 110.455 -171.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.714 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -65.27 -33.39 75.86 Favored 'General case' 0 CA--C 1.454 -2.723 0 C-N-CA 124.362 1.065 . . . . 0.0 113.103 -172.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.714 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.33 -34.85 59.0 Favored 'General case' 1 C--N 1.218 -5.114 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.815 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.2 mt -63.04 -43.42 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.444 -3.127 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' CYS . 41.2 t -55.03 -41.9 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.641 0 CA-C-N 111.518 -2.583 . . . . 0.0 111.053 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.693 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 24.7 mmtm -65.21 -37.69 88.11 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HG13 ' A' ' 49' ' ' ILE . 24.7 m -104.08 28.59 6.62 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.984 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 20.61 59.1 Favored Glycine 0 N--CA 1.4 -3.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 77.64 0.55 74.08 Favored Glycine 0 C--N 1.275 -2.847 0 CA-C-N 117.896 0.848 . . . . 0.0 111.226 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -80.4 -21.4 42.3 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 HD11 ' O ' ' A' ' 41' ' ' ALA . 75.1 mt -62.98 152.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 121.053 0.454 . . . . 0.0 110.271 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -127.68 -176.28 3.72 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 25' ' ' CYS . 37.5 tp -97.0 140.75 31.05 Favored 'General case' 1 N--CA 1.332 -6.365 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.768 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.469 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 36.1 mtpt -81.63 -50.2 9.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 121.965 0.888 . . . . 0.0 108.611 170.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -154.89 133.17 6.87 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.057 -171.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.13 110.7 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.264 1.976 . . . . 0.0 108.481 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 113.27 -170.25 13.28 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -172.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.565 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.0 ptmm? -80.49 166.8 20.86 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.769 0.795 . . . . 0.0 112.415 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.5 ' C ' ' HZ2' ' A' ' 56' ' ' LYS . 53.4 m . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 165.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.22 -76.65 1.78 Allowed Glycine 0 C--O 1.22 -0.72 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.82 129.31 9.57 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.449 ' HB3' ' HG1' ' A' ' 18' ' ' THR . 14.9 mm100 -101.55 95.62 6.58 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.413 ' O ' ' HB ' ' A' ' 18' ' ' THR . 89.2 t -90.63 140.01 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.588 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 1.8 p30 -126.45 156.26 40.92 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.74 ' SG ' HG21 ' A' ' 43' ' ' VAL . 20.5 p -41.29 -17.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 118.888 2.921 . . . . 0.0 118.888 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.584 ' N ' ' HB2' ' A' ' 39' ' ' CYS . . . -56.16 -29.12 55.58 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 119.983 1.265 . . . . 0.0 111.268 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -28.08 59.09 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 124.656 1.182 . . . . 0.0 112.432 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.558 ' C ' ' H ' ' A' ' 12' ' ' ASP . 95.6 m-85 -138.0 92.56 2.67 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-O 124.068 1.89 . . . . 0.0 111.408 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.574 ' HA ' ' CG1' ' A' ' 43' ' ' VAL . 73.3 mt-30 -40.32 -6.93 0.0 OUTLIER 'General case' 1 C--N 1.233 -4.493 1 C-N-CA 134.448 5.099 . . . . 0.0 115.745 172.131 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 10' ' ' PHE . 12.6 t0 -75.73 -161.39 0.16 Allowed 'General case' 0 C--N 1.26 -3.311 0 C-N-CA 126.202 1.801 . . . . 0.0 109.012 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -106.55 -48.98 3.42 Favored 'General case' 1 C--N 1.232 -4.518 0 C-N-CA 125.563 1.545 . . . . 0.0 114.574 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -85.34 19.6 2.25 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.562 0.745 . . . . 0.0 111.984 -170.337 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.522 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 4.3 t -107.87 130.57 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -127.12 175.5 8.08 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.703 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 12.0 p -77.98 167.12 21.97 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 113.49 -1.686 . . . . 0.0 114.347 -168.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.503 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 10.0 t -96.35 174.81 6.68 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.298 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -87.22 -3.09 59.03 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 35.1 mm-40 -69.44 119.25 13.41 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.836 -176.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -87.81 15.31 7.21 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.409 1.483 . . . . 0.0 111.589 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 18.6 t-20 -70.95 110.61 7.54 Favored Pre-proline 0 C--N 1.271 -2.843 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.434 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.8 Cg_exo -71.44 159.62 50.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.578 2.185 . . . . 0.0 112.459 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -151.75 130.64 12.5 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 123.289 0.636 . . . . 0.0 109.698 -172.918 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.456 ' O ' HD11 ' A' ' 51' ' ' LEU . 50.4 t -108.43 104.37 13.7 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.618 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -69.63 169.25 45.04 Favored Glycine 0 N--CA 1.414 -2.793 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.268 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -65.21 -19.39 65.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.554 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.7 t70 -61.26 -36.86 81.15 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 125.272 1.429 . . . . 0.0 108.953 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.73 -18.66 14.76 Favored Glycine 0 N--CA 1.398 -3.887 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.554 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.1 mt-30 -71.66 135.3 46.82 Favored 'General case' 0 CA--C 1.452 -2.822 0 CA-C-O 122.375 1.083 . . . . 0.0 113.795 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.4 m -117.86 133.17 56.2 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.019 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' ' CB ' ' A' ' 37' ' ' ALA . 66.4 m-85 -131.26 162.33 30.27 Favored 'General case' 0 N--CA 1.38 -3.928 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.398 172.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 -25.11 63.62 Favored Glycine 0 C--N 1.294 -1.773 0 CA-C-N 113.386 -1.733 . . . . 0.0 113.362 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.7 p30 -158.99 168.21 27.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.07 -35.62 73.67 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.647 0.737 . . . . 0.0 111.571 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.703 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.07 -52.67 32.67 Favored 'General case' 0 C--N 1.256 -3.499 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.335 174.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -66.33 -33.74 76.41 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.258 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.618 ' CZ ' ' HA3' ' A' ' 26' ' ' GLY . 48.2 t80 -95.0 -2.11 51.04 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.127 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.825 ' O ' HG22 ' A' ' 43' ' ' VAL . 14.5 p -61.38 -43.85 98.16 Favored 'General case' 0 CA--C 1.439 -3.296 0 O-C-N 121.908 -0.495 . . . . 0.0 111.149 -172.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.54 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -57.26 -35.57 69.9 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 126.152 1.781 . . . . 0.0 114.496 -172.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -68.59 -39.49 80.9 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.665 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.559 ' HB ' ' O ' ' A' ' 39' ' ' CYS . 34.9 mt -69.19 -48.12 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.001 -177.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.825 HG22 ' O ' ' A' ' 39' ' ' CYS . 37.1 t -50.75 -50.63 22.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 112.009 -2.359 . . . . 0.0 111.832 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -78.73 -32.59 46.82 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.87 -172.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.509 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 16.3 m -80.55 4.21 19.2 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.017 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.454 ' HA3' ' HZ1' ' A' ' 48' ' ' LYS . . . 90.45 19.05 46.7 Favored Glycine 1 N--CA 1.385 -4.706 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 171.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 -0.47 62.63 Favored Glycine 0 C--N 1.29 -2.012 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.509 ' HD2' ' O ' ' A' ' 45' ' ' SER . 38.7 mttp -71.77 -19.39 62.02 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -79.83 140.99 15.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.645 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 m -121.08 -179.71 4.12 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 25' ' ' CYS . 35.9 tp -90.16 141.06 29.07 Favored 'General case' 1 N--CA 1.324 -6.765 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.648 ' HD2' ' SG ' ' A' ' 57' ' ' CYS . 2.2 ttmp? -90.02 -54.59 3.97 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.842 170.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 58.9 m170 -139.38 137.16 18.55 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.083 -173.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.62 109.83 2.93 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 N-CA-C 105.796 -2.424 . . . . 0.0 105.796 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.434 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.84 -177.22 16.96 Favored Glycine 0 C--N 1.284 -2.341 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -169.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.2 pttp -79.21 173.35 12.67 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-O 121.901 0.857 . . . . 0.0 111.327 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.648 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 24.8 m . . . . . 0 C--N 1.281 -2.409 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 165.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.98 -138.79 24.14 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.411 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.28 91.35 0.73 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.16 165.06 11.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.88 174.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 35' ' ' LYS . 15.0 t70 -129.94 133.16 46.65 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.49 ' SG ' ' HA ' ' A' ' 16' ' ' TYR . 0.5 OUTLIER -52.54 -156.84 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 166.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.467 ' H ' ' HB2' ' A' ' 7' ' ' CYS . . . 98.24 -65.73 0.78 Allowed Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.08 -17.43 55.2 Favored 'General case' 0 N--CA 1.407 -2.589 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 12' ' ' ASP . 95.3 m-85 -114.74 81.02 1.49 Allowed 'General case' 1 N--CA 1.376 -4.142 0 CA-C-O 123.763 1.744 . . . . 0.0 110.075 -171.427 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.589 ' C ' HG13 ' A' ' 43' ' ' VAL . 65.5 mm-40 -45.0 -8.19 0.01 OUTLIER 'General case' 1 C--N 1.223 -4.892 2 C-N-CA 133.978 4.911 . . . . 0.0 114.725 173.826 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.515 ' CG ' ' HG2' ' A' ' 14' ' ' LYS . 45.5 t0 -98.35 134.6 41.13 Favored 'General case' 1 N--CA 1.371 -4.389 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 174.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -79.12 6.19 10.18 Favored 'General case' 1 C--N 1.222 -4.956 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.787 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HG2' ' CG ' ' A' ' 12' ' ' ASP . 35.4 mmtm -81.85 -25.96 34.66 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.1 t -92.26 120.68 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.072 -171.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HA ' ' SG ' ' A' ' 7' ' ' CYS 0.402 59.6 m-85 -118.2 175.12 5.84 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.617 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 28.0 p -75.84 166.94 22.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -162.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.427 HG22 ' OD2' ' A' ' 6' ' ' ASP . 9.5 t -91.9 175.1 7.01 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.13 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -91.05 -17.94 25.4 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.727 -2.033 . . . . 0.0 109.032 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.17 131.96 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.226 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' A' ' 34' ' ' ASN . 27.3 m -94.44 107.13 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 122.12 0.962 . . . . 0.0 111.077 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -110.75 100.44 45.88 Favored Pre-proline 0 C--N 1.276 -2.625 0 CA-C-N 113.161 -1.836 . . . . 0.0 109.554 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.59 125.19 8.77 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.426 2.084 . . . . 0.0 111.267 179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -151.53 129.32 11.62 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 125.236 1.415 . . . . 0.0 108.845 -174.547 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.496 ' O ' HD12 ' A' ' 51' ' ' LEU . 42.2 t -92.61 106.73 18.66 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 174.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 160.35 53.54 Favored Glycine 0 N--CA 1.401 -3.657 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.349 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HA ' ' CG ' ' A' ' 52' ' ' LYS . 50.3 m -64.61 -7.37 10.23 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.854 0.835 . . . . 0.0 110.468 173.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 30' ' ' GLN . 25.3 t70 -81.36 -10.48 59.53 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.763 2.025 . . . . 0.0 108.374 176.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.49 -31.6 6.32 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 28' ' ' ASP 0.266 26.1 mt-30 -74.72 130.08 38.85 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -177.472 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.532 HG21 ' HA ' ' A' ' 56' ' ' LYS . 89.9 m -98.81 126.04 44.35 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.695 -2.048 . . . . 0.0 110.092 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' HB2' ' HB1' ' A' ' 37' ' ' ALA . 30.1 p90 -106.99 133.03 52.24 Favored 'General case' 0 N--CA 1.39 -3.45 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.745 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.75 -42.51 61.55 Favored Glycine 0 CA--C 1.499 -0.912 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.807 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' CB ' ' HA ' ' A' ' 21' ' ' SER . 32.6 p30 -128.72 168.78 15.34 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 173.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 52.3 tttm -71.58 -35.47 70.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.733 0.777 . . . . 0.0 110.141 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.617 ' HA ' ' CB ' ' A' ' 17' ' ' CYS . 49.6 t -48.26 -44.9 33.85 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.755 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 32' ' ' TYR . . . -50.76 -42.99 58.21 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.431 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.539 ' O ' ' HB1' ' A' ' 41' ' ' ALA . 8.8 t80 -127.53 -1.36 6.18 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 117.492 -1.683 . . . . 0.0 114.186 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.719 ' O ' HG22 ' A' ' 43' ' ' VAL . 31.7 p -51.45 -55.35 19.25 Favored 'General case' 0 C--O 1.194 -1.861 0 C-N-CA 123.471 0.708 . . . . 0.0 111.38 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.548 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -65.12 -24.38 67.4 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 127.045 2.138 . . . . 0.0 114.586 -177.452 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' HB1' ' O ' ' A' ' 38' ' ' PHE . . . -82.04 -28.73 32.32 Favored 'General case' 1 C--N 1.202 -5.816 0 CA-C-N 113.179 -1.828 . . . . 0.0 110.718 173.605 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 39' ' ' CYS . 22.0 mt -66.99 -43.14 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.78 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.719 HG22 ' O ' ' A' ' 39' ' ' CYS . 46.7 t -50.34 -41.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 110.619 -2.991 . . . . 0.0 110.995 171.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -86.0 -29.46 23.48 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.464 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.472 ' HB3' ' HD3' ' A' ' 48' ' ' LYS . 64.3 m -86.85 12.96 9.77 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.43 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.36 3.48 72.15 Favored Glycine 0 N--CA 1.413 -2.895 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.68 14.12 82.83 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.472 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 4.5 pttm -64.74 -25.0 67.74 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-O 121.94 0.876 . . . . 0.0 109.671 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 HD13 ' HA ' ' A' ' 42' ' ' ILE . 4.1 mp -79.02 131.51 34.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.688 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 p -130.84 -177.82 4.53 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.498 ' HG ' ' N ' ' A' ' 52' ' ' LYS . 27.8 tp -95.16 141.48 28.72 Favored 'General case' 1 N--CA 1.343 -5.806 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.608 ' NZ ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.23 -54.95 3.72 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.458 164.09 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 25.1 t-80 -149.72 135.09 9.79 Favored Pre-proline 0 C--N 1.262 -3.219 0 CA-C-N 113.575 -1.648 . . . . 0.0 112.175 -167.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.8 110.3 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.965 1.776 . . . . 0.0 108.453 170.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.92 168.74 15.35 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' HA ' HG21 ' A' ' 31' ' ' THR . 12.3 mtpp -56.03 162.51 1.88 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.413 -2.289 0 CA-C-N 109.435 -3.53 . . . . 0.0 101.817 158.292 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.415 -2.188 0 CA-C-O 123.4 1.572 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 2.7 t-20 -111.06 96.29 29.18 Favored Pre-proline 0 C--N 1.253 -3.629 0 CA-C-N 112.252 -2.249 . . . . 0.0 108.369 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.3 Cg_exo -68.6 154.96 70.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.914 1.743 . . . . 0.0 112.578 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -148.94 128.26 12.96 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 34.0 t -104.02 103.46 13.28 Favored 'General case' 0 C--N 1.254 -3.584 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.18 160.24 52.33 Favored Glycine 0 N--CA 1.4 -3.711 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.057 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.2 m -66.93 -4.73 10.21 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 120.701 0.286 . . . . 0.0 110.666 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -7.77 53.03 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.17 1.462 . . . . 0.0 107.749 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.25 -34.37 5.77 Favored Glycine 0 N--CA 1.397 -3.941 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.321 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.16 155.12 30.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 88.4 m -110.92 131.22 55.23 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.053 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -120.77 138.24 54.11 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.542 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.83 -34.72 65.62 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 114.874 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.8 p30 -147.28 178.26 8.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -74.54 -30.07 61.62 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-O 122.148 0.975 . . . . 0.0 111.217 -174.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -39.13 86.62 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.128 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.774 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 27.5 t80 -81.17 -15.65 55.16 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.66 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.738 ' O ' HG23 ' A' ' 43' ' ' VAL . 40.9 m -58.17 -52.77 64.18 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 112.766 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.79 -25.2 62.77 Favored 'General case' 0 CA--C 1.462 -2.433 0 CA-C-O 123.413 1.578 . . . . 0.0 111.048 -176.498 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.75 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -75.81 -25.8 56.67 Favored 'General case' 1 C--N 1.206 -5.664 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.927 175.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.789 HG22 ' HA2' ' A' ' 47' ' ' GLY . 20.5 mt -73.16 -41.37 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.049 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 39' ' ' CYS . 84.3 t -57.9 -29.89 36.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 110.85 -2.886 . . . . 0.0 110.516 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -48.38 -43.63 34.02 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 178.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 49' ' ' ILE . 5.6 m -134.39 61.67 1.67 Allowed 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 122.169 0.985 . . . . 0.0 111.669 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.5 0.33 89.94 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 118.561 2.184 . . . . 0.0 118.561 167.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.789 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 88.76 -19.31 38.09 Favored Glycine 0 C--N 1.27 -3.123 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.525 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 30.9 mmtm -78.0 -10.65 59.7 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.746 1.219 . . . . 0.0 113.72 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 45' ' ' SER . 59.2 mt -62.26 148.98 9.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.9 m -125.6 -179.35 4.6 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.29 141.36 32.16 Favored 'General case' 1 N--CA 1.331 -6.382 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -87.02 -55.48 3.81 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.385 1.088 . . . . 0.0 108.839 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -131.07 133.2 24.42 Favored Pre-proline 0 C--N 1.288 -2.096 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.637 -166.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.08 109.33 2.81 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 N-CA-C 104.987 -2.736 . . . . 0.0 104.987 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.69 -175.24 15.76 Favored Glycine 0 C--N 1.281 -2.476 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.6 pttp -80.65 174.35 11.7 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 121.766 0.793 . . . . 0.0 111.138 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 165.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 122.982 1.372 . . . . 0.0 107.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.35 110.65 13.09 Favored Pre-proline 0 C--N 1.263 -3.182 0 CA-C-N 112.112 -2.313 . . . . 0.0 111.408 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 149.84 84.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.682 2.255 . . . . 0.0 111.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.68 131.35 12.32 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.64 0.776 . . . . 0.0 109.546 -172.306 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.574 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 42.0 t -100.69 108.88 20.86 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HE3' ' A' ' 52' ' ' LYS . . . -74.41 151.24 43.1 Favored Glycine 1 N--CA 1.395 -4.071 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.695 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 p -59.31 -25.86 64.5 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 124.031 0.932 . . . . 0.0 109.826 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.529 ' CB ' HG12 ' A' ' 49' ' ' ILE . 14.6 t70 -74.52 3.42 7.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 126.384 1.874 . . . . 0.0 109.872 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.95 -29.85 8.2 Favored Glycine 0 CA--C 1.468 -2.856 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.956 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -74.19 128.68 36.16 Favored 'General case' 0 CA--C 1.45 -2.867 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' HG2' ' A' ' 56' ' ' LYS . 87.7 m -107.7 132.54 53.23 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.32 -1.764 . . . . 0.0 108.843 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 96.8 m-85 -119.96 143.41 48.03 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.92 -32.21 55.78 Favored Glycine 0 C--O 1.219 -0.792 0 O-C-N 124.671 1.232 . . . . 0.0 113.969 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 31.0 p30 -155.1 174.64 14.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 38' ' ' PHE . 18.5 tptm -66.53 -32.92 74.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.141 0.972 . . . . 0.0 111.102 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 3.7 t -50.6 -53.63 29.1 Favored 'General case' 1 C--N 1.236 -4.344 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.861 171.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -70.28 -40.42 74.34 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.852 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' A' ' 35' ' ' LYS . 65.1 t80 -68.02 -46.55 70.9 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.119 -1.4 . . . . 0.0 113.529 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.791 ' HA ' HD12 ' A' ' 42' ' ' ILE . 21.9 t -70.17 -36.76 74.91 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.789 -171.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' NZ ' ' HB2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -85.78 -7.81 58.52 Favored 'General case' 0 N--CA 1.392 -3.329 0 CA-C-O 122.102 0.953 . . . . 0.0 110.581 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.07 -28.02 21.6 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.654 -2.066 . . . . 0.0 110.629 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 39' ' ' CYS . 68.8 mt -60.47 -45.42 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.904 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.8 t -52.7 -32.29 17.17 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 110.491 -3.05 . . . . 0.0 111.013 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 44' ' ' LYS . 1.8 mmpm? -86.45 -42.41 13.63 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.671 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 35.7 t -74.47 -15.98 60.87 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 123.787 0.679 . . . . 0.0 110.894 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.42 18.6 7.03 Favored Glycine 0 N--CA 1.401 -3.647 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.963 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.97 -5.59 61.85 Favored Glycine 0 C--N 1.295 -1.704 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.354 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HD3' ' O ' ' A' ' 45' ' ' SER . 3.8 mtpm? -60.49 -25.06 65.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 28' ' ' ASP . 9.5 mt -85.05 132.71 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.489 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.0 m -128.39 -179.37 4.99 Favored 'General case' 0 C--N 1.267 -3.022 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 170.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.7 tp -98.66 140.99 32.04 Favored 'General case' 1 N--CA 1.333 -6.314 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.649 ' HE3' ' O ' ' A' ' 26' ' ' GLY . 77.4 mttt -88.05 -56.89 3.14 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 122.55 1.167 . . . . 0.0 107.858 165.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 41.8 t-80 -153.88 140.13 12.63 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.218 -167.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 12.1 Cg_exo -72.06 110.28 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.085 1.857 . . . . 0.0 108.848 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 161.05 11.31 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 8.9 mtpm? -57.94 165.65 1.75 Allowed 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 C--N 1.274 -2.715 0 N-CA-C 101.522 -3.51 . . . . 0.0 101.522 159.72 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.421 -1.907 0 CA-C-O 122.988 1.375 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.48 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 6.5 m-20 -110.26 94.93 19.77 Favored Pre-proline 0 C--N 1.257 -3.449 0 CA-C-N 112.218 -2.264 . . . . 0.0 107.343 175.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 61.2 Cg_endo -75.3 132.35 14.94 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.799 1.666 . . . . 0.0 112.241 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -141.97 127.71 19.23 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.3 t -102.11 107.58 18.72 Favored 'General case' 0 C--N 1.249 -3.771 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 169.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 52' ' ' LYS . . . -71.14 165.26 53.37 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.685 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -51.76 -28.77 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.444 0.698 . . . . 0.0 110.481 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 8.9 t70 -60.5 -37.32 80.74 Favored 'General case' 0 CA--C 1.48 -1.729 0 C-N-CA 126.374 1.87 . . . . 0.0 110.085 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.07 -20.08 14.65 Favored Glycine 0 CA--C 1.459 -3.451 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 46.1 mt-30 -72.2 131.97 43.47 Favored 'General case' 0 CA--C 1.468 -2.184 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.515 HG21 ' CB ' ' A' ' 56' ' ' LYS . 95.4 m -102.31 131.32 48.98 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.234 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 65.4 m-85 -123.21 143.12 50.24 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.986 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.22 95.75 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.439 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 36.9 p30 -133.15 177.14 7.9 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 117.651 0.726 . . . . 0.0 109.413 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 83.6 tttt -67.97 -35.28 78.1 Favored 'General case' 0 C--O 1.189 -2.128 0 CA-C-O 121.336 0.589 . . . . 0.0 111.35 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -38.57 88.34 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.421 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.09 -39.44 94.72 Favored 'General case' 0 C--N 1.26 -3.32 0 CA-C-N 112.977 -1.919 . . . . 0.0 109.821 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 42' ' ' ILE . 22.6 t80 -88.91 -27.55 20.9 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.153 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.804 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.9 t -57.9 -40.88 81.4 Favored 'General case' 0 CA--C 1.481 -1.71 0 C-N-CA 124.612 1.165 . . . . 0.0 110.938 -173.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -73.86 -24.08 59.69 Favored 'General case' 0 N--CA 1.409 -2.494 0 CA-C-O 122.853 1.311 . . . . 0.0 110.485 -170.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -79.7 -29.27 40.69 Favored 'General case' 0 C--N 1.265 -3.078 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.703 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.5 mt -67.08 -42.91 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 39' ' ' CYS . 10.3 t -62.56 -27.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.943 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -70.33 -39.5 74.69 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.8 -0.562 . . . . 0.0 112.275 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HG13 ' A' ' 49' ' ' ILE . 31.2 m -105.82 22.62 15.28 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.51 14.8 75.29 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 170.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.29 0.74 88.45 Favored Glycine 0 C--N 1.274 -2.88 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 48' ' ' LYS . 3.0 mmmp? -68.55 -28.71 67.21 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 45' ' ' SER . 40.5 mt -76.69 145.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.004 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -130.24 -175.34 3.6 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 51' ' ' LEU . 31.4 tp -86.18 141.37 29.39 Favored 'General case' 1 N--CA 1.326 -6.663 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 21.0 ttmm -91.75 -52.15 4.89 Favored 'General case' 0 N--CA 1.38 -3.936 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.514 172.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -145.21 137.27 13.16 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.856 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.04 110.38 3.06 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 107.137 -1.909 . . . . 0.0 107.137 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.79 179.47 17.8 Favored Glycine 0 C--N 1.288 -2.09 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -171.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.0 pttp -78.73 170.43 16.67 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-O 121.433 0.635 . . . . 0.0 110.617 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 32.4 m . . . . . 0 C--N 1.273 -2.742 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 21.4 m . . . . . 0 N--CA 1.428 -1.554 0 CA-C-O 122.212 1.006 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 7.4 t30 -111.66 94.33 23.25 Favored Pre-proline 0 C--N 1.268 -2.974 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.085 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.45 123.9 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.105 1.203 . . . . 0.0 109.584 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.742 ' HB2' HD13 ' A' ' 51' ' ' LEU . 48.7 p-80 -153.63 133.57 13.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.537 ' O ' HD12 ' A' ' 51' ' ' LEU . 44.1 t -92.74 114.19 26.68 Favored 'General case' 0 C--N 1.264 -3.143 0 CA-C-N 113.877 -1.51 . . . . 0.0 106.993 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.23 147.53 50.1 Favored Glycine 1 N--CA 1.393 -4.172 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.561 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 p -45.69 -41.27 10.26 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 124.826 1.251 . . . . 0.0 110.757 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.91 3.35 5.39 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.136 0.974 . . . . 0.0 112.81 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.43 54.59 Favored Glycine 0 CA--C 1.46 -3.358 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -73.2 122.77 22.44 Favored 'General case' 0 CA--C 1.45 -2.877 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 56' ' ' LYS . 94.7 m -116.95 127.7 54.48 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.676 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.557 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 31.6 m-85 -134.61 161.11 36.03 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.315 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.51 -31.7 52.2 Favored Glycine 0 C--N 1.298 -1.539 0 CA-C-N 113.182 -1.826 . . . . 0.0 114.563 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.8 p30 -162.7 -175.57 4.51 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 117.467 0.633 . . . . 0.0 109.549 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -68.1 -42.57 80.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.418 0.628 . . . . 0.0 111.862 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -32.6 74.08 Favored 'General case' 0 C--N 1.247 -3.879 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.586 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -53.61 -43.21 68.46 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.681 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -133.1 26.01 4.23 Favored 'General case' 0 C--O 1.195 -1.787 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.864 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.9 ' HA ' HD12 ' A' ' 42' ' ' ILE . 49.8 t -54.5 -45.56 73.28 Favored 'General case' 0 C--O 1.202 -1.406 0 C-N-CA 122.924 0.49 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -69.0 -25.91 64.75 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 125.69 1.596 . . . . 0.0 114.489 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.16 -25.93 33.88 Favored 'General case' 1 C--N 1.203 -5.78 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.016 174.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 39' ' ' CYS . 12.8 mt -65.45 -42.54 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 39' ' ' CYS . 80.6 t -49.5 -44.56 18.88 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.354 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.54 -31.05 29.31 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.297 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.4 m -80.89 8.4 8.38 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.358 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 2.31 58.01 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.99 -6.11 68.21 Favored Glycine 0 C--N 1.29 -2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.2 mtpm? -61.03 -25.77 67.15 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 124.627 1.171 . . . . 0.0 113.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 42' ' ' ILE . 14.4 mt -66.42 125.86 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 CA-C-O 123.02 1.39 . . . . 0.0 112.406 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -131.31 -175.33 3.66 Favored 'General case' 0 C--N 1.261 -3.258 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 24' ' ' HIS . 35.6 tp -94.98 141.21 28.92 Favored 'General case' 1 N--CA 1.328 -6.556 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 24.4 mmtm -77.46 -65.44 0.96 Allowed 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 55.6 t-80 -167.5 151.19 6.11 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 112.208 -2.269 . . . . 0.0 108.098 -171.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.61 138.56 80.75 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.136 1.89 . . . . 0.0 110.664 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.52 163.98 29.37 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.1 mtpm? -63.77 162.84 12.68 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 98.5 m . . . . . 0 C--N 1.271 -2.824 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 158.428 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.797 0.808 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.832 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 5.5 m-20 -56.91 102.51 0.31 Allowed Pre-proline 0 C--N 1.273 -2.74 0 CA-C-N 113.363 -1.744 . . . . 0.0 113.153 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 2.4 Cg_endo -76.18 151.84 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.846 1.697 . . . . 0.0 111.48 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.473 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 88.2 m-70 -148.49 129.05 14.03 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 110.482 -173.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 34.7 t -103.38 101.54 11.45 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 169.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -77.39 170.08 54.97 Favored Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.251 -171.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 m -68.37 -4.47 14.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.679 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.77 -8.09 58.41 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.668 1.187 . . . . 0.0 107.886 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.02 -29.53 8.61 Favored Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.857 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -74.26 145.06 44.33 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.2 m -108.92 131.6 54.88 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.307 -1.77 . . . . 0.0 109.249 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 95.0 m-85 -129.28 151.34 50.05 Favored 'General case' 0 N--CA 1.398 -3.035 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.257 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.49 -26.09 59.02 Favored Glycine 0 C--O 1.208 -1.508 0 CA-C-N 114.5 -1.227 . . . . 0.0 115.469 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 7.8 p30 -164.5 173.59 11.89 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.661 0.731 . . . . 0.0 109.277 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -62.44 -32.58 73.46 Favored 'General case' 0 C--O 1.182 -2.448 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.63 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 61.7 m -57.13 -39.94 76.14 Favored 'General case' 0 C--N 1.255 -3.519 0 CA-C-O 122.351 1.072 . . . . 0.0 111.829 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.16 -38.31 56.82 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.738 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 21.4 t80 -81.43 -6.09 58.58 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.745 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 t -63.89 -41.99 97.57 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.591 -0.693 . . . . 0.0 111.396 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -71.41 -17.56 62.39 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 125.244 1.418 . . . . 0.0 113.856 -176.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -87.22 -26.7 23.39 Favored 'General case' 1 C--N 1.208 -5.575 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.593 173.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.9 mt -72.02 -36.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 93.8 t -54.07 -33.13 24.01 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 CA-C-N 110.611 -2.995 . . . . 0.0 111.246 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 3.0 mmmm -48.11 -43.01 30.56 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.2 m -124.36 29.65 6.28 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.46 26.34 28.06 Favored Glycine 0 N--CA 1.4 -3.721 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.72 -8.87 54.26 Favored Glycine 0 C--N 1.277 -2.738 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.618 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -72.8 -19.89 61.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.8 mt -69.68 150.76 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.351 0.596 . . . . 0.0 110.989 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -125.46 -176.38 3.58 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HA2' ' A' ' 26' ' ' GLY . 41.6 tp -97.56 140.94 31.23 Favored 'General case' 1 N--CA 1.329 -6.512 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 7.2 mtmp? -93.42 -50.71 5.32 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.698 0.761 . . . . 0.0 110.583 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -126.34 130.24 23.97 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.907 -170.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.64 109.68 2.8 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 163.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 110.78 -179.23 20.07 Favored Glycine 0 C--N 1.285 -2.267 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -169.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.0 pttp -78.4 174.07 11.67 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-O 122.188 0.994 . . . . 0.0 111.911 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.28 -2.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.208 165.327 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.416 -2.17 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 46.4 t-20 -111.11 105.59 57.11 Favored Pre-proline 0 C--N 1.277 -2.544 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.53 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.08 148.69 63.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.791 1.661 . . . . 0.0 112.183 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' THR . 69.7 m-70 -148.07 130.81 16.01 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -106.69 102.6 11.96 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -68.98 160.16 52.53 Favored Glycine 0 N--CA 1.405 -3.397 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.0 m -60.8 -21.17 62.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -73.36 -16.34 61.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 125.54 1.536 . . . . 0.0 110.894 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.19 -20.68 30.33 Favored Glycine 1 CA--C 1.448 -4.14 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.456 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.92 130.37 40.84 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 96.8 m -115.85 127.86 55.36 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.368 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.4 m-85 -132.88 155.28 49.32 Favored 'General case' 0 N--CA 1.388 -3.569 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.624 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.2 -22.86 72.94 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 113.232 -1.804 . . . . 0.0 114.483 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 33.2 p30 -156.79 169.33 24.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.458 0.629 . . . . 0.0 110.403 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -61.24 -33.71 73.95 Favored 'General case' 0 C--O 1.196 -1.724 0 CA-C-O 121.286 0.565 . . . . 0.0 111.922 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.505 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 97.3 m -57.44 -41.17 79.99 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.142 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -77.04 -40.78 45.12 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.157 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 33.7 t80 -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.963 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.807 ' O ' HG23 ' A' ' 43' ' ' VAL . 52.4 t -59.49 -40.98 88.76 Favored 'General case' 0 C--O 1.192 -1.942 0 C-N-CA 123.224 0.61 . . . . 0.0 111.556 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.09 -20.84 61.59 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-O 122.732 1.253 . . . . 0.0 112.05 -170.449 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -74.22 -39.2 63.25 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 112.793 -2.003 . . . . 0.0 107.847 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.8 mt -71.15 -49.34 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.087 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 39' ' ' CYS . 59.5 t -50.34 -53.69 11.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.177 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -71.74 -33.95 69.13 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.522 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 m -83.48 0.99 43.94 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.425 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 14.3 52.9 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -6.77 58.05 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -67.21 -16.01 64.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.6 mt -78.77 147.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.27 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.6 m -121.69 176.78 5.54 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 38.9 tp -99.31 141.44 32.09 Favored 'General case' 1 N--CA 1.329 -6.484 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -88.42 -57.14 3.03 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 122.449 1.118 . . . . 0.0 108.81 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -130.92 138.96 34.16 Favored Pre-proline 0 C--N 1.285 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 113.282 -165.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.81 109.47 2.61 Favored 'Trans proline' 0 N--CA 1.435 -1.946 0 N-CA-C 104.537 -2.909 . . . . 0.0 104.537 161.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.23 178.33 18.66 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -168.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.49 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.7 pttp -78.05 175.65 9.91 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 122.031 0.92 . . . . 0.0 111.403 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 165.893 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 122.826 1.298 . . . . 0.0 108.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.8 m-20 -69.36 116.82 46.4 Favored Pre-proline 0 C--N 1.272 -2.777 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.933 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.96 148.46 70.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.838 2.359 . . . . 0.0 112.239 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -152.5 127.12 9.43 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 124.08 0.952 . . . . 0.0 108.757 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 14.0 t -100.05 99.11 9.8 Favored 'General case' 0 C--N 1.254 -3.562 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -80.14 170.96 54.12 Favored Glycine 0 CA--C 1.46 -3.401 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.372 -168.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 m -73.82 5.17 4.32 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.848 0.833 . . . . 0.0 109.398 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -68.69 -19.84 64.39 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.529 2.332 . . . . 0.0 105.839 169.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 -36.04 4.52 Favored Glycine 1 N--CA 1.394 -4.143 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -85.54 155.59 21.12 Favored 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 93.7 m -96.21 124.75 40.33 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.678 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.631 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 56.8 m-85 -113.21 142.74 45.44 Favored 'General case' 1 N--CA 1.377 -4.121 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.67 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.35 -35.82 80.7 Favored Glycine 0 CA--C 1.49 -1.509 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.691 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.3 p-10 -149.69 168.71 22.85 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.349 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -59.03 -29.99 67.69 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.513 1.125 . . . . 0.0 111.982 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 0.7 OUTLIER -55.53 -50.79 69.06 Favored 'General case' 0 C--N 1.249 -3.788 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.73 174.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -69.44 -33.95 73.7 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.893 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 42' ' ' ILE . 13.5 t80 -83.14 -16.71 45.66 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.588 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.776 ' O ' HG23 ' A' ' 43' ' ' VAL . 42.5 t -68.09 -31.65 71.42 Favored 'General case' 0 CA--C 1.47 -2.126 0 O-C-N 122.034 -0.416 . . . . 0.0 110.373 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -66.62 -29.52 69.57 Favored 'General case' 0 CA--C 1.454 -2.722 0 CA-C-O 122.33 1.062 . . . . 0.0 112.471 -169.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.738 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.0 -35.14 66.78 Favored 'General case' 1 C--N 1.224 -4.886 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.268 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.4 mt -68.32 -42.13 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.081 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.6 t -58.56 -33.02 47.29 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.392 0 CA-C-N 111.107 -2.769 . . . . 0.0 111.387 174.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 7.7 mmpt? -81.11 -37.4 28.98 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.708 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.1 t -84.51 -20.57 31.41 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.667 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.87 31.99 4.58 Favored Glycine 0 N--CA 1.4 -3.756 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.32 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.81 -13.19 57.36 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -67.36 -24.81 65.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 41' ' ' ALA . 70.0 mt -80.74 146.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.203 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -134.71 -176.62 4.29 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.3 tp -93.11 141.13 28.75 Favored 'General case' 1 N--CA 1.34 -5.973 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -88.77 -49.7 6.67 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.141 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -146.1 132.22 9.57 Favored Pre-proline 0 C--N 1.283 -2.311 0 C-N-CA 118.507 -1.277 . . . . 0.0 112.075 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.26 109.91 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.89 1.727 . . . . 0.0 108.33 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.46 -167.46 13.78 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 12.6 pttp -86.98 169.4 12.47 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-O 121.439 0.638 . . . . 0.0 110.831 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.273 -2.727 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.035 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.413 -2.312 0 CA-C-O 122.599 1.19 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -111.01 97.06 32.89 Favored Pre-proline 0 C--N 1.258 -3.396 0 CA-C-N 113.065 -1.879 . . . . 0.0 108.628 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 57.1 Cg_endo -73.91 133.8 18.87 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.047 1.165 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' THR . 62.1 m-70 -141.67 128.34 20.33 Favored 'General case' 0 CA--C 1.464 -2.349 0 CA-C-O 121.491 0.662 . . . . 0.0 109.842 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.9 t -101.95 108.77 20.33 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 167.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.21 162.8 52.75 Favored Glycine 1 N--CA 1.393 -4.209 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -60.06 -22.17 62.36 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.875 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HB2' HG13 ' A' ' 49' ' ' ILE . 33.1 t70 -81.86 6.17 16.58 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.683 1.23 . . . . 0.0 110.106 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.01 -27.17 9.38 Favored Glycine 0 CA--C 1.467 -2.917 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.564 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.51 145.97 47.14 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.54 HG21 ' CB ' ' A' ' 56' ' ' LYS . 94.2 m -119.18 134.02 55.44 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.569 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 36.3 m-85 -133.62 152.54 51.91 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 121.222 0.534 . . . . 0.0 111.946 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -37.01 93.75 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 113.903 -1.498 . . . . 0.0 115.132 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.2 p30 -141.92 175.82 9.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -67.77 -36.87 81.27 Favored 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.348 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.22 -37.66 86.21 Favored 'General case' 0 C--N 1.252 -3.643 0 CA-C-O 122.422 1.106 . . . . 0.0 110.801 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.41 -36.46 83.81 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.987 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -92.24 -25.32 18.69 Favored 'General case' 0 C--O 1.195 -1.792 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.706 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG23 ' A' ' 43' ' ' VAL . 12.9 t -51.68 -50.55 60.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.887 1.275 . . . . 0.0 111.68 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.19 -29.38 67.35 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-O 122.186 0.993 . . . . 0.0 113.626 -176.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -78.52 -28.08 46.17 Favored 'General case' 1 C--N 1.224 -4.851 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.546 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.826 ' HA ' HD13 ' A' ' 49' ' ' ILE . 35.3 mt -64.43 -43.31 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.614 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.2 t -56.96 -36.84 51.74 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 111.443 -2.617 . . . . 0.0 111.351 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 38.5 mmtm -82.44 -38.69 23.63 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.144 0.497 . . . . 0.0 112.301 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 49' ' ' ILE . 9.5 t -81.88 -14.85 55.65 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.367 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.59 0.2 6.23 Favored Glycine 0 N--CA 1.401 -3.663 0 N-CA-C 117.002 1.561 . . . . 0.0 117.002 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.11 84.21 Favored Glycine 0 C--N 1.283 -2.382 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.807 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.293 44.1 mttt -56.89 -36.52 70.23 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 122.029 0.919 . . . . 0.0 109.812 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.826 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.2 mp -59.69 132.05 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.683 -166.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.2 m -138.22 178.47 7.11 Favored 'General case' 0 C--N 1.26 -3.313 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 171.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 51' ' ' LEU . 22.0 tp -91.9 140.37 29.74 Favored 'General case' 1 N--CA 1.321 -6.918 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.4 ttmt -96.17 -52.78 3.88 Favored 'General case' 1 N--CA 1.343 -5.777 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.093 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -141.11 139.21 18.84 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.659 -173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.13 110.13 2.82 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 106.766 -2.052 . . . . 0.0 106.766 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.6 173.77 17.04 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -171.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.4 pttp -75.93 172.23 13.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 121.665 0.745 . . . . 0.0 110.646 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 27.9 m . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 166.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 122.397 1.094 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.23 111.21 12.72 Favored Pre-proline 0 C--N 1.267 -3.0 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.995 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 39.3 Cg_exo -60.0 143.03 99.61 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 123.775 2.983 . . . . 0.0 112.673 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.44 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.5 130.58 11.87 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 123.729 0.811 . . . . 0.0 110.039 -170.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.9 t -103.35 105.44 15.71 Favored 'General case' 0 C--N 1.258 -3.396 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.697 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -86.16 177.04 49.03 Favored Glycine 0 CA--C 1.464 -3.144 0 C-N-CA 119.284 -1.436 . . . . 0.0 113.798 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 49' ' ' ILE . 35.8 m -76.03 4.08 9.09 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-O 121.827 0.822 . . . . 0.0 109.094 173.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.59 -18.28 65.28 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.603 2.361 . . . . 0.0 105.746 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -32.91 6.46 Favored Glycine 0 N--CA 1.399 -3.793 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.662 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -91.71 156.14 17.79 Favored 'General case' 0 CA--C 1.47 -2.116 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 75.8 m -96.48 128.76 43.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.109 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 91.8 m-85 -116.02 147.88 40.75 Favored 'General case' 0 N--CA 1.38 -3.955 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.7 -27.44 61.52 Favored Glycine 0 C--N 1.299 -1.509 0 O-C-N 124.873 1.358 . . . . 0.0 113.011 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 27.0 p30 -159.66 171.17 20.07 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 41.0 ttmt -63.17 -32.78 74.26 Favored 'General case' 0 C--O 1.182 -2.467 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.567 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 2.7 t -49.11 -53.86 18.75 Favored 'General case' 1 C--N 1.242 -4.082 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.572 173.237 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.0 -41.9 90.42 Favored 'General case' 0 C--N 1.264 -3.124 0 C-N-CA 125.566 1.547 . . . . 0.0 111.03 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.697 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 19.2 t80 -85.53 -17.41 36.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.1 t -61.78 -31.09 71.27 Favored 'General case' 0 C--O 1.181 -2.516 0 O-C-N 121.707 -0.621 . . . . 0.0 110.501 -172.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.7 -32.2 73.77 Favored 'General case' 0 CA--C 1.461 -2.48 0 CA-C-O 122.398 1.094 . . . . 0.0 112.454 -171.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.789 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -66.28 -40.56 90.17 Favored 'General case' 1 C--N 1.234 -4.455 0 CA-C-N 111.971 -2.377 . . . . 0.0 108.014 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 39' ' ' CYS . 53.5 mt -71.22 -50.63 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.37 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 39' ' ' CYS . 18.3 t -53.85 -52.1 38.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.196 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.84 -30.61 68.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.436 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.5 m -90.44 12.27 19.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.491 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.64 6.03 68.31 Favored Glycine 0 N--CA 1.408 -3.219 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 93.4 -4.37 73.37 Favored Glycine 1 C--N 1.248 -4.345 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 10.0 mptt -68.48 -29.78 68.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.7 mt -75.93 149.07 6.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.048 173.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -132.16 -177.48 4.47 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.8 tp -87.2 140.79 29.19 Favored 'General case' 1 N--CA 1.331 -6.401 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.6 ttmt -85.44 -56.32 3.58 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.299 170.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 63.7 m170 -140.33 136.48 16.86 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.589 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.3 110.19 3.06 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 N-CA-C 106.643 -2.099 . . . . 0.0 106.643 167.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 109.4 -173.93 17.57 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 9.0 mtpm? -67.05 170.22 7.19 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 66.3 m . . . . . 0 C--N 1.275 -2.655 0 CA-C-N 109.956 -3.293 . . . . 0.0 103.055 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.412 -2.343 0 CA-C-O 122.919 1.342 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 79.2 m-20 -111.14 92.43 15.43 Favored Pre-proline 0 C--N 1.264 -3.141 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.731 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -63.79 125.33 15.21 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.961 1.774 . . . . 0.0 110.445 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -141.7 125.07 16.56 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-O 122.187 0.994 . . . . 0.0 110.915 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 43.0 t -100.05 106.79 18.58 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.22 159.27 53.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.412 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.7 m -53.46 -22.1 7.33 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 123.575 0.75 . . . . 0.0 112.072 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.9 11.6 7.44 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.773 0.797 . . . . 0.0 110.521 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.55 -27.34 5.29 Favored Glycine 0 CA--C 1.479 -2.185 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.571 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.84 129.89 38.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 56' ' ' LYS . 84.6 m -107.8 134.7 50.38 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 112.575 -2.102 . . . . 0.0 112.208 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 11.3 m-85 -132.01 165.73 23.31 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.711 169.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.87 97.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.991 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.4 p30 -141.78 177.49 8.14 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 117.783 0.791 . . . . 0.0 109.408 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 32.8 ttpt -66.25 -39.33 89.43 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-O 121.432 0.634 . . . . 0.0 112.498 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -60.57 -38.22 83.88 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.283 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -59.44 -40.82 88.01 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.567 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 11.4 t80 -102.65 -2.06 29.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.793 ' HA ' HD12 ' A' ' 42' ' ' ILE . 10.6 t -58.42 -40.95 83.88 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 123.536 0.735 . . . . 0.0 112.156 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.572 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.48 -26.24 58.03 Favored 'General case' 0 CA--C 1.472 -2.056 0 CA-C-O 123.036 1.398 . . . . 0.0 109.637 -171.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 40' ' ' LYS . . . -80.36 -27.24 38.28 Favored 'General case' 1 C--N 1.229 -4.635 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.999 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 39' ' ' CYS . 37.6 mt -67.59 -41.31 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.4 t -56.05 -39.12 56.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.672 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 68.1 mmtt -84.59 -36.91 21.75 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.255 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.596 ' HB2' HD11 ' A' ' 49' ' ' ILE . 75.7 m -88.77 20.51 3.46 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.26 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.45 63.67 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 118.19 2.036 . . . . 0.0 118.19 166.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.77 0.46 49.85 Favored Glycine 0 C--N 1.283 -2.368 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.563 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 45' ' ' SER . 1.3 mtpm? -55.64 -26.46 44.51 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 123.286 0.634 . . . . 0.0 111.084 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.3 mp -64.99 133.24 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 123.072 1.415 . . . . 0.0 111.633 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -137.94 -176.03 4.29 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 51' ' ' LEU . 16.2 tp -89.73 139.47 30.53 Favored 'General case' 1 N--CA 1.316 -7.138 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.433 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 11.7 tptp -99.01 -39.08 8.71 Favored 'General case' 0 N--CA 1.384 -3.735 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.26 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 32.9 t-80 -164.38 136.29 3.62 Favored Pre-proline 0 C--N 1.28 -2.428 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.588 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 5.8 Cg_exo -78.24 109.65 2.72 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 170.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.54 168.82 21.86 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' THR . 2.3 mmmp? -48.37 154.55 0.6 Allowed 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 118.666 2.839 . . . . 0.0 118.666 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' C ' ' HZ3' ' A' ' 56' ' ' LYS . 98.5 m . . . . . 0 C--N 1.253 -3.6 0 CA-C-N 108.914 -3.767 . . . . 0.0 102.922 165.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.423 -1.824 0 CA-C-O 121.715 0.769 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.58 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 3.0 t-20 -111.15 92.74 16.12 Favored Pre-proline 0 C--N 1.275 -2.659 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.341 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 72.3 Cg_endo -88.37 124.98 1.75 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.705 1.603 . . . . 0.0 112.839 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 60.8 m-70 -152.14 128.98 10.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 C-N-CA 125.161 1.384 . . . . 0.0 108.596 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.7 t -96.14 110.53 22.78 Favored 'General case' 0 C--N 1.261 -3.252 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.7 164.48 54.75 Favored Glycine 0 N--CA 1.4 -3.761 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.003 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.7 p -62.42 -8.48 6.17 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 123.264 0.626 . . . . 0.0 110.58 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.96 -23.02 59.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 126.362 1.865 . . . . 0.0 108.578 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -27.4 20.45 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -76.86 141.8 40.47 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 87.7 m -107.09 126.31 52.19 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.699 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 29.8 p90 -102.17 134.46 45.39 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.293 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -34.07 67.65 Favored Glycine 0 CA--C 1.503 -0.682 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.926 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 33.9 p30 -143.7 167.7 21.65 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 172.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -72.61 -33.35 66.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.667 0.746 . . . . 0.0 110.219 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -52.4 -36.16 53.47 Favored 'General case' 0 C--N 1.254 -3.581 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.427 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -47.95 -49.39 30.49 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 125.408 1.693 . . . . 0.0 111.115 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 32' ' ' TYR 0.407 44.1 p90 -145.58 42.24 1.25 Allowed 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 118.007 -1.477 . . . . 0.0 114.869 174.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.772 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.5 t -60.8 -38.17 84.44 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.538 175.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.574 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.05 -29.3 64.01 Favored 'General case' 0 CA--C 1.458 -2.59 0 CA-C-O 123.201 1.476 . . . . 0.0 107.948 -171.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -73.06 -29.84 63.26 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.195 178.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 39' ' ' CYS . 17.1 mt -70.83 -41.5 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.598 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 39' ' ' CYS . 25.6 t -60.06 -31.8 48.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.874 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.415 172.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.35 -41.92 75.95 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.986 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 44.5 t -70.2 -44.18 69.2 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.278 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.77 2.91 Favored Glycine 1 N--CA 1.388 -4.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.939 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.37 0.25 89.98 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' SER . 55.9 mttt -65.8 -23.18 66.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 42' ' ' ILE . 30.3 mt -71.19 128.18 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.537 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m -109.5 -178.56 3.58 Favored 'General case' 0 C--N 1.26 -3.305 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 29.7 tp -95.51 140.67 30.02 Favored 'General case' 1 N--CA 1.317 -7.075 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 54.3 tttm -99.73 -43.22 6.53 Favored 'General case' 1 N--CA 1.351 -5.399 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.606 172.386 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 22.8 m170 -139.18 133.83 16.38 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.365 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.5 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 164.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 105.01 -171.98 19.42 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -169.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.4 pttp -79.45 173.28 12.74 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 122.042 0.925 . . . . 0.0 111.834 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.284 -2.263 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.598 166.107 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.624 ' O ' ' HD3' ' A' ' 23' ' ' PRO 0.278 14.8 m . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.792 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 87.4 m-20 -94.0 91.8 0.65 Allowed Pre-proline 0 C--N 1.269 -2.926 0 C-N-CA 124.357 1.063 . . . . 0.0 111.836 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 21' ' ' SER . 6.2 Cg_exo -78.68 157.36 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.174 1.916 . . . . 0.0 110.999 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -145.34 126.27 14.49 Favored 'General case' 0 CA--C 1.465 -2.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.798 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 44.8 t -103.26 110.86 23.0 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 171.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 163.44 54.68 Favored Glycine 0 N--CA 1.409 -3.157 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 p -64.33 -9.5 18.18 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.518 0.675 . . . . 0.0 110.325 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.23 -29.31 66.1 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 126.2 1.8 . . . . 0.0 109.097 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.26 -23.31 23.2 Favored Glycine 0 N--CA 1.403 -3.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.699 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.56 138.04 46.61 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 99.4 m -107.36 128.33 54.37 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.567 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 38.2 m-85 -124.63 152.06 44.09 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.931 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.91 -38.87 38.83 Favored Glycine 0 C--N 1.31 -0.916 0 O-C-N 125.144 1.527 . . . . 0.0 114.702 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.1 p30 -155.12 -179.87 8.49 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 23.1 tptm -58.44 -46.96 85.48 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.4 m -52.15 -36.22 50.86 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -63.54 -45.62 89.7 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.703 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 32' ' ' TYR . 35.6 t80 -112.73 -2.04 14.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.786 ' O ' HG23 ' A' ' 43' ' ' VAL . 44.7 t -57.05 -46.78 82.18 Favored 'General case' 0 CA--C 1.46 -2.492 0 C-N-CA 124.091 0.956 . . . . 0.0 111.085 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.745 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.99 -33.04 73.59 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.994 1.317 . . . . 0.0 114.213 -172.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.63 -31.88 57.67 Favored 'General case' 1 C--N 1.222 -4.959 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.302 178.468 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.3 mt -65.54 -40.91 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 39' ' ' CYS . 22.1 t -57.82 -35.44 51.38 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.042 -2.344 . . . . 0.0 110.922 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 31.3 mmtm -79.08 -33.0 44.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.685 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.8 m -89.94 21.25 3.72 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.594 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.87 82.3 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.73 6.73 85.44 Favored Glycine 0 C--N 1.272 -2.991 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -68.78 -25.81 64.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.217 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.31 133.99 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -120.63 -177.37 3.45 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 53' ' ' HIS . 33.1 tp -88.35 141.03 28.88 Favored 'General case' 1 N--CA 1.321 -6.887 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 44.5 tttt -86.22 -45.92 10.85 Favored 'General case' 1 N--CA 1.366 -4.627 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.252 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.473 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.9 p80 -179.72 154.86 0.72 Allowed Pre-proline 0 C--N 1.31 -1.135 0 O-C-N 124.489 1.118 . . . . 0.0 111.681 174.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.47 149.16 74.45 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.163 1.909 . . . . 0.0 109.848 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.23 161.28 37.14 Favored Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.6 ptmm? -69.38 155.66 40.09 Favored 'General case' 0 N--CA 1.406 -2.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.125 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.25 -3.728 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.698 178.992 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.304 2.0 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -70.59 106.77 1.91 Allowed Pre-proline 0 C--N 1.264 -3.129 0 C-N-CA 123.505 0.722 . . . . 0.0 111.796 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.55 142.04 10.22 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.32 2.013 . . . . 0.0 111.851 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.414 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 73.2 m80 -150.44 127.4 11.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-O 121.745 0.783 . . . . 0.0 109.695 -172.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 51.6 t -96.22 97.96 9.93 Favored 'General case' 0 C--N 1.245 -3.949 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 170.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.16 167.79 43.93 Favored Glycine 0 CA--C 1.461 -3.338 0 C-N-CA 119.149 -1.501 . . . . 0.0 112.213 -167.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -76.51 5.45 7.31 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.207 1.004 . . . . 0.0 108.661 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.53 -14.07 62.67 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 128.339 2.656 . . . . 0.0 106.169 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.46 -35.62 4.39 Favored Glycine 0 N--CA 1.403 -3.545 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.76 155.4 18.29 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.5 m -96.93 130.01 44.3 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.048 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 50.7 m-85 -118.44 139.8 50.84 Favored 'General case' 0 N--CA 1.387 -3.617 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.855 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 -30.96 61.73 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.501 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -141.56 176.22 9.06 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.019 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -61.84 -40.22 94.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.573 0.701 . . . . 0.0 111.746 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 48.4 t -57.56 -43.69 84.66 Favored 'General case' 0 C--N 1.254 -3.579 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.492 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -67.95 -41.02 83.11 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.899 -173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 42' ' ' ILE . 38.3 t80 -85.03 -11.9 54.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.85 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -61.98 -46.05 90.96 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.554 0.742 . . . . 0.0 111.029 -178.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.79 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.24 -29.1 67.84 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-O 122.435 1.112 . . . . 0.0 112.006 -166.304 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.79 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -61.18 -41.79 97.42 Favored 'General case' 1 C--N 1.236 -4.348 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.594 178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 38' ' ' PHE . 42.2 mt -75.93 -54.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.202 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 39' ' ' CYS . 11.2 t -57.74 -33.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 112.716 -2.038 . . . . 0.0 112.953 -174.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -92.39 -31.88 15.16 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 32.4 t -70.5 -38.73 74.35 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.133 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 26.89 2.05 Favored Glycine 1 N--CA 1.379 -5.126 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.856 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.39 -5.1 64.94 Favored Glycine 0 C--N 1.305 -1.152 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 45' ' ' SER . 50.3 mttt -65.21 -27.03 68.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 41' ' ' ALA . 71.5 mt -85.28 141.15 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.416 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -126.17 -178.09 4.19 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.216 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.491 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.9 tp -98.89 140.9 32.36 Favored 'General case' 1 N--CA 1.328 -6.545 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -80.84 -57.55 3.5 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 122.419 1.104 . . . . 0.0 108.202 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.413 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.3 m80 -145.09 139.69 15.37 Favored Pre-proline 0 C--N 1.294 -1.819 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.587 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.51 110.17 3.0 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.36 171.39 14.5 Favored Glycine 0 C--N 1.289 -2.051 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -76.13 175.13 9.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 122.748 1.261 . . . . 0.0 113.665 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.269 -2.909 0 CA-C-N 112.024 -2.353 . . . . 0.0 104.958 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 17.2 m . . . . . 0 N--CA 1.419 -2.019 0 CA-C-O 122.942 1.354 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 83.7 m-20 -111.28 103.28 54.77 Favored Pre-proline 0 C--N 1.258 -3.405 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.501 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.57 136.79 31.68 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.469 1.446 . . . . 0.0 111.125 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.58 ' HB3' HD13 ' A' ' 51' ' ' LEU . 79.2 m-70 -143.88 127.61 17.18 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.924 0.869 . . . . 0.0 109.977 -175.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.1 t -93.7 103.25 15.41 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.26 161.03 45.49 Favored Glycine 0 N--CA 1.41 -3.071 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.888 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.6 p -54.03 -28.38 38.12 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 123.895 0.878 . . . . 0.0 110.398 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.639 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.0 t70 -60.85 -46.37 90.84 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.687 1.232 . . . . 0.0 109.085 173.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.35 -16.63 7.09 Favored Glycine 1 CA--C 1.445 -4.294 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.5 mt-30 -72.23 135.57 46.1 Favored 'General case' 0 CA--C 1.455 -2.691 0 CA-C-N 114.002 -1.099 . . . . 0.0 113.704 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.537 HG21 ' HG2' ' A' ' 56' ' ' LYS . 90.0 m -102.34 121.38 42.18 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.873 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HD2' ' O ' ' A' ' 34' ' ' ASN . 5.3 p90 -111.64 135.48 52.18 Favored 'General case' 1 N--CA 1.377 -4.082 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.447 177.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.08 -39.95 92.84 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.386 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 21' ' ' SER . 28.9 p30 -140.55 170.22 16.19 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.59 -36.33 80.68 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.542 0.687 . . . . 0.0 112.397 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -33.57 75.07 Favored 'General case' 0 C--N 1.246 -3.897 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.891 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.555 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -50.58 -43.54 56.5 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.35 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -118.37 -1.75 11.22 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.301 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.804 ' HA ' HD12 ' A' ' 42' ' ' ILE . 52.1 t -52.17 -50.94 60.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.81 1.244 . . . . 0.0 111.644 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.712 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -66.6 -26.19 66.97 Favored 'General case' 0 N--CA 1.408 -2.532 0 C-N-CA 124.942 1.297 . . . . 0.0 114.001 -175.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -84.12 -27.19 28.35 Favored 'General case' 1 C--N 1.218 -5.115 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.732 176.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 39' ' ' CYS . 28.2 mt -66.03 -41.16 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.789 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.1 t -53.21 -44.18 51.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.4 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 42.4 mmtm -69.87 -34.84 74.12 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.733 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.7 m -81.76 -9.07 59.73 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.512 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.11 -19.5 5.44 Favored Glycine 1 N--CA 1.396 -4.024 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 97.56 -0.42 59.66 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -173.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -61.68 -32.31 72.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.165 -1.018 . . . . 0.0 112.898 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.596 ' HB ' HG12 ' A' ' 42' ' ' ILE . 3.4 mp -70.61 136.81 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 122.017 0.913 . . . . 0.0 109.724 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -131.07 -178.55 4.88 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 24' ' ' HIS . 37.9 tp -96.8 141.52 29.92 Favored 'General case' 1 N--CA 1.326 -6.67 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 42.5 mttp -89.95 -58.35 2.54 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 122.468 1.128 . . . . 0.0 109.169 165.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -138.01 143.99 41.89 Favored Pre-proline 0 C--N 1.28 -2.426 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.655 -165.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.67 109.91 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 165.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.48 165.47 12.32 Favored Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 31' ' ' THR . 12.8 mtpp -56.59 161.96 2.47 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.283 -2.308 0 CA-C-N 109.585 -3.461 . . . . 0.0 102.553 159.259 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 122.289 1.042 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -111.82 97.05 36.15 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.993 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.438 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 58.5 Cg_endo -74.65 123.93 8.42 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.618 0.878 . . . . 0.0 110.191 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 49.6 p-80 -153.06 138.29 17.44 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 46.0 t -108.69 109.77 21.02 Favored 'General case' 0 C--N 1.249 -3.761 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.17 162.91 52.86 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 19.9 m -54.91 -18.83 5.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.721 0.808 . . . . 0.0 111.64 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.3 t70 -64.92 -30.59 71.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.494 1.14 . . . . 0.0 109.081 174.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.01 -16.6 35.94 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.1 mt-30 -73.24 136.03 44.58 Favored 'General case' 0 CA--C 1.465 -2.327 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.457 HG21 ' CB ' ' A' ' 56' ' ' LYS . 99.0 m -111.13 130.21 55.69 Favored 'General case' 0 C--N 1.263 -3.189 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.101 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 54.2 m-85 -135.25 156.83 48.3 Favored 'General case' 0 N--CA 1.396 -3.143 0 CA-C-O 122.136 0.97 . . . . 0.0 112.251 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.16 -20.98 78.4 Favored Glycine 0 C--N 1.287 -2.176 0 CA-C-N 112.669 -2.06 . . . . 0.0 114.796 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 p30 -162.95 172.16 15.49 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 118.342 1.071 . . . . 0.0 108.787 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -63.86 -38.82 92.51 Favored 'General case' 0 C--O 1.197 -1.692 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -53.05 -43.93 67.03 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.931 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.7 -40.78 97.63 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.945 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 30' ' ' GLN . 44.6 t80 -104.03 5.2 35.19 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.3 t -61.43 -41.01 96.51 Favored 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 122.362 0.265 . . . . 0.0 110.361 -171.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.86 -30.01 71.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 125.618 1.567 . . . . 0.0 114.181 -174.084 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.55 -36.12 65.59 Favored 'General case' 1 C--N 1.209 -5.515 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.67 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 39' ' ' CYS . 40.3 mt -72.56 -44.44 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.954 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 39' ' ' CYS . 48.9 t -51.9 -50.97 31.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -66.93 -37.72 84.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.263 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m -87.06 13.25 9.63 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.865 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.85 79.99 Favored Glycine 0 N--CA 1.401 -3.636 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.406 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 79.05 2.72 87.52 Favored Glycine 0 C--N 1.279 -2.616 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.99 -21.98 62.23 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.1 mt -71.12 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.262 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 m -124.0 -173.45 2.76 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 32.6 tp -88.59 141.14 28.77 Favored 'General case' 1 N--CA 1.329 -6.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 52.0 tttm -99.88 -42.23 6.89 Favored 'General case' 1 N--CA 1.361 -4.882 0 C-N-CA 124.585 1.154 . . . . 0.0 111.152 174.599 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 28.3 m170 -138.26 132.65 16.87 Favored Pre-proline 0 C--N 1.284 -2.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.669 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.05 109.49 2.89 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 N-CA-C 105.067 -2.705 . . . . 0.0 105.067 163.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 107.58 176.52 22.48 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -169.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.2 ptmm? -70.29 169.24 14.2 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.449 1.119 . . . . 0.0 113.322 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.286 -2.174 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.672 166.232 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.424 -1.743 0 CA-C-O 122.907 1.336 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 49.4 t-20 -111.16 95.65 26.42 Favored Pre-proline 0 C--N 1.25 -3.75 0 CA-C-N 112.073 -2.331 . . . . 0.0 106.577 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.6 Cg_exo -71.08 150.06 59.53 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.581 1.521 . . . . 0.0 111.434 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 31' ' ' THR . 18.9 m80 -138.94 122.52 17.38 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -98.0 100.35 11.68 Favored 'General case' 0 C--N 1.254 -3.554 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 171.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -75.72 166.81 54.66 Favored Glycine 0 N--CA 1.407 -3.242 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.993 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.5 m -65.86 -6.52 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.796 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.82 -7.97 59.65 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.908 1.283 . . . . 0.0 108.424 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.95 -27.15 10.51 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.79 136.2 43.56 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 56' ' ' LYS . 98.3 m -106.33 128.95 54.38 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.228 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -123.66 147.05 47.76 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.575 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.56 -38.63 82.05 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.834 1.334 . . . . 0.0 115.289 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.8 p30 -143.67 174.77 10.5 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -67.9 -31.43 71.2 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.613 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -38.98 90.1 Favored 'General case' 0 C--N 1.25 -3.723 0 CA-C-O 122.905 1.336 . . . . 0.0 110.074 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.79 -32.47 69.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 112.609 -2.087 . . . . 0.0 108.659 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 30.3 t80 -85.11 -10.61 56.62 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.482 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.792 ' O ' HG23 ' A' ' 43' ' ' VAL . 31.2 m -58.84 -52.43 65.76 Favored 'General case' 0 C--O 1.188 -2.164 0 O-C-N 121.366 -0.834 . . . . 0.0 112.765 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -65.39 -32.41 74.03 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 123.339 1.542 . . . . 0.0 111.27 -177.075 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -66.49 -26.49 67.2 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.465 176.551 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.862 HG22 ' HA2' ' A' ' 47' ' ' GLY . 33.3 mt -81.47 -44.24 20.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.252 1.501 . . . . 0.0 108.344 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 39' ' ' CYS . 96.0 t -54.31 -36.69 34.36 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.976 0 CA-C-N 111.495 -2.593 . . . . 0.0 112.21 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.1 ptmm? -56.96 -26.09 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.551 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.57 ' HB2' HD11 ' A' ' 49' ' ' ILE . 17.6 m -134.26 57.47 1.81 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 122.185 0.993 . . . . 0.0 112.463 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.32 -0.17 69.48 Favored Glycine 0 N--CA 1.41 -3.064 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 168.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.862 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.6 -0.94 84.58 Favored Glycine 0 N--CA 1.411 -3.018 0 C-N-CA 120.285 -0.959 . . . . 0.0 111.917 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.1 -14.94 58.12 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 45' ' ' SER . 68.2 mt -62.22 149.92 8.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.636 0.732 . . . . 0.0 110.423 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -125.74 178.4 5.72 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.8 tp -94.43 141.87 28.08 Favored 'General case' 1 N--CA 1.336 -6.155 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 178.366 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HA ' ' HZ1' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.32 -51.62 5.47 Favored 'General case' 0 CA--C 1.453 -2.763 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.609 166.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.8 t-80 -149.21 132.34 8.24 Favored Pre-proline 0 C--N 1.258 -3.407 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.909 -169.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 4.3 Cg_exo -76.39 109.83 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 N-CA-C 107.211 -1.88 . . . . 0.0 107.211 168.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 119.75 165.12 12.87 Favored Glycine 0 C--N 1.279 -2.622 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -171.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 9.0 mtpm? -60.1 164.41 4.08 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 C--N 1.269 -2.903 0 N-CA-C 102.082 -3.303 . . . . 0.0 102.082 158.763 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.218 -0.557 0 CA-C-O 122.168 0.985 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.7 m-20 -62.28 112.8 7.06 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.34 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.01 148.11 34.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.558 2.172 . . . . 0.0 112.007 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.467 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 94.1 m-70 -152.06 128.07 10.37 Favored 'General case' 0 CA--C 1.476 -1.876 0 CA-C-O 121.964 0.887 . . . . 0.0 110.901 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 42.2 t -94.42 98.79 11.12 Favored 'General case' 0 C--N 1.256 -3.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 170.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -82.89 166.3 44.66 Favored Glycine 0 CA--C 1.463 -3.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.417 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -77.36 4.75 10.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.01 -18.11 65.22 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 127.515 2.326 . . . . 0.0 106.539 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.42 -35.3 5.15 Favored Glycine 1 N--CA 1.391 -4.363 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 75.1 mt-30 -91.6 156.28 17.74 Favored 'General case' 0 CA--C 1.457 -2.602 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.525 HG21 ' HG2' ' A' ' 56' ' ' LYS . 95.3 m -96.21 124.63 40.28 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 112.847 -1.979 . . . . 0.0 108.106 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 93.6 m-85 -110.98 145.2 38.85 Favored 'General case' 0 N--CA 1.381 -3.887 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.564 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.22 85.66 Favored Glycine 0 C--N 1.3 -1.42 0 O-C-N 125.114 1.509 . . . . 0.0 112.522 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.4 p-10 -156.47 173.35 17.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.187 0.518 . . . . 0.0 111.097 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -28.38 66.48 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 125.71 1.604 . . . . 0.0 110.558 -176.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.5 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 0.7 OUTLIER -57.0 -49.23 76.42 Favored 'General case' 1 C--N 1.241 -4.116 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.476 175.172 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -76.7 -35.18 58.03 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.811 -175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 29.2 t80 -86.76 -24.61 25.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.7 t -67.56 -28.5 67.84 Favored 'General case' 0 C--O 1.188 -2.137 0 CA-C-N 119.55 1.068 . . . . 0.0 110.686 -172.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.83 -31.8 73.2 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.817 1.294 . . . . 0.0 111.468 -170.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.806 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -64.59 -40.23 95.15 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 111.569 -2.559 . . . . 0.0 108.648 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.3 mt -73.31 -46.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.822 -175.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 39' ' ' CYS . 26.4 t -56.6 -35.18 44.06 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.655 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' NZ ' ' HA ' ' A' ' 44' ' ' LYS . 1.9 mmpm? -84.53 -35.91 22.53 Favored 'General case' 0 C--N 1.281 -2.382 0 O-C-N 121.692 -0.63 . . . . 0.0 112.59 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 t -74.92 -23.49 58.35 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.843 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.89 7.96 Favored Glycine 0 N--CA 1.401 -3.661 0 C-N-CA 121.073 -0.585 . . . . 0.0 113.383 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 -8.49 79.71 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -65.92 -28.26 68.8 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 41' ' ' ALA . 74.3 mt -82.93 147.94 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.911 173.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.1 m -137.99 179.98 6.11 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 46.6 tp -88.92 141.46 28.47 Favored 'General case' 1 N--CA 1.339 -6.002 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -81.1 -59.22 2.73 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.105 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -143.59 142.05 20.16 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.784 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.08 110.34 2.87 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.861 1.708 . . . . 0.0 107.983 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.71 175.3 17.6 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HG2' HG21 ' A' ' 31' ' ' THR . 8.6 mtpm? -64.3 162.04 15.58 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--N 1.267 -2.997 1 N-CA-C 99.58 -4.23 . . . . 0.0 99.58 158.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.617 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 t . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 79.1 m-20 -106.61 92.92 7.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 C-N-CA 117.904 -1.519 . . . . 0.0 114.29 -173.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 21' ' ' SER . 4.0 Cg_endo -83.19 153.6 14.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.126 1.884 . . . . 0.0 110.53 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -150.63 128.41 11.66 Favored 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.3 t -99.46 95.77 7.23 Favored 'General case' 1 C--N 1.242 -4.069 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 168.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.8 165.17 39.89 Favored Glycine 0 CA--C 1.451 -3.909 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.863 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 49' ' ' ILE . 41.4 m -67.93 4.85 1.03 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 117.912 0.856 . . . . 0.0 111.441 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.2 -24.35 66.26 Favored 'General case' 0 C--N 1.364 1.225 0 C-N-CA 127.189 2.196 . . . . 0.0 105.757 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.11 -31.04 8.99 Favored Glycine 0 N--CA 1.396 -3.98 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.236 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.04 155.99 19.13 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 97.6 m -97.72 124.32 42.01 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.239 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.1 m-85 -117.58 142.51 47.12 Favored 'General case' 0 N--CA 1.383 -3.789 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.435 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -36.19 82.24 Favored Glycine 0 C--N 1.309 -0.97 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.199 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.3 p30 -145.72 -178.29 6.02 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 117.258 0.529 . . . . 0.0 109.602 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -67.59 -37.35 82.44 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.121 0.486 . . . . 0.0 112.175 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.79 -38.39 87.89 Favored 'General case' 0 C--N 1.25 -3.728 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.702 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.04 -37.44 87.19 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.141 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 13.5 t80 -94.55 -8.75 37.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.832 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.796 ' O ' HG23 ' A' ' 43' ' ' VAL . 16.1 t -62.51 -37.59 86.64 Favored 'General case' 0 CA--C 1.472 -2.024 0 C-N-CA 123.088 0.555 . . . . 0.0 110.455 -171.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -65.27 -33.39 75.86 Favored 'General case' 0 CA--C 1.454 -2.723 0 C-N-CA 124.362 1.065 . . . . 0.0 113.103 -172.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.742 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.33 -34.85 59.0 Favored 'General case' 1 C--N 1.218 -5.114 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.815 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.2 mt -63.04 -43.42 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.444 -3.127 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 39' ' ' CYS . 41.2 t -55.03 -41.9 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.641 0 CA-C-N 111.518 -2.583 . . . . 0.0 111.053 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 24.7 mmtm -65.21 -37.69 88.11 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HG13 ' A' ' 49' ' ' ILE . 24.7 m -104.08 28.59 6.62 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.984 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 20.61 59.1 Favored Glycine 0 N--CA 1.4 -3.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 77.64 0.55 74.08 Favored Glycine 0 C--N 1.275 -2.847 0 CA-C-N 117.896 0.848 . . . . 0.0 111.226 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -80.4 -21.4 42.3 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' SER . 75.1 mt -62.98 152.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 121.053 0.454 . . . . 0.0 110.271 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -127.68 -176.28 3.72 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.5 tp -97.0 140.75 31.05 Favored 'General case' 1 N--CA 1.332 -6.365 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 36.1 mtpt -81.63 -50.2 9.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 121.965 0.888 . . . . 0.0 108.611 170.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 17.8 t-80 -154.89 133.17 6.87 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.057 -171.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.13 110.7 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.264 1.976 . . . . 0.0 108.481 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 113.27 -170.25 13.28 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -172.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.0 ptmm? -80.49 166.8 20.86 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.769 0.795 . . . . 0.0 112.415 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 165.909 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.5 0.667 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 18.6 t-20 -70.95 110.61 7.54 Favored Pre-proline 0 C--N 1.271 -2.843 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.8 Cg_exo -71.44 159.62 50.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.578 2.185 . . . . 0.0 112.459 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -151.75 130.64 12.5 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 123.289 0.636 . . . . 0.0 109.698 -172.918 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 50.4 t -108.43 104.37 13.7 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -69.63 169.25 45.04 Favored Glycine 0 N--CA 1.414 -2.793 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.268 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -65.21 -19.39 65.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.7 t70 -61.26 -36.86 81.15 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 125.272 1.429 . . . . 0.0 108.953 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.73 -18.66 14.76 Favored Glycine 0 N--CA 1.398 -3.887 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.1 mt-30 -71.66 135.3 46.82 Favored 'General case' 0 CA--C 1.452 -2.822 0 CA-C-O 122.375 1.083 . . . . 0.0 113.795 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.4 m -117.86 133.17 56.2 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.019 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 66.4 m-85 -131.26 162.33 30.27 Favored 'General case' 0 N--CA 1.38 -3.928 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.398 172.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 -25.11 63.62 Favored Glycine 0 C--N 1.294 -1.773 0 CA-C-N 113.386 -1.733 . . . . 0.0 113.362 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.7 p30 -158.99 168.21 27.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.07 -35.62 73.67 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.647 0.737 . . . . 0.0 111.571 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -52.67 32.67 Favored 'General case' 0 C--N 1.256 -3.499 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.335 174.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.33 -33.74 76.41 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.258 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 26' ' ' GLY . 48.2 t80 -95.0 -2.11 51.04 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.127 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.832 ' O ' HG23 ' A' ' 43' ' ' VAL . 14.5 p -61.38 -43.85 98.16 Favored 'General case' 0 CA--C 1.439 -3.296 0 O-C-N 121.908 -0.495 . . . . 0.0 111.149 -172.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -57.26 -35.57 69.9 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 126.152 1.781 . . . . 0.0 114.496 -172.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -68.59 -39.49 80.9 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.665 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 39' ' ' CYS . 34.9 mt -69.19 -48.12 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.001 -177.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 39' ' ' CYS . 37.1 t -50.75 -50.63 22.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 112.009 -2.359 . . . . 0.0 111.832 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 28.6 mmtm -78.73 -32.59 46.82 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.87 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.479 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 16.3 m -80.55 4.21 19.2 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.017 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.45 19.05 46.7 Favored Glycine 1 N--CA 1.385 -4.706 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 171.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 -0.47 62.63 Favored Glycine 0 C--N 1.29 -2.012 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 45' ' ' SER . 38.7 mttp -71.77 -19.39 62.02 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -79.83 140.99 15.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.645 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 m -121.08 -179.71 4.12 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.493 HD12 ' HA2' ' A' ' 26' ' ' GLY . 35.9 tp -90.16 141.06 29.07 Favored 'General case' 1 N--CA 1.324 -6.765 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.655 ' HD2' ' SG ' ' A' ' 57' ' ' CYS . 2.2 ttmp? -90.02 -54.59 3.97 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.842 170.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 58.9 m170 -139.38 137.16 18.55 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.083 -173.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.62 109.83 2.93 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 N-CA-C 105.796 -2.424 . . . . 0.0 105.796 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.84 -177.22 16.96 Favored Glycine 0 C--N 1.284 -2.341 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -169.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.2 pttp -79.21 173.35 12.67 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-O 121.901 0.857 . . . . 0.0 111.327 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.655 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 24.8 m . . . . . 0 C--N 1.281 -2.409 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 165.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 34' ' ' ASN . 27.3 m . . . . . 0 N--CA 1.414 -2.257 0 CA-C-O 122.12 0.962 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -110.75 100.44 45.88 Favored Pre-proline 0 C--N 1.276 -2.625 0 CA-C-N 113.161 -1.836 . . . . 0.0 109.554 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 6.8 Cg_exo -75.59 125.19 8.77 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.426 2.084 . . . . 0.0 111.267 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -151.53 129.32 11.62 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 125.236 1.415 . . . . 0.0 108.845 -174.547 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -92.61 106.73 18.66 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 160.35 53.54 Favored Glycine 0 N--CA 1.401 -3.657 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.349 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 50.3 m -64.61 -7.37 10.23 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.854 0.835 . . . . 0.0 110.468 173.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -81.36 -10.48 59.53 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.763 2.025 . . . . 0.0 108.374 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.49 -31.6 6.32 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.266 26.1 mt-30 -74.72 130.08 38.85 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 56' ' ' LYS . 89.9 m -98.81 126.04 44.35 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.695 -2.048 . . . . 0.0 110.092 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 30.1 p90 -106.99 133.03 52.24 Favored 'General case' 0 N--CA 1.39 -3.45 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.745 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.75 -42.51 61.55 Favored Glycine 0 CA--C 1.499 -0.912 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.807 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 21' ' ' SER . 32.6 p30 -128.72 168.78 15.34 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -71.58 -35.47 70.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.733 0.777 . . . . 0.0 110.141 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -48.26 -44.9 33.85 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.755 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -50.76 -42.99 58.21 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.431 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 8.8 t80 -127.53 -1.36 6.18 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 117.492 -1.683 . . . . 0.0 114.186 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 42' ' ' ILE . 31.7 p -51.45 -55.35 19.25 Favored 'General case' 0 C--O 1.194 -1.861 0 C-N-CA 123.471 0.708 . . . . 0.0 111.38 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -65.12 -24.38 67.4 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 127.045 2.138 . . . . 0.0 114.586 -177.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -82.04 -28.73 32.32 Favored 'General case' 1 C--N 1.202 -5.816 0 CA-C-N 113.179 -1.828 . . . . 0.0 110.718 173.605 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.0 mt -66.99 -43.14 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.78 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.7 t -50.34 -41.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 110.619 -2.991 . . . . 0.0 110.995 171.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -86.0 -29.46 23.48 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.464 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' HD3' ' A' ' 48' ' ' LYS . 64.3 m -86.85 12.96 9.77 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.43 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.36 3.48 72.15 Favored Glycine 0 N--CA 1.413 -2.895 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.68 14.12 82.83 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 4.5 pttm -64.74 -25.0 67.74 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-O 121.94 0.876 . . . . 0.0 109.671 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 42' ' ' ILE . 4.1 mp -79.02 131.51 34.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.688 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 p -130.84 -177.82 4.53 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.8 tp -95.16 141.48 28.72 Favored 'General case' 1 N--CA 1.343 -5.806 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.688 ' HA ' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.23 -54.95 3.72 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.458 164.09 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 25.1 t-80 -149.72 135.09 9.79 Favored Pre-proline 0 C--N 1.262 -3.219 0 CA-C-N 113.575 -1.648 . . . . 0.0 112.175 -167.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 8.2 Cg_exo -73.8 110.3 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.965 1.776 . . . . 0.0 108.453 170.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.92 168.74 15.35 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 31' ' ' THR . 12.3 mtpp -56.03 162.51 1.88 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.413 -2.289 0 CA-C-N 109.435 -3.53 . . . . 0.0 101.817 158.292 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 C--O 1.219 -0.542 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.76 43.0 0.47 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 148.39 51.04 0.02 OUTLIER Glycine 0 CA--C 1.482 -2.013 0 CA-C-O 122.467 1.037 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.617 ' HG2' ' N ' ' A' ' 5' ' ' VAL . 6.8 tt0 -151.4 179.21 8.54 Favored 'General case' 1 N--CA 1.351 -5.386 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' N ' ' HG2' ' A' ' 4' ' ' GLN . 10.8 p -71.4 47.72 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 CA-C-O 122.655 1.217 . . . . 0.0 108.353 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -65.89 96.55 0.3 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.454 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.607 ' HB2' HG12 ' A' ' 15' ' ' VAL . 80.1 m -49.43 100.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.584 168.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.55 8.48 0.5 Allowed Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.557 1.075 . . . . 0.0 115.651 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB3' HG21 ' A' ' 43' ' ' VAL . 39.4 mt-10 -78.03 -45.05 24.73 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.9 t80 42.19 47.09 3.96 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 127.406 2.282 . . . . 0.0 114.871 159.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.609 ' HG3' HG13 ' A' ' 43' ' ' VAL . 88.2 mm-40 -69.35 -12.52 61.73 Favored 'General case' 1 C--N 1.238 -4.268 0 CA-C-O 123.235 1.493 . . . . 0.0 112.185 174.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.554 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 3.4 t70 -143.04 -176.08 4.77 Favored 'General case' 1 N--CA 1.364 -4.771 0 CA-C-N 112.779 -2.009 . . . . 0.0 106.329 177.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 t -100.04 -27.51 13.52 Favored 'General case' 0 C--N 1.257 -3.444 0 CA-C-O 121.484 0.659 . . . . 0.0 110.762 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HG2' ' OD2' ' A' ' 12' ' ' ASP . 23.8 pttm -84.69 18.6 2.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.913 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 7' ' ' CYS . 3.4 t -92.7 86.11 2.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.445 0.641 . . . . 0.0 109.848 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -133.61 148.74 51.59 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.748 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 9.1 p -115.99 178.77 4.19 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 35' ' ' LYS . 17.2 p -96.12 152.26 18.71 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 113.752 -1.567 . . . . 0.0 113.563 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -12.6 25.9 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -105.18 174.56 5.82 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.438 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -98.04 89.62 4.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 123.4 1.572 . . . . 0.0 111.046 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 2.7 t-20 -111.06 96.29 29.18 Favored Pre-proline 0 C--N 1.253 -3.629 0 CA-C-N 112.252 -2.249 . . . . 0.0 108.369 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.3 Cg_exo -68.6 154.96 70.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.914 1.743 . . . . 0.0 112.578 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -148.94 128.26 12.96 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 34.0 t -104.02 103.46 13.28 Favored 'General case' 0 C--N 1.254 -3.584 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.18 160.24 52.33 Favored Glycine 0 N--CA 1.4 -3.711 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.057 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.2 m -66.93 -4.73 10.21 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 120.701 0.286 . . . . 0.0 110.666 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -7.77 53.03 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.17 1.462 . . . . 0.0 107.749 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.25 -34.37 5.77 Favored Glycine 0 N--CA 1.397 -3.941 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.321 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.16 155.12 30.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 88.4 m -110.92 131.22 55.23 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.053 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -120.77 138.24 54.11 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.542 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.83 -34.72 65.62 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 114.874 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.8 p30 -147.28 178.26 8.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 18' ' ' THR . 68.1 tttt -74.54 -30.07 61.62 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-O 122.148 0.975 . . . . 0.0 111.217 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.748 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -60.5 -39.13 86.62 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.128 173.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.774 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 27.5 t80 -81.17 -15.65 55.16 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.66 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.738 ' O ' HG23 ' A' ' 43' ' ' VAL . 40.9 m -58.17 -52.77 64.18 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 112.766 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.79 -25.2 62.77 Favored 'General case' 0 CA--C 1.462 -2.433 0 CA-C-O 123.413 1.578 . . . . 0.0 111.048 -176.498 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.75 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -75.81 -25.8 56.67 Favored 'General case' 1 C--N 1.206 -5.664 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.927 175.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.789 HG22 ' HA2' ' A' ' 47' ' ' GLY . 20.5 mt -73.16 -41.37 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.049 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 39' ' ' CYS . 84.3 t -57.9 -29.89 36.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 110.85 -2.886 . . . . 0.0 110.516 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -48.38 -43.63 34.02 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 178.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 49' ' ' ILE . 5.6 m -134.39 61.67 1.67 Allowed 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 122.169 0.985 . . . . 0.0 111.669 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.5 0.33 89.94 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 118.561 2.184 . . . . 0.0 118.561 167.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.789 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 88.76 -19.31 38.09 Favored Glycine 0 C--N 1.27 -3.123 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.525 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 30.9 mmtm -78.0 -10.65 59.7 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.746 1.219 . . . . 0.0 113.72 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 45' ' ' SER . 59.2 mt -62.26 148.98 9.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.9 m -125.6 -179.35 4.6 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.29 141.36 32.16 Favored 'General case' 1 N--CA 1.331 -6.382 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -87.02 -55.48 3.81 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.385 1.088 . . . . 0.0 108.839 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -131.07 133.2 24.42 Favored Pre-proline 0 C--N 1.288 -2.096 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.637 -166.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.08 109.33 2.81 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 N-CA-C 104.987 -2.736 . . . . 0.0 104.987 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.69 -175.24 15.76 Favored Glycine 0 C--N 1.281 -2.476 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.6 pttp -80.65 174.35 11.7 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 121.766 0.793 . . . . 0.0 111.138 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 165.922 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.44 106.2 3.08 Favored Glycine 0 C--O 1.243 0.664 0 N-CA-C 115.65 1.02 . . . . 0.0 115.65 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.94 -94.1 1.95 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 113.791 0.276 . . . . 0.0 113.791 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -73.39 173.64 9.28 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.146 0.578 . . . . 0.0 110.254 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.24 77.86 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 122.554 1.169 . . . . 0.0 108.951 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -128.8 82.38 2.08 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HA ' HG13 ' A' ' 15' ' ' VAL 0.254 17.8 p 36.53 85.67 0.01 OUTLIER 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -175.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.45 -35.47 4.11 Favored Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.4 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 3.4 mp0 -79.68 -41.66 26.37 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.69 ' HA ' HG22 ' A' ' 43' ' ' VAL . 53.1 t80 66.7 -4.96 0.68 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.87 1.668 . . . . 0.0 115.232 169.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -134.74 -0.51 2.85 Favored 'General case' 0 C--N 1.256 -3.482 0 C-N-CA 124.054 0.942 . . . . 0.0 110.273 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.635 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 11.6 t70 -78.26 -150.74 0.05 OUTLIER 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.625 -175.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.411 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 12.5 t -137.54 -39.27 0.58 Allowed 'General case' 1 C--N 1.217 -5.152 0 O-C-N 121.653 -0.654 . . . . 0.0 111.898 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 20.1 pttm -79.27 0.12 30.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.919 0.888 . . . . 0.0 110.719 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.635 ' CG2' ' HB3' ' A' ' 12' ' ' ASP . 46.4 t -53.56 116.4 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.111 0 C-N-CA 125.307 1.443 . . . . 0.0 113.086 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -75.57 174.19 10.04 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 112.719 -2.037 . . . . 0.0 108.975 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.566 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 11.2 p -99.43 179.95 4.41 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.776 HG21 ' HG3' ' A' ' 35' ' ' LYS . 53.8 p -78.6 175.35 10.46 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 123.077 1.418 . . . . 0.0 114.737 -174.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -85.36 -5.58 59.29 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 110.842 -2.89 . . . . 0.0 109.274 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 41.3 mt-10 -99.21 141.79 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -108.98 20.24 18.64 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.982 1.372 . . . . 0.0 107.382 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.35 110.65 13.09 Favored Pre-proline 0 C--N 1.263 -3.182 0 CA-C-N 112.112 -2.313 . . . . 0.0 111.408 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 149.84 84.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.682 2.255 . . . . 0.0 111.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.68 131.35 12.32 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.64 0.776 . . . . 0.0 109.546 -172.306 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.574 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 42.0 t -100.69 108.88 20.86 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HE3' ' A' ' 52' ' ' LYS . . . -74.41 151.24 43.1 Favored Glycine 1 N--CA 1.395 -4.071 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.695 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 p -59.31 -25.86 64.5 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 124.031 0.932 . . . . 0.0 109.826 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' CB ' HG12 ' A' ' 49' ' ' ILE . 14.6 t70 -74.52 3.42 7.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 126.384 1.874 . . . . 0.0 109.872 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.95 -29.85 8.2 Favored Glycine 0 CA--C 1.468 -2.856 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.956 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -74.19 128.68 36.16 Favored 'General case' 0 CA--C 1.45 -2.867 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' HG2' ' A' ' 56' ' ' LYS . 87.7 m -107.7 132.54 53.23 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.32 -1.764 . . . . 0.0 108.843 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 96.8 m-85 -119.96 143.41 48.03 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.92 -32.21 55.78 Favored Glycine 0 C--O 1.219 -0.792 0 O-C-N 124.671 1.232 . . . . 0.0 113.969 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 31.0 p30 -155.1 174.64 14.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.776 ' HG3' HG21 ' A' ' 18' ' ' THR . 18.5 tptm -66.53 -32.92 74.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.141 0.972 . . . . 0.0 111.102 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.697 ' HA ' ' H ' ' A' ' 18' ' ' THR . 3.7 t -50.6 -53.63 29.1 Favored 'General case' 1 C--N 1.236 -4.344 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.861 171.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -70.28 -40.42 74.34 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.852 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' A' ' 35' ' ' LYS . 65.1 t80 -68.02 -46.55 70.9 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.119 -1.4 . . . . 0.0 113.529 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.791 ' HA ' HD12 ' A' ' 42' ' ' ILE . 21.9 t -70.17 -36.76 74.91 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.789 -171.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' NZ ' ' HB2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -85.78 -7.81 58.52 Favored 'General case' 0 N--CA 1.392 -3.329 0 CA-C-O 122.102 0.953 . . . . 0.0 110.581 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.07 -28.02 21.6 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.654 -2.066 . . . . 0.0 110.629 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 39' ' ' CYS . 68.8 mt -60.47 -45.42 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.904 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.8 t -52.7 -32.29 17.17 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 110.491 -3.05 . . . . 0.0 111.013 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 44' ' ' LYS . 1.8 mmpm? -86.45 -42.41 13.63 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.671 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 35.7 t -74.47 -15.98 60.87 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 123.787 0.679 . . . . 0.0 110.894 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.42 18.6 7.03 Favored Glycine 0 N--CA 1.401 -3.647 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.963 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.97 -5.59 61.85 Favored Glycine 0 C--N 1.295 -1.704 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.354 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HD3' ' O ' ' A' ' 45' ' ' SER . 3.8 mtpm? -60.49 -25.06 65.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 28' ' ' ASP . 9.5 mt -85.05 132.71 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.489 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.0 m -128.39 -179.37 4.99 Favored 'General case' 0 C--N 1.267 -3.022 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 170.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.7 tp -98.66 140.99 32.04 Favored 'General case' 1 N--CA 1.333 -6.314 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.649 ' HE3' ' O ' ' A' ' 26' ' ' GLY . 77.4 mttt -88.05 -56.89 3.14 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 122.55 1.167 . . . . 0.0 107.858 165.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 41.8 t-80 -153.88 140.13 12.63 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.218 -167.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 12.1 Cg_exo -72.06 110.28 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.085 1.857 . . . . 0.0 108.848 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 161.05 11.31 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 8.9 mtpm? -57.94 165.65 1.75 Allowed 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 C--N 1.274 -2.715 0 N-CA-C 101.522 -3.51 . . . . 0.0 101.522 159.72 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.526 ' H3 ' ' CG ' ' A' ' 6' ' ' ASP . 11.7 mm100 . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 17' ' ' CYS . . . 117.78 140.87 6.65 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.49 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.38 -69.92 0.26 Allowed Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.505 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 4.3 pm0 -73.02 -176.25 2.04 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 123.699 0.8 . . . . 0.0 110.193 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 p -70.89 4.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.291 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.526 ' CG ' ' H3 ' ' A' ' 1' ' ' GLN . 0.0 OUTLIER -72.95 105.33 4.4 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 122.93 1.348 . . . . 0.0 111.704 -171.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 47.2 t -78.04 6.0 8.78 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.907 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.32 -67.68 3.44 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 40' ' ' LYS . 37.0 mt-10 -94.72 -30.3 14.35 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.505 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' HA ' ' HB3' ' A' ' 7' ' ' CYS . 60.3 t80 62.9 84.12 0.15 Allowed 'General case' 0 C--N 1.364 1.236 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 43' ' ' VAL . 6.6 mm100 -54.27 -66.18 0.44 Allowed 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.958 166.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.639 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 21.6 t0 -149.16 173.34 13.53 Favored 'General case' 0 N--CA 1.386 -3.626 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.088 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -65.22 -16.79 63.91 Favored 'General case' 0 C--N 1.257 -3.428 0 C-N-CA 128.111 2.564 . . . . 0.0 113.767 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.639 ' HG2' ' OD2' ' A' ' 12' ' ' ASP . 34.7 mmtm -88.62 -16.87 31.34 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.813 1.292 . . . . 0.0 107.788 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.6 t -103.21 101.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.31 -173.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -136.43 156.38 48.7 Favored 'General case' 0 C--O 1.261 1.658 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.686 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 14.9 p -109.6 178.42 4.44 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.981 0.896 . . . . 0.0 112.637 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 35' ' ' LYS . 5.1 t -135.09 166.53 22.85 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.053 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -94.36 -38.26 11.07 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -55.74 139.67 44.36 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 111.309 -2.678 . . . . 0.0 109.999 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 99.25 1.87 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 122.988 1.375 . . . . 0.0 112.811 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.48 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 6.5 m-20 -110.26 94.93 19.77 Favored Pre-proline 0 C--N 1.257 -3.449 0 CA-C-N 112.218 -2.264 . . . . 0.0 107.343 175.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 61.2 Cg_endo -75.3 132.35 14.94 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.799 1.666 . . . . 0.0 112.241 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -141.97 127.71 19.23 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.3 t -102.11 107.58 18.72 Favored 'General case' 0 C--N 1.249 -3.771 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 169.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 52' ' ' LYS . . . -71.14 165.26 53.37 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.685 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -51.76 -28.77 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.444 0.698 . . . . 0.0 110.481 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 8.9 t70 -60.5 -37.32 80.74 Favored 'General case' 0 CA--C 1.48 -1.729 0 C-N-CA 126.374 1.87 . . . . 0.0 110.085 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.07 -20.08 14.65 Favored Glycine 0 CA--C 1.459 -3.451 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 46.1 mt-30 -72.2 131.97 43.47 Favored 'General case' 0 CA--C 1.468 -2.184 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.515 HG21 ' CB ' ' A' ' 56' ' ' LYS . 95.4 m -102.31 131.32 48.98 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.234 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 65.4 m-85 -123.21 143.12 50.24 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.986 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.22 95.75 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.439 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 36.9 p30 -133.15 177.14 7.9 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 117.651 0.726 . . . . 0.0 109.413 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB3' HG22 ' A' ' 18' ' ' THR . 83.6 tttt -67.97 -35.28 78.1 Favored 'General case' 0 C--O 1.189 -2.128 0 CA-C-O 121.336 0.589 . . . . 0.0 111.35 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.686 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -61.7 -38.57 88.34 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.421 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.09 -39.44 94.72 Favored 'General case' 0 C--N 1.26 -3.32 0 CA-C-N 112.977 -1.919 . . . . 0.0 109.821 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 42' ' ' ILE . 22.6 t80 -88.91 -27.55 20.9 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.153 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.804 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.9 t -57.9 -40.88 81.4 Favored 'General case' 0 CA--C 1.481 -1.71 0 C-N-CA 124.612 1.165 . . . . 0.0 110.938 -173.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -73.86 -24.08 59.69 Favored 'General case' 0 N--CA 1.409 -2.494 0 CA-C-O 122.853 1.311 . . . . 0.0 110.485 -170.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -79.7 -29.27 40.69 Favored 'General case' 0 C--N 1.265 -3.078 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.703 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.5 mt -67.08 -42.91 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 39' ' ' CYS . 10.3 t -62.56 -27.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.943 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -70.33 -39.5 74.69 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.8 -0.562 . . . . 0.0 112.275 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HG13 ' A' ' 49' ' ' ILE . 31.2 m -105.82 22.62 15.28 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.51 14.8 75.29 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 170.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.29 0.74 88.45 Favored Glycine 0 C--N 1.274 -2.88 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' NZ ' ' HA ' ' A' ' 48' ' ' LYS . 3.0 mmmp? -68.55 -28.71 67.21 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 45' ' ' SER . 40.5 mt -76.69 145.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.004 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -130.24 -175.34 3.6 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 51' ' ' LEU . 31.4 tp -86.18 141.37 29.39 Favored 'General case' 1 N--CA 1.326 -6.663 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 21.0 ttmm -91.75 -52.15 4.89 Favored 'General case' 0 N--CA 1.38 -3.936 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.514 172.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -145.21 137.27 13.16 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.856 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.04 110.38 3.06 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 107.137 -1.909 . . . . 0.0 107.137 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.79 179.47 17.8 Favored Glycine 0 C--N 1.288 -2.09 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -171.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.0 pttp -78.73 170.43 16.67 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-O 121.433 0.635 . . . . 0.0 110.617 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 32.4 m . . . . . 0 C--N 1.273 -2.742 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.86 54.5 14.28 Favored Glycine 0 C--O 1.219 -0.835 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.87 -51.51 0.75 Allowed Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -64.35 125.74 25.58 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.912 -1.144 . . . . 0.0 108.917 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG22 ' NH2' ' A' ' 19' ' ' ARG . 39.3 t -59.37 -14.9 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 126.218 1.807 . . . . 0.0 114.939 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.09 81.39 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -167.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HB3' HG12 ' A' ' 15' ' ' VAL . 71.7 m -87.43 79.67 8.35 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 164.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.95 -17.97 59.27 Favored Glycine 0 CA--C 1.496 -1.121 0 CA-C-N 113.447 -1.706 . . . . 0.0 114.147 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 43' ' ' VAL . 43.0 mt-10 -67.17 -47.11 71.96 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.8 t80 45.33 32.75 1.08 Allowed 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 125.201 1.4 . . . . 0.0 113.577 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' CG ' HG13 ' A' ' 43' ' ' VAL . 87.2 mm-40 -58.63 -24.26 60.72 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-O 122.686 1.232 . . . . 0.0 113.924 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.534 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 7.5 t70 -131.11 152.8 50.03 Favored 'General case' 2 C--N 1.24 -4.184 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.472 175.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -65.3 -28.82 69.59 Favored 'General case' 0 C--N 1.249 -3.782 0 C-N-CA 125.174 1.39 . . . . 0.0 113.435 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.534 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 7.7 ptpp? -85.73 5.19 33.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.296 0.57 . . . . 0.0 110.869 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG12 ' HB3' ' A' ' 7' ' ' CYS . 89.8 t -86.37 79.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.684 1.23 . . . . 0.0 113.847 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -138.09 151.66 48.02 Favored 'General case' 0 C--O 1.271 2.237 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.798 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 6.3 p -111.71 176.13 5.15 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 35' ' ' LYS . 17.3 p -101.4 174.3 6.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 126.263 1.825 . . . . 0.0 113.763 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' NH2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -126.23 -8.07 6.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.161 -1.836 . . . . 0.0 107.663 168.078 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -93.04 148.02 22.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 21.4 m -86.66 101.11 12.96 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 122.212 1.006 . . . . 0.0 110.651 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 7.4 t30 -111.66 94.33 23.25 Favored Pre-proline 0 C--N 1.268 -2.974 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.085 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.45 123.9 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.105 1.203 . . . . 0.0 109.584 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.742 ' HB2' HD13 ' A' ' 51' ' ' LEU . 48.7 p-80 -153.63 133.57 13.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.537 ' O ' HD12 ' A' ' 51' ' ' LEU . 44.1 t -92.74 114.19 26.68 Favored 'General case' 0 C--N 1.264 -3.143 0 CA-C-N 113.877 -1.51 . . . . 0.0 106.993 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.23 147.53 50.1 Favored Glycine 1 N--CA 1.393 -4.172 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.561 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 p -45.69 -41.27 10.26 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 124.826 1.251 . . . . 0.0 110.757 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.91 3.35 5.39 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.136 0.974 . . . . 0.0 112.81 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.43 54.59 Favored Glycine 0 CA--C 1.46 -3.358 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -73.2 122.77 22.44 Favored 'General case' 0 CA--C 1.45 -2.877 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 56' ' ' LYS . 94.7 m -116.95 127.7 54.48 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.676 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.557 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 31.6 m-85 -134.61 161.11 36.03 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.315 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.51 -31.7 52.2 Favored Glycine 0 C--N 1.298 -1.539 0 CA-C-N 113.182 -1.826 . . . . 0.0 114.563 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.8 p30 -162.7 -175.57 4.51 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 117.467 0.633 . . . . 0.0 109.549 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HB3' HG23 ' A' ' 18' ' ' THR . 23.9 tptm -68.1 -42.57 80.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.418 0.628 . . . . 0.0 111.862 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.798 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.0 OUTLIER -63.39 -32.6 74.08 Favored 'General case' 0 C--N 1.247 -3.879 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.586 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -53.61 -43.21 68.46 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.681 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -133.1 26.01 4.23 Favored 'General case' 0 C--O 1.195 -1.787 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.864 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.9 ' HA ' HD12 ' A' ' 42' ' ' ILE . 49.8 t -54.5 -45.56 73.28 Favored 'General case' 0 C--O 1.202 -1.406 0 C-N-CA 122.924 0.49 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -69.0 -25.91 64.75 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 125.69 1.596 . . . . 0.0 114.489 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.16 -25.93 33.88 Favored 'General case' 1 C--N 1.203 -5.78 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.016 174.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 39' ' ' CYS . 12.8 mt -65.45 -42.54 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 39' ' ' CYS . 80.6 t -49.5 -44.56 18.88 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.354 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.54 -31.05 29.31 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.297 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.4 m -80.89 8.4 8.38 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.358 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 2.31 58.01 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.99 -6.11 68.21 Favored Glycine 0 C--N 1.29 -2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.2 mtpm? -61.03 -25.77 67.15 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 124.627 1.171 . . . . 0.0 113.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 42' ' ' ILE . 14.4 mt -66.42 125.86 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 CA-C-O 123.02 1.39 . . . . 0.0 112.406 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -131.31 -175.33 3.66 Favored 'General case' 0 C--N 1.261 -3.258 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 24' ' ' HIS . 35.6 tp -94.98 141.21 28.92 Favored 'General case' 1 N--CA 1.328 -6.556 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 24.4 mmtm -77.46 -65.44 0.96 Allowed 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 55.6 t-80 -167.5 151.19 6.11 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 112.208 -2.269 . . . . 0.0 108.098 -171.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.61 138.56 80.75 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.136 1.89 . . . . 0.0 110.664 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.52 163.98 29.37 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.1 mtpm? -63.77 162.84 12.68 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 98.5 m . . . . . 0 C--N 1.271 -2.824 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 158.428 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.41 -36.34 0.27 Allowed Glycine 0 C--O 1.22 -0.773 0 C-N-CA 119.72 -1.229 . . . . 0.0 113.154 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.63 35.72 3.46 Favored Glycine 0 CA--C 1.487 -1.705 0 CA-C-O 123.256 1.476 . . . . 0.0 109.547 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -121.53 -162.32 0.97 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 111.864 -2.168 . . . . 0.0 105.405 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -73.38 84.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-O 122.503 1.144 . . . . 0.0 108.537 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -93.46 99.59 12.05 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.394 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB2' HG12 ' A' ' 15' ' ' VAL . 46.6 m -30.73 119.71 0.19 Allowed 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 126.915 2.086 . . . . 0.0 113.789 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.69 -12.16 81.94 Favored Glycine 0 N--CA 1.424 -2.165 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.018 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -68.81 -49.71 56.23 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.9 t80 49.94 33.28 6.44 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.636 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' CG ' HG13 ' A' ' 43' ' ' VAL . 16.0 mm100 -46.08 -35.25 4.74 Favored 'General case' 0 C--N 1.272 -2.763 0 C-N-CA 125.256 1.422 . . . . 0.0 114.557 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 10.6 t70 -141.98 176.48 8.91 Favored 'General case' 2 N--CA 1.372 -4.369 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -88.02 -2.06 58.38 Favored 'General case' 0 C--N 1.244 -3.988 0 C-N-CA 124.793 1.237 . . . . 0.0 112.233 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.64 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 38.3 mmtm -92.61 -8.16 44.98 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 7' ' ' CYS . 21.3 t -85.97 73.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.934 -175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -137.11 146.0 44.55 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.639 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 16.7 p -110.89 -172.34 2.01 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -174.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 35' ' ' LYS . 4.2 p -79.38 173.17 12.85 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 113.402 -1.727 . . . . 0.0 114.686 -176.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -124.7 -11.01 7.29 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 112.918 -1.946 . . . . 0.0 107.381 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' OE2' ' HG2' ' A' ' 19' ' ' ARG . 24.8 mp0 -88.33 -172.48 3.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 126.247 1.819 . . . . 0.0 109.794 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -116.48 23.12 12.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.797 0.808 . . . . 0.0 109.445 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.832 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 5.5 m-20 -56.91 102.51 0.31 Allowed Pre-proline 0 C--N 1.273 -2.74 0 CA-C-N 113.363 -1.744 . . . . 0.0 113.153 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 2.4 Cg_endo -76.18 151.84 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.846 1.697 . . . . 0.0 111.48 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.473 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 88.2 m-70 -148.49 129.05 14.03 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 110.482 -173.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 34.7 t -103.38 101.54 11.45 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 169.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -77.39 170.08 54.97 Favored Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.251 -171.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 m -68.37 -4.47 14.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.679 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.77 -8.09 58.41 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.668 1.187 . . . . 0.0 107.886 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.02 -29.53 8.61 Favored Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.857 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -74.26 145.06 44.33 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.2 m -108.92 131.6 54.88 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.307 -1.77 . . . . 0.0 109.249 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 95.0 m-85 -129.28 151.34 50.05 Favored 'General case' 0 N--CA 1.398 -3.035 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.257 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.49 -26.09 59.02 Favored Glycine 0 C--O 1.208 -1.508 0 CA-C-N 114.5 -1.227 . . . . 0.0 115.469 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 7.8 p30 -164.5 173.59 11.89 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.661 0.731 . . . . 0.0 109.277 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HB3' HG23 ' A' ' 18' ' ' THR . 74.3 tttt -62.44 -32.58 73.46 Favored 'General case' 0 C--O 1.182 -2.448 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.639 ' HA ' ' CB ' ' A' ' 17' ' ' CYS . 61.7 m -57.13 -39.94 76.14 Favored 'General case' 0 C--N 1.255 -3.519 0 CA-C-O 122.351 1.072 . . . . 0.0 111.829 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.16 -38.31 56.82 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.738 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 21.4 t80 -81.43 -6.09 58.58 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.745 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 t -63.89 -41.99 97.57 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.591 -0.693 . . . . 0.0 111.396 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -71.41 -17.56 62.39 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 125.244 1.418 . . . . 0.0 113.856 -176.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -87.22 -26.7 23.39 Favored 'General case' 1 C--N 1.208 -5.575 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.593 173.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.9 mt -72.02 -36.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 93.8 t -54.07 -33.13 24.01 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 CA-C-N 110.611 -2.995 . . . . 0.0 111.246 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 3.0 mmmm -48.11 -43.01 30.56 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.2 m -124.36 29.65 6.28 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.46 26.34 28.06 Favored Glycine 0 N--CA 1.4 -3.721 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.72 -8.87 54.26 Favored Glycine 0 C--N 1.277 -2.738 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.618 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -72.8 -19.89 61.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.8 mt -69.68 150.76 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.351 0.596 . . . . 0.0 110.989 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -125.46 -176.38 3.58 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HA2' ' A' ' 26' ' ' GLY . 41.6 tp -97.56 140.94 31.23 Favored 'General case' 1 N--CA 1.329 -6.512 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 7.2 mtmp? -93.42 -50.71 5.32 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.698 0.761 . . . . 0.0 110.583 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 0.3 OUTLIER -126.34 130.24 23.97 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.907 -170.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.64 109.68 2.8 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 163.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 110.78 -179.23 20.07 Favored Glycine 0 C--N 1.285 -2.267 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -169.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.0 pttp -78.4 174.07 11.67 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-O 122.188 0.994 . . . . 0.0 111.911 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.28 -2.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.208 165.327 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 119.967 -0.063 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.38 -96.39 2.38 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.53 99.46 1.47 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -45.91 36.75 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 120.635 3.569 . . . . 0.0 120.635 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.1 -20.27 6.37 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.972 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 16' ' ' TYR . 25.1 p-10 -81.85 66.17 7.31 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.718 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 16.8 m 29.56 102.68 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.404 0 C-N-CA 126.638 1.975 . . . . 0.0 115.757 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.43 -23.19 60.0 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.166 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.62 ' HB3' HG11 ' A' ' 43' ' ' VAL . 14.2 mm-40 -68.26 -54.37 18.13 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 124.429 1.092 . . . . 0.0 109.381 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.484 51.2 p90 48.4 84.39 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.504 ' OE1' HG22 ' A' ' 42' ' ' ILE . 12.1 pt20 -62.26 -43.3 99.15 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.205 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -140.85 151.58 44.44 Favored 'General case' 1 N--CA 1.364 -4.728 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.474 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.9 p -51.38 -47.65 62.8 Favored 'General case' 1 C--N 1.239 -4.229 0 C-N-CA 128.667 2.787 . . . . 0.0 116.417 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.618 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -93.05 11.58 27.09 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 48.4 t -85.78 105.2 14.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.332 0.587 . . . . 0.0 109.666 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 40.2 p90 -111.46 149.84 30.73 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.426 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' N ' ' A' ' 36' ' ' CYS . 25.9 p -96.15 -165.27 1.26 Allowed 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.56 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 20' ' ' GLU . 1.1 p -77.76 145.46 36.45 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -95.83 -30.22 13.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.57 ' O ' ' HB ' ' A' ' 18' ' ' THR . 34.6 mp0 -90.88 -166.03 1.49 Allowed 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 111.615 -2.538 . . . . 0.0 107.172 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -128.13 105.41 8.36 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 46.4 t-20 -111.11 105.59 57.11 Favored Pre-proline 0 C--N 1.277 -2.544 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.53 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.08 148.69 63.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.791 1.661 . . . . 0.0 112.183 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' THR . 69.7 m-70 -148.07 130.81 16.01 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -106.69 102.6 11.96 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -68.98 160.16 52.53 Favored Glycine 0 N--CA 1.405 -3.397 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.0 m -60.8 -21.17 62.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -73.36 -16.34 61.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 125.54 1.536 . . . . 0.0 110.894 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.19 -20.68 30.33 Favored Glycine 1 CA--C 1.448 -4.14 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.456 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.92 130.37 40.84 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 96.8 m -115.85 127.86 55.36 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.368 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.4 m-85 -132.88 155.28 49.32 Favored 'General case' 0 N--CA 1.388 -3.569 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.624 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.2 -22.86 72.94 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 113.232 -1.804 . . . . 0.0 114.483 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 33.2 p30 -156.79 169.33 24.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.458 0.629 . . . . 0.0 110.403 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 79.3 tttt -61.24 -33.71 73.95 Favored 'General case' 0 C--O 1.196 -1.724 0 CA-C-O 121.286 0.565 . . . . 0.0 111.922 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.601 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 97.3 m -57.44 -41.17 79.99 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.142 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -77.04 -40.78 45.12 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.157 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 33.7 t80 -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.963 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.807 ' O ' HG23 ' A' ' 43' ' ' VAL . 52.4 t -59.49 -40.98 88.76 Favored 'General case' 0 C--O 1.192 -1.942 0 C-N-CA 123.224 0.61 . . . . 0.0 111.556 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.09 -20.84 61.59 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-O 122.732 1.253 . . . . 0.0 112.05 -170.449 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -74.22 -39.2 63.25 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 112.793 -2.003 . . . . 0.0 107.847 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.8 mt -71.15 -49.34 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.087 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 39' ' ' CYS . 59.5 t -50.34 -53.69 11.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.177 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -71.74 -33.95 69.13 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.522 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 m -83.48 0.99 43.94 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.425 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 14.3 52.9 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -6.77 58.05 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -67.21 -16.01 64.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.6 mt -78.77 147.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.27 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.6 m -121.69 176.78 5.54 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 38.9 tp -99.31 141.44 32.09 Favored 'General case' 1 N--CA 1.329 -6.484 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -88.42 -57.14 3.03 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 122.449 1.118 . . . . 0.0 108.81 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -130.92 138.96 34.16 Favored Pre-proline 0 C--N 1.285 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 113.282 -165.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.81 109.47 2.61 Favored 'Trans proline' 0 N--CA 1.435 -1.946 0 N-CA-C 104.537 -2.909 . . . . 0.0 104.537 161.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.23 178.33 18.66 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -168.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.49 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.7 pttp -78.05 175.65 9.91 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 122.031 0.92 . . . . 0.0 111.403 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 165.893 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 . . . . . 0 C--O 1.221 -0.433 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.68 87.05 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.415 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.1 -71.98 0.9 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -91.07 130.06 37.01 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.25 60.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.689 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -131.53 91.51 3.02 Favored 'General case' 0 C--N 1.258 -3.404 0 CA-C-N 113.51 -1.677 . . . . 0.0 107.082 166.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 10' ' ' PHE 0.386 2.4 p 38.08 -103.04 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.57 -83.76 0.2 Allowed Glycine 0 N--CA 1.437 -1.273 0 O-C-N 124.089 0.868 . . . . 0.0 112.926 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.83 -5.03 56.75 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 125.204 1.402 . . . . 0.0 113.49 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' C ' ' H ' ' A' ' 12' ' ' ASP . 8.2 m-85 -53.87 -46.11 71.22 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.575 ' H ' HG13 ' A' ' 43' ' ' VAL . 54.8 mt-30 62.19 -17.83 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 126.828 2.051 . . . . 0.0 114.007 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.612 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 4.8 t70 -75.02 -152.07 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.076 0 C-N-CA 127.696 2.399 . . . . 0.0 111.797 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 15' ' ' VAL . 20.4 p -126.47 -12.75 6.12 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 129.957 3.303 . . . . 0.0 111.037 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.612 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -78.9 3.02 18.15 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-O 122.987 1.375 . . . . 0.0 108.587 176.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.532 HG22 ' HB3' ' A' ' 10' ' ' PHE . 73.8 t -52.22 107.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.255 -3.524 0 C-N-CA 128.767 2.827 . . . . 0.0 113.438 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -96.57 127.3 42.43 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.29 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 36' ' ' CYS . 22.6 p -89.6 -172.52 3.61 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 124.345 1.028 . . . . 0.0 111.098 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.517 ' HB ' ' H ' ' A' ' 20' ' ' GLU . 63.7 p -77.92 174.97 10.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 122.79 1.281 . . . . 0.0 114.277 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' NE ' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -106.57 -10.64 16.14 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 112.246 -2.252 . . . . 0.0 109.115 171.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.517 ' H ' ' HB ' ' A' ' 18' ' ' THR . 2.1 mp0 -63.24 140.62 58.89 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.871 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -107.03 13.11 27.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.826 1.298 . . . . 0.0 108.163 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.8 m-20 -69.36 116.82 46.4 Favored Pre-proline 0 C--N 1.272 -2.777 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.933 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.96 148.46 70.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.838 2.359 . . . . 0.0 112.239 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -152.5 127.12 9.43 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 124.08 0.952 . . . . 0.0 108.757 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 14.0 t -100.05 99.11 9.8 Favored 'General case' 0 C--N 1.254 -3.562 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -80.14 170.96 54.12 Favored Glycine 0 CA--C 1.46 -3.401 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.372 -168.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 m -73.82 5.17 4.32 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.848 0.833 . . . . 0.0 109.398 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -68.69 -19.84 64.39 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.529 2.332 . . . . 0.0 105.839 169.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 -36.04 4.52 Favored Glycine 1 N--CA 1.394 -4.143 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -85.54 155.59 21.12 Favored 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.578 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 93.7 m -96.21 124.75 40.33 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.678 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.631 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 56.8 m-85 -113.21 142.74 45.44 Favored 'General case' 1 N--CA 1.377 -4.121 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.67 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.35 -35.82 80.7 Favored Glycine 0 CA--C 1.49 -1.509 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.691 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.3 p-10 -149.69 168.71 22.85 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.349 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HG2' HG21 ' A' ' 18' ' ' THR . 48.4 tttm -59.03 -29.99 67.69 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.513 1.125 . . . . 0.0 111.982 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.719 ' HA ' ' HB2' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -55.53 -50.79 69.06 Favored 'General case' 0 C--N 1.249 -3.788 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.73 174.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -69.44 -33.95 73.7 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.893 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 42' ' ' ILE . 13.5 t80 -83.14 -16.71 45.66 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.588 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.776 ' O ' HG23 ' A' ' 43' ' ' VAL . 42.5 t -68.09 -31.65 71.42 Favored 'General case' 0 CA--C 1.47 -2.126 0 O-C-N 122.034 -0.416 . . . . 0.0 110.373 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -66.62 -29.52 69.57 Favored 'General case' 0 CA--C 1.454 -2.722 0 CA-C-O 122.33 1.062 . . . . 0.0 112.471 -169.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.738 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.0 -35.14 66.78 Favored 'General case' 1 C--N 1.224 -4.886 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.268 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.4 mt -68.32 -42.13 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.081 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.6 t -58.56 -33.02 47.29 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.392 0 CA-C-N 111.107 -2.769 . . . . 0.0 111.387 174.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 7.7 mmpt? -81.11 -37.4 28.98 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.708 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.1 t -84.51 -20.57 31.41 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.667 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.87 31.99 4.58 Favored Glycine 0 N--CA 1.4 -3.756 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.32 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.81 -13.19 57.36 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -67.36 -24.81 65.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 41' ' ' ALA . 70.0 mt -80.74 146.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.203 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -134.71 -176.62 4.29 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.3 tp -93.11 141.13 28.75 Favored 'General case' 1 N--CA 1.34 -5.973 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -88.77 -49.7 6.67 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.141 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -146.1 132.22 9.57 Favored Pre-proline 0 C--N 1.283 -2.311 0 C-N-CA 118.507 -1.277 . . . . 0.0 112.075 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.26 109.91 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.89 1.727 . . . . 0.0 108.33 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.46 -167.46 13.78 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 12.6 pttp -86.98 169.4 12.47 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-O 121.439 0.638 . . . . 0.0 110.831 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.273 -2.727 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.035 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.7 -82.24 1.32 Allowed Glycine 0 CA--C 1.506 -0.493 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.93 121.25 11.65 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -70.47 92.44 0.82 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.91 0.386 . . . . 0.0 111.965 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 7.9 p -138.57 -1.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.49 68.32 0.06 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -165.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.56 ' HB3' HG12 ' A' ' 15' ' ' VAL . 68.7 m -104.3 79.34 1.58 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.187 0.994 . . . . 0.0 108.867 168.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -4.46 90.25 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.553 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HB3' HG11 ' A' ' 43' ' ' VAL . 57.2 mt-10 -73.8 -48.53 30.78 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.8 t80 50.32 30.93 4.82 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.609 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 122.657 1.218 . . . . 0.0 112.99 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t0 -129.75 150.31 51.11 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.623 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -74.29 -19.3 60.53 Favored 'General case' 0 C--N 1.247 -3.868 0 C-N-CA 124.899 1.28 . . . . 0.0 112.752 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -86.46 -10.39 54.29 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.779 0.8 . . . . 0.0 109.145 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 39' ' ' CYS . 78.5 t -75.41 73.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -172.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.46 143.2 37.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 162.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.595 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 16.1 p -109.31 -176.57 3.06 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.141 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 t -134.37 170.44 15.73 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.999 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -99.45 -21.57 15.9 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 113.367 -1.742 . . . . 0.0 107.287 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -69.66 140.2 53.6 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.075 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 p -79.87 100.5 8.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 122.599 1.19 . . . . 0.0 111.829 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -111.01 97.06 32.89 Favored Pre-proline 0 C--N 1.258 -3.396 0 CA-C-N 113.065 -1.879 . . . . 0.0 108.628 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 57.1 Cg_endo -73.91 133.8 18.87 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.047 1.165 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' THR . 62.1 m-70 -141.67 128.34 20.33 Favored 'General case' 0 CA--C 1.464 -2.349 0 CA-C-O 121.491 0.662 . . . . 0.0 109.842 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.9 t -101.95 108.77 20.33 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 167.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.21 162.8 52.75 Favored Glycine 1 N--CA 1.393 -4.209 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -60.06 -22.17 62.36 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.875 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HB2' HG13 ' A' ' 49' ' ' ILE . 33.1 t70 -81.86 6.17 16.58 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.683 1.23 . . . . 0.0 110.106 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.01 -27.17 9.38 Favored Glycine 0 CA--C 1.467 -2.917 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.564 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.51 145.97 47.14 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.54 HG21 ' CB ' ' A' ' 56' ' ' LYS . 94.2 m -119.18 134.02 55.44 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.569 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 36.3 m-85 -133.62 152.54 51.91 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 121.222 0.534 . . . . 0.0 111.946 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -37.01 93.75 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 113.903 -1.498 . . . . 0.0 115.132 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.2 p30 -141.92 175.82 9.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -67.77 -36.87 81.27 Favored 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.348 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.3 t -62.22 -37.66 86.21 Favored 'General case' 0 C--N 1.252 -3.643 0 CA-C-O 122.422 1.106 . . . . 0.0 110.801 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.41 -36.46 83.81 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.987 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -92.24 -25.32 18.69 Favored 'General case' 0 C--O 1.195 -1.792 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.706 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG23 ' A' ' 43' ' ' VAL . 12.9 t -51.68 -50.55 60.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.887 1.275 . . . . 0.0 111.68 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.19 -29.38 67.35 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-O 122.186 0.993 . . . . 0.0 113.626 -176.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -78.52 -28.08 46.17 Favored 'General case' 1 C--N 1.224 -4.851 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.546 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.826 ' HA ' HD13 ' A' ' 49' ' ' ILE . 35.3 mt -64.43 -43.31 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.614 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.2 t -56.96 -36.84 51.74 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 111.443 -2.617 . . . . 0.0 111.351 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 38.5 mmtm -82.44 -38.69 23.63 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.144 0.497 . . . . 0.0 112.301 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 49' ' ' ILE . 9.5 t -81.88 -14.85 55.65 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.367 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.59 0.2 6.23 Favored Glycine 0 N--CA 1.401 -3.663 0 N-CA-C 117.002 1.561 . . . . 0.0 117.002 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.11 84.21 Favored Glycine 0 C--N 1.283 -2.382 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.807 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.293 44.1 mttt -56.89 -36.52 70.23 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 122.029 0.919 . . . . 0.0 109.812 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.826 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.2 mp -59.69 132.05 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.683 -166.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.2 m -138.22 178.47 7.11 Favored 'General case' 0 C--N 1.26 -3.313 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 171.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 51' ' ' LEU . 22.0 tp -91.9 140.37 29.74 Favored 'General case' 1 N--CA 1.321 -6.918 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.4 ttmt -96.17 -52.78 3.88 Favored 'General case' 1 N--CA 1.343 -5.777 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.093 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -141.11 139.21 18.84 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.659 -173.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.13 110.13 2.82 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 106.766 -2.052 . . . . 0.0 106.766 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.6 173.77 17.04 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -171.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.4 pttp -75.93 172.23 13.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 121.665 0.745 . . . . 0.0 110.646 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 27.9 m . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 166.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.2 -73.05 2.23 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 150.71 19.7 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -83.41 45.72 1.07 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.231 1.015 . . . . 0.0 111.803 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.44 134.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.259 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 12.9 t70 -129.4 126.2 38.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.708 ' SG ' ' HA ' ' A' ' 16' ' ' TYR . 83.6 m -22.83 -48.03 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.31 1.844 . . . . 0.0 115.029 169.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.31 -79.09 0.01 OUTLIER Glycine 0 N--CA 1.467 0.758 0 O-C-N 124.061 0.85 . . . . 0.0 114.985 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 6.6 tm-20 -70.81 -40.57 72.42 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.733 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 65.3 t80 77.84 5.73 2.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.57 165.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.17 -8.34 5.9 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 110.068 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 15' ' ' VAL . 20.8 t0 -95.55 121.38 37.18 Favored 'General case' 0 N--CA 1.386 -3.655 0 CA-C-O 123.141 1.448 . . . . 0.0 111.59 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -43.44 -20.36 0.02 OUTLIER 'General case' 1 C--N 1.237 -4.298 0 C-N-CA 129.861 3.264 . . . . 0.0 116.233 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -93.32 -32.44 14.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.921 0.867 . . . . 0.0 110.998 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -98.91 93.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.336 -170.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.708 ' HA ' ' SG ' ' A' ' 7' ' ' CYS . 50.4 p90 -138.22 174.12 10.9 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 6' ' ' ASP 0.35 0.3 OUTLIER 65.64 165.79 0.18 Allowed 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.45 -166.163 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 t -147.35 176.02 10.33 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.802 0.811 . . . . 0.0 111.459 -171.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.62 ' HD3' ' H ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -70.12 -19.49 63.23 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.56 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.48 122.82 28.02 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 m -96.78 17.36 16.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.141 1.776 . . . . 0.0 109.756 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.23 111.21 12.72 Favored Pre-proline 0 C--N 1.267 -3.0 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.995 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 39.3 Cg_exo -60.0 143.03 99.61 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 123.775 2.983 . . . . 0.0 112.673 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.44 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.5 130.58 11.87 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 123.729 0.811 . . . . 0.0 110.039 -170.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.9 t -103.35 105.44 15.71 Favored 'General case' 0 C--N 1.258 -3.396 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.697 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -86.16 177.04 49.03 Favored Glycine 0 CA--C 1.464 -3.144 0 C-N-CA 119.284 -1.436 . . . . 0.0 113.798 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 49' ' ' ILE . 35.8 m -76.03 4.08 9.09 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-O 121.827 0.822 . . . . 0.0 109.094 173.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.59 -18.28 65.28 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.603 2.361 . . . . 0.0 105.746 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -32.91 6.46 Favored Glycine 0 N--CA 1.399 -3.793 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.662 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -91.71 156.14 17.79 Favored 'General case' 0 CA--C 1.47 -2.116 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 75.8 m -96.48 128.76 43.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.109 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 91.8 m-85 -116.02 147.88 40.75 Favored 'General case' 0 N--CA 1.38 -3.955 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.7 -27.44 61.52 Favored Glycine 0 C--N 1.299 -1.509 0 O-C-N 124.873 1.358 . . . . 0.0 113.011 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 27.0 p30 -159.66 171.17 20.07 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 41.0 ttmt -63.17 -32.78 74.26 Favored 'General case' 0 C--O 1.182 -2.467 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 2.7 t -49.11 -53.86 18.75 Favored 'General case' 1 C--N 1.242 -4.082 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.572 173.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.0 -41.9 90.42 Favored 'General case' 0 C--N 1.264 -3.124 0 C-N-CA 125.566 1.547 . . . . 0.0 111.03 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.697 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 19.2 t80 -85.53 -17.41 36.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.1 t -61.78 -31.09 71.27 Favored 'General case' 0 C--O 1.181 -2.516 0 O-C-N 121.707 -0.621 . . . . 0.0 110.501 -172.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.7 -32.2 73.77 Favored 'General case' 0 CA--C 1.461 -2.48 0 CA-C-O 122.398 1.094 . . . . 0.0 112.454 -171.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.789 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -66.28 -40.56 90.17 Favored 'General case' 1 C--N 1.234 -4.455 0 CA-C-N 111.971 -2.377 . . . . 0.0 108.014 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 39' ' ' CYS . 53.5 mt -71.22 -50.63 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.37 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 39' ' ' CYS . 18.3 t -53.85 -52.1 38.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.196 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.84 -30.61 68.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.436 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.5 m -90.44 12.27 19.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.491 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.64 6.03 68.31 Favored Glycine 0 N--CA 1.408 -3.219 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 93.4 -4.37 73.37 Favored Glycine 1 C--N 1.248 -4.345 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 10.0 mptt -68.48 -29.78 68.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.7 mt -75.93 149.07 6.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.048 173.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -132.16 -177.48 4.47 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.8 tp -87.2 140.79 29.19 Favored 'General case' 1 N--CA 1.331 -6.401 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.6 ttmt -85.44 -56.32 3.58 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.299 170.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 63.7 m170 -140.33 136.48 16.86 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.589 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.3 110.19 3.06 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 N-CA-C 106.643 -2.099 . . . . 0.0 106.643 167.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 109.4 -173.93 17.57 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 9.0 mtpm? -67.05 170.22 7.19 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 66.3 m . . . . . 0 C--N 1.275 -2.655 0 CA-C-N 109.956 -3.293 . . . . 0.0 103.055 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.67 -24.29 2.88 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.151 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.9 -64.23 0.03 OUTLIER Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -78.29 -179.51 6.3 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -83.99 72.57 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.184 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' HB2' ' CD1' ' A' ' 10' ' ' PHE . 9.0 p-10 -87.1 91.46 8.72 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . 0.41 72.0 m -25.76 77.84 0.0 OUTLIER 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 120.746 3.61 . . . . 0.0 120.746 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.9 -76.63 0.01 OUTLIER Glycine 0 C--N 1.36 1.9 0 O-C-N 126.084 2.115 . . . . 0.0 112.136 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.38 -33.71 17.83 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 113.432 -1.384 . . . . 0.0 109.801 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 25.8 t80 49.27 41.51 20.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 123.047 1.403 . . . . 0.0 109.951 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -48.84 -35.62 15.01 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 112.943 -1.935 . . . . 0.0 113.9 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -127.48 157.57 39.72 Favored 'General case' 2 N--CA 1.367 -4.62 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.211 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.9 p -49.06 -52.78 23.53 Favored 'General case' 0 C--N 1.245 -3.975 0 C-N-CA 130.091 3.356 . . . . 0.0 117.033 -173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.37 6.6 48.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 121.218 -0.927 . . . . 0.0 111.0 -170.5 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG12 ' SG ' ' A' ' 39' ' ' CYS . 2.7 t -87.56 74.39 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-O 122.017 0.913 . . . . 0.0 113.201 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -127.33 149.65 49.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.671 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 3.3 p -113.97 179.36 3.98 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.644 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -137.35 171.77 13.97 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.567 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -15.58 19.27 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.293 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.55 163.57 27.59 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.5 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -97.0 102.5 14.29 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-O 122.919 1.342 . . . . 0.0 111.972 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.0 m120 -111.14 92.43 15.43 Favored Pre-proline 0 C--N 1.264 -3.141 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.731 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -63.79 125.33 15.21 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.961 1.774 . . . . 0.0 110.445 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -141.7 125.07 16.56 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-O 122.187 0.994 . . . . 0.0 110.915 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 43.0 t -100.05 106.79 18.58 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.22 159.27 53.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.412 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.7 m -53.46 -22.1 7.33 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 123.575 0.75 . . . . 0.0 112.072 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.9 11.6 7.44 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.773 0.797 . . . . 0.0 110.521 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.55 -27.34 5.29 Favored Glycine 0 CA--C 1.479 -2.185 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.571 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -73.84 129.89 38.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 56' ' ' LYS . 84.6 m -107.8 134.7 50.38 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 112.575 -2.102 . . . . 0.0 112.208 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 11.3 m-85 -132.01 165.73 23.31 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.711 169.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.87 97.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.991 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.4 p30 -141.78 177.49 8.14 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 117.783 0.791 . . . . 0.0 109.408 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 32.8 ttpt -66.25 -39.33 89.43 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-O 121.432 0.634 . . . . 0.0 112.498 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.671 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 2.0 t -60.57 -38.22 83.88 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -59.44 -40.82 88.01 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.567 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 11.4 t80 -102.65 -2.06 29.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.793 ' HA ' HD12 ' A' ' 42' ' ' ILE . 10.6 t -58.42 -40.95 83.88 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 123.536 0.735 . . . . 0.0 112.156 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.572 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.48 -26.24 58.03 Favored 'General case' 0 CA--C 1.472 -2.056 0 CA-C-O 123.036 1.398 . . . . 0.0 109.637 -171.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 40' ' ' LYS . . . -80.36 -27.24 38.28 Favored 'General case' 1 C--N 1.229 -4.635 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.999 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 39' ' ' CYS . 37.6 mt -67.59 -41.31 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.4 t -56.05 -39.12 56.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.672 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 68.1 mmtt -84.59 -36.91 21.75 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.255 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.596 ' HB2' HD11 ' A' ' 49' ' ' ILE . 75.7 m -88.77 20.51 3.46 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.26 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.45 63.67 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 118.19 2.036 . . . . 0.0 118.19 166.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.77 0.46 49.85 Favored Glycine 0 C--N 1.283 -2.368 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.563 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 45' ' ' SER . 1.3 mtpm? -55.64 -26.46 44.51 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 123.286 0.634 . . . . 0.0 111.084 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.3 mp -64.99 133.24 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 123.072 1.415 . . . . 0.0 111.633 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -137.94 -176.03 4.29 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 51' ' ' LEU . 16.2 tp -89.73 139.47 30.53 Favored 'General case' 1 N--CA 1.316 -7.138 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.433 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 11.7 tptp -99.01 -39.08 8.71 Favored 'General case' 0 N--CA 1.384 -3.735 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.26 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 32.9 t-80 -164.38 136.29 3.62 Favored Pre-proline 0 C--N 1.28 -2.428 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.588 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 5.8 Cg_exo -78.24 109.65 2.72 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 170.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.54 168.82 21.86 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' THR . 2.3 mmmp? -48.37 154.55 0.6 Allowed 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 118.666 2.839 . . . . 0.0 118.666 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' C ' ' HZ3' ' A' ' 56' ' ' LYS . 98.5 m . . . . . 0 C--N 1.253 -3.6 0 CA-C-N 108.914 -3.767 . . . . 0.0 102.922 165.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.413 ' OE1' ' HA ' ' A' ' 1' ' ' GLN . 14.9 mm-40 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.8 -158.97 53.76 Favored Glycine 0 C--N 1.333 0.381 0 O-C-N 123.947 0.78 . . . . 0.0 113.28 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.37 69.56 3.25 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -86.21 178.34 7.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.074 0.94 . . . . 0.0 112.732 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG12 ' SG ' ' A' ' 17' ' ' CYS . 80.4 t -76.74 157.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.977 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 40' ' ' LYS 0.431 26.5 t70 -67.7 74.33 0.18 Allowed 'General case' 0 C--N 1.353 0.726 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 -169.482 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.9 m -120.16 46.47 1.96 Allowed 'General case' 1 C--N 1.242 -4.097 0 CA-C-N 111.918 -2.401 . . . . 0.0 104.524 150.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -16.93 58.73 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 113.625 -1.625 . . . . 0.0 114.263 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' CB ' HG11 ' A' ' 43' ' ' VAL . 28.0 mt-10 -72.29 -21.3 61.37 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 117.225 0.512 . . . . 0.0 110.672 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 13' ' ' THR . 27.8 t80 63.03 63.92 0.9 Allowed 'General case' 0 C--N 1.352 0.682 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 161.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 12' ' ' ASP . 3.9 pt20 -53.33 -51.46 62.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.704 1.24 . . . . 0.0 112.728 170.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.444 ' HB3' HG23 ' A' ' 15' ' ' VAL . 64.5 t0 -132.34 164.19 27.02 Favored 'General case' 2 N--CA 1.375 -4.185 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 6.9 t -71.77 -35.77 70.17 Favored 'General case' 1 C--N 1.243 -4.064 0 C-N-CA 125.997 1.719 . . . . 0.0 114.84 -167.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.62 8.63 44.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -174.21 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 12' ' ' ASP . 37.4 t -91.83 114.5 29.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 0.0 111.731 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 43.8 p90 -132.98 150.42 52.16 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.713 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 22.8 p -78.16 168.37 19.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.21 -0.996 . . . . 0.0 113.597 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -79.24 151.46 31.16 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.243 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.414 ' HG3' ' OE2' ' A' ' 20' ' ' GLU . 5.4 ptm180 -111.13 -9.56 14.35 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.195 170.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' OE2' ' HG3' ' A' ' 19' ' ' ARG . 30.2 mp0 -94.9 176.19 6.35 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.375 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -98.16 110.99 23.48 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.715 0.769 . . . . 0.0 109.154 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.58 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 3.0 t-20 -111.15 92.74 16.12 Favored Pre-proline 0 C--N 1.275 -2.659 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.341 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 72.3 Cg_endo -88.37 124.98 1.75 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.705 1.603 . . . . 0.0 112.839 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 60.8 m-70 -152.14 128.98 10.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 C-N-CA 125.161 1.384 . . . . 0.0 108.596 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.7 t -96.14 110.53 22.78 Favored 'General case' 0 C--N 1.261 -3.252 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.7 164.48 54.75 Favored Glycine 0 N--CA 1.4 -3.761 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.003 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.7 p -62.42 -8.48 6.17 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 123.264 0.626 . . . . 0.0 110.58 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.96 -23.02 59.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 126.362 1.865 . . . . 0.0 108.578 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -27.4 20.45 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -76.86 141.8 40.47 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 87.7 m -107.09 126.31 52.19 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.699 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 29.8 p90 -102.17 134.46 45.39 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.293 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -34.07 67.65 Favored Glycine 0 CA--C 1.503 -0.682 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.926 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 33.9 p30 -143.7 167.7 21.65 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 172.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -72.61 -33.35 66.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.667 0.746 . . . . 0.0 110.219 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.713 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 4.6 t -52.4 -36.16 53.47 Favored 'General case' 0 C--N 1.254 -3.581 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.427 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -47.95 -49.39 30.49 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 125.408 1.693 . . . . 0.0 111.115 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 32' ' ' TYR 0.407 44.1 p90 -145.58 42.24 1.25 Allowed 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 118.007 -1.477 . . . . 0.0 114.869 174.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.772 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.5 t -60.8 -38.17 84.44 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.538 175.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.574 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.05 -29.3 64.01 Favored 'General case' 0 CA--C 1.458 -2.59 0 CA-C-O 123.201 1.476 . . . . 0.0 107.948 -171.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -73.06 -29.84 63.26 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.195 178.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 39' ' ' CYS . 17.1 mt -70.83 -41.5 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.598 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 39' ' ' CYS . 25.6 t -60.06 -31.8 48.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.874 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.415 172.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.35 -41.92 75.95 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.986 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 44.5 t -70.2 -44.18 69.2 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.278 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.77 2.91 Favored Glycine 1 N--CA 1.388 -4.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.939 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.37 0.25 89.98 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' SER . 55.9 mttt -65.8 -23.18 66.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 42' ' ' ILE . 30.3 mt -71.19 128.18 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.537 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m -109.5 -178.56 3.58 Favored 'General case' 0 C--N 1.26 -3.305 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 29.7 tp -95.51 140.67 30.02 Favored 'General case' 1 N--CA 1.317 -7.075 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 54.3 tttm -99.73 -43.22 6.53 Favored 'General case' 1 N--CA 1.351 -5.399 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.606 172.386 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 22.8 m170 -139.18 133.83 16.38 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.365 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.5 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 164.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 105.01 -171.98 19.42 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -169.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.4 pttp -79.45 173.28 12.74 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 122.042 0.925 . . . . 0.0 111.834 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.284 -2.263 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.598 166.107 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.87 -150.91 1.36 Allowed Glycine 0 CA--C 1.525 0.657 0 O-C-N 123.82 0.7 . . . . 0.0 114.099 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 100.84 84.12 1.78 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -69.06 102.92 1.74 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.353 1.061 . . . . 0.0 112.152 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.91 134.55 50.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.051 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.639 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.8 t0 -93.43 111.96 23.76 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 172.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 19.7 m -78.64 78.52 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -167.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -113.87 19.92 17.88 Favored Glycine 1 N--CA 1.375 -5.393 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 171.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.51 -53.07 3.56 Favored 'General case' 1 N--CA 1.319 -6.997 0 C-N-CA 122.778 0.431 . . . . 0.0 111.547 -176.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.327 78.9 m-85 -132.8 -24.52 1.93 Allowed 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 120.348 3.462 . . . . 0.0 120.348 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.751 ' HG2' HG22 ' A' ' 43' ' ' VAL . 13.4 mm-40 -58.55 -45.05 89.76 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 124.465 2.078 . . . . 0.0 108.993 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.731 ' HB3' HG23 ' A' ' 15' ' ' VAL 0.29 11.9 t70 -177.82 -166.08 0.11 Allowed 'General case' 1 N--CA 1.379 -4.023 1 N-CA-C 99.596 -4.224 . . . . 0.0 99.596 -177.204 . . . . . . . . 5 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 t -99.85 -23.68 14.89 Favored 'General case' 1 C--N 1.242 -4.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 21.5 pttm -96.68 10.51 38.44 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.731 HG23 ' HB3' ' A' ' 12' ' ' ASP . 5.5 t -97.56 73.24 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 118.834 -1.146 . . . . 0.0 109.926 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -76.77 173.53 11.56 Favored 'General case' 0 C--O 1.273 2.305 0 CA-C-O 123.063 1.411 . . . . 0.0 113.374 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 6' ' ' ASP . 29.7 p -109.43 -172.7 2.1 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.343 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.6 ' H ' ' HB3' ' A' ' 35' ' ' LYS . 2.7 t -134.31 147.92 50.67 Favored 'General case' 0 CA--C 1.443 -3.161 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.618 ' HG2' ' OE2' ' A' ' 20' ' ' GLU . 3.3 ptp180 -124.97 3.73 8.02 Favored 'General case' 1 C--N 1.224 -4.876 0 O-C-N 125.939 2.024 . . . . 0.0 109.924 -167.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.618 ' OE2' ' HG2' ' A' ' 19' ' ' ARG . 1.8 mp0 -82.59 -168.78 2.15 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.413 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.624 ' O ' ' HD3' ' A' ' 23' ' ' PRO 0.278 14.8 m -76.07 31.18 0.12 Allowed 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 125.318 1.447 . . . . 0.0 112.444 -177.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.792 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 87.4 m-20 -94.0 91.8 0.65 Allowed Pre-proline 0 C--N 1.269 -2.926 0 C-N-CA 124.357 1.063 . . . . 0.0 111.836 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 21' ' ' SER . 6.2 Cg_exo -78.68 157.36 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.174 1.916 . . . . 0.0 110.999 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -145.34 126.27 14.49 Favored 'General case' 0 CA--C 1.465 -2.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.798 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 44.8 t -103.26 110.86 23.0 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 171.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 163.44 54.68 Favored Glycine 0 N--CA 1.409 -3.157 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 p -64.33 -9.5 18.18 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.518 0.675 . . . . 0.0 110.325 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.23 -29.31 66.1 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 126.2 1.8 . . . . 0.0 109.097 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.26 -23.31 23.2 Favored Glycine 0 N--CA 1.403 -3.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.699 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.56 138.04 46.61 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 99.4 m -107.36 128.33 54.37 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.567 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 38.2 m-85 -124.63 152.06 44.09 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.931 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.91 -38.87 38.83 Favored Glycine 0 C--N 1.31 -0.916 0 O-C-N 125.144 1.527 . . . . 0.0 114.702 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.1 p30 -155.12 -179.87 8.49 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.6 ' HB3' ' H ' ' A' ' 18' ' ' THR . 23.1 tptm -58.44 -46.96 85.48 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 69.4 m -52.15 -36.22 50.86 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -63.54 -45.62 89.7 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.703 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 32' ' ' TYR . 35.6 t80 -112.73 -2.04 14.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.786 ' O ' HG23 ' A' ' 43' ' ' VAL . 44.7 t -57.05 -46.78 82.18 Favored 'General case' 0 CA--C 1.46 -2.492 0 C-N-CA 124.091 0.956 . . . . 0.0 111.085 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.745 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.99 -33.04 73.59 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.994 1.317 . . . . 0.0 114.213 -172.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.63 -31.88 57.67 Favored 'General case' 1 C--N 1.222 -4.959 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.302 178.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.3 mt -65.54 -40.91 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 39' ' ' CYS . 22.1 t -57.82 -35.44 51.38 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.042 -2.344 . . . . 0.0 110.922 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 31.3 mmtm -79.08 -33.0 44.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.685 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.8 m -89.94 21.25 3.72 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.594 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.87 82.3 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA2' HE22 ' A' ' 11' ' ' GLN . . . 76.73 6.73 85.44 Favored Glycine 0 C--N 1.272 -2.991 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -176.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -68.78 -25.81 64.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.217 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.31 133.99 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -120.63 -177.37 3.45 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 53' ' ' HIS . 33.1 tp -88.35 141.03 28.88 Favored 'General case' 1 N--CA 1.321 -6.887 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 44.5 tttt -86.22 -45.92 10.85 Favored 'General case' 1 N--CA 1.366 -4.627 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.252 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.473 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.9 p80 -179.72 154.86 0.72 Allowed Pre-proline 0 C--N 1.31 -1.135 0 O-C-N 124.489 1.118 . . . . 0.0 111.681 174.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.47 149.16 74.45 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.163 1.909 . . . . 0.0 109.848 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.23 161.28 37.14 Favored Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.6 ptmm? -69.38 155.66 40.09 Favored 'General case' 0 N--CA 1.406 -2.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.125 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.25 -3.728 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.698 178.992 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.36 -33.79 72.29 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.78 -119.71 1.32 Allowed Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.29 -175.3 2.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.58 114.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 22.4 t70 -130.45 124.2 31.52 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 170.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.672 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 6.6 p -49.93 -88.0 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 169.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.16 -83.96 0.02 OUTLIER Glycine 0 C--O 1.207 -1.554 0 CA-C-O 121.787 0.66 . . . . 0.0 112.94 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -99.92 -3.03 33.24 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 126.357 1.863 . . . . 0.0 108.95 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.438 ' HB3' HG21 ' A' ' 15' ' ' VAL . 84.6 m-85 -104.25 83.19 2.04 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-O 124.518 2.104 . . . . 0.0 110.362 -173.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.733 ' HA ' HG13 ' A' ' 43' ' ' VAL . 71.8 mm-40 -37.42 -22.19 0.01 OUTLIER 'General case' 1 C--N 1.22 -5.058 2 C-N-CA 134.649 5.18 . . . . 0.0 114.434 172.223 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -80.44 122.61 27.2 Favored 'General case' 0 N--CA 1.384 -3.752 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -73.05 -15.14 61.52 Favored 'General case' 1 C--N 1.214 -5.306 0 CA-C-N 112.609 -2.087 . . . . 0.0 113.475 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.9 5.87 46.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.337 0.589 . . . . 0.0 111.377 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.672 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 16.0 t -96.62 123.15 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' ASP . 47.0 p90 -115.09 160.18 19.97 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 19.3 p -74.04 166.44 23.39 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 125.91 2.006 . . . . 0.0 115.238 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 9.7 t -89.49 173.98 8.04 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.242 171.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -15.99 25.28 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.387 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 34' ' ' ASN 0.445 18.5 mm-40 -48.1 131.81 15.8 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 118.55 2.796 . . . . 0.0 118.55 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.304 2.0 m -68.89 23.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 131.146 3.778 . . . . 0.0 114.196 -169.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -70.59 106.77 1.91 Allowed Pre-proline 0 C--N 1.264 -3.129 0 C-N-CA 123.505 0.722 . . . . 0.0 111.796 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.55 142.04 10.22 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.32 2.013 . . . . 0.0 111.851 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.414 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 73.2 m80 -150.44 127.4 11.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-O 121.745 0.783 . . . . 0.0 109.695 -172.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 51.6 t -96.22 97.96 9.93 Favored 'General case' 0 C--N 1.245 -3.949 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 170.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.16 167.79 43.93 Favored Glycine 0 CA--C 1.461 -3.338 0 C-N-CA 119.149 -1.501 . . . . 0.0 112.213 -167.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -76.51 5.45 7.31 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.207 1.004 . . . . 0.0 108.661 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.53 -14.07 62.67 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 128.339 2.656 . . . . 0.0 106.169 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.46 -35.62 4.39 Favored Glycine 0 N--CA 1.403 -3.545 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.76 155.4 18.29 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.5 m -96.93 130.01 44.3 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.048 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 50.7 m-85 -118.44 139.8 50.84 Favored 'General case' 0 N--CA 1.387 -3.617 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.855 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 -30.96 61.73 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.501 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.696 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 12.3 p-10 -141.56 176.22 9.06 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.019 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -61.84 -40.22 94.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.573 0.701 . . . . 0.0 111.746 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 18' ' ' THR . 48.4 t -57.56 -43.69 84.66 Favored 'General case' 0 C--N 1.254 -3.579 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.492 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -67.95 -41.02 83.11 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.899 -173.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 42' ' ' ILE . 38.3 t80 -85.03 -11.9 54.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.85 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -61.98 -46.05 90.96 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.554 0.742 . . . . 0.0 111.029 -178.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.79 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.24 -29.1 67.84 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-O 122.435 1.112 . . . . 0.0 112.006 -166.304 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.79 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -61.18 -41.79 97.42 Favored 'General case' 1 C--N 1.236 -4.348 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.594 178.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 38' ' ' PHE . 42.2 mt -75.93 -54.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.202 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 39' ' ' CYS . 11.2 t -57.74 -33.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 112.716 -2.038 . . . . 0.0 112.953 -174.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -92.39 -31.88 15.16 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 32.4 t -70.5 -38.73 74.35 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.133 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 26.89 2.05 Favored Glycine 1 N--CA 1.379 -5.126 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.856 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.39 -5.1 64.94 Favored Glycine 0 C--N 1.305 -1.152 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 45' ' ' SER . 50.3 mttt -65.21 -27.03 68.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 41' ' ' ALA . 71.5 mt -85.28 141.15 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.416 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -126.17 -178.09 4.19 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.216 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.491 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.9 tp -98.89 140.9 32.36 Favored 'General case' 1 N--CA 1.328 -6.545 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -80.84 -57.55 3.5 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 122.419 1.104 . . . . 0.0 108.202 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.413 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.3 m80 -145.09 139.69 15.37 Favored Pre-proline 0 C--N 1.294 -1.819 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.587 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.51 110.17 3.0 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.36 171.39 14.5 Favored Glycine 0 C--N 1.289 -2.051 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -76.13 175.13 9.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 122.748 1.261 . . . . 0.0 113.665 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.269 -2.909 0 CA-C-N 112.024 -2.353 . . . . 0.0 104.958 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.412 ' OE1' ' HA ' ' A' ' 1' ' ' GLN . 12.4 mm-40 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.56 81.05 0.23 Allowed Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.85 -68.52 3.52 Favored Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -91.51 169.6 10.63 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.87 136.33 22.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.337 0.589 . . . . 0.0 110.588 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -129.21 133.31 47.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 168.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -73.82 74.73 1.61 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.794 0.807 . . . . 0.0 110.409 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.0 -7.02 65.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.97 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.23 -45.02 82.15 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 172.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.0 t80 46.96 43.73 13.98 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.407 1.483 . . . . 0.0 112.956 166.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' HG2' HG13 ' A' ' 43' ' ' VAL . 61.6 mm-40 -42.72 -46.47 5.12 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.065 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD1' ' HD2' ' A' ' 14' ' ' LYS . 7.5 t0 -129.03 149.91 50.65 Favored 'General case' 2 N--CA 1.37 -4.455 0 CA-C-N 111.82 -2.445 . . . . 0.0 106.135 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 p -55.99 -27.59 53.5 Favored 'General case' 1 C--N 1.231 -4.579 0 C-N-CA 127.963 2.505 . . . . 0.0 115.474 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' HD2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -87.47 -5.75 58.68 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.976 -1.077 . . . . 0.0 109.755 -175.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 12' ' ' ASP . 3.7 t -96.83 79.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -167.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -136.84 144.12 43.46 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 15.5 p -108.07 -179.8 4.0 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.987 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.422 HG21 ' OD1' ' A' ' 22' ' ' ASN . 6.2 t -131.39 169.38 16.11 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.549 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -97.28 -21.61 17.15 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 109.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.02 152.18 25.5 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.461 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 17.2 m -83.94 97.65 9.36 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.942 1.354 . . . . 0.0 112.42 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' OD1' HG21 ' A' ' 18' ' ' THR . 13.4 m120 -111.28 103.28 54.77 Favored Pre-proline 0 C--N 1.258 -3.405 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.501 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.57 136.79 31.68 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.469 1.446 . . . . 0.0 111.125 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.58 ' HB3' HD13 ' A' ' 51' ' ' LEU . 79.2 m-70 -143.88 127.61 17.18 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.924 0.869 . . . . 0.0 109.977 -175.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.1 t -93.7 103.25 15.41 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.26 161.03 45.49 Favored Glycine 0 N--CA 1.41 -3.071 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.888 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.6 p -54.03 -28.38 38.12 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 123.895 0.878 . . . . 0.0 110.398 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.639 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.0 t70 -60.85 -46.37 90.84 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.687 1.232 . . . . 0.0 109.085 173.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.35 -16.63 7.09 Favored Glycine 1 CA--C 1.445 -4.294 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.5 mt-30 -72.23 135.57 46.1 Favored 'General case' 0 CA--C 1.455 -2.691 0 CA-C-N 114.002 -1.099 . . . . 0.0 113.704 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.537 HG21 ' HG2' ' A' ' 56' ' ' LYS . 90.0 m -102.34 121.38 42.18 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.873 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HD2' ' O ' ' A' ' 34' ' ' ASN . 5.3 p90 -111.64 135.48 52.18 Favored 'General case' 1 N--CA 1.377 -4.082 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.447 177.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.08 -39.95 92.84 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.386 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 21' ' ' SER . 28.9 p30 -140.55 170.22 16.19 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.59 -36.33 80.68 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.542 0.687 . . . . 0.0 112.397 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -62.43 -33.57 75.07 Favored 'General case' 0 C--N 1.246 -3.897 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.891 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.555 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -50.58 -43.54 56.5 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.35 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -118.37 -1.75 11.22 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.301 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.804 ' HA ' HD12 ' A' ' 42' ' ' ILE . 52.1 t -52.17 -50.94 60.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.81 1.244 . . . . 0.0 111.644 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.712 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -66.6 -26.19 66.97 Favored 'General case' 0 N--CA 1.408 -2.532 0 C-N-CA 124.942 1.297 . . . . 0.0 114.001 -175.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -84.12 -27.19 28.35 Favored 'General case' 1 C--N 1.218 -5.115 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.732 176.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 39' ' ' CYS . 28.2 mt -66.03 -41.16 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.789 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.1 t -53.21 -44.18 51.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.4 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 42.4 mmtm -69.87 -34.84 74.12 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.733 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.7 m -81.76 -9.07 59.73 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.512 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.11 -19.5 5.44 Favored Glycine 1 N--CA 1.396 -4.024 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 97.56 -0.42 59.66 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -173.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -61.68 -32.31 72.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.165 -1.018 . . . . 0.0 112.898 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.596 ' HB ' HG12 ' A' ' 42' ' ' ILE . 3.4 mp -70.61 136.81 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 122.017 0.913 . . . . 0.0 109.724 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -131.07 -178.55 4.88 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 24' ' ' HIS . 37.9 tp -96.8 141.52 29.92 Favored 'General case' 1 N--CA 1.326 -6.67 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 42.5 mttp -89.95 -58.35 2.54 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 122.468 1.128 . . . . 0.0 109.169 165.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -138.01 143.99 41.89 Favored Pre-proline 0 C--N 1.28 -2.426 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.655 -165.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.67 109.91 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 165.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.48 165.47 12.32 Favored Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 31' ' ' THR . 12.8 mtpp -56.59 161.96 2.47 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.283 -2.308 0 CA-C-N 109.585 -3.461 . . . . 0.0 102.553 159.259 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . 0.518 ' CD ' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' H ' ' CD ' ' A' ' 1' ' ' GLN . . . -125.64 126.08 5.77 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 119.176 0.898 . . . . 0.0 111.216 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.98 53.61 29.39 Favored Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.586 HE21 ' HB2' ' A' ' 6' ' ' ASP . 3.8 pm0 -137.23 173.33 11.8 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 114.313 -0.943 . . . . 0.0 113.082 -169.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 17' ' ' CYS . 89.5 t -101.3 125.95 55.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 161.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.586 ' HB2' HE21 ' A' ' 4' ' ' GLN 0.251 1.6 t0 -105.18 89.18 3.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 119.244 3.053 . . . . 0.0 119.244 -162.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 m -116.06 40.64 2.77 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 153.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -0.76 63.86 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.036 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.3 -22.03 62.88 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 171.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.0 t80 73.05 76.78 0.14 Allowed 'General case' 0 C--N 1.362 1.148 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 163.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.561 ' OE1' HG11 ' A' ' 15' ' ' VAL . 3.2 pt20 -72.0 -50.51 28.06 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.605 167.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.609 ' HB3' HG23 ' A' ' 15' ' ' VAL . 7.8 t0 -142.56 155.71 45.03 Favored 'General case' 1 C--N 1.241 -4.111 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 172.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 t -71.75 -29.56 64.64 Favored 'General case' 0 C--N 1.258 -3.397 0 C-N-CA 124.865 1.266 . . . . 0.0 112.82 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 7.9 ptpp? -84.54 3.98 34.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.182 0.515 . . . . 0.0 111.524 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 12' ' ' ASP . 28.2 t -101.58 119.82 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-O 121.897 0.856 . . . . 0.0 112.078 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -122.32 165.31 16.46 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 30.7 p -92.68 178.27 5.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 122.101 0.953 . . . . 0.0 113.02 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 p -82.76 154.79 24.59 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.216 -1.356 . . . . 0.0 114.079 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -112.41 -9.28 13.85 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.319 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -95.07 155.77 16.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -91.85 107.1 18.97 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.289 1.042 . . . . 0.0 110.63 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.82 97.05 36.15 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.993 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.438 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 58.5 Cg_endo -74.65 123.93 8.42 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.618 0.878 . . . . 0.0 110.191 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 49.6 p-80 -153.06 138.29 17.44 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 46.0 t -108.69 109.77 21.02 Favored 'General case' 0 C--N 1.249 -3.761 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.17 162.91 52.86 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 19.9 m -54.91 -18.83 5.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.721 0.808 . . . . 0.0 111.64 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.3 t70 -64.92 -30.59 71.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.494 1.14 . . . . 0.0 109.081 174.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.01 -16.6 35.94 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.1 mt-30 -73.24 136.03 44.58 Favored 'General case' 0 CA--C 1.465 -2.327 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.457 HG21 ' CB ' ' A' ' 56' ' ' LYS . 99.0 m -111.13 130.21 55.69 Favored 'General case' 0 C--N 1.263 -3.189 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.101 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 54.2 m-85 -135.25 156.83 48.3 Favored 'General case' 0 N--CA 1.396 -3.143 0 CA-C-O 122.136 0.97 . . . . 0.0 112.251 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.16 -20.98 78.4 Favored Glycine 0 C--N 1.287 -2.176 0 CA-C-N 112.669 -2.06 . . . . 0.0 114.796 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 p30 -162.95 172.16 15.49 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 118.342 1.071 . . . . 0.0 108.787 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -63.86 -38.82 92.51 Favored 'General case' 0 C--O 1.197 -1.692 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.647 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.9 t -53.05 -43.93 67.03 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.931 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.7 -40.78 97.63 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.945 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 30' ' ' GLN . 44.6 t80 -104.03 5.2 35.19 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.3 t -61.43 -41.01 96.51 Favored 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 122.362 0.265 . . . . 0.0 110.361 -171.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.86 -30.01 71.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 125.618 1.567 . . . . 0.0 114.181 -174.084 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.55 -36.12 65.59 Favored 'General case' 1 C--N 1.209 -5.515 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.67 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 39' ' ' CYS . 40.3 mt -72.56 -44.44 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.954 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 39' ' ' CYS . 48.9 t -51.9 -50.97 31.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -66.93 -37.72 84.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.263 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m -87.06 13.25 9.63 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.865 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.85 79.99 Favored Glycine 0 N--CA 1.401 -3.636 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.406 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 79.05 2.72 87.52 Favored Glycine 0 C--N 1.279 -2.616 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.99 -21.98 62.23 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.1 mt -71.12 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.262 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 m -124.0 -173.45 2.76 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 32.6 tp -88.59 141.14 28.77 Favored 'General case' 1 N--CA 1.329 -6.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 52.0 tttm -99.88 -42.23 6.89 Favored 'General case' 1 N--CA 1.361 -4.882 0 C-N-CA 124.585 1.154 . . . . 0.0 111.152 174.599 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 28.3 m170 -138.26 132.65 16.87 Favored Pre-proline 0 C--N 1.284 -2.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.669 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.05 109.49 2.89 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 N-CA-C 105.067 -2.705 . . . . 0.0 105.067 163.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 107.58 176.52 22.48 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -169.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.2 ptmm? -70.29 169.24 14.2 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.449 1.119 . . . . 0.0 113.322 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.286 -2.174 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.672 166.232 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.74 -64.86 0.04 OUTLIER Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 106.181 -2.768 . . . . 0.0 106.181 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.7 139.09 17.62 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 106.862 -2.495 . . . . 0.0 106.862 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -83.74 105.84 14.96 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 16' ' ' TYR . 48.0 t -103.1 146.49 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 166.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . 0.284 6.0 t70 -92.78 79.27 4.74 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.945 -2.302 . . . . 0.0 116.75 -170.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 83.8 m -110.25 67.34 0.64 Allowed 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.11 -3.24 16.69 Favored Glycine 0 C--N 1.359 1.817 0 CA-C-N 113.096 -1.865 . . . . 0.0 112.576 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' A' ' 40' ' ' LYS . 44.9 mt-10 -62.98 -45.37 92.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.0 t80 46.04 34.66 2.11 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 126.391 1.877 . . . . 0.0 115.153 159.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.583 ' CG ' HG13 ' A' ' 43' ' ' VAL . 87.7 mm-40 -58.02 -20.73 41.0 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-O 123.132 1.444 . . . . 0.0 113.895 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.58 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 15.3 t70 -145.5 164.95 30.04 Favored 'General case' 2 N--CA 1.355 -5.204 0 CA-C-N 112.946 -1.934 . . . . 0.0 106.609 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -72.42 -34.06 67.57 Favored 'General case' 0 C--N 1.259 -3.369 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.237 -173.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.58 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 23.3 pttm -80.63 9.44 6.13 Favored 'General case' 0 C--O 1.26 1.642 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 7' ' ' CYS . 13.6 t -92.31 83.79 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.071 0.938 . . . . 0.0 110.595 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 52.6 p90 -137.68 152.73 49.58 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 16.5 p -115.57 -175.27 2.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 t -129.17 165.22 21.74 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.386 -1.734 . . . . 0.0 106.567 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.615 ' HG2' ' OE1' ' A' ' 20' ' ' GLU . 24.9 ptt-85 -110.09 -17.82 13.48 Favored 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.07 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' OE1' ' HG2' ' A' ' 19' ' ' ARG . 4.8 mp0 -74.75 146.82 41.86 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-N 113.859 -1.518 . . . . 0.0 107.047 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -81.44 90.35 6.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.907 1.336 . . . . 0.0 112.353 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 49.4 t-20 -111.16 95.65 26.42 Favored Pre-proline 0 C--N 1.25 -3.75 0 CA-C-N 112.073 -2.331 . . . . 0.0 106.577 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.6 Cg_exo -71.08 150.06 59.53 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.581 1.521 . . . . 0.0 111.434 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 31' ' ' THR . 18.9 m80 -138.94 122.52 17.38 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -98.0 100.35 11.68 Favored 'General case' 0 C--N 1.254 -3.554 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 171.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -75.72 166.81 54.66 Favored Glycine 0 N--CA 1.407 -3.242 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.993 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.5 m -65.86 -6.52 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.796 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.82 -7.97 59.65 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.908 1.283 . . . . 0.0 108.424 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.95 -27.15 10.51 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.79 136.2 43.56 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 56' ' ' LYS . 98.3 m -106.33 128.95 54.38 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.228 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -123.66 147.05 47.76 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.575 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.56 -38.63 82.05 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.834 1.334 . . . . 0.0 115.289 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.8 p30 -143.67 174.77 10.5 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -67.9 -31.43 71.2 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.613 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.503 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.4 OUTLIER -61.79 -38.98 90.1 Favored 'General case' 0 C--N 1.25 -3.723 0 CA-C-O 122.905 1.336 . . . . 0.0 110.074 178.603 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.79 -32.47 69.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 112.609 -2.087 . . . . 0.0 108.659 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 30.3 t80 -85.11 -10.61 56.62 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.482 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.792 ' O ' HG23 ' A' ' 43' ' ' VAL . 31.2 m -58.84 -52.43 65.76 Favored 'General case' 0 C--O 1.188 -2.164 0 O-C-N 121.366 -0.834 . . . . 0.0 112.765 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -65.39 -32.41 74.03 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 123.339 1.542 . . . . 0.0 111.27 -177.075 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -66.49 -26.49 67.2 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.465 176.551 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.862 HG22 ' HA2' ' A' ' 47' ' ' GLY . 33.3 mt -81.47 -44.24 20.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.252 1.501 . . . . 0.0 108.344 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 39' ' ' CYS . 96.0 t -54.31 -36.69 34.36 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.976 0 CA-C-N 111.495 -2.593 . . . . 0.0 112.21 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.1 ptmm? -56.96 -26.09 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.551 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.57 ' HB2' HD11 ' A' ' 49' ' ' ILE . 17.6 m -134.26 57.47 1.81 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 122.185 0.993 . . . . 0.0 112.463 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.32 -0.17 69.48 Favored Glycine 0 N--CA 1.41 -3.064 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 168.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.862 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.6 -0.94 84.58 Favored Glycine 0 N--CA 1.411 -3.018 0 C-N-CA 120.285 -0.959 . . . . 0.0 111.917 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.1 -14.94 58.12 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 45' ' ' SER . 68.2 mt -62.22 149.92 8.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.636 0.732 . . . . 0.0 110.423 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -125.74 178.4 5.72 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.8 tp -94.43 141.87 28.08 Favored 'General case' 1 N--CA 1.336 -6.155 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 178.366 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HA ' ' HZ1' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.32 -51.62 5.47 Favored 'General case' 0 CA--C 1.453 -2.763 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.609 166.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.8 t-80 -149.21 132.34 8.24 Favored Pre-proline 0 C--N 1.258 -3.407 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.909 -169.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 4.3 Cg_exo -76.39 109.83 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 N-CA-C 107.211 -1.88 . . . . 0.0 107.211 168.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 119.75 165.12 12.87 Favored Glycine 0 C--N 1.279 -2.622 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -171.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 9.0 mtpm? -60.1 164.41 4.08 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 C--N 1.269 -2.903 0 N-CA-C 102.082 -3.303 . . . . 0.0 102.082 158.763 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.73 75.16 Favored Glycine 0 C--O 1.214 -1.103 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.6 159.94 11.16 Favored Glycine 0 N--CA 1.417 -2.611 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? -77.62 144.28 37.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 118.601 1.2 . . . . 0.0 111.154 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 14.1 p -144.08 151.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.665 ' HB2' HG22 ' A' ' 18' ' ' THR . 7.5 p-10 -88.62 104.6 17.0 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.446 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HA ' HG13 ' A' ' 15' ' ' VAL 0.743 3.3 p 62.64 -33.87 0.11 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 50.77 -88.99 0.01 OUTLIER Glycine 0 N--CA 1.463 0.489 0 O-C-N 124.21 0.944 . . . . 0.0 115.318 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.751 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 35.1 mp0 -70.41 -30.2 67.02 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 123.382 0.673 . . . . 0.0 110.35 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.765 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.6 t80 73.16 -0.78 3.26 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 124.216 1.006 . . . . 0.0 113.598 164.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 79.6 mt-30 -133.13 -3.99 3.1 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.425 1.107 . . . . 0.0 109.248 172.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.751 ' HB2' ' HB2' ' A' ' 9' ' ' GLU . 7.1 t70 -78.58 -158.44 0.14 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.208 -1.814 . . . . 0.0 112.463 -169.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.469 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 9.4 t -138.34 -22.47 1.02 Allowed 'General case' 0 C--N 1.252 -3.65 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.777 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -83.49 9.74 10.54 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.358 1.075 . . . . 0.0 109.378 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.693 HG21 HG11 ' A' ' 43' ' ' VAL . 26.8 t -55.43 120.57 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 127.556 2.343 . . . . 0.0 113.959 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 15.0 m-85 -97.1 147.97 23.5 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' HB2' ' HA ' ' A' ' 36' ' ' CYS . 12.1 p -85.51 -178.45 6.69 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.665 HG22 ' HB2' ' A' ' 6' ' ' ASP . 73.8 p -78.29 169.53 18.11 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -169.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.481 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 26.1 ptt85 -100.28 1.36 41.62 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 109.282 -3.599 . . . . 0.0 106.684 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.625 ' H ' ' HB ' ' A' ' 18' ' ' THR . 59.3 mt-10 -104.06 140.66 37.45 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.328 -174.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -105.69 14.27 28.58 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.554 1.141 . . . . 0.0 109.907 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.7 m-20 -62.28 112.8 7.06 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.34 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.01 148.11 34.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.558 2.172 . . . . 0.0 112.007 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.467 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 94.1 m-70 -152.06 128.07 10.37 Favored 'General case' 0 CA--C 1.476 -1.876 0 CA-C-O 121.964 0.887 . . . . 0.0 110.901 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 42.2 t -94.42 98.79 11.12 Favored 'General case' 0 C--N 1.256 -3.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 170.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -82.89 166.3 44.66 Favored Glycine 0 CA--C 1.463 -3.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.417 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -77.36 4.75 10.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.01 -18.11 65.22 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 127.515 2.326 . . . . 0.0 106.539 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.42 -35.3 5.15 Favored Glycine 1 N--CA 1.391 -4.363 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 75.1 mt-30 -91.6 156.28 17.74 Favored 'General case' 0 CA--C 1.457 -2.602 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.525 HG21 ' HG2' ' A' ' 56' ' ' LYS . 95.3 m -96.21 124.63 40.28 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 112.847 -1.979 . . . . 0.0 108.106 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 93.6 m-85 -110.98 145.2 38.85 Favored 'General case' 0 N--CA 1.381 -3.887 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.564 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.22 85.66 Favored Glycine 0 C--N 1.3 -1.42 0 O-C-N 125.114 1.509 . . . . 0.0 112.522 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.4 p-10 -156.47 173.35 17.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.187 0.518 . . . . 0.0 111.097 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 0.3 OUTLIER -59.11 -28.38 66.48 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 125.71 1.604 . . . . 0.0 110.558 -176.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.645 ' HA ' ' HB2' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -57.0 -49.23 76.42 Favored 'General case' 1 C--N 1.241 -4.116 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.476 175.172 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -76.7 -35.18 58.03 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.811 -175.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 29.2 t80 -86.76 -24.61 25.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.7 t -67.56 -28.5 67.84 Favored 'General case' 0 C--O 1.188 -2.137 0 CA-C-N 119.55 1.068 . . . . 0.0 110.686 -172.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.83 -31.8 73.2 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.817 1.294 . . . . 0.0 111.468 -170.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.806 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -64.59 -40.23 95.15 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 111.569 -2.559 . . . . 0.0 108.648 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.3 mt -73.31 -46.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.822 -175.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 39' ' ' CYS . 26.4 t -56.6 -35.18 44.06 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.655 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' NZ ' ' HA ' ' A' ' 44' ' ' LYS . 1.9 mmpm? -84.53 -35.91 22.53 Favored 'General case' 0 C--N 1.281 -2.382 0 O-C-N 121.692 -0.63 . . . . 0.0 112.59 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 t -74.92 -23.49 58.35 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.843 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.89 7.96 Favored Glycine 0 N--CA 1.401 -3.661 0 C-N-CA 121.073 -0.585 . . . . 0.0 113.383 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 -8.49 79.71 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -65.92 -28.26 68.8 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 41' ' ' ALA . 74.3 mt -82.93 147.94 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.911 173.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.1 m -137.99 179.98 6.11 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 46.6 tp -88.92 141.46 28.47 Favored 'General case' 1 N--CA 1.339 -6.002 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -81.1 -59.22 2.73 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.105 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -143.59 142.05 20.16 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.784 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.08 110.34 2.87 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.861 1.708 . . . . 0.0 107.983 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.71 175.3 17.6 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HG2' HG21 ' A' ' 31' ' ' THR . 8.6 mtpm? -64.3 162.04 15.58 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--N 1.267 -2.997 1 N-CA-C 99.58 -4.23 . . . . 0.0 99.58 158.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.49 -1.337 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.52 -68.95 3.44 Favored Glycine 0 C--O 1.215 -1.07 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 -171.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.7 170.55 13.35 Favored Glycine 0 C--O 1.271 2.463 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -77.52 132.43 38.37 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.93 0.395 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.78 155.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.05 111.28 12.34 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 88.0 m -114.59 63.58 0.67 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 156.038 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.47 -5.07 34.47 Favored Glycine 0 CA--C 1.49 -1.49 0 CA-C-N 112.589 -2.096 . . . . 0.0 114.212 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' CB ' HG11 ' A' ' 43' ' ' VAL . 45.9 mt-10 -64.3 -40.83 96.71 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 170.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 t80 49.04 31.9 3.64 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 125.009 1.443 . . . . 0.0 113.361 165.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.06 -13.86 30.46 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-O 122.792 1.282 . . . . 0.0 114.025 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.643 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 15.0 t70 -139.67 143.96 37.39 Favored 'General case' 0 C--N 1.248 -3.812 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -65.67 -34.47 78.28 Favored 'General case' 0 C--N 1.248 -3.814 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.643 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 24.1 pttm -86.82 12.79 10.13 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -176.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 43' ' ' VAL . 21.2 t -94.86 100.3 10.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.952 0.882 . . . . 0.0 112.728 -174.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -137.13 155.05 50.07 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.663 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 23.6 p -113.94 -175.06 2.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.154 0.978 . . . . 0.0 112.883 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 5.7 t -146.23 163.44 35.46 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 7.3 ptm180 -115.31 -18.58 11.03 Favored 'General case' 1 C--N 1.235 -4.373 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.703 -176.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.27 126.31 49.23 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -170.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.617 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 t 62.84 -4.58 0.24 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 163.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.2 m120 -106.61 92.92 7.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 C-N-CA 117.904 -1.519 . . . . 0.0 114.29 -173.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 21' ' ' SER . 4.0 Cg_endo -83.19 153.6 14.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.126 1.884 . . . . 0.0 110.53 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -150.63 128.41 11.66 Favored 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.3 t -99.46 95.77 7.23 Favored 'General case' 1 C--N 1.242 -4.069 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 168.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.8 165.17 39.89 Favored Glycine 0 CA--C 1.451 -3.909 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.863 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 49' ' ' ILE . 41.4 m -67.93 4.85 1.03 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 117.912 0.856 . . . . 0.0 111.441 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.2 -24.35 66.26 Favored 'General case' 0 C--N 1.364 1.225 0 C-N-CA 127.189 2.196 . . . . 0.0 105.757 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.11 -31.04 8.99 Favored Glycine 0 N--CA 1.396 -3.98 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.236 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.04 155.99 19.13 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 97.6 m -97.72 124.32 42.01 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.239 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.1 m-85 -117.58 142.51 47.12 Favored 'General case' 0 N--CA 1.383 -3.789 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.435 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -36.19 82.24 Favored Glycine 0 C--N 1.309 -0.97 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.199 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.3 p30 -145.72 -178.29 6.02 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 117.258 0.529 . . . . 0.0 109.602 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 18' ' ' THR . 25.0 ttmm -67.59 -37.35 82.44 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.121 0.486 . . . . 0.0 112.175 -174.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -61.79 -38.39 87.89 Favored 'General case' 0 C--N 1.25 -3.728 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.702 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.04 -37.44 87.19 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.141 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 13.5 t80 -94.55 -8.75 37.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.832 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.796 ' O ' HG23 ' A' ' 43' ' ' VAL . 16.1 t -62.51 -37.59 86.64 Favored 'General case' 0 CA--C 1.472 -2.024 0 C-N-CA 123.088 0.555 . . . . 0.0 110.455 -171.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -65.27 -33.39 75.86 Favored 'General case' 0 CA--C 1.454 -2.723 0 C-N-CA 124.362 1.065 . . . . 0.0 113.103 -172.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.742 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.33 -34.85 59.0 Favored 'General case' 1 C--N 1.218 -5.114 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.815 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.2 mt -63.04 -43.42 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.444 -3.127 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 39' ' ' CYS . 41.2 t -55.03 -41.9 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.641 0 CA-C-N 111.518 -2.583 . . . . 0.0 111.053 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 24.7 mmtm -65.21 -37.69 88.11 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HG13 ' A' ' 49' ' ' ILE . 24.7 m -104.08 28.59 6.62 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.984 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 20.61 59.1 Favored Glycine 0 N--CA 1.4 -3.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 77.64 0.55 74.08 Favored Glycine 0 C--N 1.275 -2.847 0 CA-C-N 117.896 0.848 . . . . 0.0 111.226 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -80.4 -21.4 42.3 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' SER . 75.1 mt -62.98 152.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 121.053 0.454 . . . . 0.0 110.271 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -127.68 -176.28 3.72 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.5 tp -97.0 140.75 31.05 Favored 'General case' 1 N--CA 1.332 -6.365 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 36.1 mtpt -81.63 -50.2 9.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 121.965 0.888 . . . . 0.0 108.611 170.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 17.8 t-80 -154.89 133.17 6.87 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.057 -171.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.13 110.7 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.264 1.976 . . . . 0.0 108.481 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 113.27 -170.25 13.28 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -172.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.0 ptmm? -80.49 166.8 20.86 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.769 0.795 . . . . 0.0 112.415 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 165.909 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.22 -76.65 1.78 Allowed Glycine 0 C--O 1.22 -0.72 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.82 129.31 9.57 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -101.55 95.62 6.58 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 18' ' ' THR . 89.2 t -90.63 140.01 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 1.8 p30 -126.45 156.26 40.92 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.745 ' SG ' HG21 ' A' ' 43' ' ' VAL . 20.5 p -41.29 -17.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 118.888 2.921 . . . . 0.0 118.888 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.6 ' N ' ' HB2' ' A' ' 39' ' ' CYS . . . -56.16 -29.12 55.58 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 119.983 1.265 . . . . 0.0 111.268 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -28.08 59.09 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 124.656 1.182 . . . . 0.0 112.432 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.648 ' HB2' HG11 ' A' ' 15' ' ' VAL . 95.6 m-85 -138.0 92.56 2.67 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-O 124.068 1.89 . . . . 0.0 111.408 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.743 ' HA ' HG13 ' A' ' 43' ' ' VAL . 73.3 mt-30 -40.32 -6.93 0.0 OUTLIER 'General case' 1 C--N 1.233 -4.493 1 C-N-CA 134.448 5.099 . . . . 0.0 115.745 172.131 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 10' ' ' PHE . 12.6 t0 -75.73 -161.39 0.16 Allowed 'General case' 0 C--N 1.26 -3.311 0 C-N-CA 126.202 1.801 . . . . 0.0 109.012 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -106.55 -48.98 3.42 Favored 'General case' 1 C--N 1.232 -4.518 0 C-N-CA 125.563 1.545 . . . . 0.0 114.574 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.607 ' H ' ' HD2' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -85.34 19.6 2.25 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.562 0.745 . . . . 0.0 111.984 -170.337 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.648 HG11 ' HB2' ' A' ' 10' ' ' PHE . 4.3 t -107.87 130.57 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -127.12 175.5 8.08 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 12.0 p -77.98 167.12 21.97 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 113.49 -1.686 . . . . 0.0 114.347 -168.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.525 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 10.0 t -96.35 174.81 6.68 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.298 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -87.22 -3.09 59.03 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 35.1 mm-40 -69.44 119.25 13.41 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.836 -176.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -87.81 15.31 7.21 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.409 1.483 . . . . 0.0 111.589 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 18.6 t-20 -70.95 110.61 7.54 Favored Pre-proline 0 C--N 1.271 -2.843 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.8 Cg_exo -71.44 159.62 50.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.578 2.185 . . . . 0.0 112.459 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -151.75 130.64 12.5 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 123.289 0.636 . . . . 0.0 109.698 -172.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 50.4 t -108.43 104.37 13.7 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -69.63 169.25 45.04 Favored Glycine 0 N--CA 1.414 -2.793 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.268 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -65.21 -19.39 65.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.7 t70 -61.26 -36.86 81.15 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 125.272 1.429 . . . . 0.0 108.953 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.73 -18.66 14.76 Favored Glycine 0 N--CA 1.398 -3.887 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.1 mt-30 -71.66 135.3 46.82 Favored 'General case' 0 CA--C 1.452 -2.822 0 CA-C-O 122.375 1.083 . . . . 0.0 113.795 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.4 m -117.86 133.17 56.2 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.019 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 66.4 m-85 -131.26 162.33 30.27 Favored 'General case' 0 N--CA 1.38 -3.928 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.398 172.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 -25.11 63.62 Favored Glycine 0 C--N 1.294 -1.773 0 CA-C-N 113.386 -1.733 . . . . 0.0 113.362 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.7 p30 -158.99 168.21 27.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.07 -35.62 73.67 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.647 0.737 . . . . 0.0 111.571 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.692 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.07 -52.67 32.67 Favored 'General case' 0 C--N 1.256 -3.499 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.335 174.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.33 -33.74 76.41 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.258 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 26' ' ' GLY . 48.2 t80 -95.0 -2.11 51.04 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.127 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.832 ' O ' HG23 ' A' ' 43' ' ' VAL . 14.5 p -61.38 -43.85 98.16 Favored 'General case' 0 CA--C 1.439 -3.296 0 O-C-N 121.908 -0.495 . . . . 0.0 111.149 -172.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -57.26 -35.57 69.9 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 126.152 1.781 . . . . 0.0 114.496 -172.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -68.59 -39.49 80.9 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.665 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 39' ' ' CYS . 34.9 mt -69.19 -48.12 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.001 -177.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 39' ' ' CYS . 37.1 t -50.75 -50.63 22.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 112.009 -2.359 . . . . 0.0 111.832 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 28.6 mmtm -78.73 -32.59 46.82 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.87 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.479 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 16.3 m -80.55 4.21 19.2 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.017 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.45 19.05 46.7 Favored Glycine 1 N--CA 1.385 -4.706 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 171.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 -0.47 62.63 Favored Glycine 0 C--N 1.29 -2.012 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 45' ' ' SER . 38.7 mttp -71.77 -19.39 62.02 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -79.83 140.99 15.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.645 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 m -121.08 -179.71 4.12 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.493 HD12 ' HA2' ' A' ' 26' ' ' GLY . 35.9 tp -90.16 141.06 29.07 Favored 'General case' 1 N--CA 1.324 -6.765 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.655 ' HD2' ' SG ' ' A' ' 57' ' ' CYS . 2.2 ttmp? -90.02 -54.59 3.97 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.842 170.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 58.9 m170 -139.38 137.16 18.55 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.083 -173.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.62 109.83 2.93 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 N-CA-C 105.796 -2.424 . . . . 0.0 105.796 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.84 -177.22 16.96 Favored Glycine 0 C--N 1.284 -2.341 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -169.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.2 pttp -79.21 173.35 12.67 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-O 121.901 0.857 . . . . 0.0 111.327 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.655 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 24.8 m . . . . . 0 C--N 1.281 -2.409 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 165.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.98 -138.79 24.14 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.411 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.28 91.35 0.73 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.16 165.06 11.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.88 174.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 15.0 t70 -129.94 133.16 46.65 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -52.54 -156.84 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 166.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 7' ' ' CYS . . . 98.24 -65.73 0.78 Allowed Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.08 -17.43 55.2 Favored 'General case' 0 N--CA 1.407 -2.589 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.689 ' HB3' HG21 ' A' ' 15' ' ' VAL . 95.3 m-85 -114.74 81.02 1.49 Allowed 'General case' 1 N--CA 1.376 -4.142 0 CA-C-O 123.763 1.744 . . . . 0.0 110.075 -171.427 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.583 ' C ' HG13 ' A' ' 43' ' ' VAL . 65.5 mm-40 -45.0 -8.19 0.01 OUTLIER 'General case' 1 C--N 1.223 -4.892 2 C-N-CA 133.978 4.911 . . . . 0.0 114.725 173.826 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' CG ' ' HG2' ' A' ' 14' ' ' LYS . 45.5 t0 -98.35 134.6 41.13 Favored 'General case' 1 N--CA 1.371 -4.389 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 174.535 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -79.12 6.19 10.18 Favored 'General case' 1 C--N 1.222 -4.956 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.787 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.536 ' HG2' ' CG ' ' A' ' 12' ' ' ASP . 35.4 mmtm -81.85 -25.96 34.66 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.689 HG21 ' HB3' ' A' ' 10' ' ' PHE . 3.1 t -92.26 120.68 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.072 -171.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' HA ' ' SG ' ' A' ' 7' ' ' CYS 0.402 59.6 m-85 -118.2 175.12 5.84 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 28.0 p -75.84 166.94 22.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -162.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.433 HG22 ' OD2' ' A' ' 6' ' ' ASP . 9.5 t -91.9 175.1 7.01 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.13 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -91.05 -17.94 25.4 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.727 -2.033 . . . . 0.0 109.032 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.17 131.96 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.226 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 34' ' ' ASN . 27.3 m -94.44 107.13 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 122.12 0.962 . . . . 0.0 111.077 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -110.75 100.44 45.88 Favored Pre-proline 0 C--N 1.276 -2.625 0 CA-C-N 113.161 -1.836 . . . . 0.0 109.554 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 6.8 Cg_exo -75.59 125.19 8.77 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.426 2.084 . . . . 0.0 111.267 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -151.53 129.32 11.62 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 125.236 1.415 . . . . 0.0 108.845 -174.547 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -92.61 106.73 18.66 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 160.35 53.54 Favored Glycine 0 N--CA 1.401 -3.657 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.349 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 50.3 m -64.61 -7.37 10.23 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.854 0.835 . . . . 0.0 110.468 173.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -81.36 -10.48 59.53 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.763 2.025 . . . . 0.0 108.374 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.49 -31.6 6.32 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.266 26.1 mt-30 -74.72 130.08 38.85 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 56' ' ' LYS . 89.9 m -98.81 126.04 44.35 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.695 -2.048 . . . . 0.0 110.092 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 30.1 p90 -106.99 133.03 52.24 Favored 'General case' 0 N--CA 1.39 -3.45 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.745 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.75 -42.51 61.55 Favored Glycine 0 CA--C 1.499 -0.912 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.807 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 21' ' ' SER . 32.6 p30 -128.72 168.78 15.34 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 52.3 tttm -71.58 -35.47 70.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.733 0.777 . . . . 0.0 110.141 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HA ' ' CB ' ' A' ' 17' ' ' CYS . 49.6 t -48.26 -44.9 33.85 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.755 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -50.76 -42.99 58.21 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.431 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 8.8 t80 -127.53 -1.36 6.18 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 117.492 -1.683 . . . . 0.0 114.186 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 42' ' ' ILE . 31.7 p -51.45 -55.35 19.25 Favored 'General case' 0 C--O 1.194 -1.861 0 C-N-CA 123.471 0.708 . . . . 0.0 111.38 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -65.12 -24.38 67.4 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 127.045 2.138 . . . . 0.0 114.586 -177.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -82.04 -28.73 32.32 Favored 'General case' 1 C--N 1.202 -5.816 0 CA-C-N 113.179 -1.828 . . . . 0.0 110.718 173.605 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.0 mt -66.99 -43.14 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.78 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.7 t -50.34 -41.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 110.619 -2.991 . . . . 0.0 110.995 171.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -86.0 -29.46 23.48 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.464 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' HD3' ' A' ' 48' ' ' LYS . 64.3 m -86.85 12.96 9.77 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.43 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.36 3.48 72.15 Favored Glycine 0 N--CA 1.413 -2.895 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.68 14.12 82.83 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 4.5 pttm -64.74 -25.0 67.74 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-O 121.94 0.876 . . . . 0.0 109.671 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 42' ' ' ILE . 4.1 mp -79.02 131.51 34.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.688 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 p -130.84 -177.82 4.53 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.8 tp -95.16 141.48 28.72 Favored 'General case' 1 N--CA 1.343 -5.806 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.688 ' HA ' ' NZ ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.23 -54.95 3.72 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.458 164.09 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 25.1 t-80 -149.72 135.09 9.79 Favored Pre-proline 0 C--N 1.262 -3.219 0 CA-C-N 113.575 -1.648 . . . . 0.0 112.175 -167.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 8.2 Cg_exo -73.8 110.3 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.965 1.776 . . . . 0.0 108.453 170.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.92 168.74 15.35 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 31' ' ' THR . 12.3 mtpp -56.03 162.51 1.88 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.413 -2.289 0 CA-C-N 109.435 -3.53 . . . . 0.0 101.817 158.292 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.415 -2.188 0 CA-C-O 123.4 1.572 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 2.7 t-20 -111.06 96.29 29.18 Favored Pre-proline 0 C--N 1.253 -3.629 0 CA-C-N 112.252 -2.249 . . . . 0.0 108.369 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.3 Cg_exo -68.6 154.96 70.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.914 1.743 . . . . 0.0 112.578 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -148.94 128.26 12.96 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 34.0 t -104.02 103.46 13.28 Favored 'General case' 0 C--N 1.254 -3.584 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.18 160.24 52.33 Favored Glycine 0 N--CA 1.4 -3.711 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.057 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.2 m -66.93 -4.73 10.21 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 120.701 0.286 . . . . 0.0 110.666 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -7.77 53.03 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.17 1.462 . . . . 0.0 107.749 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.25 -34.37 5.77 Favored Glycine 0 N--CA 1.397 -3.941 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.321 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.16 155.12 30.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 88.4 m -110.92 131.22 55.23 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.053 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -120.77 138.24 54.11 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.542 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.83 -34.72 65.62 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 114.874 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.8 p30 -147.28 178.26 8.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -74.54 -30.07 61.62 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-O 122.148 0.975 . . . . 0.0 111.217 -174.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -39.13 86.62 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.128 173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.774 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 27.5 t80 -81.17 -15.65 55.16 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.66 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.738 ' O ' HG23 ' A' ' 43' ' ' VAL . 40.9 m -58.17 -52.77 64.18 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 112.766 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.79 -25.2 62.77 Favored 'General case' 0 CA--C 1.462 -2.433 0 CA-C-O 123.413 1.578 . . . . 0.0 111.048 -176.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.75 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -75.81 -25.8 56.67 Favored 'General case' 1 C--N 1.206 -5.664 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.927 175.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.789 HG22 ' HA2' ' A' ' 47' ' ' GLY . 20.5 mt -73.16 -41.37 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.049 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 39' ' ' CYS . 84.3 t -57.9 -29.89 36.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 110.85 -2.886 . . . . 0.0 110.516 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -48.38 -43.63 34.02 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 178.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 49' ' ' ILE . 5.6 m -134.39 61.67 1.67 Allowed 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 122.169 0.985 . . . . 0.0 111.669 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.5 0.33 89.94 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 118.561 2.184 . . . . 0.0 118.561 167.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.789 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 88.76 -19.31 38.09 Favored Glycine 0 C--N 1.27 -3.123 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.525 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 30.9 mmtm -78.0 -10.65 59.7 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.746 1.219 . . . . 0.0 113.72 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 45' ' ' SER . 59.2 mt -62.26 148.98 9.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.9 m -125.6 -179.35 4.6 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.29 141.36 32.16 Favored 'General case' 1 N--CA 1.331 -6.382 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -87.02 -55.48 3.81 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.385 1.088 . . . . 0.0 108.839 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -131.07 133.2 24.42 Favored Pre-proline 0 C--N 1.288 -2.096 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.637 -166.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.08 109.33 2.81 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 N-CA-C 104.987 -2.736 . . . . 0.0 104.987 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.69 -175.24 15.76 Favored Glycine 0 C--N 1.281 -2.476 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.6 pttp -80.65 174.35 11.7 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 121.766 0.793 . . . . 0.0 111.138 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 165.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.539 0.538 0 CA-C-O 122.982 1.372 . . . . 0.0 107.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.35 110.65 13.09 Favored Pre-proline 0 C--N 1.263 -3.182 0 CA-C-N 112.112 -2.313 . . . . 0.0 111.408 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 149.84 84.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.682 2.255 . . . . 0.0 111.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.68 131.35 12.32 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.64 0.776 . . . . 0.0 109.546 -172.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.574 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 42.0 t -100.69 108.88 20.86 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HE3' ' A' ' 52' ' ' LYS . . . -74.41 151.24 43.1 Favored Glycine 1 N--CA 1.395 -4.071 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.695 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 p -59.31 -25.86 64.5 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 124.031 0.932 . . . . 0.0 109.826 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.529 ' CB ' HG12 ' A' ' 49' ' ' ILE . 14.6 t70 -74.52 3.42 7.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 126.384 1.874 . . . . 0.0 109.872 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.95 -29.85 8.2 Favored Glycine 0 CA--C 1.468 -2.856 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.956 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -74.19 128.68 36.16 Favored 'General case' 0 CA--C 1.45 -2.867 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' HG2' ' A' ' 56' ' ' LYS . 87.7 m -107.7 132.54 53.23 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.32 -1.764 . . . . 0.0 108.843 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 96.8 m-85 -119.96 143.41 48.03 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.92 -32.21 55.78 Favored Glycine 0 C--O 1.219 -0.792 0 O-C-N 124.671 1.232 . . . . 0.0 113.969 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 31.0 p30 -155.1 174.64 14.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HA ' ' HB3' ' A' ' 38' ' ' PHE . 18.5 tptm -66.53 -32.92 74.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.141 0.972 . . . . 0.0 111.102 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.529 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 3.7 t -50.6 -53.63 29.1 Favored 'General case' 1 C--N 1.236 -4.344 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.861 171.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -70.28 -40.42 74.34 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.852 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' A' ' 35' ' ' LYS . 65.1 t80 -68.02 -46.55 70.9 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.119 -1.4 . . . . 0.0 113.529 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.791 ' HA ' HD12 ' A' ' 42' ' ' ILE . 21.9 t -70.17 -36.76 74.91 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.789 -171.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -85.78 -7.81 58.52 Favored 'General case' 0 N--CA 1.392 -3.329 0 CA-C-O 122.102 0.953 . . . . 0.0 110.581 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.07 -28.02 21.6 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.654 -2.066 . . . . 0.0 110.629 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 39' ' ' CYS . 68.8 mt -60.47 -45.42 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.904 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.8 t -52.7 -32.29 17.17 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 110.491 -3.05 . . . . 0.0 111.013 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.8 mmpm? -86.45 -42.41 13.63 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.671 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 35.7 t -74.47 -15.98 60.87 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 123.787 0.679 . . . . 0.0 110.894 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.42 18.6 7.03 Favored Glycine 0 N--CA 1.401 -3.647 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.963 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.97 -5.59 61.85 Favored Glycine 0 C--N 1.295 -1.704 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.354 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HD3' ' O ' ' A' ' 45' ' ' SER . 3.8 mtpm? -60.49 -25.06 65.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 28' ' ' ASP . 9.5 mt -85.05 132.71 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.489 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.0 m -128.39 -179.37 4.99 Favored 'General case' 0 C--N 1.267 -3.022 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 170.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.7 tp -98.66 140.99 32.04 Favored 'General case' 1 N--CA 1.333 -6.314 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.649 ' HE3' ' O ' ' A' ' 26' ' ' GLY . 77.4 mttt -88.05 -56.89 3.14 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 122.55 1.167 . . . . 0.0 107.858 165.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 41.8 t-80 -153.88 140.13 12.63 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.218 -167.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 12.1 Cg_exo -72.06 110.28 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.085 1.857 . . . . 0.0 108.848 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 161.05 11.31 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 8.9 mtpm? -57.94 165.65 1.75 Allowed 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 C--N 1.274 -2.715 0 N-CA-C 101.522 -3.51 . . . . 0.0 101.522 159.72 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 N--CA 1.421 -1.907 0 CA-C-O 122.988 1.375 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.48 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 0.9 OUTLIER -110.26 94.93 19.77 Favored Pre-proline 0 C--N 1.257 -3.449 0 CA-C-N 112.218 -2.264 . . . . 0.0 107.343 175.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 61.2 Cg_endo -75.3 132.35 14.94 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.799 1.666 . . . . 0.0 112.241 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -141.97 127.71 19.23 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.3 t -102.11 107.58 18.72 Favored 'General case' 0 C--N 1.249 -3.771 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 169.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 52' ' ' LYS . . . -71.14 165.26 53.37 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.685 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -51.76 -28.77 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.444 0.698 . . . . 0.0 110.481 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 8.9 t70 -60.5 -37.32 80.74 Favored 'General case' 0 CA--C 1.48 -1.729 0 C-N-CA 126.374 1.87 . . . . 0.0 110.085 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.07 -20.08 14.65 Favored Glycine 0 CA--C 1.459 -3.451 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 46.1 mt-30 -72.2 131.97 43.47 Favored 'General case' 0 CA--C 1.468 -2.184 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.515 HG21 ' CB ' ' A' ' 56' ' ' LYS . 95.4 m -102.31 131.32 48.98 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.234 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 65.4 m-85 -123.21 143.12 50.24 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.986 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.22 95.75 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.439 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 36.9 p30 -133.15 177.14 7.9 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 117.651 0.726 . . . . 0.0 109.413 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 83.6 tttt -67.97 -35.28 78.1 Favored 'General case' 0 C--O 1.189 -2.128 0 CA-C-O 121.336 0.589 . . . . 0.0 111.35 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -38.57 88.34 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.421 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.09 -39.44 94.72 Favored 'General case' 0 C--N 1.26 -3.32 0 CA-C-N 112.977 -1.919 . . . . 0.0 109.821 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 42' ' ' ILE . 22.6 t80 -88.91 -27.55 20.9 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.153 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.804 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.9 t -57.9 -40.88 81.4 Favored 'General case' 0 CA--C 1.481 -1.71 0 C-N-CA 124.612 1.165 . . . . 0.0 110.938 -173.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -73.86 -24.08 59.69 Favored 'General case' 0 N--CA 1.409 -2.494 0 CA-C-O 122.853 1.311 . . . . 0.0 110.485 -170.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -79.7 -29.27 40.69 Favored 'General case' 0 C--N 1.265 -3.078 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.703 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.5 mt -67.08 -42.91 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 39' ' ' CYS . 10.3 t -62.56 -27.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.943 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -70.33 -39.5 74.69 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.8 -0.562 . . . . 0.0 112.275 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HG13 ' A' ' 49' ' ' ILE . 31.2 m -105.82 22.62 15.28 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.51 14.8 75.29 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 170.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.29 0.74 88.45 Favored Glycine 0 C--N 1.274 -2.88 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 3.0 mmmp? -68.55 -28.71 67.21 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 45' ' ' SER . 40.5 mt -76.69 145.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.004 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -130.24 -175.34 3.6 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 51' ' ' LEU . 31.4 tp -86.18 141.37 29.39 Favored 'General case' 1 N--CA 1.326 -6.663 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 21.0 ttmm -91.75 -52.15 4.89 Favored 'General case' 0 N--CA 1.38 -3.936 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.514 172.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -145.21 137.27 13.16 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.856 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.04 110.38 3.06 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 107.137 -1.909 . . . . 0.0 107.137 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.79 179.47 17.8 Favored Glycine 0 C--N 1.288 -2.09 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -171.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.515 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.0 pttp -78.73 170.43 16.67 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-O 121.433 0.635 . . . . 0.0 110.617 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 32.4 m . . . . . 0 C--N 1.273 -2.742 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 21.4 m . . . . . 0 N--CA 1.428 -1.554 0 CA-C-O 122.212 1.006 . . . . 0.0 110.651 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 27.9 t-20 -111.66 94.33 23.25 Favored Pre-proline 0 C--N 1.268 -2.974 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.085 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.45 123.9 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.105 1.203 . . . . 0.0 109.584 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.742 ' HB2' HD13 ' A' ' 51' ' ' LEU . 48.7 p-80 -153.63 133.57 13.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.537 ' O ' HD12 ' A' ' 51' ' ' LEU . 44.1 t -92.74 114.19 26.68 Favored 'General case' 0 C--N 1.264 -3.143 0 CA-C-N 113.877 -1.51 . . . . 0.0 106.993 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.23 147.53 50.1 Favored Glycine 1 N--CA 1.393 -4.172 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.561 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 p -45.69 -41.27 10.26 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 124.826 1.251 . . . . 0.0 110.757 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.91 3.35 5.39 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.136 0.974 . . . . 0.0 112.81 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.43 54.59 Favored Glycine 0 CA--C 1.46 -3.358 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -73.2 122.77 22.44 Favored 'General case' 0 CA--C 1.45 -2.877 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 56' ' ' LYS . 94.7 m -116.95 127.7 54.48 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.676 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.557 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 31.6 m-85 -134.61 161.11 36.03 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.315 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.51 -31.7 52.2 Favored Glycine 0 C--N 1.298 -1.539 0 CA-C-N 113.182 -1.826 . . . . 0.0 114.563 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.8 p30 -162.7 -175.57 4.51 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 117.467 0.633 . . . . 0.0 109.549 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -68.1 -42.57 80.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.418 0.628 . . . . 0.0 111.862 -177.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -63.39 -32.6 74.08 Favored 'General case' 0 C--N 1.247 -3.879 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.586 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -53.61 -43.21 68.46 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.681 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -133.1 26.01 4.23 Favored 'General case' 0 C--O 1.195 -1.787 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.864 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.9 ' HA ' HD12 ' A' ' 42' ' ' ILE . 49.8 t -54.5 -45.56 73.28 Favored 'General case' 0 C--O 1.202 -1.406 0 C-N-CA 122.924 0.49 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -69.0 -25.91 64.75 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 125.69 1.596 . . . . 0.0 114.489 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.16 -25.93 33.88 Favored 'General case' 1 C--N 1.203 -5.78 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.016 174.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 39' ' ' CYS . 12.8 mt -65.45 -42.54 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 39' ' ' CYS . 80.6 t -49.5 -44.56 18.88 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.354 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.54 -31.05 29.31 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.297 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.4 m -80.89 8.4 8.38 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.358 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 2.31 58.01 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.99 -6.11 68.21 Favored Glycine 0 C--N 1.29 -2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.2 mtpm? -61.03 -25.77 67.15 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 124.627 1.171 . . . . 0.0 113.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 42' ' ' ILE . 14.4 mt -66.42 125.86 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 CA-C-O 123.02 1.39 . . . . 0.0 112.406 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -131.31 -175.33 3.66 Favored 'General case' 0 C--N 1.261 -3.258 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 24' ' ' HIS . 35.6 tp -94.98 141.21 28.92 Favored 'General case' 1 N--CA 1.328 -6.556 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 24.4 mmtm -77.46 -65.44 0.96 Allowed 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 55.6 t-80 -167.5 151.19 6.11 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 112.208 -2.269 . . . . 0.0 108.098 -171.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.61 138.56 80.75 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.136 1.89 . . . . 0.0 110.664 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.52 163.98 29.37 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.1 mtpm? -63.77 162.84 12.68 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 98.5 m . . . . . 0 C--N 1.271 -2.824 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 158.428 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t . . . . . 0 N--CA 1.468 0.457 0 CA-C-O 121.797 0.808 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.832 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 5.5 m-20 -56.91 102.51 0.31 Allowed Pre-proline 0 C--N 1.273 -2.74 0 CA-C-N 113.363 -1.744 . . . . 0.0 113.153 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 2.4 Cg_endo -76.18 151.84 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.846 1.697 . . . . 0.0 111.48 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.473 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 88.2 m-70 -148.49 129.05 14.03 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 110.482 -173.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 34.7 t -103.38 101.54 11.45 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 169.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -77.39 170.08 54.97 Favored Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.251 -171.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 m -68.37 -4.47 14.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.679 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.77 -8.09 58.41 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.668 1.187 . . . . 0.0 107.886 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.02 -29.53 8.61 Favored Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.857 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -74.26 145.06 44.33 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.2 m -108.92 131.6 54.88 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.307 -1.77 . . . . 0.0 109.249 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 95.0 m-85 -129.28 151.34 50.05 Favored 'General case' 0 N--CA 1.398 -3.035 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.257 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.49 -26.09 59.02 Favored Glycine 0 C--O 1.208 -1.508 0 CA-C-N 114.5 -1.227 . . . . 0.0 115.469 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 7.8 p30 -164.5 173.59 11.89 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.661 0.731 . . . . 0.0 109.277 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -62.44 -32.58 73.46 Favored 'General case' 0 C--O 1.182 -2.448 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.63 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 61.7 m -57.13 -39.94 76.14 Favored 'General case' 0 C--N 1.255 -3.519 0 CA-C-O 122.351 1.072 . . . . 0.0 111.829 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.16 -38.31 56.82 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.738 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 21.4 t80 -81.43 -6.09 58.58 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.745 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 t -63.89 -41.99 97.57 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.591 -0.693 . . . . 0.0 111.396 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -71.41 -17.56 62.39 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 125.244 1.418 . . . . 0.0 113.856 -176.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -87.22 -26.7 23.39 Favored 'General case' 1 C--N 1.208 -5.575 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.593 173.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.9 mt -72.02 -36.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 93.8 t -54.07 -33.13 24.01 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 CA-C-N 110.611 -2.995 . . . . 0.0 111.246 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 3.0 mmmm -48.11 -43.01 30.56 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.2 m -124.36 29.65 6.28 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.46 26.34 28.06 Favored Glycine 0 N--CA 1.4 -3.721 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.72 -8.87 54.26 Favored Glycine 0 C--N 1.277 -2.738 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.618 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -72.8 -19.89 61.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.8 mt -69.68 150.76 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.351 0.596 . . . . 0.0 110.989 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -125.46 -176.38 3.58 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HA2' ' A' ' 26' ' ' GLY . 41.6 tp -97.56 140.94 31.23 Favored 'General case' 1 N--CA 1.329 -6.512 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.417 ' NZ ' ' SG ' ' A' ' 57' ' ' CYS . 7.2 mtmp? -93.42 -50.71 5.32 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.698 0.761 . . . . 0.0 110.583 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 18.0 m170 -126.34 130.24 23.97 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.907 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.64 109.68 2.8 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 163.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 110.78 -179.23 20.07 Favored Glycine 0 C--N 1.285 -2.267 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -169.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.0 pttp -78.4 174.07 11.67 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-O 122.188 0.994 . . . . 0.0 111.911 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.417 ' SG ' ' NZ ' ' A' ' 52' ' ' LYS . 20.0 m . . . . . 0 C--N 1.28 -2.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.208 165.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.416 -2.17 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 46.4 t-20 -111.11 105.59 57.11 Favored Pre-proline 0 C--N 1.277 -2.544 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.53 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.08 148.69 63.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.791 1.661 . . . . 0.0 112.183 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' THR . 69.7 m-70 -148.07 130.81 16.01 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -106.69 102.6 11.96 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -68.98 160.16 52.53 Favored Glycine 0 N--CA 1.405 -3.397 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.0 m -60.8 -21.17 62.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -73.36 -16.34 61.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 125.54 1.536 . . . . 0.0 110.894 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.19 -20.68 30.33 Favored Glycine 1 CA--C 1.448 -4.14 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.456 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.92 130.37 40.84 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 96.8 m -115.85 127.86 55.36 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.368 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.4 m-85 -132.88 155.28 49.32 Favored 'General case' 0 N--CA 1.388 -3.569 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.624 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.2 -22.86 72.94 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 113.232 -1.804 . . . . 0.0 114.483 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 33.2 p30 -156.79 169.33 24.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.458 0.629 . . . . 0.0 110.403 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -61.24 -33.71 73.95 Favored 'General case' 0 C--O 1.196 -1.724 0 CA-C-O 121.286 0.565 . . . . 0.0 111.922 -177.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.505 ' HB2' ' OD1' ' A' ' 34' ' ' ASN . 97.3 m -57.44 -41.17 79.99 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.142 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -77.04 -40.78 45.12 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.157 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 33.7 t80 -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.963 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.807 ' O ' HG23 ' A' ' 43' ' ' VAL . 52.4 t -59.49 -40.98 88.76 Favored 'General case' 0 C--O 1.192 -1.942 0 C-N-CA 123.224 0.61 . . . . 0.0 111.556 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.09 -20.84 61.59 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-O 122.732 1.253 . . . . 0.0 112.05 -170.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -74.22 -39.2 63.25 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 112.793 -2.003 . . . . 0.0 107.847 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.8 mt -71.15 -49.34 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.087 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 39' ' ' CYS . 59.5 t -50.34 -53.69 11.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.177 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -71.74 -33.95 69.13 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.522 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 m -83.48 0.99 43.94 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.425 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 14.3 52.9 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -6.77 58.05 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -67.21 -16.01 64.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.6 mt -78.77 147.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.27 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.6 m -121.69 176.78 5.54 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 38.9 tp -99.31 141.44 32.09 Favored 'General case' 1 N--CA 1.329 -6.484 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -88.42 -57.14 3.03 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 122.449 1.118 . . . . 0.0 108.81 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -130.92 138.96 34.16 Favored Pre-proline 0 C--N 1.285 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 113.282 -165.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.81 109.47 2.61 Favored 'Trans proline' 0 N--CA 1.435 -1.946 0 N-CA-C 104.537 -2.909 . . . . 0.0 104.537 161.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.23 178.33 18.66 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -168.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.49 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.7 pttp -78.05 175.65 9.91 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 122.031 0.92 . . . . 0.0 111.403 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 165.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 122.826 1.298 . . . . 0.0 108.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.8 m-20 -69.36 116.82 46.4 Favored Pre-proline 0 C--N 1.272 -2.777 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.933 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.96 148.46 70.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.838 2.359 . . . . 0.0 112.239 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -152.5 127.12 9.43 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 124.08 0.952 . . . . 0.0 108.757 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 14.0 t -100.05 99.11 9.8 Favored 'General case' 0 C--N 1.254 -3.562 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -80.14 170.96 54.12 Favored Glycine 0 CA--C 1.46 -3.401 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.372 -168.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 m -73.82 5.17 4.32 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.848 0.833 . . . . 0.0 109.398 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -68.69 -19.84 64.39 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.529 2.332 . . . . 0.0 105.839 169.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 -36.04 4.52 Favored Glycine 1 N--CA 1.394 -4.143 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -85.54 155.59 21.12 Favored 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.578 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.7 m -96.21 124.75 40.33 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.678 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.631 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 56.8 m-85 -113.21 142.74 45.44 Favored 'General case' 1 N--CA 1.377 -4.121 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.67 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.35 -35.82 80.7 Favored Glycine 0 CA--C 1.49 -1.509 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.691 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.3 p-10 -149.69 168.71 22.85 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.349 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.4 tttm -59.03 -29.99 67.69 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.513 1.125 . . . . 0.0 111.982 -176.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 0.7 OUTLIER -55.53 -50.79 69.06 Favored 'General case' 0 C--N 1.249 -3.788 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.73 174.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -69.44 -33.95 73.7 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.893 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 42' ' ' ILE . 13.5 t80 -83.14 -16.71 45.66 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.588 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.776 ' O ' HG23 ' A' ' 43' ' ' VAL . 42.5 t -68.09 -31.65 71.42 Favored 'General case' 0 CA--C 1.47 -2.126 0 O-C-N 122.034 -0.416 . . . . 0.0 110.373 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -66.62 -29.52 69.57 Favored 'General case' 0 CA--C 1.454 -2.722 0 CA-C-O 122.33 1.062 . . . . 0.0 112.471 -169.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.738 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.0 -35.14 66.78 Favored 'General case' 1 C--N 1.224 -4.886 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.268 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.4 mt -68.32 -42.13 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.081 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.6 t -58.56 -33.02 47.29 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.392 0 CA-C-N 111.107 -2.769 . . . . 0.0 111.387 174.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 7.7 mmpt? -81.11 -37.4 28.98 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.708 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.1 t -84.51 -20.57 31.41 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.667 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.87 31.99 4.58 Favored Glycine 0 N--CA 1.4 -3.756 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.32 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.418 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.81 -13.19 57.36 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -67.36 -24.81 65.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 41' ' ' ALA . 70.0 mt -80.74 146.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.203 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -134.71 -176.62 4.29 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.3 tp -93.11 141.13 28.75 Favored 'General case' 1 N--CA 1.34 -5.973 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -88.77 -49.7 6.67 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.141 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -146.1 132.22 9.57 Favored Pre-proline 0 C--N 1.283 -2.311 0 C-N-CA 118.507 -1.277 . . . . 0.0 112.075 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.26 109.91 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.89 1.727 . . . . 0.0 108.33 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.46 -167.46 13.78 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 12.6 pttp -86.98 169.4 12.47 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-O 121.439 0.638 . . . . 0.0 110.831 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.273 -2.727 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.035 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.413 -2.312 0 CA-C-O 122.599 1.19 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -111.01 97.06 32.89 Favored Pre-proline 0 C--N 1.258 -3.396 0 CA-C-N 113.065 -1.879 . . . . 0.0 108.628 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 57.1 Cg_endo -73.91 133.8 18.87 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.047 1.165 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' THR . 62.1 m-70 -141.67 128.34 20.33 Favored 'General case' 0 CA--C 1.464 -2.349 0 CA-C-O 121.491 0.662 . . . . 0.0 109.842 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.9 t -101.95 108.77 20.33 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 167.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.21 162.8 52.75 Favored Glycine 1 N--CA 1.393 -4.209 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -60.06 -22.17 62.36 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.875 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HB2' HG13 ' A' ' 49' ' ' ILE . 33.1 t70 -81.86 6.17 16.58 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.683 1.23 . . . . 0.0 110.106 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.01 -27.17 9.38 Favored Glycine 0 CA--C 1.467 -2.917 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.564 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.51 145.97 47.14 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.54 HG21 ' CB ' ' A' ' 56' ' ' LYS . 94.2 m -119.18 134.02 55.44 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.569 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 36.3 m-85 -133.62 152.54 51.91 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 121.222 0.534 . . . . 0.0 111.946 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -37.01 93.75 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 113.903 -1.498 . . . . 0.0 115.132 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.2 p30 -141.92 175.82 9.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -67.77 -36.87 81.27 Favored 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.348 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.22 -37.66 86.21 Favored 'General case' 0 C--N 1.252 -3.643 0 CA-C-O 122.422 1.106 . . . . 0.0 110.801 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.41 -36.46 83.81 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.987 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -92.24 -25.32 18.69 Favored 'General case' 0 C--O 1.195 -1.792 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.706 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG23 ' A' ' 43' ' ' VAL . 12.9 t -51.68 -50.55 60.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.887 1.275 . . . . 0.0 111.68 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.19 -29.38 67.35 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-O 122.186 0.993 . . . . 0.0 113.626 -176.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -78.52 -28.08 46.17 Favored 'General case' 1 C--N 1.224 -4.851 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.546 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.826 ' HA ' HD13 ' A' ' 49' ' ' ILE . 35.3 mt -64.43 -43.31 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.614 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.2 t -56.96 -36.84 51.74 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 111.443 -2.617 . . . . 0.0 111.351 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 38.5 mmtm -82.44 -38.69 23.63 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.144 0.497 . . . . 0.0 112.301 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 49' ' ' ILE . 9.5 t -81.88 -14.85 55.65 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.367 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.59 0.2 6.23 Favored Glycine 0 N--CA 1.401 -3.663 0 N-CA-C 117.002 1.561 . . . . 0.0 117.002 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.11 84.21 Favored Glycine 0 C--N 1.283 -2.382 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.807 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.293 44.1 mttt -56.89 -36.52 70.23 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 122.029 0.919 . . . . 0.0 109.812 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.826 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.2 mp -59.69 132.05 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.683 -166.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.2 m -138.22 178.47 7.11 Favored 'General case' 0 C--N 1.26 -3.313 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 171.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 51' ' ' LEU . 22.0 tp -91.9 140.37 29.74 Favored 'General case' 1 N--CA 1.321 -6.918 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.4 ttmt -96.17 -52.78 3.88 Favored 'General case' 1 N--CA 1.343 -5.777 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.093 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -141.11 139.21 18.84 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.659 -173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.13 110.13 2.82 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 106.766 -2.052 . . . . 0.0 106.766 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.6 173.77 17.04 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -171.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.54 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.4 pttp -75.93 172.23 13.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 121.665 0.745 . . . . 0.0 110.646 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 27.9 m . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 166.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 m . . . . . 0 C--O 1.216 -0.664 0 CA-C-O 122.397 1.094 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.23 111.21 12.72 Favored Pre-proline 0 C--N 1.267 -3.0 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.995 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 39.3 Cg_exo -60.0 143.03 99.61 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 123.775 2.983 . . . . 0.0 112.673 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.44 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.5 130.58 11.87 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 123.729 0.811 . . . . 0.0 110.039 -170.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.9 t -103.35 105.44 15.71 Favored 'General case' 0 C--N 1.258 -3.396 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.697 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -86.16 177.04 49.03 Favored Glycine 0 CA--C 1.464 -3.144 0 C-N-CA 119.284 -1.436 . . . . 0.0 113.798 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 49' ' ' ILE . 35.8 m -76.03 4.08 9.09 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-O 121.827 0.822 . . . . 0.0 109.094 173.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.59 -18.28 65.28 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.603 2.361 . . . . 0.0 105.746 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -32.91 6.46 Favored Glycine 0 N--CA 1.399 -3.793 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.662 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -91.71 156.14 17.79 Favored 'General case' 0 CA--C 1.47 -2.116 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 75.8 m -96.48 128.76 43.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.109 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 91.8 m-85 -116.02 147.88 40.75 Favored 'General case' 0 N--CA 1.38 -3.955 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.7 -27.44 61.52 Favored Glycine 0 C--N 1.299 -1.509 0 O-C-N 124.873 1.358 . . . . 0.0 113.011 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 27.0 p30 -159.66 171.17 20.07 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 41.0 ttmt -63.17 -32.78 74.26 Favored 'General case' 0 C--O 1.182 -2.467 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.567 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 2.7 t -49.11 -53.86 18.75 Favored 'General case' 1 C--N 1.242 -4.082 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.572 173.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.0 -41.9 90.42 Favored 'General case' 0 C--N 1.264 -3.124 0 C-N-CA 125.566 1.547 . . . . 0.0 111.03 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.697 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 19.2 t80 -85.53 -17.41 36.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.1 t -61.78 -31.09 71.27 Favored 'General case' 0 C--O 1.181 -2.516 0 O-C-N 121.707 -0.621 . . . . 0.0 110.501 -172.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.7 -32.2 73.77 Favored 'General case' 0 CA--C 1.461 -2.48 0 CA-C-O 122.398 1.094 . . . . 0.0 112.454 -171.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.789 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -66.28 -40.56 90.17 Favored 'General case' 1 C--N 1.234 -4.455 0 CA-C-N 111.971 -2.377 . . . . 0.0 108.014 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 39' ' ' CYS . 53.5 mt -71.22 -50.63 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.37 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 39' ' ' CYS . 18.3 t -53.85 -52.1 38.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.196 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.84 -30.61 68.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.436 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.5 m -90.44 12.27 19.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.491 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.64 6.03 68.31 Favored Glycine 0 N--CA 1.408 -3.219 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 93.4 -4.37 73.37 Favored Glycine 1 C--N 1.248 -4.345 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 10.0 mptt -68.48 -29.78 68.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.7 mt -75.93 149.07 6.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.048 173.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -132.16 -177.48 4.47 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.8 tp -87.2 140.79 29.19 Favored 'General case' 1 N--CA 1.331 -6.401 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.6 ttmt -85.44 -56.32 3.58 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.299 170.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 63.7 m170 -140.33 136.48 16.86 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.589 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.3 110.19 3.06 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 N-CA-C 106.643 -2.099 . . . . 0.0 106.643 167.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 109.4 -173.93 17.57 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 9.0 mtpm? -67.05 170.22 7.19 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 66.3 m . . . . . 0 C--N 1.275 -2.655 0 CA-C-N 109.956 -3.293 . . . . 0.0 103.055 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.412 -2.343 0 CA-C-O 122.919 1.342 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.0 m120 -111.14 92.43 15.43 Favored Pre-proline 0 C--N 1.264 -3.141 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.731 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -63.79 125.33 15.21 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.961 1.774 . . . . 0.0 110.445 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -141.7 125.07 16.56 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-O 122.187 0.994 . . . . 0.0 110.915 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 43.0 t -100.05 106.79 18.58 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.22 159.27 53.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.412 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.7 m -53.46 -22.1 7.33 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 123.575 0.75 . . . . 0.0 112.072 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.9 11.6 7.44 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.773 0.797 . . . . 0.0 110.521 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.55 -27.34 5.29 Favored Glycine 0 CA--C 1.479 -2.185 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.571 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -73.84 129.89 38.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 56' ' ' LYS . 84.6 m -107.8 134.7 50.38 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 112.575 -2.102 . . . . 0.0 112.208 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 11.3 m-85 -132.01 165.73 23.31 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.711 169.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.87 97.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.991 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.4 p30 -141.78 177.49 8.14 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 117.783 0.791 . . . . 0.0 109.408 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 32.8 ttpt -66.25 -39.33 89.43 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-O 121.432 0.634 . . . . 0.0 112.498 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.0 t -60.57 -38.22 83.88 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.283 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -59.44 -40.82 88.01 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.567 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 11.4 t80 -102.65 -2.06 29.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.793 ' HA ' HD12 ' A' ' 42' ' ' ILE . 10.6 t -58.42 -40.95 83.88 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 123.536 0.735 . . . . 0.0 112.156 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.572 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.48 -26.24 58.03 Favored 'General case' 0 CA--C 1.472 -2.056 0 CA-C-O 123.036 1.398 . . . . 0.0 109.637 -171.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 40' ' ' LYS . . . -80.36 -27.24 38.28 Favored 'General case' 1 C--N 1.229 -4.635 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.999 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 39' ' ' CYS . 37.6 mt -67.59 -41.31 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.4 t -56.05 -39.12 56.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.672 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 68.1 mmtt -84.59 -36.91 21.75 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.255 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.596 ' HB2' HD11 ' A' ' 49' ' ' ILE . 75.7 m -88.77 20.51 3.46 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.26 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.45 63.67 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 118.19 2.036 . . . . 0.0 118.19 166.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.77 0.46 49.85 Favored Glycine 0 C--N 1.283 -2.368 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.563 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 45' ' ' SER . 1.3 mtpm? -55.64 -26.46 44.51 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 123.286 0.634 . . . . 0.0 111.084 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.3 mp -64.99 133.24 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 123.072 1.415 . . . . 0.0 111.633 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -137.94 -176.03 4.29 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 51' ' ' LEU . 16.2 tp -89.73 139.47 30.53 Favored 'General case' 1 N--CA 1.316 -7.138 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 11.7 tptp -99.01 -39.08 8.71 Favored 'General case' 0 N--CA 1.384 -3.735 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.26 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 32.9 t-80 -164.38 136.29 3.62 Favored Pre-proline 0 C--N 1.28 -2.428 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.588 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 5.8 Cg_exo -78.24 109.65 2.72 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 170.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.54 168.82 21.86 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' THR . 2.3 mmmp? -48.37 154.55 0.6 Allowed 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 118.666 2.839 . . . . 0.0 118.666 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.509 ' C ' ' HZ3' ' A' ' 56' ' ' LYS . 98.5 m . . . . . 0 C--N 1.253 -3.6 0 CA-C-N 108.914 -3.767 . . . . 0.0 102.922 165.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.423 -1.824 0 CA-C-O 121.715 0.769 . . . . 0.0 109.154 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.58 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 3.0 t-20 -111.15 92.74 16.12 Favored Pre-proline 0 C--N 1.275 -2.659 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.341 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 72.3 Cg_endo -88.37 124.98 1.75 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.705 1.603 . . . . 0.0 112.839 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 60.8 m-70 -152.14 128.98 10.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 C-N-CA 125.161 1.384 . . . . 0.0 108.596 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.7 t -96.14 110.53 22.78 Favored 'General case' 0 C--N 1.261 -3.252 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.7 164.48 54.75 Favored Glycine 0 N--CA 1.4 -3.761 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.003 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.7 p -62.42 -8.48 6.17 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 123.264 0.626 . . . . 0.0 110.58 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.96 -23.02 59.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 126.362 1.865 . . . . 0.0 108.578 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -27.4 20.45 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -76.86 141.8 40.47 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 87.7 m -107.09 126.31 52.19 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.699 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 29.8 p90 -102.17 134.46 45.39 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.293 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -34.07 67.65 Favored Glycine 0 CA--C 1.503 -0.682 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.926 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 33.9 p30 -143.7 167.7 21.65 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 172.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -72.61 -33.35 66.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.667 0.746 . . . . 0.0 110.219 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 4.6 t -52.4 -36.16 53.47 Favored 'General case' 0 C--N 1.254 -3.581 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.427 176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -47.95 -49.39 30.49 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 125.408 1.693 . . . . 0.0 111.115 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 32' ' ' TYR 0.407 44.1 p90 -145.58 42.24 1.25 Allowed 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 118.007 -1.477 . . . . 0.0 114.869 174.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.772 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.5 t -60.8 -38.17 84.44 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.538 175.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.574 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.05 -29.3 64.01 Favored 'General case' 0 CA--C 1.458 -2.59 0 CA-C-O 123.201 1.476 . . . . 0.0 107.948 -171.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -73.06 -29.84 63.26 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.195 178.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 39' ' ' CYS . 17.1 mt -70.83 -41.5 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.598 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 39' ' ' CYS . 25.6 t -60.06 -31.8 48.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.874 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.415 172.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.35 -41.92 75.95 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.986 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 44.5 t -70.2 -44.18 69.2 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.278 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.77 2.91 Favored Glycine 1 N--CA 1.388 -4.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.939 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.37 0.25 89.98 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' SER . 55.9 mttt -65.8 -23.18 66.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 42' ' ' ILE . 30.3 mt -71.19 128.18 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.537 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m -109.5 -178.56 3.58 Favored 'General case' 0 C--N 1.26 -3.305 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 29.7 tp -95.51 140.67 30.02 Favored 'General case' 1 N--CA 1.317 -7.075 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 54.3 tttm -99.73 -43.22 6.53 Favored 'General case' 1 N--CA 1.351 -5.399 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.606 172.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 22.8 m170 -139.18 133.83 16.38 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.365 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.5 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 164.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 105.01 -171.98 19.42 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -169.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.4 pttp -79.45 173.28 12.74 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 122.042 0.925 . . . . 0.0 111.834 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.284 -2.263 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.598 166.107 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.624 ' O ' ' HD3' ' A' ' 23' ' ' PRO 0.278 14.8 m . . . . . 0 CA--C 1.543 0.689 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.792 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 87.4 m-20 -94.0 91.8 0.65 Allowed Pre-proline 0 C--N 1.269 -2.926 0 C-N-CA 124.357 1.063 . . . . 0.0 111.836 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 21' ' ' SER . 6.2 Cg_exo -78.68 157.36 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.174 1.916 . . . . 0.0 110.999 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -145.34 126.27 14.49 Favored 'General case' 0 CA--C 1.465 -2.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.798 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 44.8 t -103.26 110.86 23.0 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 171.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 163.44 54.68 Favored Glycine 0 N--CA 1.409 -3.157 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 p -64.33 -9.5 18.18 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.518 0.675 . . . . 0.0 110.325 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.23 -29.31 66.1 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 126.2 1.8 . . . . 0.0 109.097 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.26 -23.31 23.2 Favored Glycine 0 N--CA 1.403 -3.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.699 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.56 138.04 46.61 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 99.4 m -107.36 128.33 54.37 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.567 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 38.2 m-85 -124.63 152.06 44.09 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.931 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.91 -38.87 38.83 Favored Glycine 0 C--N 1.31 -0.916 0 O-C-N 125.144 1.527 . . . . 0.0 114.702 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.1 p30 -155.12 -179.87 8.49 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 23.1 tptm -58.44 -46.96 85.48 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 69.4 m -52.15 -36.22 50.86 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -63.54 -45.62 89.7 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.703 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 32' ' ' TYR . 35.6 t80 -112.73 -2.04 14.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.786 ' O ' HG23 ' A' ' 43' ' ' VAL . 44.7 t -57.05 -46.78 82.18 Favored 'General case' 0 CA--C 1.46 -2.492 0 C-N-CA 124.091 0.956 . . . . 0.0 111.085 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.745 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.99 -33.04 73.59 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.994 1.317 . . . . 0.0 114.213 -172.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.63 -31.88 57.67 Favored 'General case' 1 C--N 1.222 -4.959 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.302 178.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.3 mt -65.54 -40.91 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 39' ' ' CYS . 22.1 t -57.82 -35.44 51.38 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.042 -2.344 . . . . 0.0 110.922 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 31.3 mmtm -79.08 -33.0 44.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.685 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.8 m -89.94 21.25 3.72 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.594 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.87 82.3 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.73 6.73 85.44 Favored Glycine 0 C--N 1.272 -2.991 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -176.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -68.78 -25.81 64.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.217 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.31 133.99 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -120.63 -177.37 3.45 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 53' ' ' HIS . 33.1 tp -88.35 141.03 28.88 Favored 'General case' 1 N--CA 1.321 -6.887 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 44.5 tttt -86.22 -45.92 10.85 Favored 'General case' 1 N--CA 1.366 -4.627 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.473 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.9 p80 -179.72 154.86 0.72 Allowed Pre-proline 0 C--N 1.31 -1.135 0 O-C-N 124.489 1.118 . . . . 0.0 111.681 174.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.47 149.16 74.45 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.163 1.909 . . . . 0.0 109.848 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.23 161.28 37.14 Favored Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.6 ptmm? -69.38 155.66 40.09 Favored 'General case' 0 N--CA 1.406 -2.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.125 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.25 -3.728 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.698 178.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.304 2.0 m . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 114.196 1.184 . . . . 0.0 114.196 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -70.59 106.77 1.91 Allowed Pre-proline 0 C--N 1.264 -3.129 0 C-N-CA 123.505 0.722 . . . . 0.0 111.796 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.55 142.04 10.22 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.32 2.013 . . . . 0.0 111.851 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.414 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 73.2 m80 -150.44 127.4 11.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-O 121.745 0.783 . . . . 0.0 109.695 -172.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 51.6 t -96.22 97.96 9.93 Favored 'General case' 0 C--N 1.245 -3.949 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 170.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.16 167.79 43.93 Favored Glycine 0 CA--C 1.461 -3.338 0 C-N-CA 119.149 -1.501 . . . . 0.0 112.213 -167.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -76.51 5.45 7.31 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.207 1.004 . . . . 0.0 108.661 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.53 -14.07 62.67 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 128.339 2.656 . . . . 0.0 106.169 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.46 -35.62 4.39 Favored Glycine 0 N--CA 1.403 -3.545 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.76 155.4 18.29 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.5 m -96.93 130.01 44.3 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.048 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 50.7 m-85 -118.44 139.8 50.84 Favored 'General case' 0 N--CA 1.387 -3.617 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.855 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 -30.96 61.73 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.501 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -141.56 176.22 9.06 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.019 -178.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -61.84 -40.22 94.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.573 0.701 . . . . 0.0 111.746 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.451 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 48.4 t -57.56 -43.69 84.66 Favored 'General case' 0 C--N 1.254 -3.579 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.492 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -67.95 -41.02 83.11 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.899 -173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 42' ' ' ILE . 38.3 t80 -85.03 -11.9 54.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.85 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -61.98 -46.05 90.96 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.554 0.742 . . . . 0.0 111.029 -178.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.79 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.24 -29.1 67.84 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-O 122.435 1.112 . . . . 0.0 112.006 -166.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.79 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -61.18 -41.79 97.42 Favored 'General case' 1 C--N 1.236 -4.348 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.594 178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 38' ' ' PHE . 42.2 mt -75.93 -54.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.202 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 39' ' ' CYS . 11.2 t -57.74 -33.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 112.716 -2.038 . . . . 0.0 112.953 -174.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -92.39 -31.88 15.16 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 32.4 t -70.5 -38.73 74.35 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.133 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 26.89 2.05 Favored Glycine 1 N--CA 1.379 -5.126 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.856 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.39 -5.1 64.94 Favored Glycine 0 C--N 1.305 -1.152 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 45' ' ' SER . 50.3 mttt -65.21 -27.03 68.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 41' ' ' ALA . 71.5 mt -85.28 141.15 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.416 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -126.17 -178.09 4.19 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.216 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.491 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.9 tp -98.89 140.9 32.36 Favored 'General case' 1 N--CA 1.328 -6.545 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -80.84 -57.55 3.5 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 122.419 1.104 . . . . 0.0 108.202 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.413 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.3 m80 -145.09 139.69 15.37 Favored Pre-proline 0 C--N 1.294 -1.819 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.587 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.51 110.17 3.0 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.36 171.39 14.5 Favored Glycine 0 C--N 1.289 -2.051 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -76.13 175.13 9.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 122.748 1.261 . . . . 0.0 113.665 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.269 -2.909 0 CA-C-N 112.024 -2.353 . . . . 0.0 104.958 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 17.2 m . . . . . 0 N--CA 1.419 -2.019 0 CA-C-O 122.942 1.354 . . . . 0.0 112.42 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 13.4 m120 -111.28 103.28 54.77 Favored Pre-proline 0 C--N 1.258 -3.405 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.501 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.57 136.79 31.68 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.469 1.446 . . . . 0.0 111.125 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.58 ' HB3' HD13 ' A' ' 51' ' ' LEU . 79.2 m-70 -143.88 127.61 17.18 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.924 0.869 . . . . 0.0 109.977 -175.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.1 t -93.7 103.25 15.41 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.26 161.03 45.49 Favored Glycine 0 N--CA 1.41 -3.071 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.888 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.6 p -54.03 -28.38 38.12 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 123.895 0.878 . . . . 0.0 110.398 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.639 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.0 t70 -60.85 -46.37 90.84 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.687 1.232 . . . . 0.0 109.085 173.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.35 -16.63 7.09 Favored Glycine 1 CA--C 1.445 -4.294 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.5 mt-30 -72.23 135.57 46.1 Favored 'General case' 0 CA--C 1.455 -2.691 0 CA-C-N 114.002 -1.099 . . . . 0.0 113.704 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.537 HG21 ' HG2' ' A' ' 56' ' ' LYS . 90.0 m -102.34 121.38 42.18 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.873 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HD2' ' O ' ' A' ' 34' ' ' ASN . 5.3 p90 -111.64 135.48 52.18 Favored 'General case' 1 N--CA 1.377 -4.082 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.447 177.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.08 -39.95 92.84 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.386 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 21' ' ' SER . 28.9 p30 -140.55 170.22 16.19 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.59 -36.33 80.68 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.542 0.687 . . . . 0.0 112.397 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -62.43 -33.57 75.07 Favored 'General case' 0 C--N 1.246 -3.897 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.891 -178.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.555 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -50.58 -43.54 56.5 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.35 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -118.37 -1.75 11.22 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.301 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.804 ' HA ' HD12 ' A' ' 42' ' ' ILE . 52.1 t -52.17 -50.94 60.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.81 1.244 . . . . 0.0 111.644 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.712 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -66.6 -26.19 66.97 Favored 'General case' 0 N--CA 1.408 -2.532 0 C-N-CA 124.942 1.297 . . . . 0.0 114.001 -175.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -84.12 -27.19 28.35 Favored 'General case' 1 C--N 1.218 -5.115 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.732 176.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 39' ' ' CYS . 28.2 mt -66.03 -41.16 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.789 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.1 t -53.21 -44.18 51.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.4 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 42.4 mmtm -69.87 -34.84 74.12 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.733 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.7 m -81.76 -9.07 59.73 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.512 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.11 -19.5 5.44 Favored Glycine 1 N--CA 1.396 -4.024 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 97.56 -0.42 59.66 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -173.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -61.68 -32.31 72.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.165 -1.018 . . . . 0.0 112.898 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.596 ' HB ' HG12 ' A' ' 42' ' ' ILE . 3.4 mp -70.61 136.81 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 122.017 0.913 . . . . 0.0 109.724 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -131.07 -178.55 4.88 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 24' ' ' HIS . 37.9 tp -96.8 141.52 29.92 Favored 'General case' 1 N--CA 1.326 -6.67 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 42.5 mttp -89.95 -58.35 2.54 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 122.468 1.128 . . . . 0.0 109.169 165.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -138.01 143.99 41.89 Favored Pre-proline 0 C--N 1.28 -2.426 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.655 -165.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.67 109.91 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 165.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.48 165.47 12.32 Favored Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 31' ' ' THR . 12.8 mtpp -56.59 161.96 2.47 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.283 -2.308 0 CA-C-N 109.585 -3.461 . . . . 0.0 102.553 159.259 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.43 -1.47 0 CA-C-O 122.289 1.042 . . . . 0.0 110.63 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.82 97.05 36.15 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.993 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.438 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 58.5 Cg_endo -74.65 123.93 8.42 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.618 0.878 . . . . 0.0 110.191 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 49.6 p-80 -153.06 138.29 17.44 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 46.0 t -108.69 109.77 21.02 Favored 'General case' 0 C--N 1.249 -3.761 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.17 162.91 52.86 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 19.9 m -54.91 -18.83 5.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.721 0.808 . . . . 0.0 111.64 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.3 t70 -64.92 -30.59 71.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.494 1.14 . . . . 0.0 109.081 174.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.01 -16.6 35.94 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.1 mt-30 -73.24 136.03 44.58 Favored 'General case' 0 CA--C 1.465 -2.327 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.457 HG21 ' CB ' ' A' ' 56' ' ' LYS . 99.0 m -111.13 130.21 55.69 Favored 'General case' 0 C--N 1.263 -3.189 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.101 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 54.2 m-85 -135.25 156.83 48.3 Favored 'General case' 0 N--CA 1.396 -3.143 0 CA-C-O 122.136 0.97 . . . . 0.0 112.251 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.16 -20.98 78.4 Favored Glycine 0 C--N 1.287 -2.176 0 CA-C-N 112.669 -2.06 . . . . 0.0 114.796 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 p30 -162.95 172.16 15.49 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 118.342 1.071 . . . . 0.0 108.787 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -63.86 -38.82 92.51 Favored 'General case' 0 C--O 1.197 -1.692 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 t -53.05 -43.93 67.03 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.931 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.7 -40.78 97.63 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.945 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 30' ' ' GLN . 44.6 t80 -104.03 5.2 35.19 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.3 t -61.43 -41.01 96.51 Favored 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 122.362 0.265 . . . . 0.0 110.361 -171.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.86 -30.01 71.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 125.618 1.567 . . . . 0.0 114.181 -174.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.55 -36.12 65.59 Favored 'General case' 1 C--N 1.209 -5.515 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.67 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 39' ' ' CYS . 40.3 mt -72.56 -44.44 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.954 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 39' ' ' CYS . 48.9 t -51.9 -50.97 31.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -66.93 -37.72 84.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.263 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m -87.06 13.25 9.63 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.865 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.85 79.99 Favored Glycine 0 N--CA 1.401 -3.636 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.406 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 79.05 2.72 87.52 Favored Glycine 0 C--N 1.279 -2.616 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.99 -21.98 62.23 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.1 mt -71.12 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.262 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 m -124.0 -173.45 2.76 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 32.6 tp -88.59 141.14 28.77 Favored 'General case' 1 N--CA 1.329 -6.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 52.0 tttm -99.88 -42.23 6.89 Favored 'General case' 1 N--CA 1.361 -4.882 0 C-N-CA 124.585 1.154 . . . . 0.0 111.152 174.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 28.3 m170 -138.26 132.65 16.87 Favored Pre-proline 0 C--N 1.284 -2.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.669 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.05 109.49 2.89 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 N-CA-C 105.067 -2.705 . . . . 0.0 105.067 163.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 107.58 176.52 22.48 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -169.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.2 ptmm? -70.29 169.24 14.2 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.449 1.119 . . . . 0.0 113.322 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.286 -2.174 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.672 166.232 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.424 -1.743 0 CA-C-O 122.907 1.336 . . . . 0.0 112.353 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 49.4 t-20 -111.16 95.65 26.42 Favored Pre-proline 0 C--N 1.25 -3.75 0 CA-C-N 112.073 -2.331 . . . . 0.0 106.577 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.6 Cg_exo -71.08 150.06 59.53 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.581 1.521 . . . . 0.0 111.434 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 31' ' ' THR . 18.9 m80 -138.94 122.52 17.38 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -98.0 100.35 11.68 Favored 'General case' 0 C--N 1.254 -3.554 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 171.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -75.72 166.81 54.66 Favored Glycine 0 N--CA 1.407 -3.242 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.993 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.5 m -65.86 -6.52 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.796 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.82 -7.97 59.65 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.908 1.283 . . . . 0.0 108.424 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.95 -27.15 10.51 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.79 136.2 43.56 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 56' ' ' LYS . 98.3 m -106.33 128.95 54.38 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.228 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -123.66 147.05 47.76 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.575 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.56 -38.63 82.05 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.834 1.334 . . . . 0.0 115.289 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.8 p30 -143.67 174.77 10.5 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -67.9 -31.43 71.2 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.613 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -61.79 -38.98 90.1 Favored 'General case' 0 C--N 1.25 -3.723 0 CA-C-O 122.905 1.336 . . . . 0.0 110.074 178.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.79 -32.47 69.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 112.609 -2.087 . . . . 0.0 108.659 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 30.3 t80 -85.11 -10.61 56.62 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.482 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.792 ' O ' HG23 ' A' ' 43' ' ' VAL . 31.2 m -58.84 -52.43 65.76 Favored 'General case' 0 C--O 1.188 -2.164 0 O-C-N 121.366 -0.834 . . . . 0.0 112.765 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -65.39 -32.41 74.03 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 123.339 1.542 . . . . 0.0 111.27 -177.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -66.49 -26.49 67.2 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.465 176.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.862 HG22 ' HA2' ' A' ' 47' ' ' GLY . 33.3 mt -81.47 -44.24 20.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.252 1.501 . . . . 0.0 108.344 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 39' ' ' CYS . 96.0 t -54.31 -36.69 34.36 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.976 0 CA-C-N 111.495 -2.593 . . . . 0.0 112.21 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.1 ptmm? -56.96 -26.09 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.551 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.57 ' HB2' HD11 ' A' ' 49' ' ' ILE . 17.6 m -134.26 57.47 1.81 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 122.185 0.993 . . . . 0.0 112.463 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.32 -0.17 69.48 Favored Glycine 0 N--CA 1.41 -3.064 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 168.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.862 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.6 -0.94 84.58 Favored Glycine 0 N--CA 1.411 -3.018 0 C-N-CA 120.285 -0.959 . . . . 0.0 111.917 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.1 -14.94 58.12 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 45' ' ' SER . 68.2 mt -62.22 149.92 8.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.636 0.732 . . . . 0.0 110.423 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -125.74 178.4 5.72 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.8 tp -94.43 141.87 28.08 Favored 'General case' 1 N--CA 1.336 -6.155 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 178.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HZ1' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.32 -51.62 5.47 Favored 'General case' 0 CA--C 1.453 -2.763 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.609 166.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.8 t-80 -149.21 132.34 8.24 Favored Pre-proline 0 C--N 1.258 -3.407 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.909 -169.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 4.3 Cg_exo -76.39 109.83 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 N-CA-C 107.211 -1.88 . . . . 0.0 107.211 168.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 119.75 165.12 12.87 Favored Glycine 0 C--N 1.279 -2.622 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -171.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.531 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 9.0 mtpm? -60.1 164.41 4.08 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 C--N 1.269 -2.903 0 N-CA-C 102.082 -3.303 . . . . 0.0 102.082 158.763 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m . . . . . 0 C--O 1.218 -0.557 0 CA-C-O 122.168 0.985 . . . . 0.0 109.907 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.7 m-20 -62.28 112.8 7.06 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.34 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.01 148.11 34.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.558 2.172 . . . . 0.0 112.007 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.467 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 94.1 m-70 -152.06 128.07 10.37 Favored 'General case' 0 CA--C 1.476 -1.876 0 CA-C-O 121.964 0.887 . . . . 0.0 110.901 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 42.2 t -94.42 98.79 11.12 Favored 'General case' 0 C--N 1.256 -3.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 170.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -82.89 166.3 44.66 Favored Glycine 0 CA--C 1.463 -3.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.417 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -77.36 4.75 10.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.01 -18.11 65.22 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 127.515 2.326 . . . . 0.0 106.539 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.42 -35.3 5.15 Favored Glycine 1 N--CA 1.391 -4.363 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 75.1 mt-30 -91.6 156.28 17.74 Favored 'General case' 0 CA--C 1.457 -2.602 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.525 HG21 ' HG2' ' A' ' 56' ' ' LYS . 95.3 m -96.21 124.63 40.28 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 112.847 -1.979 . . . . 0.0 108.106 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 93.6 m-85 -110.98 145.2 38.85 Favored 'General case' 0 N--CA 1.381 -3.887 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.564 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.22 85.66 Favored Glycine 0 C--N 1.3 -1.42 0 O-C-N 125.114 1.509 . . . . 0.0 112.522 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.4 p-10 -156.47 173.35 17.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.187 0.518 . . . . 0.0 111.097 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.11 -28.38 66.48 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 125.71 1.604 . . . . 0.0 110.558 -176.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.5 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 0.7 OUTLIER -57.0 -49.23 76.42 Favored 'General case' 1 C--N 1.241 -4.116 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.476 175.172 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -76.7 -35.18 58.03 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.811 -175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 29.2 t80 -86.76 -24.61 25.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.7 t -67.56 -28.5 67.84 Favored 'General case' 0 C--O 1.188 -2.137 0 CA-C-N 119.55 1.068 . . . . 0.0 110.686 -172.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.83 -31.8 73.2 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.817 1.294 . . . . 0.0 111.468 -170.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.806 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -64.59 -40.23 95.15 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 111.569 -2.559 . . . . 0.0 108.648 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.3 mt -73.31 -46.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.822 -175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 39' ' ' CYS . 26.4 t -56.6 -35.18 44.06 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.655 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.9 mmpm? -84.53 -35.91 22.53 Favored 'General case' 0 C--N 1.281 -2.382 0 O-C-N 121.692 -0.63 . . . . 0.0 112.59 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 t -74.92 -23.49 58.35 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.843 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.89 7.96 Favored Glycine 0 N--CA 1.401 -3.661 0 C-N-CA 121.073 -0.585 . . . . 0.0 113.383 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 -8.49 79.71 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -65.92 -28.26 68.8 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 41' ' ' ALA . 74.3 mt -82.93 147.94 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.911 173.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.1 m -137.99 179.98 6.11 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 46.6 tp -88.92 141.46 28.47 Favored 'General case' 1 N--CA 1.339 -6.002 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -81.1 -59.22 2.73 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.105 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -143.59 142.05 20.16 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.784 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.08 110.34 2.87 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.861 1.708 . . . . 0.0 107.983 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.71 175.3 17.6 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HG2' HG21 ' A' ' 31' ' ' THR . 8.6 mtpm? -64.3 162.04 15.58 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--N 1.267 -2.997 1 N-CA-C 99.58 -4.23 . . . . 0.0 99.58 158.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.617 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 t . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.2 m120 -106.61 92.92 7.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 C-N-CA 117.904 -1.519 . . . . 0.0 114.29 -173.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 21' ' ' SER . 4.0 Cg_endo -83.19 153.6 14.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.126 1.884 . . . . 0.0 110.53 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -150.63 128.41 11.66 Favored 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.3 t -99.46 95.77 7.23 Favored 'General case' 1 C--N 1.242 -4.069 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 168.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.8 165.17 39.89 Favored Glycine 0 CA--C 1.451 -3.909 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.863 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 49' ' ' ILE . 41.4 m -67.93 4.85 1.03 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 117.912 0.856 . . . . 0.0 111.441 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.2 -24.35 66.26 Favored 'General case' 0 C--N 1.364 1.225 0 C-N-CA 127.189 2.196 . . . . 0.0 105.757 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.11 -31.04 8.99 Favored Glycine 0 N--CA 1.396 -3.98 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.236 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.04 155.99 19.13 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 97.6 m -97.72 124.32 42.01 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.239 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.1 m-85 -117.58 142.51 47.12 Favored 'General case' 0 N--CA 1.383 -3.789 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.435 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -36.19 82.24 Favored Glycine 0 C--N 1.309 -0.97 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.199 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.3 p30 -145.72 -178.29 6.02 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 117.258 0.529 . . . . 0.0 109.602 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -67.59 -37.35 82.44 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.121 0.486 . . . . 0.0 112.175 -174.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -61.79 -38.39 87.89 Favored 'General case' 0 C--N 1.25 -3.728 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.702 -179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.04 -37.44 87.19 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.141 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 13.5 t80 -94.55 -8.75 37.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.832 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.796 ' O ' HG23 ' A' ' 43' ' ' VAL . 16.1 t -62.51 -37.59 86.64 Favored 'General case' 0 CA--C 1.472 -2.024 0 C-N-CA 123.088 0.555 . . . . 0.0 110.455 -171.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -65.27 -33.39 75.86 Favored 'General case' 0 CA--C 1.454 -2.723 0 C-N-CA 124.362 1.065 . . . . 0.0 113.103 -172.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.742 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.33 -34.85 59.0 Favored 'General case' 1 C--N 1.218 -5.114 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.815 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.2 mt -63.04 -43.42 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.444 -3.127 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 39' ' ' CYS . 41.2 t -55.03 -41.9 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.641 0 CA-C-N 111.518 -2.583 . . . . 0.0 111.053 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 24.7 mmtm -65.21 -37.69 88.11 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HG13 ' A' ' 49' ' ' ILE . 24.7 m -104.08 28.59 6.62 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.984 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 20.61 59.1 Favored Glycine 0 N--CA 1.4 -3.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 77.64 0.55 74.08 Favored Glycine 0 C--N 1.275 -2.847 0 CA-C-N 117.896 0.848 . . . . 0.0 111.226 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -80.4 -21.4 42.3 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' SER . 75.1 mt -62.98 152.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 121.053 0.454 . . . . 0.0 110.271 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -127.68 -176.28 3.72 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.5 tp -97.0 140.75 31.05 Favored 'General case' 1 N--CA 1.332 -6.365 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 36.1 mtpt -81.63 -50.2 9.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 121.965 0.888 . . . . 0.0 108.611 170.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 17.8 t-80 -154.89 133.17 6.87 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.057 -171.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.13 110.7 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.264 1.976 . . . . 0.0 108.481 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 113.27 -170.25 13.28 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -172.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.0 ptmm? -80.49 166.8 20.86 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.769 0.795 . . . . 0.0 112.415 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 165.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--O 1.222 -0.351 0 CA-C-O 121.5 0.667 . . . . 0.0 111.589 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 18.6 t-20 -70.95 110.61 7.54 Favored Pre-proline 0 C--N 1.271 -2.843 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.8 Cg_exo -71.44 159.62 50.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.578 2.185 . . . . 0.0 112.459 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -151.75 130.64 12.5 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 123.289 0.636 . . . . 0.0 109.698 -172.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 50.4 t -108.43 104.37 13.7 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -69.63 169.25 45.04 Favored Glycine 0 N--CA 1.414 -2.793 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.268 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -65.21 -19.39 65.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.7 t70 -61.26 -36.86 81.15 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 125.272 1.429 . . . . 0.0 108.953 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.73 -18.66 14.76 Favored Glycine 0 N--CA 1.398 -3.887 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.1 mt-30 -71.66 135.3 46.82 Favored 'General case' 0 CA--C 1.452 -2.822 0 CA-C-O 122.375 1.083 . . . . 0.0 113.795 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.4 m -117.86 133.17 56.2 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.019 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 66.4 m-85 -131.26 162.33 30.27 Favored 'General case' 0 N--CA 1.38 -3.928 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.398 172.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 -25.11 63.62 Favored Glycine 0 C--N 1.294 -1.773 0 CA-C-N 113.386 -1.733 . . . . 0.0 113.362 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.7 p30 -158.99 168.21 27.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.07 -35.62 73.67 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.647 0.737 . . . . 0.0 111.571 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.07 -52.67 32.67 Favored 'General case' 0 C--N 1.256 -3.499 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.335 174.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.33 -33.74 76.41 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.258 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 26' ' ' GLY . 48.2 t80 -95.0 -2.11 51.04 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.127 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.832 ' O ' HG23 ' A' ' 43' ' ' VAL . 14.5 p -61.38 -43.85 98.16 Favored 'General case' 0 CA--C 1.439 -3.296 0 O-C-N 121.908 -0.495 . . . . 0.0 111.149 -172.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -57.26 -35.57 69.9 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 126.152 1.781 . . . . 0.0 114.496 -172.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -68.59 -39.49 80.9 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.665 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 39' ' ' CYS . 34.9 mt -69.19 -48.12 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.001 -177.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 39' ' ' CYS . 37.1 t -50.75 -50.63 22.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 112.009 -2.359 . . . . 0.0 111.832 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 28.6 mmtm -78.73 -32.59 46.82 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.87 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.479 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 16.3 m -80.55 4.21 19.2 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.017 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.45 19.05 46.7 Favored Glycine 1 N--CA 1.385 -4.706 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 171.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 -0.47 62.63 Favored Glycine 0 C--N 1.29 -2.012 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 45' ' ' SER . 38.7 mttp -71.77 -19.39 62.02 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -79.83 140.99 15.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.645 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 m -121.08 -179.71 4.12 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.493 HD12 ' HA2' ' A' ' 26' ' ' GLY . 35.9 tp -90.16 141.06 29.07 Favored 'General case' 1 N--CA 1.324 -6.765 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.655 ' HD2' ' SG ' ' A' ' 57' ' ' CYS . 2.2 ttmp? -90.02 -54.59 3.97 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.842 170.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 58.9 m170 -139.38 137.16 18.55 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.083 -173.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.62 109.83 2.93 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 N-CA-C 105.796 -2.424 . . . . 0.0 105.796 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.84 -177.22 16.96 Favored Glycine 0 C--N 1.284 -2.341 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -169.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.2 pttp -79.21 173.35 12.67 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-O 121.901 0.857 . . . . 0.0 111.327 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.655 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 24.8 m . . . . . 0 C--N 1.281 -2.409 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 165.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 34' ' ' ASN . 27.3 m . . . . . 0 N--CA 1.414 -2.257 0 CA-C-O 122.12 0.962 . . . . 0.0 111.077 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -110.75 100.44 45.88 Favored Pre-proline 0 C--N 1.276 -2.625 0 CA-C-N 113.161 -1.836 . . . . 0.0 109.554 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 6.8 Cg_exo -75.59 125.19 8.77 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.426 2.084 . . . . 0.0 111.267 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -151.53 129.32 11.62 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 125.236 1.415 . . . . 0.0 108.845 -174.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -92.61 106.73 18.66 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 160.35 53.54 Favored Glycine 0 N--CA 1.401 -3.657 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.349 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 50.3 m -64.61 -7.37 10.23 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.854 0.835 . . . . 0.0 110.468 173.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -81.36 -10.48 59.53 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.763 2.025 . . . . 0.0 108.374 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.49 -31.6 6.32 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.266 26.1 mt-30 -74.72 130.08 38.85 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 56' ' ' LYS . 89.9 m -98.81 126.04 44.35 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.695 -2.048 . . . . 0.0 110.092 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 30.1 p90 -106.99 133.03 52.24 Favored 'General case' 0 N--CA 1.39 -3.45 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.745 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.75 -42.51 61.55 Favored Glycine 0 CA--C 1.499 -0.912 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.807 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 21' ' ' SER . 32.6 p30 -128.72 168.78 15.34 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 52.3 tttm -71.58 -35.47 70.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.733 0.777 . . . . 0.0 110.141 -173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.6 t -48.26 -44.9 33.85 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.755 174.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -50.76 -42.99 58.21 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.431 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 8.8 t80 -127.53 -1.36 6.18 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 117.492 -1.683 . . . . 0.0 114.186 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 42' ' ' ILE . 31.7 p -51.45 -55.35 19.25 Favored 'General case' 0 C--O 1.194 -1.861 0 C-N-CA 123.471 0.708 . . . . 0.0 111.38 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -65.12 -24.38 67.4 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 127.045 2.138 . . . . 0.0 114.586 -177.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -82.04 -28.73 32.32 Favored 'General case' 1 C--N 1.202 -5.816 0 CA-C-N 113.179 -1.828 . . . . 0.0 110.718 173.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.0 mt -66.99 -43.14 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.78 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.7 t -50.34 -41.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 110.619 -2.991 . . . . 0.0 110.995 171.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -86.0 -29.46 23.48 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.464 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' HD3' ' A' ' 48' ' ' LYS . 64.3 m -86.85 12.96 9.77 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.43 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.36 3.48 72.15 Favored Glycine 0 N--CA 1.413 -2.895 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.68 14.12 82.83 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 4.5 pttm -64.74 -25.0 67.74 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-O 121.94 0.876 . . . . 0.0 109.671 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 42' ' ' ILE . 4.1 mp -79.02 131.51 34.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.688 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 p -130.84 -177.82 4.53 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.8 tp -95.16 141.48 28.72 Favored 'General case' 1 N--CA 1.343 -5.806 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.688 ' NZ ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.23 -54.95 3.72 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.458 164.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 25.1 t-80 -149.72 135.09 9.79 Favored Pre-proline 0 C--N 1.262 -3.219 0 CA-C-N 113.575 -1.648 . . . . 0.0 112.175 -167.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 8.2 Cg_exo -73.8 110.3 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.965 1.776 . . . . 0.0 108.453 170.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.92 168.74 15.35 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 31' ' ' THR . 12.3 mtpp -56.03 162.51 1.88 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.413 -2.289 0 CA-C-N 109.435 -3.53 . . . . 0.0 101.817 158.292 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 16.4 mp0 . . . . . 0 C--O 1.219 -0.542 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.76 43.0 0.47 Allowed Glycine 0 N--CA 1.443 -0.874 0 N-CA-C 110.53 -1.028 . . . . 0.0 110.53 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 148.39 51.04 0.02 OUTLIER Glycine 0 CA--C 1.482 -2.013 0 CA-C-O 122.467 1.037 . . . . 0.0 110.928 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.617 ' HG2' ' N ' ' A' ' 5' ' ' VAL . 6.8 tt0 -151.4 179.21 8.54 Favored 'General case' 1 N--CA 1.351 -5.386 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 179.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.617 ' N ' ' HG2' ' A' ' 4' ' ' GLN . 10.8 p -71.4 47.72 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.585 2.314 0 CA-C-O 122.655 1.217 . . . . 0.0 108.353 172.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -65.89 96.55 0.3 Allowed 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.454 -171.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.607 ' HB2' HG12 ' A' ' 15' ' ' VAL . 80.1 m -49.43 100.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.584 168.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -64.55 8.48 0.5 Allowed Glycine 0 C--N 1.352 1.464 0 C-N-CA 124.557 1.075 . . . . 0.0 115.651 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.522 ' HB3' HG21 ' A' ' 43' ' ' VAL . 39.4 mt-10 -78.03 -45.05 24.73 Favored 'General case' 0 N--CA 1.406 -2.63 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 174.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 4.9 t80 42.19 47.09 3.96 Favored 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 127.406 2.282 . . . . 0.0 114.871 159.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.609 ' HG3' HG13 ' A' ' 43' ' ' VAL . 88.2 mm-40 -69.35 -12.52 61.73 Favored 'General case' 1 C--N 1.238 -4.268 0 CA-C-O 123.235 1.493 . . . . 0.0 112.185 174.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.554 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 3.4 t70 -143.04 -176.08 4.77 Favored 'General case' 1 N--CA 1.364 -4.771 0 CA-C-N 112.779 -2.009 . . . . 0.0 106.329 177.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 t -100.04 -27.51 13.52 Favored 'General case' 0 C--N 1.257 -3.444 0 CA-C-O 121.484 0.659 . . . . 0.0 110.762 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.519 ' HG2' ' OD2' ' A' ' 12' ' ' ASP . 23.8 pttm -84.69 18.6 2.3 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.913 -178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.607 HG12 ' HB2' ' A' ' 7' ' ' CYS . 3.4 t -92.7 86.11 2.18 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-O 121.445 0.641 . . . . 0.0 109.848 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -133.61 148.74 51.59 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.748 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 9.1 p -115.99 178.77 4.19 Favored 'General case' 0 N--CA 1.415 -2.196 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -175.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 35' ' ' LYS . 17.2 p -96.12 152.26 18.71 Favored 'General case' 0 N--CA 1.402 -2.864 0 CA-C-N 113.752 -1.567 . . . . 0.0 113.563 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.29 -12.6 25.9 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 170.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -105.18 174.56 5.82 Favored 'General case' 0 C--O 1.258 1.524 0 CA-C-N 114.572 -1.195 . . . . 0.0 110.438 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -98.04 89.62 4.61 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-O 123.4 1.572 . . . . 0.0 111.046 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 2.7 t-20 -111.06 96.29 29.18 Favored Pre-proline 0 C--N 1.253 -3.629 0 CA-C-N 112.252 -2.249 . . . . 0.0 108.369 -178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.465 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.3 Cg_exo -68.6 154.96 70.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.914 1.743 . . . . 0.0 112.578 -175.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -148.94 128.26 12.96 Favored 'General case' 0 CA--C 1.471 -2.062 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 -175.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 34.0 t -104.02 103.46 13.28 Favored 'General case' 0 C--N 1.254 -3.584 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 173.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -75.18 160.24 52.33 Favored Glycine 0 N--CA 1.4 -3.711 0 C-N-CA 120.553 -0.832 . . . . 0.0 111.057 -171.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.2 m -66.93 -4.73 10.21 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-O 120.701 0.286 . . . . 0.0 110.666 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -73.34 -7.77 53.03 Favored 'General case' 0 C--N 1.367 1.362 0 CA-C-O 123.17 1.462 . . . . 0.0 107.749 173.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.25 -34.37 5.77 Favored Glycine 0 N--CA 1.397 -3.941 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.321 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -78.16 155.12 30.6 Favored 'General case' 0 CA--C 1.478 -1.818 0 N-CA-C 116.4 2.0 . . . . 0.0 116.4 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 88.4 m -110.92 131.22 55.23 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 113.94 -1.482 . . . . 0.0 110.053 176.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -120.77 138.24 54.11 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.542 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.83 -34.72 65.62 Favored Glycine 0 C--N 1.311 -0.814 0 CA-C-N 114.441 -1.254 . . . . 0.0 114.874 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.8 p30 -147.28 178.26 8.55 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 18' ' ' THR . 68.1 tttt -74.54 -30.07 61.62 Favored 'General case' 0 C--O 1.202 -1.428 0 CA-C-O 122.148 0.975 . . . . 0.0 111.217 -174.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.748 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -60.5 -39.13 86.62 Favored 'General case' 0 C--N 1.25 -3.74 0 CA-C-N 113.956 -1.475 . . . . 0.0 111.128 173.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -69.08 -32.03 71.18 Favored 'General case' 0 C--N 1.271 -2.833 0 CA-C-N 113.438 -1.71 . . . . 0.0 108.774 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 27.5 t80 -81.17 -15.65 55.16 Favored 'General case' 0 C--O 1.192 -1.954 0 CA-C-N 115.058 -0.973 . . . . 0.0 112.66 177.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.738 ' O ' HG23 ' A' ' 43' ' ' VAL . 40.9 m -58.17 -52.77 64.18 Favored 'General case' 0 C--O 1.201 -1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 112.766 -179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.724 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -70.79 -25.2 62.77 Favored 'General case' 0 CA--C 1.462 -2.433 0 CA-C-O 123.413 1.578 . . . . 0.0 111.048 -176.498 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.75 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -75.81 -25.8 56.67 Favored 'General case' 1 C--N 1.206 -5.664 0 CA-C-N 111.457 -2.611 . . . . 0.0 111.927 175.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.789 HG22 ' HA2' ' A' ' 47' ' ' GLY . 20.5 mt -73.16 -41.37 58.66 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.049 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 39' ' ' CYS . 84.3 t -57.9 -29.89 36.9 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.105 0 CA-C-N 110.85 -2.886 . . . . 0.0 110.516 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.75 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -48.38 -43.63 34.02 Favored 'General case' 0 CA--C 1.494 -1.173 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 178.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' HB2' HD11 ' A' ' 49' ' ' ILE . 5.6 m -134.39 61.67 1.67 Allowed 'General case' 0 C--N 1.28 -2.427 0 CA-C-O 122.169 0.985 . . . . 0.0 111.669 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.5 0.33 89.94 Favored Glycine 0 N--CA 1.414 -2.771 0 N-CA-C 118.561 2.184 . . . . 0.0 118.561 167.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.789 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 88.76 -19.31 38.09 Favored Glycine 0 C--N 1.27 -3.123 0 C-N-CA 119.578 -1.296 . . . . 0.0 111.525 -177.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 48' ' ' LYS . 30.9 mmtm -78.0 -10.65 59.7 Favored 'General case' 0 C--N 1.289 -2.049 0 C-N-CA 124.746 1.219 . . . . 0.0 113.72 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' HB2' ' A' ' 45' ' ' SER . 59.2 mt -62.26 148.98 9.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.573 0.702 . . . . 0.0 110.171 177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.9 m -125.6 -179.35 4.6 Favored 'General case' 0 N--CA 1.412 -2.336 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 35.8 tp -99.29 141.36 32.16 Favored 'General case' 1 N--CA 1.331 -6.382 0 N-CA-C 114.128 1.158 . . . . 0.0 114.128 179.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -87.02 -55.48 3.81 Favored 'General case' 0 N--CA 1.429 -1.519 0 CA-C-O 122.385 1.088 . . . . 0.0 108.839 167.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -131.07 133.2 24.42 Favored Pre-proline 0 C--N 1.288 -2.096 0 CA-C-N 113.849 -1.523 . . . . 0.0 112.637 -166.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_exo -77.08 109.33 2.81 Favored 'Trans proline' 0 N--CA 1.436 -1.858 0 N-CA-C 104.987 -2.736 . . . . 0.0 104.987 163.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.465 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.69 -175.24 15.76 Favored Glycine 0 C--N 1.281 -2.476 0 N-CA-C 107.839 -2.105 . . . . 0.0 107.839 -168.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.473 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.6 pttp -80.65 174.35 11.7 Favored 'General case' 0 N--CA 1.412 -2.349 0 CA-C-O 121.766 0.793 . . . . 0.0 111.138 177.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.283 -2.297 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 165.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 107.44 106.2 3.08 Favored Glycine 0 C--O 1.243 0.664 0 N-CA-C 115.65 1.02 . . . . 0.0 115.65 173.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.94 -94.1 1.95 Allowed Glycine 0 C--O 1.222 -0.619 0 N-CA-C 113.791 0.276 . . . . 0.0 113.791 172.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -73.39 173.64 9.28 Favored 'General case' 0 C--N 1.312 -1.039 0 C-N-CA 123.146 0.578 . . . . 0.0 110.254 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.2 t -77.24 77.86 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 122.554 1.169 . . . . 0.0 108.951 176.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -128.8 82.38 2.08 Favored 'General case' 0 C--N 1.274 -2.714 0 N-CA-C 104.533 -2.395 . . . . 0.0 104.533 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.481 ' HA ' HG13 ' A' ' 15' ' ' VAL 0.254 17.8 p 36.53 85.67 0.01 OUTLIER 'General case' 0 C--O 1.244 0.778 0 N-CA-C 115.867 1.802 . . . . 0.0 115.867 -175.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -101.45 -35.47 4.11 Favored Glycine 0 N--CA 1.421 -2.363 0 C-N-CA 120.384 -0.913 . . . . 0.0 112.4 -176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 3.4 mp0 -79.68 -41.66 26.37 Favored 'General case' 0 N--CA 1.4 -2.966 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -177.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.69 ' HA ' HG22 ' A' ' 43' ' ' VAL . 53.1 t80 66.7 -4.96 0.68 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.87 1.668 . . . . 0.0 115.232 169.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -134.74 -0.51 2.85 Favored 'General case' 0 C--N 1.256 -3.482 0 C-N-CA 124.054 0.942 . . . . 0.0 110.273 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.635 ' HB3' ' CG2' ' A' ' 15' ' ' VAL . 11.6 t70 -78.26 -150.74 0.05 OUTLIER 'General case' 0 C--N 1.277 -2.554 0 CA-C-N 114.143 -1.389 . . . . 0.0 109.625 -175.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.411 ' HA ' ' HE2' ' A' ' 44' ' ' LYS . 12.5 t -137.54 -39.27 0.58 Allowed 'General case' 1 C--N 1.217 -5.152 0 O-C-N 121.653 -0.654 . . . . 0.0 111.898 -177.822 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 20.1 pttm -79.27 0.12 30.01 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.919 0.888 . . . . 0.0 110.719 -176.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.635 ' CG2' ' HB3' ' A' ' 12' ' ' ASP . 46.4 t -53.56 116.4 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.111 0 C-N-CA 125.307 1.443 . . . . 0.0 113.086 -175.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -75.57 174.19 10.04 Favored 'General case' 0 N--CA 1.413 -2.318 0 CA-C-N 112.719 -2.037 . . . . 0.0 108.975 174.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.566 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 11.2 p -99.43 179.95 4.41 Favored 'General case' 0 C--N 1.262 -3.23 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -171.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.776 HG21 ' HG3' ' A' ' 35' ' ' LYS . 53.8 p -78.6 175.35 10.46 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 123.077 1.418 . . . . 0.0 114.737 -174.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -85.36 -5.58 59.29 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 110.842 -2.89 . . . . 0.0 109.274 173.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' HB2' ' HB3' ' A' ' 35' ' ' LYS . 41.3 mt-10 -99.21 141.79 31.53 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -177.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 t -108.98 20.24 18.64 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 122.982 1.372 . . . . 0.0 107.382 176.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -77.35 110.65 13.09 Favored Pre-proline 0 C--N 1.263 -3.182 0 CA-C-N 112.112 -2.313 . . . . 0.0 111.408 -175.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.48 149.84 84.37 Favored 'Trans proline' 0 N--CA 1.491 1.381 0 C-N-CA 122.682 2.255 . . . . 0.0 111.825 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.405 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.68 131.35 12.32 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.64 0.776 . . . . 0.0 109.546 -172.306 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.574 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 42.0 t -100.69 108.88 20.86 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 173.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HE3' ' A' ' 52' ' ' LYS . . . -74.41 151.24 43.1 Favored Glycine 1 N--CA 1.395 -4.071 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.695 -174.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 43.3 p -59.31 -25.86 64.5 Favored 'General case' 0 C--N 1.288 -2.084 0 C-N-CA 124.031 0.932 . . . . 0.0 109.826 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.529 ' CB ' HG12 ' A' ' 49' ' ' ILE . 14.6 t70 -74.52 3.42 7.66 Favored 'General case' 0 C--O 1.215 -0.75 0 C-N-CA 126.384 1.874 . . . . 0.0 109.872 179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.95 -29.85 8.2 Favored Glycine 0 CA--C 1.468 -2.856 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.956 177.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -74.19 128.68 36.16 Favored 'General case' 0 CA--C 1.45 -2.867 0 N-CA-C 115.557 1.688 . . . . 0.0 115.557 -173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.507 HG21 ' HG2' ' A' ' 56' ' ' LYS . 87.7 m -107.7 132.54 53.23 Favored 'General case' 0 C--N 1.256 -3.461 0 CA-C-N 113.32 -1.764 . . . . 0.0 108.843 179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 96.8 m-85 -119.96 143.41 48.03 Favored 'General case' 0 N--CA 1.393 -3.29 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.92 -32.21 55.78 Favored Glycine 0 C--O 1.219 -0.792 0 O-C-N 124.671 1.232 . . . . 0.0 113.969 -174.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 31.0 p30 -155.1 174.64 14.9 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.776 ' HG3' HG21 ' A' ' 18' ' ' THR . 18.5 tptm -66.53 -32.92 74.57 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 122.141 0.972 . . . . 0.0 111.102 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.697 ' HA ' ' H ' ' A' ' 18' ' ' THR . 3.7 t -50.6 -53.63 29.1 Favored 'General case' 1 C--N 1.236 -4.344 0 CA-C-N 112.879 -1.964 . . . . 0.0 109.861 171.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.413 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -70.28 -40.42 74.34 Favored 'General case' 0 C--N 1.272 -2.777 0 CA-C-N 115.043 -0.981 . . . . 0.0 108.852 -178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.521 ' HB3' ' HA ' ' A' ' 35' ' ' LYS . 65.1 t80 -68.02 -46.55 70.9 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.119 -1.4 . . . . 0.0 113.529 -175.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.791 ' HA ' HD12 ' A' ' 42' ' ' ILE . 21.9 t -70.17 -36.76 74.91 Favored 'General case' 0 CA--C 1.472 -2.042 0 C-N-CA 118.905 -1.118 . . . . 0.0 112.789 -171.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.526 ' HB2' ' NZ ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -85.78 -7.81 58.52 Favored 'General case' 0 N--CA 1.392 -3.329 0 CA-C-O 122.102 0.953 . . . . 0.0 110.581 -174.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.07 -28.02 21.6 Favored 'General case' 0 C--N 1.27 -2.87 0 CA-C-N 112.654 -2.066 . . . . 0.0 110.629 171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 39' ' ' CYS . 68.8 mt -60.47 -45.42 96.91 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.904 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 175.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.8 t -52.7 -32.29 17.17 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.184 0 CA-C-N 110.491 -3.05 . . . . 0.0 111.013 174.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.595 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.8 mmpm? -86.45 -42.41 13.63 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.671 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 35.7 t -74.47 -15.98 60.87 Favored 'General case' 0 C--N 1.284 -2.249 0 O-C-N 123.787 0.679 . . . . 0.0 110.894 -178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.42 18.6 7.03 Favored Glycine 0 N--CA 1.401 -3.647 0 C-N-CA 120.679 -0.772 . . . . 0.0 114.963 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.97 -5.59 61.85 Favored Glycine 0 C--N 1.295 -1.704 0 C-N-CA 119.969 -1.11 . . . . 0.0 110.354 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HD3' ' O ' ' A' ' 45' ' ' SER . 3.8 mtpm? -60.49 -25.06 65.78 Favored 'General case' 0 CA--C 1.502 -0.902 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 28' ' ' ASP . 9.5 mt -85.05 132.71 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 C-N-CA 118.217 -1.393 . . . . 0.0 112.489 -177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.0 m -128.39 -179.37 4.99 Favored 'General case' 0 C--N 1.267 -3.022 0 N-CA-C 103.684 -2.71 . . . . 0.0 103.684 170.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.436 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.7 tp -98.66 140.99 32.04 Favored 'General case' 1 N--CA 1.333 -6.314 0 N-CA-C 116.467 2.025 . . . . 0.0 116.467 -179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.649 ' HE3' ' O ' ' A' ' 26' ' ' GLY . 77.4 mttt -88.05 -56.89 3.14 Favored 'General case' 0 CA--C 1.481 -1.708 0 CA-C-O 122.55 1.167 . . . . 0.0 107.858 165.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 41.8 t-80 -153.88 140.13 12.63 Favored Pre-proline 0 C--N 1.288 -2.069 0 CA-C-N 113.128 -1.851 . . . . 0.0 111.218 -167.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 12.1 Cg_exo -72.06 110.28 2.9 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.085 1.857 . . . . 0.0 108.848 170.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.7 161.05 11.31 Favored Glycine 0 N--CA 1.423 -2.176 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -174.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 8.9 mtpm? -57.94 165.65 1.75 Allowed 'General case' 0 N--CA 1.425 -1.683 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 176.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 C--N 1.274 -2.715 0 N-CA-C 101.522 -3.51 . . . . 0.0 101.522 159.72 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.526 ' H3 ' ' CG ' ' A' ' 6' ' ' ASP . 11.7 mm100 . . . . . 0 CA--C 1.517 -0.323 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.4 ' HA2' ' O ' ' A' ' 17' ' ' CYS . . . 117.78 140.87 6.65 Favored Glycine 0 N--CA 1.437 -1.269 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.49 177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 115.38 -69.92 0.26 Allowed Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 108.705 -1.758 . . . . 0.0 108.705 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.505 ' CD ' ' H ' ' A' ' 4' ' ' GLN . 4.3 pm0 -73.02 -176.25 2.04 Favored 'General case' 0 N--CA 1.427 -1.6 0 C-N-CA 123.699 0.8 . . . . 0.0 110.193 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.3 p -70.89 4.22 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.291 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.526 ' CG ' ' H3 ' ' A' ' 1' ' ' GLN . 0.0 OUTLIER -72.95 105.33 4.4 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-O 122.93 1.348 . . . . 0.0 111.704 -171.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.664 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 47.2 t -78.04 6.0 8.78 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-N 113.245 -1.798 . . . . 0.0 111.907 166.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 80.32 -67.68 3.44 Favored Glycine 0 N--CA 1.424 -2.163 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -174.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.46 ' OE1' ' HB2' ' A' ' 40' ' ' LYS . 37.0 mt-10 -94.72 -30.3 14.35 Favored 'General case' 0 N--CA 1.402 -2.83 0 CA-C-N 115.432 -0.384 . . . . 0.0 111.505 177.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.632 ' HA ' ' HB3' ' A' ' 7' ' ' CYS . 60.3 t80 62.9 84.12 0.15 Allowed 'General case' 0 C--N 1.364 1.236 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 169.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 43' ' ' VAL . 6.6 mm100 -54.27 -66.18 0.44 Allowed 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 112.835 -1.984 . . . . 0.0 111.958 166.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.639 ' OD2' ' HG2' ' A' ' 14' ' ' LYS . 21.6 t0 -149.16 173.34 13.53 Favored 'General case' 0 N--CA 1.386 -3.626 0 CA-C-N 111.768 -2.469 . . . . 0.0 107.088 -174.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.9 p -65.22 -16.79 63.91 Favored 'General case' 0 C--N 1.257 -3.428 0 C-N-CA 128.111 2.564 . . . . 0.0 113.767 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.639 ' HG2' ' OD2' ' A' ' 12' ' ' ASP . 34.7 mmtm -88.62 -16.87 31.34 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.813 1.292 . . . . 0.0 107.788 -178.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.664 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 3.6 t -103.21 101.44 12.19 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.474 0 CA-C-N 113.221 -1.809 . . . . 0.0 108.31 -173.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -136.43 156.38 48.7 Favored 'General case' 0 C--O 1.261 1.658 0 N-CA-C 106.768 -1.567 . . . . 0.0 106.768 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.686 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 14.9 p -109.6 178.42 4.44 Favored 'General case' 0 N--CA 1.42 -1.969 0 CA-C-O 121.981 0.896 . . . . 0.0 112.637 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.451 HG22 ' HB3' ' A' ' 35' ' ' LYS . 5.1 t -135.09 166.53 22.85 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-N 114.362 -1.29 . . . . 0.0 108.053 175.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 25.0 mtm180 -94.36 -38.26 11.07 Favored 'General case' 0 C--N 1.265 -3.098 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -175.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -55.74 139.67 44.36 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 111.309 -2.678 . . . . 0.0 109.999 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.9 m -71.23 99.25 1.87 Allowed 'General case' 0 N--CA 1.421 -1.907 0 CA-C-O 122.988 1.375 . . . . 0.0 112.811 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.48 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 0.9 OUTLIER -110.26 94.93 19.77 Favored Pre-proline 0 C--N 1.257 -3.449 0 CA-C-N 112.218 -2.264 . . . . 0.0 107.343 175.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.401 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 61.2 Cg_endo -75.3 132.35 14.94 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 121.799 1.666 . . . . 0.0 112.241 -177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 80.7 m80 -141.97 127.71 19.23 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -176.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.528 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.3 t -102.11 107.58 18.72 Favored 'General case' 0 C--N 1.249 -3.771 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 169.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.544 ' O ' ' HE2' ' A' ' 52' ' ' LYS . . . -71.14 165.26 53.37 Favored Glycine 0 N--CA 1.418 -2.563 0 C-N-CA 120.774 -0.726 . . . . 0.0 111.685 -175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.1 m -51.76 -28.77 16.32 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 123.444 0.698 . . . . 0.0 110.481 176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 8.9 t70 -60.5 -37.32 80.74 Favored 'General case' 0 CA--C 1.48 -1.729 0 C-N-CA 126.374 1.87 . . . . 0.0 110.085 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.07 -20.08 14.65 Favored Glycine 0 CA--C 1.459 -3.451 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 -173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.409 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 46.1 mt-30 -72.2 131.97 43.47 Favored 'General case' 0 CA--C 1.468 -2.184 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 178.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.515 HG21 ' CB ' ' A' ' 56' ' ' LYS . 95.4 m -102.31 131.32 48.98 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 113.068 -1.878 . . . . 0.0 109.234 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.562 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 65.4 m-85 -123.21 143.12 50.24 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.986 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -65.67 -40.22 95.75 Favored Glycine 0 C--N 1.31 -0.904 0 CA-C-N 113.819 -1.537 . . . . 0.0 114.439 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 36.9 p30 -133.15 177.14 7.9 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 117.651 0.726 . . . . 0.0 109.413 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.451 ' HB3' HG22 ' A' ' 18' ' ' THR . 83.6 tttt -67.97 -35.28 78.1 Favored 'General case' 0 C--O 1.189 -2.128 0 CA-C-O 121.336 0.589 . . . . 0.0 111.35 -175.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.686 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -61.7 -38.57 88.34 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 114.451 -1.249 . . . . 0.0 111.421 -179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.562 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.09 -39.44 94.72 Favored 'General case' 0 C--N 1.26 -3.32 0 CA-C-N 112.977 -1.919 . . . . 0.0 109.821 -179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.417 ' CE2' HD11 ' A' ' 42' ' ' ILE . 22.6 t80 -88.91 -27.55 20.9 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.153 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.804 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.9 t -57.9 -40.88 81.4 Favored 'General case' 0 CA--C 1.481 -1.71 0 C-N-CA 124.612 1.165 . . . . 0.0 110.938 -173.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.578 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.4 OUTLIER -73.86 -24.08 59.69 Favored 'General case' 0 N--CA 1.409 -2.494 0 CA-C-O 122.853 1.311 . . . . 0.0 110.485 -170.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -79.7 -29.27 40.69 Favored 'General case' 0 C--N 1.265 -3.078 0 CA-C-N 113.004 -1.907 . . . . 0.0 109.703 -179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.5 mt -67.08 -42.91 89.0 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 177.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 39' ' ' CYS . 10.3 t -62.56 -27.07 42.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.704 0 CA-C-N 111.651 -2.522 . . . . 0.0 110.943 175.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.582 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -70.33 -39.5 74.69 Favored 'General case' 0 CA--C 1.505 -0.76 0 O-C-N 121.8 -0.562 . . . . 0.0 112.275 179.678 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.446 ' HB2' HG13 ' A' ' 49' ' ' ILE . 31.2 m -105.82 22.62 15.28 Favored 'General case' 0 C--N 1.281 -2.409 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.51 14.8 75.29 Favored Glycine 0 N--CA 1.417 -2.6 0 N-CA-C 116.277 1.271 . . . . 0.0 116.277 170.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.29 0.74 88.45 Favored Glycine 0 C--N 1.274 -2.88 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -176.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HA ' ' NZ ' ' A' ' 48' ' ' LYS . 3.0 mmmp? -68.55 -28.71 67.21 Favored 'General case' 0 N--CA 1.414 -2.273 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.446 HG13 ' HB2' ' A' ' 45' ' ' SER . 40.5 mt -76.69 145.33 10.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.531 -0.868 . . . . 0.0 109.004 178.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -130.24 -175.34 3.6 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' A' ' 51' ' ' LEU . 31.4 tp -86.18 141.37 29.39 Favored 'General case' 1 N--CA 1.326 -6.663 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 177.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.544 ' HE2' ' O ' ' A' ' 26' ' ' GLY . 21.0 ttmm -91.75 -52.15 4.89 Favored 'General case' 0 N--CA 1.38 -3.936 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.514 172.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -145.21 137.27 13.16 Favored Pre-proline 0 C--N 1.286 -2.164 0 CA-C-N 115.054 -0.976 . . . . 0.0 110.856 -173.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -76.04 110.38 3.06 Favored 'Trans proline' 0 N--CA 1.448 -1.206 0 N-CA-C 107.137 -1.909 . . . . 0.0 107.137 168.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.79 179.47 17.8 Favored Glycine 0 C--N 1.288 -2.09 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 -171.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.515 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.0 pttp -78.73 170.43 16.67 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-O 121.433 0.635 . . . . 0.0 110.617 176.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.501 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 32.4 m . . . . . 0 C--N 1.273 -2.742 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 166.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.4 mm-40 . . . . . 0 CA--C 1.498 -1.048 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.86 54.5 14.28 Favored Glycine 0 C--O 1.219 -0.835 0 N-CA-C 111.334 -0.706 . . . . 0.0 111.334 179.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.87 -51.51 0.75 Allowed Glycine 0 CA--C 1.489 -1.592 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -64.35 125.74 25.58 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 113.912 -1.144 . . . . 0.0 108.917 175.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG22 ' NH2' ' A' ' 19' ' ' ARG . 39.3 t -59.37 -14.9 6.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 126.218 1.807 . . . . 0.0 114.939 -169.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -65.09 81.39 0.04 OUTLIER 'General case' 0 C--N 1.273 -2.732 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 -167.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.544 ' HB3' HG12 ' A' ' 15' ' ' VAL . 71.7 m -87.43 79.67 8.35 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 164.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.95 -17.97 59.27 Favored Glycine 0 CA--C 1.496 -1.121 0 CA-C-N 113.447 -1.706 . . . . 0.0 114.147 -175.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' HB3' HG11 ' A' ' 43' ' ' VAL . 43.0 mt-10 -67.17 -47.11 71.96 Favored 'General case' 0 N--CA 1.412 -2.346 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 174.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.8 t80 45.33 32.75 1.08 Allowed 'General case' 0 N--CA 1.516 2.864 0 C-N-CA 125.201 1.4 . . . . 0.0 113.577 168.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.442 ' CG ' HG13 ' A' ' 43' ' ' VAL . 87.2 mm-40 -58.63 -24.26 60.72 Favored 'General case' 0 C--N 1.264 -3.109 0 CA-C-O 122.686 1.232 . . . . 0.0 113.924 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.534 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 7.5 t70 -131.11 152.8 50.03 Favored 'General case' 2 C--N 1.24 -4.184 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.472 175.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -65.3 -28.82 69.59 Favored 'General case' 0 C--N 1.249 -3.782 0 C-N-CA 125.174 1.39 . . . . 0.0 113.435 -175.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.534 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 7.7 ptpp? -85.73 5.19 33.37 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.296 0.57 . . . . 0.0 110.869 -177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG12 ' HB3' ' A' ' 7' ' ' CYS . 89.8 t -86.37 79.48 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.684 1.23 . . . . 0.0 113.847 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.3 p90 -138.09 151.66 48.02 Favored 'General case' 0 C--O 1.271 2.237 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 169.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.798 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 6.3 p -111.71 176.13 5.15 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.442 HG23 ' HB3' ' A' ' 35' ' ' LYS . 17.3 p -101.4 174.3 6.05 Favored 'General case' 0 N--CA 1.437 -1.104 0 C-N-CA 126.263 1.825 . . . . 0.0 113.763 -179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.506 ' NH2' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -126.23 -8.07 6.46 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.161 -1.836 . . . . 0.0 107.663 168.078 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 29.0 mp0 -93.04 148.02 22.35 Favored 'General case' 0 N--CA 1.416 -2.173 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 21.4 m -86.66 101.11 12.96 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-O 122.212 1.006 . . . . 0.0 110.651 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 27.9 t-20 -111.66 94.33 23.25 Favored Pre-proline 0 C--N 1.268 -2.974 0 CA-C-N 113.367 -1.742 . . . . 0.0 110.085 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -73.45 123.9 9.0 Favored 'Trans proline' 0 N--CA 1.453 -0.888 0 C-N-CA 121.105 1.203 . . . . 0.0 109.584 178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.742 ' HB2' HD13 ' A' ' 51' ' ' LEU . 48.7 p-80 -153.63 133.57 13.18 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.537 ' O ' HD12 ' A' ' 51' ' ' LEU . 44.1 t -92.74 114.19 26.68 Favored 'General case' 0 C--N 1.264 -3.143 0 CA-C-N 113.877 -1.51 . . . . 0.0 106.993 -179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.23 147.53 50.1 Favored Glycine 1 N--CA 1.393 -4.172 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.561 -178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.9 p -45.69 -41.27 10.26 Favored 'General case' 0 C--N 1.276 -2.604 0 C-N-CA 124.826 1.251 . . . . 0.0 110.757 173.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.91 3.35 5.39 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.136 0.974 . . . . 0.0 112.81 177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.25 -19.43 54.59 Favored Glycine 0 CA--C 1.46 -3.358 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 175.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -73.2 122.77 22.44 Favored 'General case' 0 CA--C 1.45 -2.877 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.627 HG21 ' HA ' ' A' ' 56' ' ' LYS . 94.7 m -116.95 127.7 54.48 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-N 112.943 -1.935 . . . . 0.0 109.676 -177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.557 ' HB2' ' CD1' ' A' ' 38' ' ' PHE . 31.6 m-85 -134.61 161.11 36.03 Favored 'General case' 0 N--CA 1.402 -2.832 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.315 174.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -54.51 -31.7 52.2 Favored Glycine 0 C--N 1.298 -1.539 0 CA-C-N 113.182 -1.826 . . . . 0.0 114.563 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.8 p30 -162.7 -175.57 4.51 Favored 'General case' 0 N--CA 1.433 -1.304 0 CA-C-N 117.467 0.633 . . . . 0.0 109.549 175.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.442 ' HB3' HG23 ' A' ' 18' ' ' THR . 23.9 tptm -68.1 -42.57 80.11 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.418 0.628 . . . . 0.0 111.862 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.798 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.0 OUTLIER -63.39 -32.6 74.08 Favored 'General case' 0 C--N 1.247 -3.879 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.586 -179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.526 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -53.61 -43.21 68.46 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.013 -1.903 . . . . 0.0 110.681 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.557 ' CD1' ' HB2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -133.1 26.01 4.23 Favored 'General case' 0 C--O 1.195 -1.787 0 C-N-CA 118.394 -1.322 . . . . 0.0 113.864 177.581 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.9 ' HA ' HD12 ' A' ' 42' ' ' ILE . 49.8 t -54.5 -45.56 73.28 Favored 'General case' 0 C--O 1.202 -1.406 0 C-N-CA 122.924 0.49 . . . . 0.0 110.28 178.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.61 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -69.0 -25.91 64.75 Favored 'General case' 0 N--CA 1.411 -2.389 0 C-N-CA 125.69 1.596 . . . . 0.0 114.489 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -82.16 -25.93 33.88 Favored 'General case' 1 C--N 1.203 -5.78 0 CA-C-N 113.75 -1.568 . . . . 0.0 111.016 174.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.9 HD12 ' HA ' ' A' ' 39' ' ' CYS . 12.8 mt -65.45 -42.54 93.57 Favored 'Isoleucine or valine' 0 CA--C 1.438 -3.346 0 N-CA-C 106.37 -1.715 . . . . 0.0 106.37 176.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.72 HG23 ' O ' ' A' ' 39' ' ' CYS . 80.6 t -49.5 -44.56 18.88 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.854 0 CA-C-N 111.302 -2.681 . . . . 0.0 110.354 172.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -82.54 -31.05 29.31 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 114.995 -1.002 . . . . 0.0 112.297 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.433 ' O ' ' HD3' ' A' ' 48' ' ' LYS . 16.4 m -80.89 8.4 8.38 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.358 175.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 2.31 58.01 Favored Glycine 0 N--CA 1.418 -2.523 0 N-CA-C 116.233 1.253 . . . . 0.0 116.233 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.99 -6.11 68.21 Favored Glycine 0 C--N 1.29 -2.009 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 45' ' ' SER . 2.2 mtpm? -61.03 -25.77 67.15 Favored 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 124.627 1.171 . . . . 0.0 113.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 42' ' ' ILE . 14.4 mt -66.42 125.86 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.21 0 CA-C-O 123.02 1.39 . . . . 0.0 112.406 -174.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.5 m -131.31 -175.33 3.66 Favored 'General case' 0 C--N 1.261 -3.258 0 N-CA-C 104.09 -2.559 . . . . 0.0 104.09 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.742 HD13 ' HB2' ' A' ' 24' ' ' HIS . 35.6 tp -94.98 141.21 28.92 Favored 'General case' 1 N--CA 1.328 -6.556 0 N-CA-C 117.179 2.289 . . . . 0.0 117.179 -179.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.47 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 24.4 mmtm -77.46 -65.44 0.96 Allowed 'General case' 0 CA--C 1.477 -1.831 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 163.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.444 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 55.6 t-80 -167.5 151.19 6.11 Favored Pre-proline 0 C--N 1.292 -1.933 0 CA-C-N 112.208 -2.269 . . . . 0.0 108.098 -171.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -60.61 138.56 80.75 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.136 1.89 . . . . 0.0 110.664 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.52 163.98 29.37 Favored Glycine 0 C--N 1.292 -1.888 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.627 ' HA ' HG21 ' A' ' 31' ' ' THR . 9.1 mtpm? -63.77 162.84 12.68 Favored 'General case' 0 N--CA 1.419 -1.999 0 N-CA-C 115.681 1.734 . . . . 0.0 115.681 176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 98.5 m . . . . . 0 C--N 1.271 -2.824 0 N-CA-C 101.942 -3.355 . . . . 0.0 101.942 158.428 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.509 -0.602 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 165.41 -36.34 0.27 Allowed Glycine 0 C--O 1.22 -0.773 0 C-N-CA 119.72 -1.229 . . . . 0.0 113.154 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.63 35.72 3.46 Favored Glycine 0 CA--C 1.487 -1.705 0 CA-C-O 123.256 1.476 . . . . 0.0 109.547 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -121.53 -162.32 0.97 Allowed 'General case' 0 C--N 1.265 -3.093 0 CA-C-N 111.864 -2.168 . . . . 0.0 105.405 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.6 t -73.38 84.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 CA-C-O 122.503 1.144 . . . . 0.0 108.537 171.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.3 m-20 -93.46 99.59 12.05 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.394 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.493 ' HB2' HG12 ' A' ' 15' ' ' VAL . 46.6 m -30.73 119.71 0.19 Allowed 'General case' 0 CA--C 1.493 -1.248 0 C-N-CA 126.915 2.086 . . . . 0.0 113.789 174.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.69 -12.16 81.94 Favored Glycine 0 N--CA 1.424 -2.165 0 CA-C-N 113.572 -1.649 . . . . 0.0 111.018 -175.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -68.81 -49.71 56.23 Favored 'General case' 0 N--CA 1.402 -2.833 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 19.9 t80 49.94 33.28 6.44 Favored 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 114.107 -1.406 . . . . 0.0 113.636 165.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.554 ' CG ' HG13 ' A' ' 43' ' ' VAL . 16.0 mm100 -46.08 -35.25 4.74 Favored 'General case' 0 C--N 1.272 -2.763 0 C-N-CA 125.256 1.422 . . . . 0.0 114.557 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 10.6 t70 -141.98 176.48 8.91 Favored 'General case' 2 N--CA 1.372 -4.369 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 176.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 p -88.02 -2.06 58.38 Favored 'General case' 0 C--N 1.244 -3.988 0 C-N-CA 124.793 1.237 . . . . 0.0 112.233 -175.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.64 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 38.3 mmtm -92.61 -8.16 44.98 Favored 'General case' 0 C--O 1.261 1.674 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 177.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.493 HG12 ' HB2' ' A' ' 7' ' ' CYS . 21.3 t -85.97 73.87 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.934 -175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -137.11 146.0 44.55 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 104.844 -2.28 . . . . 0.0 104.844 171.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.639 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 16.7 p -110.89 -172.34 2.01 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -174.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 HG23 ' HB3' ' A' ' 35' ' ' LYS . 4.2 p -79.38 173.17 12.85 Favored 'General case' 0 N--CA 1.419 -1.98 0 CA-C-N 113.402 -1.727 . . . . 0.0 114.686 -176.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.502 ' HD3' ' N ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -124.7 -11.01 7.29 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 112.918 -1.946 . . . . 0.0 107.381 166.585 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.452 ' OE2' ' HG2' ' A' ' 19' ' ' ARG . 24.8 mp0 -88.33 -172.48 3.8 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 126.247 1.819 . . . . 0.0 109.794 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.7 t -116.48 23.12 12.29 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.797 0.808 . . . . 0.0 109.445 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.832 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 5.5 m-20 -56.91 102.51 0.31 Allowed Pre-proline 0 C--N 1.273 -2.74 0 CA-C-N 113.363 -1.744 . . . . 0.0 113.153 -178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 2.4 Cg_endo -76.18 151.84 34.77 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 121.846 1.697 . . . . 0.0 111.48 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.473 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 88.2 m-70 -148.49 129.05 14.03 Favored 'General case' 0 CA--C 1.478 -1.826 0 CA-C-O 121.453 0.644 . . . . 0.0 110.482 -173.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.582 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 34.7 t -103.38 101.54 11.45 Favored 'General case' 0 C--N 1.27 -2.882 0 N-CA-C 103.941 -2.614 . . . . 0.0 103.941 169.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.585 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -77.39 170.08 54.97 Favored Glycine 0 N--CA 1.407 -3.269 0 C-N-CA 120.445 -0.883 . . . . 0.0 112.251 -171.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 m -68.37 -4.47 14.68 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.088 0.471 . . . . 0.0 110.679 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -78.77 -8.09 58.41 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 124.668 1.187 . . . . 0.0 107.886 174.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.02 -29.53 8.61 Favored Glycine 0 CA--C 1.475 -2.433 0 CA-C-N 114.18 -1.373 . . . . 0.0 109.857 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -74.26 145.06 44.33 Favored 'General case' 0 CA--C 1.474 -1.959 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -176.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.2 m -108.92 131.6 54.88 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 113.307 -1.77 . . . . 0.0 109.249 175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 95.0 m-85 -129.28 151.34 50.05 Favored 'General case' 0 N--CA 1.398 -3.035 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.257 175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.49 -26.09 59.02 Favored Glycine 0 C--O 1.208 -1.508 0 CA-C-N 114.5 -1.227 . . . . 0.0 115.469 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.832 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 7.8 p30 -164.5 173.59 11.89 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.661 0.731 . . . . 0.0 109.277 176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.484 ' HB3' HG23 ' A' ' 18' ' ' THR . 74.3 tttt -62.44 -32.58 73.46 Favored 'General case' 0 C--O 1.182 -2.448 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.639 ' HA ' ' CB ' ' A' ' 17' ' ' CYS . 61.7 m -57.13 -39.94 76.14 Favored 'General case' 0 C--N 1.255 -3.519 0 CA-C-O 122.351 1.072 . . . . 0.0 111.829 174.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' CB ' ' HB3' ' A' ' 32' ' ' TYR . . . -76.16 -38.31 56.82 Favored 'General case' 0 C--N 1.256 -3.481 0 CA-C-N 113.507 -1.679 . . . . 0.0 108.738 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.585 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 21.4 t80 -81.43 -6.09 58.58 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.074 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.745 ' O ' HG23 ' A' ' 43' ' ' VAL . 3.0 t -63.89 -41.99 97.57 Favored 'General case' 0 CA--C 1.49 -1.337 0 O-C-N 121.591 -0.693 . . . . 0.0 111.396 -172.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.551 ' HD3' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -71.41 -17.56 62.39 Favored 'General case' 0 N--CA 1.416 -2.138 0 C-N-CA 125.244 1.418 . . . . 0.0 113.856 -176.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -87.22 -26.7 23.39 Favored 'General case' 1 C--N 1.208 -5.575 0 CA-C-N 112.544 -2.116 . . . . 0.0 110.593 173.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.9 mt -72.02 -36.5 57.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 175.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.745 HG23 ' O ' ' A' ' 39' ' ' CYS . 93.8 t -54.07 -33.13 24.01 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.962 0 CA-C-N 110.611 -2.995 . . . . 0.0 111.246 171.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.627 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 3.0 mmmm -48.11 -43.01 30.56 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.2 m -124.36 29.65 6.28 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.46 26.34 28.06 Favored Glycine 0 N--CA 1.4 -3.721 0 N-CA-C 117.065 1.586 . . . . 0.0 117.065 170.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.621 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.72 -8.87 54.26 Favored Glycine 0 C--N 1.277 -2.738 0 C-N-CA 120.336 -0.935 . . . . 0.0 111.618 -178.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 43.0 mmtm -72.8 -19.89 61.26 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.453 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.8 mt -69.68 150.76 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-O 121.351 0.596 . . . . 0.0 110.989 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 m -125.46 -176.38 3.58 Favored 'General case' 0 N--CA 1.421 -1.88 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.518 HD12 ' HA2' ' A' ' 26' ' ' GLY . 41.6 tp -97.56 140.94 31.23 Favored 'General case' 1 N--CA 1.329 -6.512 0 N-CA-C 114.171 1.174 . . . . 0.0 114.171 176.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.417 ' NZ ' ' SG ' ' A' ' 57' ' ' CYS . 7.2 mtmp? -93.42 -50.71 5.32 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 121.698 0.761 . . . . 0.0 110.583 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.582 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 18.0 m170 -126.34 130.24 23.97 Favored Pre-proline 0 C--N 1.282 -2.35 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.907 -170.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -77.64 109.68 2.8 Favored 'Trans proline' 0 N--CA 1.436 -1.853 0 N-CA-C 105.401 -2.577 . . . . 0.0 105.401 163.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 110.78 -179.23 20.07 Favored Glycine 0 C--N 1.285 -2.267 0 N-CA-C 108.378 -1.889 . . . . 0.0 108.378 -169.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.0 pttp -78.4 174.07 11.67 Favored 'General case' 0 N--CA 1.411 -2.383 0 CA-C-O 122.188 0.994 . . . . 0.0 111.911 178.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.417 ' SG ' ' NZ ' ' A' ' 52' ' ' LYS . 20.0 m . . . . . 0 C--N 1.28 -2.442 0 CA-C-N 113.899 -1.501 . . . . 0.0 107.208 165.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 . . . . . 0 CA--C 1.542 0.637 0 CA-C-O 119.967 -0.063 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -110.38 -96.39 2.38 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.53 99.46 1.47 Allowed Glycine 0 CA--C 1.495 -1.197 0 N-CA-C 107.723 -2.151 . . . . 0.0 107.723 175.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -45.91 36.75 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 N-CA-C 120.635 3.569 . . . . 0.0 120.635 -166.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.1 -20.27 6.37 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.972 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 169.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 16' ' ' TYR . 25.1 p-10 -81.85 66.17 7.31 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.702 -1.59 . . . . 0.0 108.718 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.537 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 16.8 m 29.56 102.68 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.404 0 C-N-CA 126.638 1.975 . . . . 0.0 115.757 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.43 -23.19 60.0 Favored Glycine 0 C--O 1.213 -1.169 0 C-N-CA 121.215 -0.517 . . . . 0.0 113.166 -178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.62 ' HB3' HG11 ' A' ' 43' ' ' VAL . 14.2 mm-40 -68.26 -54.37 18.13 Favored 'General case' 0 N--CA 1.424 -1.736 0 C-N-CA 124.429 1.092 . . . . 0.0 109.381 173.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.484 51.2 p90 48.4 84.39 0.03 OUTLIER 'General case' 0 CA--C 1.469 -2.16 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.504 ' OE1' HG22 ' A' ' 42' ' ' ILE . 12.1 pt20 -62.26 -43.3 99.15 Favored 'General case' 0 C--N 1.261 -3.273 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.205 174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -140.85 151.58 44.44 Favored 'General case' 1 N--CA 1.364 -4.728 0 CA-C-N 111.508 -2.587 . . . . 0.0 105.474 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 21.9 p -51.38 -47.65 62.8 Favored 'General case' 1 C--N 1.239 -4.229 0 C-N-CA 128.667 2.787 . . . . 0.0 116.417 -173.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.618 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -93.05 11.58 27.09 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -172.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 48.4 t -85.78 105.2 14.21 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.332 0.587 . . . . 0.0 109.666 -178.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 6' ' ' ASP . 40.2 p90 -111.46 149.84 30.73 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.426 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' N ' ' A' ' 36' ' ' CYS . 25.9 p -96.15 -165.27 1.26 Allowed 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.56 178.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 20' ' ' GLU . 1.1 p -77.76 145.46 36.45 Favored 'General case' 0 C--N 1.268 -2.943 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 39.6 mtm180 -95.83 -30.22 13.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.57 ' O ' ' HB ' ' A' ' 18' ' ' THR . 34.6 mp0 -90.88 -166.03 1.49 Allowed 'General case' 0 N--CA 1.414 -2.258 0 CA-C-N 111.615 -2.538 . . . . 0.0 107.172 177.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -128.13 105.41 8.36 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 122.063 0.935 . . . . 0.0 110.531 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.628 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 46.4 t-20 -111.11 105.59 57.11 Favored Pre-proline 0 C--N 1.277 -2.544 0 CA-C-N 113.064 -1.88 . . . . 0.0 107.53 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.08 148.69 63.52 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 121.791 1.661 . . . . 0.0 112.183 -178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.497 ' O ' ' HA ' ' A' ' 31' ' ' THR . 69.7 m-70 -148.07 130.81 16.01 Favored 'General case' 0 CA--C 1.471 -2.068 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -173.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 43.8 t -106.69 102.6 11.96 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.456 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -68.98 160.16 52.53 Favored Glycine 0 N--CA 1.405 -3.397 0 N-CA-C 111.171 -0.772 . . . . 0.0 111.171 -177.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.0 m -60.8 -21.17 62.85 Favored 'General case' 0 C--N 1.286 -2.183 0 CA-C-O 120.91 0.386 . . . . 0.0 110.61 177.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -73.36 -16.34 61.35 Favored 'General case' 0 CA--C 1.481 -1.698 0 C-N-CA 125.54 1.536 . . . . 0.0 110.894 177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.19 -20.68 30.33 Favored Glycine 1 CA--C 1.448 -4.14 0 C-N-CA 119.357 -1.401 . . . . 0.0 110.456 177.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -71.92 130.37 40.84 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 24' ' ' HIS . 96.8 m -115.85 127.86 55.36 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 112.723 -2.035 . . . . 0.0 109.368 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.4 m-85 -132.88 155.28 49.32 Favored 'General case' 0 N--CA 1.388 -3.569 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.624 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.2 -22.86 72.94 Favored Glycine 0 C--N 1.29 -1.983 0 CA-C-N 113.232 -1.804 . . . . 0.0 114.483 -176.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 33.2 p30 -156.79 169.33 24.98 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 117.458 0.629 . . . . 0.0 110.403 177.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 17' ' ' CYS . 79.3 tttt -61.24 -33.71 73.95 Favored 'General case' 0 C--O 1.196 -1.724 0 CA-C-O 121.286 0.565 . . . . 0.0 111.922 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.601 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 97.3 m -57.44 -41.17 79.99 Favored 'General case' 0 C--N 1.263 -3.173 0 CA-C-N 114.857 -1.065 . . . . 0.0 111.142 176.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -77.04 -40.78 45.12 Favored 'General case' 0 C--N 1.27 -2.877 0 CA-C-N 113.324 -1.762 . . . . 0.0 110.157 -175.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 33.7 t80 -82.25 -12.64 57.94 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.963 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.807 ' O ' HG23 ' A' ' 43' ' ' VAL . 52.4 t -59.49 -40.98 88.76 Favored 'General case' 0 C--O 1.192 -1.942 0 C-N-CA 123.224 0.61 . . . . 0.0 111.556 -174.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.602 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -72.09 -20.84 61.59 Favored 'General case' 0 CA--C 1.479 -1.77 0 CA-C-O 122.732 1.253 . . . . 0.0 112.05 -170.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.602 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -74.22 -39.2 63.25 Favored 'General case' 0 C--N 1.247 -3.848 0 CA-C-N 112.793 -2.003 . . . . 0.0 107.847 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.671 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.8 mt -71.15 -49.34 49.37 Favored 'Isoleucine or valine' 0 CA--C 1.474 -1.979 0 CA-C-N 114.619 -1.173 . . . . 0.0 109.087 -173.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.807 HG23 ' O ' ' A' ' 39' ' ' CYS . 59.5 t -50.34 -53.69 11.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.369 0 CA-C-N 112.467 -2.151 . . . . 0.0 111.177 -178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -71.74 -33.95 69.13 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-N 114.195 -1.366 . . . . 0.0 112.522 -173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.0 m -83.48 0.99 43.94 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.425 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.78 14.3 52.9 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 116.205 1.242 . . . . 0.0 116.205 173.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.89 -6.77 58.05 Favored Glycine 0 C--N 1.293 -1.86 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -67.21 -16.01 64.04 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.6 mt -78.77 147.36 6.9 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.27 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.6 m -121.69 176.78 5.54 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.439 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 38.9 tp -99.31 141.44 32.09 Favored 'General case' 1 N--CA 1.329 -6.484 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 178.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -88.42 -57.14 3.03 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-O 122.449 1.118 . . . . 0.0 108.81 167.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.0 m170 -130.92 138.96 34.16 Favored Pre-proline 0 C--N 1.285 -2.222 0 CA-C-N 113.645 -1.616 . . . . 0.0 113.282 -165.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -78.81 109.47 2.61 Favored 'Trans proline' 0 N--CA 1.435 -1.946 0 N-CA-C 104.537 -2.909 . . . . 0.0 104.537 161.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.23 178.33 18.66 Favored Glycine 0 C--N 1.279 -2.614 0 N-CA-C 108.236 -1.946 . . . . 0.0 108.236 -168.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.49 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.7 pttp -78.05 175.65 9.91 Favored 'General case' 0 N--CA 1.415 -2.22 0 CA-C-O 122.031 0.92 . . . . 0.0 111.403 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.2 m . . . . . 0 C--N 1.279 -2.461 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 165.893 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 48.2 tp60 . . . . . 0 C--O 1.221 -0.433 0 N-CA-C 111.602 0.223 . . . . 0.0 111.602 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.45 -38.68 87.05 Favored Glycine 0 C--O 1.22 -0.746 0 C-N-CA 121.431 -0.414 . . . . 0.0 112.415 -177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.1 -71.98 0.9 Allowed Glycine 0 N--CA 1.436 -1.324 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -91.07 130.06 37.01 Favored 'General case' 0 N--CA 1.42 -1.934 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -90.25 60.8 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 117.872 -1.531 . . . . 0.0 111.689 178.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -131.53 91.51 3.02 Favored 'General case' 0 C--N 1.258 -3.404 0 CA-C-N 113.51 -1.677 . . . . 0.0 107.082 166.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 10' ' ' PHE 0.386 2.4 p 38.08 -103.04 0.03 OUTLIER 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 -179.462 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.57 -83.76 0.2 Allowed Glycine 0 N--CA 1.437 -1.273 0 O-C-N 124.089 0.868 . . . . 0.0 112.926 -176.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -80.83 -5.03 56.75 Favored 'General case' 0 C--N 1.294 -1.815 0 C-N-CA 125.204 1.402 . . . . 0.0 113.49 -172.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.57 ' C ' ' H ' ' A' ' 12' ' ' ASP . 8.2 m-85 -53.87 -46.11 71.22 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.575 ' H ' HG13 ' A' ' 43' ' ' VAL . 54.8 mt-30 62.19 -17.83 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 126.828 2.051 . . . . 0.0 114.007 -176.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.612 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 4.8 t70 -75.02 -152.07 0.03 OUTLIER 'General case' 0 C--N 1.265 -3.076 0 C-N-CA 127.696 2.399 . . . . 0.0 111.797 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 15' ' ' VAL . 20.4 p -126.47 -12.75 6.12 Favored 'General case' 0 C--N 1.266 -3.03 0 C-N-CA 129.957 3.303 . . . . 0.0 111.037 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.612 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 0.1 OUTLIER -78.9 3.02 18.15 Favored 'General case' 0 N--CA 1.512 2.627 0 CA-C-O 122.987 1.375 . . . . 0.0 108.587 176.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.532 HG21 HG11 ' A' ' 43' ' ' VAL . 73.8 t -52.22 107.23 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.255 -3.524 0 C-N-CA 128.767 2.827 . . . . 0.0 113.438 -177.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -96.57 127.3 42.43 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.29 176.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.719 ' HB2' ' HA ' ' A' ' 36' ' ' CYS . 22.6 p -89.6 -172.52 3.61 Favored 'General case' 0 C--N 1.292 -1.92 0 O-C-N 124.345 1.028 . . . . 0.0 111.098 -176.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.517 ' HB ' ' H ' ' A' ' 20' ' ' GLU . 63.7 p -77.92 174.97 10.48 Favored 'General case' 0 CA--C 1.484 -1.558 0 CA-C-O 122.79 1.281 . . . . 0.0 114.277 -175.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.453 ' H ' ' NE ' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -106.57 -10.64 16.14 Favored 'General case' 0 N--CA 1.423 -1.808 0 CA-C-N 112.246 -2.252 . . . . 0.0 109.115 171.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.517 ' H ' ' HB ' ' A' ' 18' ' ' THR . 2.1 mp0 -63.24 140.62 58.89 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.012 -0.994 . . . . 0.0 109.871 174.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 t -107.03 13.11 27.88 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 122.826 1.298 . . . . 0.0 108.163 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.58 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.8 m-20 -69.36 116.82 46.4 Favored Pre-proline 0 C--N 1.272 -2.777 0 CA-C-N 112.49 -2.141 . . . . 0.0 111.933 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -68.96 148.46 70.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.838 2.359 . . . . 0.0 112.239 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -152.5 127.12 9.43 Favored 'General case' 0 CA--C 1.475 -1.94 0 C-N-CA 124.08 0.952 . . . . 0.0 108.757 -173.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 14.0 t -100.05 99.11 9.8 Favored 'General case' 0 C--N 1.254 -3.562 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -80.14 170.96 54.12 Favored Glycine 0 CA--C 1.46 -3.401 0 C-N-CA 119.817 -1.182 . . . . 0.0 112.372 -168.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.6 m -73.82 5.17 4.32 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.848 0.833 . . . . 0.0 109.398 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -68.69 -19.84 64.39 Favored 'General case' 0 CA--C 1.496 -1.128 0 C-N-CA 127.529 2.332 . . . . 0.0 105.839 169.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.84 -36.04 4.52 Favored Glycine 1 N--CA 1.394 -4.143 0 N-CA-C 108.124 -1.991 . . . . 0.0 108.124 -178.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -85.54 155.59 21.12 Favored 'General case' 0 CA--C 1.464 -2.33 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.578 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.7 m -96.21 124.75 40.33 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 112.875 -1.966 . . . . 0.0 108.678 173.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.631 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 56.8 m-85 -113.21 142.74 45.44 Favored 'General case' 1 N--CA 1.377 -4.121 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.67 177.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.35 -35.82 80.7 Favored Glycine 0 CA--C 1.49 -1.509 0 CA-C-N 113.38 -1.736 . . . . 0.0 112.691 -175.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.3 p-10 -149.69 168.71 22.85 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.349 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.434 ' HG2' HG21 ' A' ' 18' ' ' THR . 48.4 tttm -59.03 -29.99 67.69 Favored 'General case' 0 C--N 1.308 -1.22 0 C-N-CA 124.513 1.125 . . . . 0.0 111.982 -176.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.719 ' HA ' ' HB2' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -55.53 -50.79 69.06 Favored 'General case' 0 C--N 1.249 -3.788 0 CA-C-N 113.358 -1.746 . . . . 0.0 110.73 174.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.631 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -69.44 -33.95 73.7 Favored 'General case' 0 C--N 1.272 -2.769 0 CA-C-N 112.903 -1.953 . . . . 0.0 109.893 -175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.414 ' CE2' HD11 ' A' ' 42' ' ' ILE . 13.5 t80 -83.14 -16.71 45.66 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.588 178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.776 ' O ' HG23 ' A' ' 43' ' ' VAL . 42.5 t -68.09 -31.65 71.42 Favored 'General case' 0 CA--C 1.47 -2.126 0 O-C-N 122.034 -0.416 . . . . 0.0 110.373 -174.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.738 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -66.62 -29.52 69.57 Favored 'General case' 0 CA--C 1.454 -2.722 0 CA-C-O 122.33 1.062 . . . . 0.0 112.471 -169.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.738 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.0 -35.14 66.78 Favored 'General case' 1 C--N 1.224 -4.886 0 CA-C-N 112.545 -2.116 . . . . 0.0 110.268 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.699 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.4 mt -68.32 -42.13 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.081 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.6 t -58.56 -33.02 47.29 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.392 0 CA-C-N 111.107 -2.769 . . . . 0.0 111.387 174.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.599 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 7.7 mmpt? -81.11 -37.4 28.98 Favored 'General case' 0 C--N 1.311 -1.076 0 C-N-CA 119.662 -0.815 . . . . 0.0 112.708 -177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.1 t -84.51 -20.57 31.41 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.667 -177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 103.87 31.99 4.58 Favored Glycine 0 N--CA 1.4 -3.756 0 C-N-CA 120.56 -0.828 . . . . 0.0 113.32 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.418 ' HA2' HG23 ' A' ' 42' ' ' ILE . . . 85.81 -13.19 57.36 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -175.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -67.36 -24.81 65.74 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 115.657 1.725 . . . . 0.0 115.657 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 41' ' ' ALA . 70.0 mt -80.74 146.1 8.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 118.973 -1.091 . . . . 0.0 111.203 173.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -134.71 -176.62 4.29 Favored 'General case' 0 C--N 1.28 -2.438 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 -176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.3 tp -93.11 141.13 28.75 Favored 'General case' 1 N--CA 1.34 -5.973 0 N-CA-C 114.496 1.295 . . . . 0.0 114.496 177.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 23.0 mtmm -88.77 -49.7 6.67 Favored 'General case' 0 CA--C 1.481 -1.683 0 C-N-CA 119.94 -0.704 . . . . 0.0 110.141 168.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -146.1 132.22 9.57 Favored Pre-proline 0 C--N 1.283 -2.311 0 C-N-CA 118.507 -1.277 . . . . 0.0 112.075 -172.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.26 109.91 2.97 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 121.89 1.727 . . . . 0.0 108.33 172.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.46 -167.46 13.78 Favored Glycine 0 C--N 1.285 -2.302 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 -171.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 12.6 pttp -86.98 169.4 12.47 Favored 'General case' 0 N--CA 1.395 -3.21 0 CA-C-O 121.439 0.638 . . . . 0.0 110.831 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 56.7 m . . . . . 0 C--N 1.273 -2.727 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 167.035 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 CA--C 1.504 -0.793 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.7 -82.24 1.32 Allowed Glycine 0 CA--C 1.506 -0.493 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 -178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.93 121.25 11.65 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 108.48 -1.848 . . . . 0.0 108.48 175.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -70.47 92.44 0.82 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.91 0.386 . . . . 0.0 111.965 -174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 7.9 p -138.57 -1.52 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -66.49 68.32 0.06 Allowed 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 -165.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.56 ' HB3' HG12 ' A' ' 15' ' ' VAL . 68.7 m -104.3 79.34 1.58 Allowed 'General case' 0 C--N 1.286 -2.156 0 CA-C-O 122.187 0.994 . . . . 0.0 108.867 168.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -4.46 90.25 Favored Glycine 0 N--CA 1.433 -1.512 0 CA-C-N 114.101 -1.409 . . . . 0.0 112.553 -177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.425 ' HB3' HG11 ' A' ' 43' ' ' VAL . 57.2 mt-10 -73.8 -48.53 30.78 Favored 'General case' 0 N--CA 1.413 -2.296 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.8 t80 50.32 30.93 4.82 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.505 -1.225 . . . . 0.0 113.609 168.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -66.26 -14.03 61.33 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 122.657 1.218 . . . . 0.0 112.99 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 6.3 t0 -129.75 150.31 51.11 Favored 'General case' 0 C--N 1.245 -3.936 0 CA-C-N 112.619 -2.082 . . . . 0.0 106.623 174.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -74.29 -19.3 60.53 Favored 'General case' 0 C--N 1.247 -3.868 0 C-N-CA 124.899 1.28 . . . . 0.0 112.752 -172.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -86.46 -10.39 54.29 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.779 0.8 . . . . 0.0 109.145 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 39' ' ' CYS . 78.5 t -75.41 73.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 -172.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -139.46 143.2 37.44 Favored 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 103.695 -2.706 . . . . 0.0 103.695 162.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.595 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 16.1 p -109.31 -176.57 3.06 Favored 'General case' 0 C--N 1.281 -2.372 0 C-N-CA 119.395 -0.922 . . . . 0.0 113.141 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.7 t -134.37 170.44 15.73 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.509 -1.223 . . . . 0.0 108.999 176.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 36.7 ptt180 -99.45 -21.57 15.9 Favored 'General case' 0 C--N 1.276 -2.601 0 CA-C-N 113.367 -1.742 . . . . 0.0 107.287 -178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -69.66 140.2 53.6 Favored 'General case' 0 C--O 1.251 1.144 0 CA-C-N 114.23 -1.35 . . . . 0.0 109.075 179.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 p -79.87 100.5 8.05 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 122.599 1.19 . . . . 0.0 111.829 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -111.01 97.06 32.89 Favored Pre-proline 0 C--N 1.258 -3.396 0 CA-C-N 113.065 -1.879 . . . . 0.0 108.628 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.449 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 57.1 Cg_endo -73.91 133.8 18.87 Favored 'Trans proline' 0 N--CA 1.443 -1.445 0 C-N-CA 121.047 1.165 . . . . 0.0 110.328 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' THR . 62.1 m-70 -141.67 128.34 20.33 Favored 'General case' 0 CA--C 1.464 -2.349 0 CA-C-O 121.491 0.662 . . . . 0.0 109.842 -173.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 49.9 t -101.95 108.77 20.33 Favored 'General case' 0 C--N 1.26 -3.294 0 N-CA-C 102.79 -3.041 . . . . 0.0 102.79 167.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -76.21 162.8 52.75 Favored Glycine 1 N--CA 1.393 -4.209 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.662 -174.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.2 m -60.06 -22.17 62.36 Favored 'General case' 0 C--N 1.278 -2.502 0 CA-C-N 114.577 -0.812 . . . . 0.0 109.875 175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.409 ' HB2' HG13 ' A' ' 49' ' ' ILE . 33.1 t70 -81.86 6.17 16.58 Favored 'General case' 0 CA--C 1.498 -1.034 0 CA-C-O 122.683 1.23 . . . . 0.0 110.106 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.01 -27.17 9.38 Favored Glycine 0 CA--C 1.467 -2.917 0 CA-C-N 114.711 -1.132 . . . . 0.0 111.564 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -72.51 145.97 47.14 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 115.07 1.507 . . . . 0.0 115.07 -175.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.54 HG21 ' CB ' ' A' ' 56' ' ' LYS . 94.2 m -119.18 134.02 55.44 Favored 'General case' 0 C--N 1.282 -2.332 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.569 178.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' CD2' ' HA ' ' A' ' 38' ' ' PHE . 36.3 m-85 -133.62 152.54 51.91 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 121.222 0.534 . . . . 0.0 111.946 172.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.97 -37.01 93.75 Favored Glycine 0 N--CA 1.464 0.55 0 CA-C-N 113.903 -1.498 . . . . 0.0 115.132 -177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 31.2 p30 -141.92 175.82 9.42 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -67.77 -36.87 81.27 Favored 'General case' 0 C--O 1.198 -1.643 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.348 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.595 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.3 t -62.22 -37.66 86.21 Favored 'General case' 0 C--N 1.252 -3.643 0 CA-C-O 122.422 1.106 . . . . 0.0 110.801 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.41 -36.46 83.81 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 112.798 -2.001 . . . . 0.0 109.987 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -92.24 -25.32 18.69 Favored 'General case' 0 C--O 1.195 -1.792 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.706 -178.296 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.769 ' O ' HG23 ' A' ' 43' ' ' VAL . 12.9 t -51.68 -50.55 60.21 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 124.887 1.275 . . . . 0.0 111.68 -170.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.687 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.19 -29.38 67.35 Favored 'General case' 0 N--CA 1.403 -2.777 0 CA-C-O 122.186 0.993 . . . . 0.0 113.626 -176.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -78.52 -28.08 46.17 Favored 'General case' 1 C--N 1.224 -4.851 0 CA-C-N 113.353 -1.749 . . . . 0.0 110.546 177.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.826 ' HA ' HD13 ' A' ' 49' ' ' ILE . 35.3 mt -64.43 -43.31 96.97 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.614 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 176.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.769 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.2 t -56.96 -36.84 51.74 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.093 0 CA-C-N 111.443 -2.617 . . . . 0.0 111.351 175.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.687 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 38.5 mmtm -82.44 -38.69 23.63 Favored 'General case' 0 CA--C 1.495 -1.169 0 CA-C-O 121.144 0.497 . . . . 0.0 112.301 -174.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.656 ' HB3' HD11 ' A' ' 49' ' ' ILE . 9.5 t -81.88 -14.85 55.65 Favored 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.367 -175.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 128.59 0.2 6.23 Favored Glycine 0 N--CA 1.401 -3.663 0 N-CA-C 117.002 1.561 . . . . 0.0 117.002 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.64 6.11 84.21 Favored Glycine 0 C--N 1.283 -2.382 0 C-N-CA 120.098 -1.048 . . . . 0.0 110.807 -175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . 0.293 44.1 mttt -56.89 -36.52 70.23 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 122.029 0.919 . . . . 0.0 109.812 177.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.826 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.2 mp -59.69 132.05 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.138 0 CA-C-N 113.415 -1.721 . . . . 0.0 113.683 -166.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.2 m -138.22 178.47 7.11 Favored 'General case' 0 C--N 1.26 -3.313 0 N-CA-C 101.842 -3.392 . . . . 0.0 101.842 171.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.516 HD12 ' HA ' ' A' ' 51' ' ' LEU . 22.0 tp -91.9 140.37 29.74 Favored 'General case' 1 N--CA 1.321 -6.918 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 -179.315 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.4 ttmt -96.17 -52.78 3.88 Favored 'General case' 1 N--CA 1.343 -5.777 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.093 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -141.11 139.21 18.84 Favored Pre-proline 0 C--N 1.295 -1.762 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.659 -173.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.13 110.13 2.82 Favored 'Trans proline' 0 N--CA 1.442 -1.535 0 N-CA-C 106.766 -2.052 . . . . 0.0 106.766 166.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 116.6 173.77 17.04 Favored Glycine 0 C--N 1.287 -2.144 0 N-CA-C 108.271 -1.932 . . . . 0.0 108.271 -171.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.54 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.4 pttp -75.93 172.23 13.08 Favored 'General case' 0 N--CA 1.41 -2.47 0 CA-C-O 121.665 0.745 . . . . 0.0 110.646 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.437 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 27.9 m . . . . . 0 C--N 1.275 -2.661 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 166.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 67.6 mm-40 . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.2 -73.05 2.23 Favored Glycine 0 C--O 1.219 -0.825 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -174.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -96.18 150.71 19.7 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 108.81 -1.716 . . . . 0.0 108.81 173.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -83.41 45.72 1.07 Allowed 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 122.231 1.015 . . . . 0.0 111.803 -178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.0 t -109.44 134.4 51.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.162 0 CA-C-N 114.472 -1.24 . . . . 0.0 109.259 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.548 ' HA ' ' O ' ' A' ' 17' ' ' CYS . 12.9 t70 -129.4 126.2 38.3 Favored 'General case' 0 N--CA 1.42 -1.943 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 172.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.708 ' SG ' ' HA ' ' A' ' 16' ' ' TYR . 83.6 m -22.83 -48.03 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 126.31 1.844 . . . . 0.0 115.029 169.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 54.31 -79.09 0.01 OUTLIER Glycine 0 N--CA 1.467 0.758 0 O-C-N 124.061 0.85 . . . . 0.0 114.985 176.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 10' ' ' PHE . 6.6 tm-20 -70.81 -40.57 72.42 Favored 'General case' 0 N--CA 1.434 -1.267 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.733 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 65.3 t80 77.84 5.73 2.84 Favored 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.57 165.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -127.17 -8.34 5.9 Favored 'General case' 0 C--N 1.274 -2.707 0 CA-C-O 121.459 0.647 . . . . 0.0 110.068 171.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 15' ' ' VAL . 20.8 t0 -95.55 121.38 37.18 Favored 'General case' 0 N--CA 1.386 -3.655 0 CA-C-O 123.141 1.448 . . . . 0.0 111.59 -176.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.6 p -43.44 -20.36 0.02 OUTLIER 'General case' 1 C--N 1.237 -4.298 0 C-N-CA 129.861 3.264 . . . . 0.0 116.233 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 39.3 mttp -93.32 -32.44 14.3 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-O 121.921 0.867 . . . . 0.0 110.998 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -98.91 93.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.162 0 CA-C-N 114.347 -1.297 . . . . 0.0 110.336 -170.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.708 ' HA ' ' SG ' ' A' ' 7' ' ' CYS . 50.4 p90 -138.22 174.12 10.9 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 177.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 6' ' ' ASP 0.35 0.3 OUTLIER 65.64 165.79 0.18 Allowed 'General case' 0 N--CA 1.402 -2.857 0 CA-C-N 113.856 -1.52 . . . . 0.0 112.45 -166.163 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 t -147.35 176.02 10.33 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-O 121.802 0.811 . . . . 0.0 111.459 -171.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.62 ' H ' ' HD3' ' A' ' 19' ' ' ARG . 0.0 OUTLIER -70.12 -19.49 63.23 Favored 'General case' 0 C--N 1.291 -1.936 0 CA-C-N 113.7 -1.591 . . . . 0.0 108.56 179.27 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -81.48 122.82 28.02 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -174.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.6 m -96.78 17.36 16.78 Favored 'General case' 0 C--N 1.316 -0.862 0 C-N-CA 126.141 1.776 . . . . 0.0 109.756 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -75.23 111.21 12.72 Favored Pre-proline 0 C--N 1.267 -3.0 0 CA-C-N 113.082 -1.872 . . . . 0.0 110.995 -176.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.453 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 39.3 Cg_exo -60.0 143.03 99.61 Favored 'Trans proline' 0 N--CA 1.5 1.877 0 C-N-CA 123.775 2.983 . . . . 0.0 112.673 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.44 ' CD2' HD13 ' A' ' 51' ' ' LEU . 0.3 OUTLIER -152.5 130.58 11.87 Favored 'General case' 0 CA--C 1.48 -1.712 0 C-N-CA 123.729 0.811 . . . . 0.0 110.039 -170.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.634 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.9 t -103.35 105.44 15.71 Favored 'General case' 0 C--N 1.258 -3.396 0 N-CA-C 102.909 -2.997 . . . . 0.0 102.909 170.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.697 ' HA3' ' CE1' ' A' ' 38' ' ' PHE . . . -86.16 177.04 49.03 Favored Glycine 0 CA--C 1.464 -3.144 0 C-N-CA 119.284 -1.436 . . . . 0.0 113.798 -170.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.444 ' HB2' HG23 ' A' ' 49' ' ' ILE . 35.8 m -76.03 4.08 9.09 Favored 'General case' 0 CA--C 1.565 1.539 0 CA-C-O 121.827 0.822 . . . . 0.0 109.094 173.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.59 -18.28 65.28 Favored 'General case' 0 C--N 1.367 1.339 0 C-N-CA 127.603 2.361 . . . . 0.0 105.746 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.5 -32.91 6.46 Favored Glycine 0 N--CA 1.399 -3.793 0 CA-C-N 113.093 -1.867 . . . . 0.0 108.662 -179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -91.71 156.14 17.79 Favored 'General case' 0 CA--C 1.47 -2.116 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 -172.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 75.8 m -96.48 128.76 43.71 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 112.898 -1.955 . . . . 0.0 109.109 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.56 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 91.8 m-85 -116.02 147.88 40.75 Favored 'General case' 0 N--CA 1.38 -3.955 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.7 -27.44 61.52 Favored Glycine 0 C--N 1.299 -1.509 0 O-C-N 124.873 1.358 . . . . 0.0 113.011 -175.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.567 ' OD1' ' HB3' ' A' ' 36' ' ' CYS . 27.0 p30 -159.66 171.17 20.07 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 178.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 41.0 ttmt -63.17 -32.78 74.26 Favored 'General case' 0 C--O 1.182 -2.467 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.983 -179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 2.7 t -49.11 -53.86 18.75 Favored 'General case' 1 C--N 1.242 -4.082 0 CA-C-N 114.315 -1.311 . . . . 0.0 110.572 173.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.0 -41.9 90.42 Favored 'General case' 0 C--N 1.264 -3.124 0 C-N-CA 125.566 1.547 . . . . 0.0 111.03 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.697 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 19.2 t80 -85.53 -17.41 36.45 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 114.571 1.323 . . . . 0.0 114.571 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.849 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.1 t -61.78 -31.09 71.27 Favored 'General case' 0 C--O 1.181 -2.516 0 O-C-N 121.707 -0.621 . . . . 0.0 110.501 -172.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.789 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.7 -32.2 73.77 Favored 'General case' 0 CA--C 1.461 -2.48 0 CA-C-O 122.398 1.094 . . . . 0.0 112.454 -171.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.789 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -66.28 -40.56 90.17 Favored 'General case' 1 C--N 1.234 -4.455 0 CA-C-N 111.971 -2.377 . . . . 0.0 108.014 -179.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.655 HD12 ' HA ' ' A' ' 39' ' ' CYS . 53.5 mt -71.22 -50.63 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.042 0 CA-C-N 114.202 -1.363 . . . . 0.0 108.37 -175.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 39' ' ' CYS . 18.3 t -53.85 -52.1 38.52 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.212 0 CA-C-N 112.998 -1.91 . . . . 0.0 111.196 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -69.84 -30.61 68.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.436 -173.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 45.5 m -90.44 12.27 19.06 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.491 172.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.64 6.03 68.31 Favored Glycine 0 N--CA 1.408 -3.219 0 N-CA-C 117.106 1.602 . . . . 0.0 117.106 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 93.4 -4.37 73.37 Favored Glycine 1 C--N 1.248 -4.345 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -175.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 48' ' ' LYS . 10.0 mptt -68.48 -29.78 68.48 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 -179.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 41' ' ' ALA . 64.7 mt -75.93 149.07 6.86 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.065 0 C-N-CA 119.586 -0.846 . . . . 0.0 109.048 173.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 30.9 m -132.16 -177.48 4.47 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 -175.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.8 tp -87.2 140.79 29.19 Favored 'General case' 1 N--CA 1.331 -6.401 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 176.676 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.569 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 28.6 ttmt -85.44 -56.32 3.58 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.299 170.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.409 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 63.7 m170 -140.33 136.48 16.86 Favored Pre-proline 0 C--N 1.292 -1.913 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.589 -174.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.3 110.19 3.06 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 N-CA-C 106.643 -2.099 . . . . 0.0 106.643 167.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 109.4 -173.93 17.57 Favored Glycine 0 N--CA 1.426 -2.024 0 N-CA-C 110.06 -1.216 . . . . 0.0 110.06 -172.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 9.0 mtpm? -67.05 170.22 7.19 Favored 'General case' 0 N--CA 1.42 -1.971 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.513 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 66.3 m . . . . . 0 C--N 1.275 -2.655 0 CA-C-N 109.956 -3.293 . . . . 0.0 103.055 158.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -119.67 -24.29 2.88 Favored Glycine 0 C--N 1.311 -0.806 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.151 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -166.9 -64.23 0.03 OUTLIER Glycine 0 CA--C 1.489 -1.583 0 N-CA-C 110.529 -1.029 . . . . 0.0 110.529 -179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.29 -179.51 6.3 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.7 t -83.99 72.57 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 C-N-CA 118.262 -1.375 . . . . 0.0 110.184 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.464 ' HB2' ' CD1' ' A' ' 10' ' ' PHE . 9.0 p-10 -87.1 91.46 8.72 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 172.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . 0.41 72.0 m -25.76 77.84 0.0 OUTLIER 'General case' 0 CA--C 1.461 -2.443 0 N-CA-C 120.746 3.61 . . . . 0.0 120.746 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.9 -76.63 0.01 OUTLIER Glycine 0 C--N 1.36 1.9 0 O-C-N 126.084 2.115 . . . . 0.0 112.136 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -88.38 -33.71 17.83 Favored 'General case' 0 N--CA 1.39 -3.427 0 CA-C-N 113.432 -1.384 . . . . 0.0 109.801 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.464 ' CD1' ' HB2' ' A' ' 6' ' ' ASP . 25.8 t80 49.27 41.51 20.3 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 123.047 1.403 . . . . 0.0 109.951 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -48.84 -35.62 15.01 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 112.943 -1.935 . . . . 0.0 113.9 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -127.48 157.57 39.72 Favored 'General case' 2 N--CA 1.367 -4.62 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.211 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.9 p -49.06 -52.78 23.53 Favored 'General case' 0 C--N 1.245 -3.975 0 C-N-CA 130.091 3.356 . . . . 0.0 117.033 -173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.413 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -95.37 6.6 48.56 Favored 'General case' 0 N--CA 1.422 -1.867 0 O-C-N 121.218 -0.927 . . . . 0.0 111.0 -170.5 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.53 HG12 ' SG ' ' A' ' 39' ' ' CYS . 2.7 t -87.56 74.39 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.66 0 CA-C-O 122.017 0.913 . . . . 0.0 113.201 -170.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -127.33 149.65 49.95 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 174.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.671 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 3.3 p -113.97 179.36 3.98 Favored 'General case' 0 C--N 1.283 -2.3 0 C-N-CA 118.443 -1.303 . . . . 0.0 112.644 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.7 t -137.35 171.77 13.97 Favored 'General case' 0 N--CA 1.414 -2.266 0 CA-C-N 114.349 -1.296 . . . . 0.0 108.567 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.75 -15.58 19.27 Favored 'General case' 0 C--N 1.268 -2.976 0 CA-C-N 113.33 -1.759 . . . . 0.0 109.293 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -74.55 163.57 27.59 Favored 'General case' 0 C--O 1.251 1.139 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.5 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.0 m -97.0 102.5 14.29 Favored 'General case' 0 N--CA 1.412 -2.343 0 CA-C-O 122.919 1.342 . . . . 0.0 111.972 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.0 m120 -111.14 92.43 15.43 Favored Pre-proline 0 C--N 1.264 -3.141 0 CA-C-N 113.367 -1.742 . . . . 0.0 108.731 178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -63.79 125.33 15.21 Favored 'Trans proline' 0 C--O 1.245 0.828 0 C-N-CA 121.961 1.774 . . . . 0.0 110.445 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 5.2 m-70 -141.7 125.07 16.56 Favored 'General case' 0 CA--C 1.465 -2.32 0 CA-C-O 122.187 0.994 . . . . 0.0 110.915 -172.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.505 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 43.0 t -100.05 106.79 18.58 Favored 'General case' 0 C--N 1.253 -3.619 0 N-CA-C 102.518 -3.142 . . . . 0.0 102.518 169.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.22 159.27 53.66 Favored Glycine 0 N--CA 1.416 -2.659 0 C-N-CA 120.177 -1.011 . . . . 0.0 111.412 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.7 m -53.46 -22.1 7.33 Favored 'General case' 0 C--N 1.294 -1.806 0 C-N-CA 123.575 0.75 . . . . 0.0 112.072 173.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -83.9 11.6 7.44 Favored 'General case' 0 CA--C 1.491 -1.325 0 CA-C-O 121.773 0.797 . . . . 0.0 110.521 175.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.55 -27.34 5.29 Favored Glycine 0 CA--C 1.479 -2.185 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.571 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -73.84 129.89 38.83 Favored 'General case' 0 C--N 1.286 -2.187 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.578 HG21 ' HA ' ' A' ' 56' ' ' LYS . 84.6 m -107.8 134.7 50.38 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 112.575 -2.102 . . . . 0.0 112.208 -176.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.536 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 11.3 m-85 -132.01 165.73 23.31 Favored 'General case' 0 N--CA 1.407 -2.622 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.711 169.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -64.09 -39.87 97.59 Favored Glycine 0 C--N 1.301 -1.386 0 CA-C-N 113.568 -1.651 . . . . 0.0 113.991 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.4 p30 -141.78 177.49 8.14 Favored 'General case' 0 N--CA 1.436 -1.142 0 CA-C-N 117.783 0.791 . . . . 0.0 109.408 176.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 39' ' ' CYS . 32.8 ttpt -66.25 -39.33 89.43 Favored 'General case' 0 C--O 1.204 -1.339 0 CA-C-O 121.432 0.634 . . . . 0.0 112.498 -175.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.671 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 2.0 t -60.57 -38.22 83.88 Favored 'General case' 0 C--N 1.258 -3.374 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.283 178.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 34' ' ' ASN . . . -59.44 -40.82 88.01 Favored 'General case' 0 C--N 1.261 -3.279 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.567 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.536 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 11.4 t80 -102.65 -2.06 29.02 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.784 0.326 . . . . 0.0 110.889 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.793 ' HA ' HD12 ' A' ' 42' ' ' ILE . 10.6 t -58.42 -40.95 83.88 Favored 'General case' 0 C--O 1.196 -1.72 0 C-N-CA 123.536 0.735 . . . . 0.0 112.156 -172.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.572 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -75.48 -26.24 58.03 Favored 'General case' 0 CA--C 1.472 -2.056 0 CA-C-O 123.036 1.398 . . . . 0.0 109.637 -171.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.525 ' N ' ' HG2' ' A' ' 40' ' ' LYS . . . -80.36 -27.24 38.28 Favored 'General case' 1 C--N 1.229 -4.635 0 CA-C-N 112.303 -2.226 . . . . 0.0 110.999 179.567 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.793 HD12 ' HA ' ' A' ' 39' ' ' CYS . 37.6 mt -67.59 -41.31 85.56 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.484 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 176.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.4 t -56.05 -39.12 56.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.746 0 CA-C-N 112.048 -2.342 . . . . 0.0 110.672 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 68.1 mmtt -84.59 -36.91 21.75 Favored 'General case' 0 N--CA 1.433 -1.32 0 C-N-CA 119.645 -0.822 . . . . 0.0 112.255 -175.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.596 ' HB2' HD11 ' A' ' 49' ' ' ILE . 75.7 m -88.77 20.51 3.46 Favored 'General case' 0 C--N 1.271 -2.832 0 CA-C-N 114.872 -1.058 . . . . 0.0 112.26 -178.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.08 3.45 63.67 Favored Glycine 0 N--CA 1.423 -2.232 0 N-CA-C 118.19 2.036 . . . . 0.0 118.19 166.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.77 0.46 49.85 Favored Glycine 0 C--N 1.283 -2.368 0 C-N-CA 120.426 -0.892 . . . . 0.0 111.563 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HD3' ' O ' ' A' ' 45' ' ' SER . 1.3 mtpm? -55.64 -26.46 44.51 Favored 'General case' 0 CA--C 1.499 -0.988 0 C-N-CA 123.286 0.634 . . . . 0.0 111.084 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.668 HD13 ' HA ' ' A' ' 42' ' ' ILE . 1.3 mp -64.99 133.24 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.764 0 CA-C-O 123.072 1.415 . . . . 0.0 111.633 -174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.2 m -137.94 -176.03 4.29 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 174.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' HA ' HD12 ' A' ' 51' ' ' LEU . 16.2 tp -89.73 139.47 30.53 Favored 'General case' 1 N--CA 1.316 -7.138 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 178.433 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 11.7 tptp -99.01 -39.08 8.71 Favored 'General case' 0 N--CA 1.384 -3.735 0 CA-C-N 113.729 -1.578 . . . . 0.0 109.26 173.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 25' ' ' CYS . 32.9 t-80 -164.38 136.29 3.62 Favored Pre-proline 0 C--N 1.28 -2.428 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.588 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 5.8 Cg_exo -78.24 109.65 2.72 Favored 'Trans proline' 0 N--CA 1.438 -1.769 0 N-CA-C 108.208 -1.497 . . . . 0.0 108.208 170.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.54 168.82 21.86 Favored Glycine 0 N--CA 1.428 -1.861 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.578 ' HA ' HG21 ' A' ' 31' ' ' THR . 2.3 mmmp? -48.37 154.55 0.6 Allowed 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 118.666 2.839 . . . . 0.0 118.666 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.509 ' C ' ' HZ3' ' A' ' 56' ' ' LYS . 98.5 m . . . . . 0 C--N 1.253 -3.6 0 CA-C-N 108.914 -3.767 . . . . 0.0 102.922 165.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.413 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 14.9 mm-40 . . . . . 0 N--CA 1.47 0.552 0 CA-C-O 119.682 -0.199 . . . . 0.0 110.578 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.8 -158.97 53.76 Favored Glycine 0 C--N 1.333 0.381 0 O-C-N 123.947 0.78 . . . . 0.0 113.28 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -81.37 69.56 3.25 Favored Glycine 0 CA--C 1.504 -0.646 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -86.21 178.34 7.22 Favored 'General case' 0 N--CA 1.419 -2.02 0 CA-C-O 122.074 0.94 . . . . 0.0 112.732 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.605 HG12 ' SG ' ' A' ' 17' ' ' CYS . 80.4 t -76.74 157.01 5.54 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.33 0 CA-C-N 114.053 -1.43 . . . . 0.0 108.977 175.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' OD2' ' NZ ' ' A' ' 40' ' ' LYS 0.431 26.5 t70 -67.7 74.33 0.18 Allowed 'General case' 0 C--N 1.353 0.726 0 N-CA-C 120.367 3.469 . . . . 0.0 120.367 -169.482 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 84.9 m -120.16 46.47 1.96 Allowed 'General case' 1 C--N 1.242 -4.097 0 CA-C-N 111.918 -2.401 . . . . 0.0 104.524 150.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.28 -16.93 58.73 Favored Glycine 0 C--N 1.341 0.819 0 CA-C-N 113.625 -1.625 . . . . 0.0 114.263 -173.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.423 ' CB ' HG11 ' A' ' 43' ' ' VAL . 28.0 mt-10 -72.29 -21.3 61.37 Favored 'General case' 0 N--CA 1.419 -1.981 0 CA-C-N 117.225 0.512 . . . . 0.0 110.672 176.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.638 ' CZ ' ' HA ' ' A' ' 13' ' ' THR . 27.8 t80 63.03 63.92 0.9 Allowed 'General case' 0 C--N 1.352 0.682 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 161.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.416 ' HG3' ' N ' ' A' ' 12' ' ' ASP . 3.9 pt20 -53.33 -51.46 62.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 122.704 1.24 . . . . 0.0 112.728 170.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.444 ' HB3' HG23 ' A' ' 15' ' ' VAL . 64.5 t0 -132.34 164.19 27.02 Favored 'General case' 2 N--CA 1.375 -4.185 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 178.31 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.638 ' HA ' ' CZ ' ' A' ' 10' ' ' PHE . 6.9 t -71.77 -35.77 70.17 Favored 'General case' 1 C--N 1.243 -4.064 0 C-N-CA 125.997 1.719 . . . . 0.0 114.84 -167.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -97.62 8.63 44.3 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -174.21 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 12' ' ' ASP . 37.4 t -91.83 114.5 29.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 CA-C-O 121.511 0.672 . . . . 0.0 111.731 -173.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.501 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 43.8 p90 -132.98 150.42 52.16 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 174.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.713 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 22.8 p -78.16 168.37 19.97 Favored 'General case' 0 N--CA 1.439 -0.991 0 C-N-CA 119.21 -0.996 . . . . 0.0 113.597 -174.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.2 p -79.24 151.46 31.16 Favored 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 114.083 -1.417 . . . . 0.0 114.243 -174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.414 ' HG3' ' OE2' ' A' ' 20' ' ' GLU . 5.4 ptm180 -111.13 -9.56 14.35 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-N 113.252 -1.794 . . . . 0.0 107.195 170.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.414 ' OE2' ' HG3' ' A' ' 19' ' ' ARG . 30.2 mp0 -94.9 176.19 6.35 Favored 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 113.948 -1.478 . . . . 0.0 107.375 176.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 m -98.16 110.99 23.48 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 121.715 0.769 . . . . 0.0 109.154 173.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.58 ' H ' ' HA ' ' A' ' 34' ' ' ASN . 3.0 t-20 -111.15 92.74 16.12 Favored Pre-proline 0 C--N 1.275 -2.659 0 CA-C-N 114.216 -1.357 . . . . 0.0 109.341 -178.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.447 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 72.3 Cg_endo -88.37 124.98 1.75 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.705 1.603 . . . . 0.0 112.839 -177.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.526 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 60.8 m-70 -152.14 128.98 10.92 Favored 'General case' 0 CA--C 1.468 -2.184 0 C-N-CA 125.161 1.384 . . . . 0.0 108.596 -178.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.627 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 49.7 t -96.14 110.53 22.78 Favored 'General case' 0 C--N 1.261 -3.252 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.7 164.48 54.75 Favored Glycine 0 N--CA 1.4 -3.761 0 C-N-CA 120.398 -0.906 . . . . 0.0 111.003 -174.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 61.7 p -62.42 -8.48 6.17 Favored 'General case' 0 C--N 1.283 -2.319 0 C-N-CA 123.264 0.626 . . . . 0.0 110.58 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.96 -23.02 59.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 C-N-CA 126.362 1.865 . . . . 0.0 108.578 174.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.65 -27.4 20.45 Favored Glycine 0 N--CA 1.41 -3.045 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -176.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -76.86 141.8 40.47 Favored 'General case' 0 CA--C 1.476 -1.899 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.523 ' HA ' ' HA ' ' A' ' 25' ' ' CYS . 87.7 m -107.09 126.31 52.19 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.601 -1.636 . . . . 0.0 110.699 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' HB2' ' HB3' ' A' ' 37' ' ' ALA . 29.8 p90 -102.17 134.46 45.39 Favored 'General case' 0 N--CA 1.4 -2.958 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.293 175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.54 -34.07 67.65 Favored Glycine 0 CA--C 1.503 -0.682 0 CA-C-N 114.827 -1.078 . . . . 0.0 110.926 178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.58 ' HA ' ' H ' ' A' ' 22' ' ' ASN . 33.9 p30 -143.7 167.7 21.65 Favored 'General case' 0 N--CA 1.408 -2.55 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 172.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.3 tttp -72.61 -33.35 66.62 Favored 'General case' 0 C--N 1.285 -2.227 0 CA-C-O 121.667 0.746 . . . . 0.0 110.219 -172.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.713 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 4.6 t -52.4 -36.16 53.47 Favored 'General case' 0 C--N 1.254 -3.581 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.427 176.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.531 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -47.95 -49.39 30.49 Favored 'General case' 0 C--N 1.289 -2.041 0 O-C-N 125.408 1.693 . . . . 0.0 111.115 -179.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' CE2' ' HB3' ' A' ' 32' ' ' TYR 0.407 44.1 p90 -145.58 42.24 1.25 Allowed 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 118.007 -1.477 . . . . 0.0 114.869 174.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.772 ' O ' HG23 ' A' ' 43' ' ' VAL . 37.5 t -60.8 -38.17 84.44 Favored 'General case' 0 C--O 1.198 -1.638 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.538 175.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.574 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -72.05 -29.3 64.01 Favored 'General case' 0 CA--C 1.458 -2.59 0 CA-C-O 123.201 1.476 . . . . 0.0 107.948 -171.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -73.06 -29.84 63.26 Favored 'General case' 1 C--N 1.241 -4.114 0 CA-C-N 112.175 -2.284 . . . . 0.0 111.195 178.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.707 HD12 ' HA ' ' A' ' 39' ' ' CYS . 17.1 mt -70.83 -41.5 77.33 Favored 'Isoleucine or valine' 0 CA--C 1.457 -2.598 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.772 HG23 ' O ' ' A' ' 39' ' ' CYS . 25.6 t -60.06 -31.8 48.74 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.874 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.415 172.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -69.35 -41.92 75.95 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.135 0.493 . . . . 0.0 110.986 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 44.5 t -70.2 -44.18 69.2 Favored 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 114.936 -1.029 . . . . 0.0 109.278 177.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 125.58 15.77 2.91 Favored Glycine 1 N--CA 1.388 -4.537 0 CA-C-N 116.145 -0.479 . . . . 0.0 112.939 -176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.37 0.25 89.98 Favored Glycine 0 C--N 1.294 -1.784 0 N-CA-C 109.289 -1.525 . . . . 0.0 109.289 -175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 45' ' ' SER . 55.9 mttt -65.8 -23.18 66.65 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 42' ' ' ILE . 30.3 mt -71.19 128.18 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 C-N-CA 118.466 -1.294 . . . . 0.0 108.537 177.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 m -109.5 -178.56 3.58 Favored 'General case' 0 C--N 1.26 -3.305 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 29.7 tp -95.51 140.67 30.02 Favored 'General case' 1 N--CA 1.317 -7.075 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 177.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 54.3 tttm -99.73 -43.22 6.53 Favored 'General case' 1 N--CA 1.351 -5.399 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.606 172.386 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.627 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 22.8 m170 -139.18 133.83 16.38 Favored Pre-proline 0 C--N 1.29 -1.998 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.365 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -75.5 110.1 3.03 Favored 'Trans proline' 0 N--CA 1.444 -1.39 0 N-CA-C 105.808 -2.42 . . . . 0.0 105.808 164.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 105.01 -171.98 19.42 Favored Glycine 0 N--CA 1.424 -2.112 0 N-CA-C 107.948 -2.061 . . . . 0.0 107.948 -169.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' CB ' HG21 ' A' ' 31' ' ' THR . 14.4 pttp -79.45 173.28 12.74 Favored 'General case' 0 N--CA 1.411 -2.387 0 CA-C-O 122.042 0.925 . . . . 0.0 111.834 178.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 17.2 m . . . . . 0 C--N 1.284 -2.263 0 CA-C-N 114.105 -1.407 . . . . 0.0 107.598 166.107 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 . . . . . 0 N--CA 1.47 0.566 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.87 -150.91 1.36 Allowed Glycine 0 CA--C 1.525 0.657 0 O-C-N 123.82 0.7 . . . . 0.0 114.099 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 100.84 84.12 1.78 Allowed Glycine 0 N--CA 1.441 -0.976 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -176.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 pm0 -69.06 102.92 1.74 Allowed 'General case' 0 N--CA 1.435 -1.213 0 C-N-CA 124.353 1.061 . . . . 0.0 112.152 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.8 t -108.91 134.55 50.52 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.051 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.639 ' HA ' ' SG ' ' A' ' 17' ' ' CYS . 12.8 t0 -93.43 111.96 23.76 Favored 'General case' 0 N--CA 1.435 -1.215 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 172.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 15' ' ' VAL . 19.7 m -78.64 78.52 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 -167.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -113.87 19.92 17.88 Favored Glycine 1 N--CA 1.375 -5.393 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 171.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.51 -53.07 3.56 Favored 'General case' 1 N--CA 1.319 -6.997 0 C-N-CA 122.778 0.431 . . . . 0.0 111.547 -176.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . 0.327 78.9 m-85 -132.8 -24.52 1.93 Allowed 'General case' 0 CA--C 1.483 -1.603 0 N-CA-C 120.348 3.462 . . . . 0.0 120.348 -167.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.751 ' HG2' HG22 ' A' ' 43' ' ' VAL . 13.4 mm-40 -58.55 -45.05 89.76 Favored 'General case' 0 C--N 1.284 -2.241 0 CA-C-O 124.465 2.078 . . . . 0.0 108.993 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.731 ' HB3' HG23 ' A' ' 15' ' ' VAL 0.29 11.9 t70 -177.82 -166.08 0.11 Allowed 'General case' 1 N--CA 1.379 -4.023 1 N-CA-C 99.596 -4.224 . . . . 0.0 99.596 -177.204 . . . . . . . . 5 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.1 t -99.85 -23.68 14.89 Favored 'General case' 1 C--N 1.242 -4.103 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 176.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 21.5 pttm -96.68 10.51 38.44 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.731 HG23 ' HB3' ' A' ' 12' ' ' ASP . 5.5 t -97.56 73.24 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 C-N-CA 118.834 -1.146 . . . . 0.0 109.926 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -76.77 173.53 11.56 Favored 'General case' 0 C--O 1.273 2.305 0 CA-C-O 123.063 1.411 . . . . 0.0 113.374 -173.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.639 ' SG ' ' HA ' ' A' ' 6' ' ' ASP . 29.7 p -109.43 -172.7 2.1 Favored 'General case' 0 C--N 1.278 -2.523 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.343 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.6 ' H ' ' HB3' ' A' ' 35' ' ' LYS . 2.7 t -134.31 147.92 50.67 Favored 'General case' 0 CA--C 1.443 -3.161 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 174.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.618 ' HG2' ' OE2' ' A' ' 20' ' ' GLU . 3.3 ptp180 -124.97 3.73 8.02 Favored 'General case' 1 C--N 1.224 -4.876 0 O-C-N 125.939 2.024 . . . . 0.0 109.924 -167.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.618 ' OE2' ' HG2' ' A' ' 19' ' ' ARG . 1.8 mp0 -82.59 -168.78 2.15 Favored 'General case' 0 N--CA 1.403 -2.816 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.413 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.624 ' O ' ' HD3' ' A' ' 23' ' ' PRO 0.278 14.8 m -76.07 31.18 0.12 Allowed 'General case' 0 C--N 1.293 -1.885 0 C-N-CA 125.318 1.447 . . . . 0.0 112.444 -177.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.792 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 87.4 m-20 -94.0 91.8 0.65 Allowed Pre-proline 0 C--N 1.269 -2.926 0 C-N-CA 124.357 1.063 . . . . 0.0 111.836 -175.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.624 ' HD3' ' O ' ' A' ' 21' ' ' SER . 6.2 Cg_exo -78.68 157.36 28.15 Favored 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 122.174 1.916 . . . . 0.0 110.999 -176.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 28.0 m80 -145.34 126.27 14.49 Favored 'General case' 0 CA--C 1.465 -2.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.798 ' SG ' ' HD3' ' A' ' 52' ' ' LYS . 44.8 t -103.26 110.86 23.0 Favored 'General case' 0 C--N 1.251 -3.694 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 171.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -72.45 163.44 54.68 Favored Glycine 0 N--CA 1.409 -3.157 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 73.1 p -64.33 -9.5 18.18 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.518 0.675 . . . . 0.0 110.325 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -70.23 -29.31 66.1 Favored 'General case' 0 CA--C 1.486 -1.492 0 C-N-CA 126.2 1.8 . . . . 0.0 109.097 174.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.26 -23.31 23.2 Favored Glycine 0 N--CA 1.403 -3.556 0 CA-C-N 114.129 -1.396 . . . . 0.0 109.699 -175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -72.56 138.04 46.61 Favored 'General case' 0 CA--C 1.482 -1.66 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 99.4 m -107.36 128.33 54.37 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-N 113.678 -1.601 . . . . 0.0 109.567 176.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.446 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 38.2 m-85 -124.63 152.06 44.09 Favored 'General case' 0 N--CA 1.399 -3.021 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.931 174.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -50.91 -38.87 38.83 Favored Glycine 0 C--N 1.31 -0.916 0 O-C-N 125.144 1.527 . . . . 0.0 114.702 -175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.792 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.1 p30 -155.12 -179.87 8.49 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 177.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.6 ' HB3' ' H ' ' A' ' 18' ' ' THR . 23.1 tptm -58.44 -46.96 85.48 Favored 'General case' 0 C--O 1.202 -1.414 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.567 ' N ' ' HB2' ' A' ' 17' ' ' CYS . 69.4 m -52.15 -36.22 50.86 Favored 'General case' 0 C--N 1.275 -2.642 0 C-N-CA 125.022 1.329 . . . . 0.0 111.638 -178.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -63.54 -45.62 89.7 Favored 'General case' 0 C--N 1.268 -2.944 0 CA-C-N 112.661 -2.063 . . . . 0.0 112.703 -176.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.446 ' HB2' ' CG ' ' A' ' 32' ' ' TYR . 35.6 t80 -112.73 -2.04 14.57 Favored 'General case' 0 N--CA 1.484 1.267 0 CA-C-O 121.155 0.502 . . . . 0.0 112.21 -176.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.786 ' O ' HG23 ' A' ' 43' ' ' VAL . 44.7 t -57.05 -46.78 82.18 Favored 'General case' 0 CA--C 1.46 -2.492 0 C-N-CA 124.091 0.956 . . . . 0.0 111.085 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.745 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -61.99 -33.04 73.59 Favored 'General case' 0 N--CA 1.394 -3.232 0 C-N-CA 124.994 1.317 . . . . 0.0 114.213 -172.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.63 -31.88 57.67 Favored 'General case' 1 C--N 1.222 -4.959 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.302 178.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.668 HD12 ' HA ' ' A' ' 39' ' ' CYS . 25.3 mt -65.54 -40.91 89.58 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.24 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.786 HG23 ' O ' ' A' ' 39' ' ' CYS . 22.1 t -57.82 -35.44 51.38 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.55 0 CA-C-N 112.042 -2.344 . . . . 0.0 110.922 174.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.745 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 31.3 mmtm -79.08 -33.0 44.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 119.58 -0.848 . . . . 0.0 110.685 -175.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.8 m -89.94 21.25 3.72 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.594 174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 75.04 13.87 82.3 Favored Glycine 0 N--CA 1.421 -2.339 0 N-CA-C 116.903 1.521 . . . . 0.0 116.903 170.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' HA2' HE22 ' A' ' 11' ' ' GLN . . . 76.73 6.73 85.44 Favored Glycine 0 C--N 1.272 -2.991 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 -176.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -68.78 -25.81 64.89 Favored 'General case' 0 N--CA 1.43 -1.472 0 C-N-CA 120.125 -0.63 . . . . 0.0 112.217 174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 30.7 mt -79.31 133.99 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 171.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.4 m -120.63 -177.37 3.45 Favored 'General case' 0 C--N 1.254 -3.574 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 -179.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 53' ' ' HIS . 33.1 tp -88.35 141.03 28.88 Favored 'General case' 1 N--CA 1.321 -6.887 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 175.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.798 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 44.5 tttt -86.22 -45.92 10.85 Favored 'General case' 1 N--CA 1.366 -4.627 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.252 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.473 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.9 p80 -179.72 154.86 0.72 Allowed Pre-proline 0 C--N 1.31 -1.135 0 O-C-N 124.489 1.118 . . . . 0.0 111.681 174.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -68.47 149.16 74.45 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.163 1.909 . . . . 0.0 109.848 172.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 91.23 161.28 37.14 Favored Glycine 0 C--N 1.295 -1.733 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -175.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.6 ptmm? -69.38 155.66 40.09 Favored 'General case' 0 N--CA 1.406 -2.667 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.125 174.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 C--N 1.25 -3.728 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.698 178.992 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 . . . . . 0 CA--C 1.51 -0.587 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.36 -33.79 72.29 Favored Glycine 0 N--CA 1.478 1.494 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 172.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.78 -119.71 1.32 Allowed Glycine 0 N--CA 1.421 -2.326 0 N-CA-C 106.475 -2.65 . . . . 0.0 106.475 170.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -74.29 -175.3 2.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 87.7 t -75.58 114.87 16.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 172.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.422 ' HA ' ' O ' ' A' ' 16' ' ' TYR . 22.4 t70 -130.45 124.2 31.52 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 170.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.672 ' HB3' ' O ' ' A' ' 15' ' ' VAL . 6.6 p -49.93 -88.0 0.0 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 169.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.16 -83.96 0.02 OUTLIER Glycine 0 C--O 1.207 -1.554 0 CA-C-O 121.787 0.66 . . . . 0.0 112.94 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -99.92 -3.03 33.24 Favored 'General case' 0 C--N 1.275 -2.646 0 C-N-CA 126.357 1.863 . . . . 0.0 108.95 -172.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.438 ' HB3' HG21 ' A' ' 15' ' ' VAL . 84.6 m-85 -104.25 83.19 2.04 Favored 'General case' 0 N--CA 1.387 -3.575 0 CA-C-O 124.518 2.104 . . . . 0.0 110.362 -173.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.733 ' HA ' HG13 ' A' ' 43' ' ' VAL . 71.8 mm-40 -37.42 -22.19 0.01 OUTLIER 'General case' 1 C--N 1.22 -5.058 2 C-N-CA 134.649 5.18 . . . . 0.0 114.434 172.223 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -80.44 122.61 27.2 Favored 'General case' 0 N--CA 1.384 -3.752 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.4 t -73.05 -15.14 61.52 Favored 'General case' 1 C--N 1.214 -5.306 0 CA-C-N 112.609 -2.087 . . . . 0.0 113.475 -167.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -90.9 5.87 46.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.337 0.589 . . . . 0.0 111.377 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.672 ' O ' ' HB3' ' A' ' 7' ' ' CYS . 16.0 t -96.62 123.15 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 N-CA-C 103.353 -2.832 . . . . 0.0 103.353 174.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.422 ' O ' ' HA ' ' A' ' 6' ' ' ASP . 47.0 p90 -115.09 160.18 19.97 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.463 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 19.3 p -74.04 166.44 23.39 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 125.91 2.006 . . . . 0.0 115.238 -169.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.48 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 9.7 t -89.49 173.98 8.04 Favored 'General case' 0 N--CA 1.412 -2.327 0 CA-C-N 113.878 -1.51 . . . . 0.0 109.242 171.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.23 -15.99 25.28 Favored 'General case' 0 C--N 1.267 -2.996 0 CA-C-N 113.789 -1.55 . . . . 0.0 108.387 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.696 ' O ' ' HB2' ' A' ' 34' ' ' ASN 0.445 18.5 mm-40 -48.1 131.81 15.8 Favored 'General case' 0 CA--C 1.499 -0.995 0 N-CA-C 118.55 2.796 . . . . 0.0 118.55 -175.055 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . 0.304 2.0 m -68.89 23.47 0.03 OUTLIER 'General case' 0 C--N 1.309 -1.185 0 C-N-CA 131.146 3.778 . . . . 0.0 114.196 -169.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -70.59 106.77 1.91 Allowed Pre-proline 0 C--N 1.264 -3.129 0 C-N-CA 123.505 0.722 . . . . 0.0 111.796 -176.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -83.55 142.04 10.22 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 122.32 2.013 . . . . 0.0 111.851 -177.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.414 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 73.2 m80 -150.44 127.4 11.12 Favored 'General case' 0 CA--C 1.47 -2.1 0 CA-C-O 121.745 0.783 . . . . 0.0 109.695 -172.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 51.6 t -96.22 97.96 9.93 Favored 'General case' 0 C--N 1.245 -3.949 0 N-CA-C 102.786 -3.042 . . . . 0.0 102.786 170.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.491 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.16 167.79 43.93 Favored Glycine 0 CA--C 1.461 -3.338 0 C-N-CA 119.149 -1.501 . . . . 0.0 112.213 -167.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 42.1 m -76.51 5.45 7.31 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.207 1.004 . . . . 0.0 108.661 173.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -69.53 -14.07 62.67 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 128.339 2.656 . . . . 0.0 106.169 171.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.46 -35.62 4.39 Favored Glycine 0 N--CA 1.403 -3.545 0 N-CA-C 108.204 -1.958 . . . . 0.0 108.204 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -91.76 155.4 18.29 Favored 'General case' 0 N--CA 1.401 -2.906 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 -172.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.511 HG21 ' CB ' ' A' ' 56' ' ' LYS . 97.5 m -96.93 130.01 44.3 Favored 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 112.935 -1.939 . . . . 0.0 109.048 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 50.7 m-85 -118.44 139.8 50.84 Favored 'General case' 0 N--CA 1.387 -3.617 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.855 177.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.36 -30.96 61.73 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.501 -174.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.696 ' HB2' ' O ' ' A' ' 20' ' ' GLU . 12.3 p-10 -141.56 176.22 9.06 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.019 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -61.84 -40.22 94.56 Favored 'General case' 0 CA--C 1.496 -1.13 0 CA-C-O 121.573 0.701 . . . . 0.0 111.746 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 18' ' ' THR . 48.4 t -57.56 -43.69 84.66 Favored 'General case' 0 C--N 1.254 -3.579 0 CA-C-N 113.762 -1.563 . . . . 0.0 111.492 177.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -67.95 -41.02 83.11 Favored 'General case' 0 C--N 1.275 -2.635 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.899 -173.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.527 ' CE2' HD11 ' A' ' 42' ' ' ILE . 38.3 t80 -85.03 -11.9 54.37 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-N 115.751 -0.658 . . . . 0.0 111.85 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.828 ' O ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -61.98 -46.05 90.96 Favored 'General case' 0 CA--C 1.463 -2.393 0 C-N-CA 123.554 0.742 . . . . 0.0 111.029 -178.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.79 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -68.24 -29.1 67.84 Favored 'General case' 0 N--CA 1.4 -2.936 0 CA-C-O 122.435 1.112 . . . . 0.0 112.006 -166.304 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.79 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -61.18 -41.79 97.42 Favored 'General case' 1 C--N 1.236 -4.348 0 CA-C-N 111.556 -2.566 . . . . 0.0 107.594 178.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 HD11 ' CE2' ' A' ' 38' ' ' PHE . 42.2 mt -75.93 -54.9 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.202 -174.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.828 HG23 ' O ' ' A' ' 39' ' ' CYS . 11.2 t -57.74 -33.26 44.8 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.645 0 CA-C-N 112.716 -2.038 . . . . 0.0 112.953 -174.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -92.39 -31.88 15.16 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 -175.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.454 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 32.4 t -70.5 -38.73 74.35 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.133 175.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 120.65 26.89 2.05 Favored Glycine 1 N--CA 1.379 -5.126 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.856 -177.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.39 -5.1 64.94 Favored Glycine 0 C--N 1.305 -1.152 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' A' ' 45' ' ' SER . 50.3 mttt -65.21 -27.03 68.4 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.614 HD12 ' O ' ' A' ' 41' ' ' ALA . 71.5 mt -85.28 141.15 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.416 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.7 p -126.17 -178.09 4.19 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.397 -1.729 . . . . 0.0 107.216 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.491 HD12 ' HA2' ' A' ' 26' ' ' GLY . 43.9 tp -98.89 140.9 32.36 Favored 'General case' 1 N--CA 1.328 -6.545 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.3 mttp -80.84 -57.55 3.5 Favored 'General case' 0 CA--C 1.49 -1.349 0 CA-C-O 122.419 1.104 . . . . 0.0 108.202 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.413 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 33.3 m80 -145.09 139.69 15.37 Favored Pre-proline 0 C--N 1.294 -1.819 0 CA-C-N 113.804 -1.544 . . . . 0.0 111.587 -168.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.51 110.17 3.0 Favored 'Trans proline' 0 N--CA 1.444 -1.399 0 N-CA-C 107.371 -1.819 . . . . 0.0 107.371 168.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.36 171.39 14.5 Favored Glycine 0 C--N 1.289 -2.051 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' CB ' HG21 ' A' ' 31' ' ' THR . 0.0 OUTLIER -76.13 175.13 9.24 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-O 122.748 1.261 . . . . 0.0 113.665 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.269 -2.909 0 CA-C-N 112.024 -2.353 . . . . 0.0 104.958 175.687 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.412 ' HA ' ' OE1' ' A' ' 1' ' ' GLN . 12.4 mm-40 . . . . . 0 CA--C 1.507 -0.707 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -143.56 81.05 0.23 Allowed Glycine 0 CA--C 1.499 -0.937 0 N-CA-C 111.136 -0.786 . . . . 0.0 111.136 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.85 -68.52 3.52 Favored Glycine 0 CA--C 1.502 -0.771 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -177.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -91.51 169.6 10.63 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -84.87 136.33 22.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-O 121.337 0.589 . . . . 0.0 110.588 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -129.21 133.31 47.49 Favored 'General case' 0 C--N 1.286 -2.175 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 168.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -73.82 74.73 1.61 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.794 0.807 . . . . 0.0 110.409 175.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.0 -7.02 65.52 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 113.996 -1.456 . . . . 0.0 111.97 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -66.23 -45.02 82.15 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 172.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 11.0 t80 46.96 43.73 13.98 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 125.407 1.483 . . . . 0.0 112.956 166.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.477 ' HG2' HG13 ' A' ' 43' ' ' VAL . 9.3 mm100 -42.72 -46.47 5.12 Favored 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 113.477 -1.692 . . . . 0.0 113.065 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' OD1' ' HD2' ' A' ' 14' ' ' LYS . 7.5 t0 -129.03 149.91 50.65 Favored 'General case' 2 N--CA 1.37 -4.455 0 CA-C-N 111.82 -2.445 . . . . 0.0 106.135 176.81 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.3 p -55.99 -27.59 53.5 Favored 'General case' 1 C--N 1.231 -4.579 0 C-N-CA 127.963 2.505 . . . . 0.0 115.474 -178.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' HD2' ' OD1' ' A' ' 12' ' ' ASP . 0.0 OUTLIER -87.47 -5.75 58.68 Favored 'General case' 0 N--CA 1.423 -1.781 0 O-C-N 120.976 -1.077 . . . . 0.0 109.755 -175.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.407 HG23 ' HB3' ' A' ' 12' ' ' ASP . 3.7 t -96.83 79.15 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.579 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -167.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -136.84 144.12 43.46 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 171.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.601 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 15.5 p -108.07 -179.8 4.0 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 120.115 -0.634 . . . . 0.0 111.987 -175.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.422 HG21 ' OD1' ' A' ' 22' ' ' ASN . 6.2 t -131.39 169.38 16.11 Favored 'General case' 0 N--CA 1.414 -2.274 0 CA-C-N 114.513 -1.221 . . . . 0.0 108.549 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.3 ptm180 -97.28 -21.61 17.15 Favored 'General case' 0 C--N 1.26 -3.31 0 CA-C-N 113.021 -1.899 . . . . 0.0 109.274 -178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -83.02 152.18 25.5 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.461 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.47 ' HA ' ' HB3' ' A' ' 34' ' ' ASN . 17.2 m -83.94 97.65 9.36 Favored 'General case' 0 N--CA 1.419 -2.019 0 CA-C-O 122.942 1.354 . . . . 0.0 112.42 -177.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.422 ' OD1' HG21 ' A' ' 18' ' ' THR . 13.4 m120 -111.28 103.28 54.77 Favored Pre-proline 0 C--N 1.258 -3.405 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.501 178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -70.57 136.79 31.68 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 121.469 1.446 . . . . 0.0 111.125 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.58 ' HB3' HD13 ' A' ' 51' ' ' LEU . 79.2 m-70 -143.88 127.61 17.18 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 121.924 0.869 . . . . 0.0 109.977 -175.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.1 t -93.7 103.25 15.41 Favored 'General case' 0 C--N 1.263 -3.157 0 N-CA-C 105.769 -1.938 . . . . 0.0 105.769 172.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.26 161.03 45.49 Favored Glycine 0 N--CA 1.41 -3.071 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.888 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 47.6 p -54.03 -28.38 38.12 Favored 'General case' 0 C--N 1.281 -2.404 0 C-N-CA 123.895 0.878 . . . . 0.0 110.398 175.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.639 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.0 t70 -60.85 -46.37 90.84 Favored 'General case' 0 CA--C 1.48 -1.714 0 CA-C-O 122.687 1.232 . . . . 0.0 109.085 173.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 125.35 -16.63 7.09 Favored Glycine 1 CA--C 1.445 -4.294 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 -172.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.639 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.5 mt-30 -72.23 135.57 46.1 Favored 'General case' 0 CA--C 1.455 -2.691 0 CA-C-N 114.002 -1.099 . . . . 0.0 113.704 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.537 HG21 ' HG2' ' A' ' 56' ' ' LYS . 90.0 m -102.34 121.38 42.18 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.051 -1.886 . . . . 0.0 109.873 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.419 ' HD2' ' O ' ' A' ' 34' ' ' ASN . 5.3 p90 -111.64 135.48 52.18 Favored 'General case' 1 N--CA 1.377 -4.082 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.447 177.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.08 -39.95 92.84 Favored Glycine 0 N--CA 1.472 1.091 0 CA-C-N 114.039 -1.437 . . . . 0.0 113.386 -176.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' HB3' ' HA ' ' A' ' 21' ' ' SER . 28.9 p30 -140.55 170.22 16.19 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 105.12 -2.178 . . . . 0.0 105.12 172.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -67.59 -36.33 80.68 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-O 121.542 0.687 . . . . 0.0 112.397 -174.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.601 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.8 OUTLIER -62.43 -33.57 75.07 Favored 'General case' 0 C--N 1.246 -3.897 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.891 -178.326 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.555 ' O ' ' HE2' ' A' ' 40' ' ' LYS . . . -50.58 -43.54 56.5 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 112.867 -1.969 . . . . 0.0 111.35 178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -118.37 -1.75 11.22 Favored 'General case' 0 C--O 1.206 -1.189 0 C-N-CA 118.606 -1.238 . . . . 0.0 112.301 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.804 ' HA ' HD12 ' A' ' 42' ' ' ILE . 52.1 t -52.17 -50.94 60.82 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 124.81 1.244 . . . . 0.0 111.644 -176.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.712 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -66.6 -26.19 66.97 Favored 'General case' 0 N--CA 1.408 -2.532 0 C-N-CA 124.942 1.297 . . . . 0.0 114.001 -175.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.539 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -84.12 -27.19 28.35 Favored 'General case' 1 C--N 1.218 -5.115 0 CA-C-N 113.321 -1.763 . . . . 0.0 110.732 176.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.804 HD12 ' HA ' ' A' ' 39' ' ' CYS . 28.2 mt -66.03 -41.16 89.13 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.789 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 176.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 39' ' ' CYS . 58.1 t -53.21 -44.18 51.96 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-N 111.457 -2.61 . . . . 0.0 110.4 172.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 42.4 mmtm -69.87 -34.84 74.12 Favored 'General case' 0 CA--C 1.493 -1.236 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.733 -173.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.447 ' HB2' ' CD1' ' A' ' 49' ' ' ILE . 20.7 m -81.76 -9.07 59.73 Favored 'General case' 0 C--N 1.285 -2.218 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.512 178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 129.11 -19.5 5.44 Favored Glycine 1 N--CA 1.396 -4.024 0 N-CA-C 115.941 1.137 . . . . 0.0 115.941 178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.537 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 97.56 -0.42 59.66 Favored Glycine 0 C--N 1.284 -2.345 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -173.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -61.68 -32.31 72.49 Favored 'General case' 0 N--CA 1.446 -0.638 0 CA-C-N 114.165 -1.018 . . . . 0.0 112.898 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.596 ' HB ' HG12 ' A' ' 42' ' ' ILE . 3.4 mp -70.61 136.81 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 CA-C-O 122.017 0.913 . . . . 0.0 109.724 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 m -131.07 -178.55 4.88 Favored 'General case' 0 C--N 1.264 -3.134 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 24' ' ' HIS . 37.9 tp -96.8 141.52 29.92 Favored 'General case' 1 N--CA 1.326 -6.67 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 178.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 42.5 mttp -89.95 -58.35 2.54 Favored 'General case' 0 CA--C 1.481 -1.705 0 CA-C-O 122.468 1.128 . . . . 0.0 109.169 165.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -138.01 143.99 41.89 Favored Pre-proline 0 C--N 1.28 -2.426 0 CA-C-N 113.534 -1.666 . . . . 0.0 112.655 -165.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -80.67 109.91 2.32 Favored 'Trans proline' 0 N--CA 1.437 -1.843 0 N-CA-C 107.193 -1.887 . . . . 0.0 107.193 165.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 123.48 165.47 12.32 Favored Glycine 0 C--N 1.29 -1.995 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 31' ' ' THR . 12.8 mtpp -56.59 161.96 2.47 Favored 'General case' 0 N--CA 1.429 -1.511 0 N-CA-C 118.064 2.616 . . . . 0.0 118.064 176.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 68.8 m . . . . . 0 C--N 1.283 -2.308 0 CA-C-N 109.585 -3.461 . . . . 0.0 102.553 159.259 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.518 ' CD ' ' H ' ' A' ' 2' ' ' GLY . 0.0 OUTLIER . . . . . 0 CA--C 1.548 0.887 0 N-CA-C 105.268 -2.123 . . . . 0.0 105.268 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.518 ' H ' ' CD ' ' A' ' 1' ' ' GLN . . . -125.64 126.08 5.77 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 119.176 0.898 . . . . 0.0 111.216 178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 65.98 53.61 29.39 Favored Glycine 0 CA--C 1.496 -1.126 0 N-CA-C 110.234 -1.146 . . . . 0.0 110.234 -177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.586 HE21 ' HB2' ' A' ' 6' ' ' ASP . 3.8 pm0 -137.23 173.33 11.8 Favored 'General case' 0 N--CA 1.409 -2.51 0 CA-C-N 114.313 -0.943 . . . . 0.0 113.082 -169.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 17' ' ' CYS . 89.5 t -101.3 125.95 55.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 N-CA-C 102.322 -3.214 . . . . 0.0 102.322 161.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.586 ' HB2' HE21 ' A' ' 4' ' ' GLN 0.251 1.6 t0 -105.18 89.18 3.05 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 119.244 3.053 . . . . 0.0 119.244 -162.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 42.0 m -116.06 40.64 2.77 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 153.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -75.56 -0.76 63.86 Favored Glycine 0 N--CA 1.434 -1.485 0 CA-C-N 113.965 -1.47 . . . . 0.0 112.036 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.3 -22.03 62.88 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 171.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.0 t80 73.05 76.78 0.14 Allowed 'General case' 0 C--N 1.362 1.148 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 163.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.561 ' OE1' HG11 ' A' ' 15' ' ' VAL . 3.2 pt20 -72.0 -50.51 28.06 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.605 167.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.609 ' HB3' HG23 ' A' ' 15' ' ' VAL . 7.8 t0 -142.56 155.71 45.03 Favored 'General case' 1 C--N 1.241 -4.111 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 172.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 t -71.75 -29.56 64.64 Favored 'General case' 0 C--N 1.258 -3.397 0 C-N-CA 124.865 1.266 . . . . 0.0 112.82 -175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.504 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 7.9 ptpp? -84.54 3.98 34.12 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 121.182 0.515 . . . . 0.0 111.524 -176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 12' ' ' ASP . 28.2 t -101.58 119.82 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.139 0 CA-C-O 121.897 0.856 . . . . 0.0 112.078 -175.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -122.32 165.31 16.46 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 104.956 -2.238 . . . . 0.0 104.956 173.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.647 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 30.7 p -92.68 178.27 5.84 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-O 122.101 0.953 . . . . 0.0 113.02 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.3 p -82.76 154.79 24.59 Favored 'General case' 0 C--N 1.279 -2.463 0 CA-C-N 114.216 -1.356 . . . . 0.0 114.079 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.9 ptm180 -112.41 -9.28 13.85 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.001 -1.454 . . . . 0.0 107.319 169.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -95.07 155.77 16.59 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -178.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -91.85 107.1 18.97 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 122.289 1.042 . . . . 0.0 110.63 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -111.82 97.05 36.15 Favored Pre-proline 0 C--N 1.275 -2.658 0 CA-C-N 113.854 -1.521 . . . . 0.0 109.993 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.438 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 58.5 Cg_endo -74.65 123.93 8.42 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 120.618 0.878 . . . . 0.0 110.191 179.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 51' ' ' LEU . 49.6 p-80 -153.06 138.29 17.44 Favored 'General case' 0 N--CA 1.407 -2.577 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -175.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 53' ' ' HIS . 46.0 t -108.69 109.77 21.02 Favored 'General case' 0 C--N 1.249 -3.761 0 N-CA-C 105.11 -2.182 . . . . 0.0 105.11 174.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -70.17 162.91 52.86 Favored Glycine 0 N--CA 1.41 -3.071 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 52' ' ' LYS . 19.9 m -54.91 -18.83 5.45 Favored 'General case' 0 C--N 1.292 -1.892 0 C-N-CA 123.721 0.808 . . . . 0.0 111.64 175.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.3 t70 -64.92 -30.59 71.6 Favored 'General case' 0 CA--C 1.492 -1.255 0 CA-C-O 122.494 1.14 . . . . 0.0 109.081 174.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.01 -16.6 35.94 Favored Glycine 0 N--CA 1.413 -2.839 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.535 ' HB2' ' CE1' ' A' ' 38' ' ' PHE . 78.1 mt-30 -73.24 136.03 44.58 Favored 'General case' 0 CA--C 1.465 -2.327 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.457 HG21 ' CB ' ' A' ' 56' ' ' LYS . 99.0 m -111.13 130.21 55.69 Favored 'General case' 0 C--N 1.263 -3.189 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.101 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.489 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . 54.2 m-85 -135.25 156.83 48.3 Favored 'General case' 0 N--CA 1.396 -3.143 0 CA-C-O 122.136 0.97 . . . . 0.0 112.251 175.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -71.16 -20.98 78.4 Favored Glycine 0 C--N 1.287 -2.176 0 CA-C-N 112.669 -2.06 . . . . 0.0 114.796 -178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 p30 -162.95 172.16 15.49 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 118.342 1.071 . . . . 0.0 108.787 177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -63.86 -38.82 92.51 Favored 'General case' 0 C--O 1.197 -1.692 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -174.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.647 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 1.9 t -53.05 -43.93 67.03 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.931 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HE3' ' A' ' 40' ' ' LYS . . . -63.7 -40.78 97.63 Favored 'General case' 0 C--N 1.282 -2.329 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.945 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 30' ' ' GLN . 44.6 t80 -104.03 5.2 35.19 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.815 ' O ' HG23 ' A' ' 43' ' ' VAL . 18.3 t -61.43 -41.01 96.51 Favored 'General case' 0 C--O 1.189 -2.087 0 C-N-CA 122.362 0.265 . . . . 0.0 110.361 -171.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -63.86 -30.01 71.14 Favored 'General case' 0 N--CA 1.419 -2.011 0 C-N-CA 125.618 1.567 . . . . 0.0 114.181 -174.084 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -73.55 -36.12 65.59 Favored 'General case' 1 C--N 1.209 -5.515 0 CA-C-N 113.111 -1.859 . . . . 0.0 108.67 177.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.629 HD12 ' HA ' ' A' ' 39' ' ' CYS . 40.3 mt -72.56 -44.44 61.05 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.868 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.954 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 39' ' ' CYS . 48.9 t -51.9 -50.97 31.44 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 CA-C-N 112.618 -2.083 . . . . 0.0 110.83 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -66.93 -37.72 84.83 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.725 -1.125 . . . . 0.0 112.263 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 21.7 m -87.06 13.25 9.63 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.865 178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.23 13.85 79.99 Favored Glycine 0 N--CA 1.401 -3.636 0 N-CA-C 116.23 1.252 . . . . 0.0 116.23 171.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.406 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 79.05 2.72 87.52 Favored Glycine 0 C--N 1.279 -2.616 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 -177.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -70.99 -21.98 62.23 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 56.1 mt -71.12 141.64 16.56 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 C-N-CA 119.644 -0.822 . . . . 0.0 110.262 177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 24.4 m -124.0 -173.45 2.76 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -178.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.598 ' CD1' ' HB2' ' A' ' 24' ' ' HIS . 32.6 tp -88.59 141.14 28.77 Favored 'General case' 1 N--CA 1.329 -6.491 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 25' ' ' CYS . 52.0 tttm -99.88 -42.23 6.89 Favored 'General case' 1 N--CA 1.361 -4.882 0 C-N-CA 124.585 1.154 . . . . 0.0 111.152 174.599 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.631 ' HB2' ' HB3' ' A' ' 25' ' ' CYS . 28.3 m170 -138.26 132.65 16.87 Favored Pre-proline 0 C--N 1.284 -2.281 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.669 -177.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.05 109.49 2.89 Favored 'Trans proline' 0 N--CA 1.437 -1.834 0 N-CA-C 105.067 -2.705 . . . . 0.0 105.067 163.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 107.58 176.52 22.48 Favored Glycine 0 C--N 1.289 -2.082 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -169.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.457 ' CB ' HG21 ' A' ' 31' ' ' THR . 13.2 ptmm? -70.29 169.24 14.2 Favored 'General case' 0 N--CA 1.424 -1.75 0 CA-C-O 122.449 1.119 . . . . 0.0 113.322 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.286 -2.174 0 CA-C-N 113.576 -1.647 . . . . 0.0 106.672 166.232 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 . . . . . 0 CA--C 1.5 -0.948 0 N-CA-C 110.602 -0.147 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.74 -64.86 0.04 OUTLIER Glycine 0 CA--C 1.495 -1.184 0 N-CA-C 106.181 -2.768 . . . . 0.0 106.181 176.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.7 139.09 17.62 Favored Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 106.862 -2.495 . . . . 0.0 106.862 168.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -83.74 105.84 14.96 Favored 'General case' 0 N--CA 1.426 -1.626 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.519 ' HB ' ' HB2' ' A' ' 16' ' ' TYR . 48.0 t -103.1 146.49 10.83 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 N-CA-C 102.875 -3.009 . . . . 0.0 102.875 166.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . 0.284 6.0 t70 -92.78 79.27 4.74 Favored 'General case' 0 C--N 1.301 -1.538 0 C-N-CA 115.945 -2.302 . . . . 0.0 116.75 -170.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.64 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 83.8 m -110.25 67.34 0.64 Allowed 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 153.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -66.11 -3.24 16.69 Favored Glycine 0 C--N 1.359 1.817 0 CA-C-N 113.096 -1.865 . . . . 0.0 112.576 -177.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE2' ' HB3' ' A' ' 40' ' ' LYS . 44.9 mt-10 -62.98 -45.37 92.73 Favored 'General case' 0 N--CA 1.406 -2.673 0 N-CA-C 105.253 -2.128 . . . . 0.0 105.253 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 20.0 t80 46.04 34.66 2.11 Favored 'General case' 0 N--CA 1.517 2.896 0 C-N-CA 126.391 1.877 . . . . 0.0 115.153 159.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.583 ' CG ' HG13 ' A' ' 43' ' ' VAL . 87.7 mm-40 -58.02 -20.73 41.0 Favored 'General case' 0 C--N 1.247 -3.851 0 CA-C-O 123.132 1.444 . . . . 0.0 113.895 178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.58 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 15.3 t70 -145.5 164.95 30.04 Favored 'General case' 2 N--CA 1.355 -5.204 0 CA-C-N 112.946 -1.934 . . . . 0.0 106.609 178.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.8 t -72.42 -34.06 67.57 Favored 'General case' 0 C--N 1.259 -3.369 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.237 -173.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.58 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 23.3 pttm -80.63 9.44 6.13 Favored 'General case' 0 C--O 1.26 1.642 0 N-CA-C 112.799 0.666 . . . . 0.0 112.799 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 7' ' ' CYS . 13.6 t -92.31 83.79 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.071 0.938 . . . . 0.0 110.595 -178.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.519 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 52.6 p90 -137.68 152.73 49.58 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 104.025 -2.583 . . . . 0.0 104.025 173.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.64 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 16.5 p -115.57 -175.27 2.68 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -176.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.9 t -129.17 165.22 21.74 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 113.386 -1.734 . . . . 0.0 106.567 176.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.615 ' HG2' ' OE1' ' A' ' 20' ' ' GLU . 24.9 ptt-85 -110.09 -17.82 13.48 Favored 'General case' 0 C--N 1.255 -3.525 0 CA-C-N 114.294 -1.321 . . . . 0.0 108.07 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.615 ' OE1' ' HG2' ' A' ' 19' ' ' ARG . 4.8 mp0 -74.75 146.82 41.86 Favored 'General case' 0 N--CA 1.403 -2.783 0 CA-C-N 113.859 -1.518 . . . . 0.0 107.047 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -81.44 90.35 6.2 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 122.907 1.336 . . . . 0.0 112.353 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 49.4 t-20 -111.16 95.65 26.42 Favored Pre-proline 0 C--N 1.25 -3.75 0 CA-C-N 112.073 -2.331 . . . . 0.0 106.577 178.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.4 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.6 Cg_exo -71.08 150.06 59.53 Favored 'Trans proline' 0 N--CA 1.444 -1.436 0 C-N-CA 121.581 1.521 . . . . 0.0 111.434 -177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 31' ' ' THR . 18.9 m80 -138.94 122.52 17.38 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -176.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.2 t -98.0 100.35 11.68 Favored 'General case' 0 C--N 1.254 -3.554 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 171.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.42 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -75.72 166.81 54.66 Favored Glycine 0 N--CA 1.407 -3.242 0 C-N-CA 120.097 -1.049 . . . . 0.0 111.993 -172.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 66.5 m -65.86 -6.52 12.42 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.183 0.516 . . . . 0.0 110.796 175.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -81.82 -7.97 59.65 Favored 'General case' 0 CA--C 1.502 -0.9 0 C-N-CA 124.908 1.283 . . . . 0.0 108.424 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.95 -27.15 10.51 Favored Glycine 0 CA--C 1.481 -2.066 0 N-CA-C 109.888 -1.285 . . . . 0.0 109.888 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.9 mt-30 -73.79 136.2 43.56 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.527 HG21 ' HA ' ' A' ' 56' ' ' LYS . 98.3 m -106.33 128.95 54.38 Favored 'General case' 0 C--N 1.283 -2.325 0 CA-C-N 112.815 -1.993 . . . . 0.0 110.228 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -123.66 147.05 47.76 Favored 'General case' 0 N--CA 1.414 -2.275 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.575 175.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -56.56 -38.63 82.05 Favored Glycine 0 N--CA 1.473 1.141 0 O-C-N 124.834 1.334 . . . . 0.0 115.289 -175.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.8 p30 -143.67 174.77 10.5 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -67.9 -31.43 71.2 Favored 'General case' 0 C--O 1.194 -1.852 0 C-N-CA 119.887 -0.725 . . . . 0.0 112.613 -175.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.503 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.4 OUTLIER -61.79 -38.98 90.1 Favored 'General case' 0 C--N 1.25 -3.723 0 CA-C-O 122.905 1.336 . . . . 0.0 110.074 178.603 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.79 -32.47 69.58 Favored 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 112.609 -2.087 . . . . 0.0 108.659 177.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.572 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 30.3 t80 -85.11 -10.61 56.62 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.997 -1.001 . . . . 0.0 112.482 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.792 ' O ' HG23 ' A' ' 43' ' ' VAL . 31.2 m -58.84 -52.43 65.76 Favored 'General case' 0 C--O 1.188 -2.164 0 O-C-N 121.366 -0.834 . . . . 0.0 112.765 -177.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -65.39 -32.41 74.03 Favored 'General case' 0 CA--C 1.474 -1.981 0 CA-C-O 123.339 1.542 . . . . 0.0 111.27 -177.075 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' O ' ' HG2' ' A' ' 44' ' ' LYS . . . -66.49 -26.49 67.2 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 111.564 -2.562 . . . . 0.0 110.465 176.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.862 HG22 ' HA2' ' A' ' 47' ' ' GLY . 33.3 mt -81.47 -44.24 20.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 123.252 1.501 . . . . 0.0 108.344 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.792 HG23 ' O ' ' A' ' 39' ' ' CYS . 96.0 t -54.31 -36.69 34.36 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.976 0 CA-C-N 111.495 -2.593 . . . . 0.0 112.21 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.668 ' HG2' ' O ' ' A' ' 41' ' ' ALA . 10.1 ptmm? -56.96 -26.09 59.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.551 -178.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.57 ' HB2' HD11 ' A' ' 49' ' ' ILE . 17.6 m -134.26 57.47 1.81 Allowed 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 122.185 0.993 . . . . 0.0 112.463 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.32 -0.17 69.48 Favored Glycine 0 N--CA 1.41 -3.064 0 N-CA-C 117.279 1.672 . . . . 0.0 117.279 168.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.862 ' HA2' HG22 ' A' ' 42' ' ' ILE . . . 80.6 -0.94 84.58 Favored Glycine 0 N--CA 1.411 -3.018 0 C-N-CA 120.285 -0.959 . . . . 0.0 111.917 -176.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -80.1 -14.94 58.12 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 45' ' ' SER . 68.2 mt -62.22 149.92 8.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 CA-C-O 121.636 0.732 . . . . 0.0 110.423 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.7 p -125.74 178.4 5.72 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 51' ' ' LEU . 29.8 tp -94.43 141.87 28.08 Favored 'General case' 1 N--CA 1.336 -6.155 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 178.366 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.532 ' HZ1' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -89.32 -51.62 5.47 Favored 'General case' 0 CA--C 1.453 -2.763 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.609 166.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 19.8 t-80 -149.21 132.34 8.24 Favored Pre-proline 0 C--N 1.258 -3.407 0 CA-C-N 114.136 -1.393 . . . . 0.0 112.909 -169.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 4.3 Cg_exo -76.39 109.83 2.94 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 N-CA-C 107.211 -1.88 . . . . 0.0 107.211 168.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.4 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 119.75 165.12 12.87 Favored Glycine 0 C--N 1.279 -2.622 0 N-CA-C 108.601 -1.8 . . . . 0.0 108.601 -171.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.531 ' NZ ' ' HB3' ' A' ' 56' ' ' LYS . 9.0 mtpm? -60.1 164.41 4.08 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 93.7 m . . . . . 0 C--N 1.269 -2.903 0 N-CA-C 102.082 -3.303 . . . . 0.0 102.082 158.763 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 . . . . . 0 CA--C 1.494 -1.184 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.18 21.73 75.16 Favored Glycine 0 C--O 1.214 -1.103 0 N-CA-C 108.159 -1.976 . . . . 0.0 108.159 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 163.6 159.94 11.16 Favored Glycine 0 N--CA 1.417 -2.611 0 N-CA-C 104.968 -3.253 . . . . 0.0 104.968 -174.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.62 144.28 37.59 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 118.601 1.2 . . . . 0.0 111.154 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 14.1 p -144.08 151.09 16.36 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.075 0 N-CA-C 102.709 -3.071 . . . . 0.0 102.709 173.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.665 ' HB2' HG22 ' A' ' 18' ' ' THR . 7.5 p-10 -88.62 104.6 17.0 Favored 'General case' 0 C--N 1.282 -2.342 0 C-N-CA 117.827 -1.549 . . . . 0.0 111.446 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HA ' HG13 ' A' ' 15' ' ' VAL 0.743 3.3 p 62.64 -33.87 0.11 Allowed 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 120.694 3.59 . . . . 0.0 120.694 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 50.77 -88.99 0.01 OUTLIER Glycine 0 N--CA 1.463 0.489 0 O-C-N 124.21 0.944 . . . . 0.0 115.318 171.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.751 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 35.1 mp0 -70.41 -30.2 67.02 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 123.382 0.673 . . . . 0.0 110.35 -177.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.765 ' O ' ' HA ' ' A' ' 43' ' ' VAL . 41.6 t80 73.16 -0.78 3.26 Favored 'General case' 0 C--O 1.215 -0.76 0 C-N-CA 124.216 1.006 . . . . 0.0 113.598 164.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 43' ' ' VAL . 79.6 mt-30 -133.13 -3.99 3.1 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-O 122.425 1.107 . . . . 0.0 109.248 172.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.751 ' HB2' ' HB2' ' A' ' 9' ' ' GLU . 7.1 t70 -78.58 -158.44 0.14 Allowed 'General case' 0 C--N 1.277 -2.572 0 CA-C-N 113.208 -1.814 . . . . 0.0 112.463 -169.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.469 ' H ' ' CG ' ' A' ' 12' ' ' ASP . 9.4 t -138.34 -22.47 1.02 Allowed 'General case' 0 C--N 1.252 -3.65 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.777 -174.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.0 ptpp? -83.49 9.74 10.54 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.358 1.075 . . . . 0.0 109.378 177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.693 HG21 HG11 ' A' ' 43' ' ' VAL . 26.8 t -55.43 120.57 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.47 0 C-N-CA 127.556 2.343 . . . . 0.0 113.959 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' HB2' ' O ' ' A' ' 5' ' ' VAL . 15.0 m-85 -97.1 147.97 23.5 Favored 'General case' 0 C--N 1.28 -2.425 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 173.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.645 ' HB2' ' HA ' ' A' ' 36' ' ' CYS . 12.1 p -85.51 -178.45 6.69 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.419 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.665 HG22 ' HB2' ' A' ' 6' ' ' ASP . 73.8 p -78.29 169.53 18.11 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 -169.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.481 ' H ' ' HG2' ' A' ' 19' ' ' ARG . 26.1 ptt85 -100.28 1.36 41.62 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 109.282 -3.599 . . . . 0.0 106.684 174.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.625 ' H ' ' HB ' ' A' ' 18' ' ' THR . 59.3 mt-10 -104.06 140.66 37.45 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.328 -174.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.8 m -105.69 14.27 28.58 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.554 1.141 . . . . 0.0 109.907 -177.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 1.7 m-20 -62.28 112.8 7.06 Favored Pre-proline 0 C--N 1.274 -2.71 0 CA-C-N 113.098 -1.865 . . . . 0.0 111.34 -176.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -75.01 148.11 34.78 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.558 2.172 . . . . 0.0 112.007 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.467 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 94.1 m-70 -152.06 128.07 10.37 Favored 'General case' 0 CA--C 1.476 -1.876 0 CA-C-O 121.964 0.887 . . . . 0.0 110.901 -172.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.511 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 42.2 t -94.42 98.79 11.12 Favored 'General case' 0 C--N 1.256 -3.467 0 N-CA-C 103.489 -2.782 . . . . 0.0 103.489 170.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.449 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -82.89 166.3 44.66 Favored Glycine 0 CA--C 1.463 -3.171 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.417 -168.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -77.36 4.75 10.1 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.01 -18.11 65.22 Favored 'General case' 0 CA--C 1.493 -1.214 0 C-N-CA 127.515 2.326 . . . . 0.0 106.539 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.42 -35.3 5.15 Favored Glycine 1 N--CA 1.391 -4.363 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.455 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 75.1 mt-30 -91.6 156.28 17.74 Favored 'General case' 0 CA--C 1.457 -2.602 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.525 HG21 ' HG2' ' A' ' 56' ' ' LYS . 95.3 m -96.21 124.63 40.28 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 112.847 -1.979 . . . . 0.0 108.106 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.589 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 93.6 m-85 -110.98 145.2 38.85 Favored 'General case' 0 N--CA 1.381 -3.887 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.564 177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.22 85.66 Favored Glycine 0 C--N 1.3 -1.42 0 O-C-N 125.114 1.509 . . . . 0.0 112.522 -177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 35.4 p-10 -156.47 173.35 17.03 Favored 'General case' 0 N--CA 1.427 -1.606 0 CA-C-O 121.187 0.518 . . . . 0.0 111.097 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HD2' ' CG2' ' A' ' 18' ' ' THR . 0.3 OUTLIER -59.11 -28.38 66.48 Favored 'General case' 0 C--O 1.203 -1.351 0 C-N-CA 125.71 1.604 . . . . 0.0 110.558 -176.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.645 ' HA ' ' HB2' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -57.0 -49.23 76.42 Favored 'General case' 1 C--N 1.241 -4.116 0 CA-C-N 113.657 -1.611 . . . . 0.0 110.476 175.172 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.589 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -76.7 -35.18 58.03 Favored 'General case' 0 C--N 1.252 -3.657 0 CA-C-N 112.657 -2.065 . . . . 0.0 109.811 -175.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.498 ' CZ ' HD11 ' A' ' 42' ' ' ILE . 29.2 t80 -86.76 -24.61 25.04 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' VAL . 13.7 t -67.56 -28.5 67.84 Favored 'General case' 0 C--O 1.188 -2.137 0 CA-C-N 119.55 1.068 . . . . 0.0 110.686 -172.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.806 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -64.83 -31.8 73.2 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-O 122.817 1.294 . . . . 0.0 111.468 -170.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.806 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -64.59 -40.23 95.15 Favored 'General case' 1 C--N 1.24 -4.162 0 CA-C-N 111.569 -2.559 . . . . 0.0 108.648 -179.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 39' ' ' CYS . 46.3 mt -73.31 -46.27 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.683 0 CA-C-N 114.041 -1.436 . . . . 0.0 107.822 -175.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 39' ' ' CYS . 26.4 t -56.6 -35.18 44.06 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.775 0 CA-C-N 112.34 -2.209 . . . . 0.0 111.655 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . 1.9 mmpm? -84.53 -35.91 22.53 Favored 'General case' 0 C--N 1.281 -2.382 0 O-C-N 121.692 -0.63 . . . . 0.0 112.59 -178.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.9 t -74.92 -23.49 58.35 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.843 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.31 20.89 7.96 Favored Glycine 0 N--CA 1.401 -3.661 0 C-N-CA 121.073 -0.585 . . . . 0.0 113.383 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 89.22 -8.49 79.71 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -65.92 -28.26 68.8 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.458 HD12 ' O ' ' A' ' 41' ' ' ALA . 74.3 mt -82.93 147.94 5.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.911 173.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 51.1 m -137.99 179.98 6.11 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 -177.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.467 ' CD1' ' HB3' ' A' ' 24' ' ' HIS . 46.6 tp -88.92 141.46 28.47 Favored 'General case' 1 N--CA 1.339 -6.002 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 178.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.2 mttp -81.1 -59.22 2.73 Favored 'General case' 0 CA--C 1.491 -1.301 0 C-N-CA 118.904 -1.119 . . . . 0.0 108.105 166.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -143.59 142.05 20.16 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 113.87 -1.514 . . . . 0.0 111.784 -168.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -78.08 110.34 2.87 Favored 'Trans proline' 0 N--CA 1.445 -1.342 0 C-N-CA 121.861 1.708 . . . . 0.0 107.983 169.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.71 175.3 17.6 Favored Glycine 0 N--CA 1.428 -1.89 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 -173.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' HG2' HG21 ' A' ' 31' ' ' THR . 8.6 mtpm? -64.3 162.04 15.58 Favored 'General case' 0 N--CA 1.42 -1.939 0 N-CA-C 116.829 2.159 . . . . 0.0 116.829 177.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 84.6 m . . . . . 0 C--N 1.267 -2.997 1 N-CA-C 99.58 -4.23 . . . . 0.0 99.58 158.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 . . . . . 0 CA--C 1.49 -1.337 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.52 -68.95 3.44 Favored Glycine 0 C--O 1.215 -1.07 0 N-CA-C 107.666 -2.174 . . . . 0.0 107.666 -171.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -115.7 170.55 13.35 Favored Glycine 0 C--O 1.271 2.463 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 172.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -77.52 132.43 38.37 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.93 0.395 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.78 155.2 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 105.661 -1.977 . . . . 0.0 105.661 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -130.05 111.28 12.34 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 -174.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 17' ' ' CYS . 88.0 m -114.59 63.58 0.67 Allowed 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 156.038 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.47 -5.07 34.47 Favored Glycine 0 CA--C 1.49 -1.49 0 CA-C-N 112.589 -2.096 . . . . 0.0 114.212 -175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.469 ' CB ' HG11 ' A' ' 43' ' ' VAL . 45.9 mt-10 -64.3 -40.83 96.71 Favored 'General case' 0 N--CA 1.41 -2.444 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 170.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 17.2 t80 49.04 31.9 3.64 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 125.009 1.443 . . . . 0.0 113.361 165.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -62.06 -13.86 30.46 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-O 122.792 1.282 . . . . 0.0 114.025 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.643 ' OD1' ' HG2' ' A' ' 14' ' ' LYS . 15.0 t70 -139.67 143.96 37.39 Favored 'General case' 0 C--N 1.248 -3.812 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 169.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 15.0 t -65.67 -34.47 78.28 Favored 'General case' 0 C--N 1.248 -3.814 0 N-CA-C 114.935 1.458 . . . . 0.0 114.935 -170.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.643 ' HG2' ' OD1' ' A' ' 12' ' ' ASP . 24.1 pttm -86.82 12.79 10.13 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -176.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.577 HG11 HG22 ' A' ' 43' ' ' VAL . 21.2 t -94.86 100.3 10.85 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 121.952 0.882 . . . . 0.0 112.728 -174.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 31.7 p90 -137.13 155.05 50.07 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 173.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.663 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 23.6 p -113.94 -175.06 2.59 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.154 0.978 . . . . 0.0 112.883 179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 5.7 t -146.23 163.44 35.46 Favored 'General case' 0 N--CA 1.41 -2.427 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 169.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.43 ' HA ' ' ND2' ' A' ' 34' ' ' ASN . 7.3 ptm180 -115.31 -18.58 11.03 Favored 'General case' 1 C--N 1.235 -4.373 0 CA-C-N 113.578 -1.646 . . . . 0.0 110.703 -176.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -102.27 126.31 49.23 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -170.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.617 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 19.1 t 62.84 -4.58 0.24 Allowed 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 117.407 2.373 . . . . 0.0 117.407 163.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 12.2 m120 -106.61 92.92 7.75 Favored Pre-proline 0 C--N 1.295 -1.8 0 C-N-CA 117.904 -1.519 . . . . 0.0 114.29 -173.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 21' ' ' SER . 4.0 Cg_endo -83.19 153.6 14.29 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 C-N-CA 122.126 1.884 . . . . 0.0 110.53 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -150.63 128.41 11.66 Favored 'General case' 0 CA--C 1.456 -2.646 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 -172.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 31' ' ' THR . 30.3 t -99.46 95.77 7.23 Favored 'General case' 1 C--N 1.242 -4.069 0 N-CA-C 101.62 -3.474 . . . . 0.0 101.62 168.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.607 ' HA2' HD12 ' A' ' 51' ' ' LEU . . . -84.8 165.17 39.89 Favored Glycine 0 CA--C 1.451 -3.909 0 C-N-CA 119.728 -1.225 . . . . 0.0 110.863 -169.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.534 ' HB2' HG23 ' A' ' 49' ' ' ILE . 41.4 m -67.93 4.85 1.03 Allowed 'General case' 0 CA--C 1.572 1.79 0 CA-C-N 117.912 0.856 . . . . 0.0 111.441 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -61.2 -24.35 66.26 Favored 'General case' 0 C--N 1.364 1.225 0 C-N-CA 127.189 2.196 . . . . 0.0 105.757 165.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.11 -31.04 8.99 Favored Glycine 0 N--CA 1.396 -3.98 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.236 -178.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -89.04 155.99 19.13 Favored 'General case' 0 CA--C 1.466 -2.281 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.549 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 97.6 m -97.72 124.32 42.01 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 112.571 -2.104 . . . . 0.0 109.239 174.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 60.1 m-85 -117.58 142.51 47.12 Favored 'General case' 0 N--CA 1.383 -3.789 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.435 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -58.32 -36.19 82.24 Favored Glycine 0 C--N 1.309 -0.97 0 CA-C-N 113.748 -1.569 . . . . 0.0 114.199 -176.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.699 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 31.3 p30 -145.72 -178.29 6.02 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 117.258 0.529 . . . . 0.0 109.602 178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.412 ' HB3' HG22 ' A' ' 18' ' ' THR . 25.0 ttmm -67.59 -37.35 82.44 Favored 'General case' 0 C--O 1.193 -1.892 0 CA-C-O 121.121 0.486 . . . . 0.0 112.175 -174.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.5 OUTLIER -61.79 -38.39 87.89 Favored 'General case' 0 C--N 1.25 -3.728 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.702 -179.732 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -63.04 -37.44 87.19 Favored 'General case' 0 C--N 1.255 -3.537 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.141 -178.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.575 ' CE1' ' HA3' ' A' ' 26' ' ' GLY . 13.5 t80 -94.55 -8.75 37.33 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.832 178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.796 ' O ' HG23 ' A' ' 43' ' ' VAL . 16.1 t -62.51 -37.59 86.64 Favored 'General case' 0 CA--C 1.472 -2.024 0 C-N-CA 123.088 0.555 . . . . 0.0 110.455 -171.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.742 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -65.27 -33.39 75.86 Favored 'General case' 0 CA--C 1.454 -2.723 0 C-N-CA 124.362 1.065 . . . . 0.0 113.103 -172.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.742 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -76.33 -34.85 59.0 Favored 'General case' 1 C--N 1.218 -5.114 0 CA-C-N 112.895 -1.957 . . . . 0.0 109.815 -178.566 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.764 HD12 ' HA ' ' A' ' 39' ' ' CYS . 24.2 mt -63.04 -43.42 99.02 Favored 'Isoleucine or valine' 0 CA--C 1.444 -3.127 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.796 HG23 ' O ' ' A' ' 39' ' ' CYS . 41.2 t -55.03 -41.9 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.641 0 CA-C-N 111.518 -2.583 . . . . 0.0 111.053 176.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HG2' ' O ' ' A' ' 40' ' ' LYS . 24.7 mmtm -65.21 -37.69 88.11 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -169.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.52 ' HB2' HG13 ' A' ' 49' ' ' ILE . 24.7 m -104.08 28.59 6.62 Favored 'General case' 0 C--N 1.275 -2.652 0 C-N-CA 119.79 -0.764 . . . . 0.0 111.984 175.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.95 20.61 59.1 Favored Glycine 0 N--CA 1.4 -3.702 0 N-CA-C 117.283 1.673 . . . . 0.0 117.283 169.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA2' ' CG2' ' A' ' 42' ' ' ILE . . . 77.64 0.55 74.08 Favored Glycine 0 C--N 1.275 -2.847 0 CA-C-N 117.896 0.848 . . . . 0.0 111.226 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 41.3 mmtm -80.4 -21.4 42.3 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 -179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.534 HG23 ' HB2' ' A' ' 27' ' ' SER . 75.1 mt -62.98 152.5 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 CA-C-O 121.053 0.454 . . . . 0.0 110.271 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.7 m -127.68 -176.28 3.72 Favored 'General case' 0 N--CA 1.416 -2.138 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.607 HD12 ' HA2' ' A' ' 26' ' ' GLY . 37.5 tp -97.0 140.75 31.05 Favored 'General case' 1 N--CA 1.332 -6.365 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 176.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' HD3' ' SG ' ' A' ' 25' ' ' CYS . 36.1 mtpt -81.63 -50.2 9.61 Favored 'General case' 0 CA--C 1.472 -2.033 0 CA-C-O 121.965 0.888 . . . . 0.0 108.611 170.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.408 ' N ' ' HG ' ' A' ' 51' ' ' LEU . 17.8 t-80 -154.89 133.17 6.87 Favored Pre-proline 0 C--N 1.286 -2.155 0 CA-C-N 114.036 -1.438 . . . . 0.0 112.057 -171.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -71.13 110.7 2.89 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.264 1.976 . . . . 0.0 108.481 171.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.43 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 113.27 -170.25 13.28 Favored Glycine 0 N--CA 1.418 -2.557 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 -172.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.549 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 13.0 ptmm? -80.49 166.8 20.86 Favored 'General case' 0 N--CA 1.407 -2.617 0 CA-C-O 121.769 0.795 . . . . 0.0 112.415 177.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.4 m . . . . . 0 C--N 1.281 -2.381 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 165.909 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.22 -76.65 1.78 Allowed Glycine 0 C--O 1.22 -0.72 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -88.82 129.31 9.57 Favored Glycine 0 N--CA 1.417 -2.626 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 172.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -101.55 95.62 6.58 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.436 ' O ' ' HB ' ' A' ' 18' ' ' THR . 89.2 t -90.63 140.01 16.67 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.439 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.598 ' CB ' ' HA ' ' A' ' 17' ' ' CYS . 1.8 p30 -126.45 156.26 40.92 Favored 'General case' 0 C--N 1.279 -2.466 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 162.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.745 ' SG ' HG21 ' A' ' 43' ' ' VAL . 20.5 p -41.29 -17.4 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 118.888 2.921 . . . . 0.0 118.888 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.6 ' N ' ' HB2' ' A' ' 39' ' ' CYS . . . -56.16 -29.12 55.58 Favored Glycine 0 C--N 1.342 0.869 0 CA-C-N 119.983 1.265 . . . . 0.0 111.268 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.48 -28.08 59.09 Favored 'General case' 0 N--CA 1.416 -2.162 0 C-N-CA 124.656 1.182 . . . . 0.0 112.432 178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.648 ' HB2' HG11 ' A' ' 15' ' ' VAL . 95.6 m-85 -138.0 92.56 2.67 Favored 'General case' 0 N--CA 1.391 -3.379 0 CA-C-O 124.068 1.89 . . . . 0.0 111.408 -171.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.743 ' HA ' HG13 ' A' ' 43' ' ' VAL . 73.3 mt-30 -40.32 -6.93 0.0 OUTLIER 'General case' 1 C--N 1.233 -4.493 1 C-N-CA 134.448 5.099 . . . . 0.0 115.745 172.131 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 10' ' ' PHE . 12.6 t0 -75.73 -161.39 0.16 Allowed 'General case' 0 C--N 1.26 -3.311 0 C-N-CA 126.202 1.801 . . . . 0.0 109.012 -178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 p -106.55 -48.98 3.42 Favored 'General case' 1 C--N 1.232 -4.518 0 C-N-CA 125.563 1.545 . . . . 0.0 114.574 -174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.607 ' HD2' ' H ' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -85.34 19.6 2.25 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.562 0.745 . . . . 0.0 111.984 -170.337 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.648 HG11 ' HB2' ' A' ' 10' ' ' PHE . 4.3 t -107.87 130.57 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.229 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -175.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -127.12 175.5 8.08 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 114.071 1.138 . . . . 0.0 114.071 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.692 ' HB2' ' CA ' ' A' ' 36' ' ' CYS . 12.0 p -77.98 167.12 21.97 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 113.49 -1.686 . . . . 0.0 114.347 -168.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.525 ' H ' ' HB3' ' A' ' 6' ' ' ASP . 10.0 t -96.35 174.81 6.68 Favored 'General case' 0 N--CA 1.424 -1.733 0 CA-C-N 114.55 -1.204 . . . . 0.0 111.298 -178.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -87.22 -3.09 59.03 Favored 'General case' 0 C--N 1.281 -2.374 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 35.1 mm-40 -69.44 119.25 13.41 Favored 'General case' 0 N--CA 1.434 -1.264 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.836 -176.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 t -87.81 15.31 7.21 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 125.409 1.483 . . . . 0.0 111.589 -173.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 34' ' ' ASN . 18.6 t-20 -70.95 110.61 7.54 Favored Pre-proline 0 C--N 1.271 -2.843 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.318 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.503 ' HB2' ' HA2' ' A' ' 55' ' ' GLY . 3.8 Cg_exo -71.44 159.62 50.96 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.578 2.185 . . . . 0.0 112.459 -177.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.411 ' O ' ' HA ' ' A' ' 31' ' ' THR . 0.3 OUTLIER -151.75 130.64 12.5 Favored 'General case' 0 CA--C 1.478 -1.806 0 C-N-CA 123.289 0.636 . . . . 0.0 109.698 -172.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 52' ' ' LYS . 50.4 t -108.43 104.37 13.7 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 104.065 -2.569 . . . . 0.0 104.065 168.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.635 ' HA3' ' CZ ' ' A' ' 38' ' ' PHE . . . -69.63 169.25 45.04 Favored Glycine 0 N--CA 1.414 -2.793 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.268 -176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.7 p -65.21 -19.39 65.95 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.604 ' OD1' ' HG3' ' A' ' 30' ' ' GLN . 11.7 t70 -61.26 -36.86 81.15 Favored 'General case' 0 CA--C 1.48 -1.716 0 C-N-CA 125.272 1.429 . . . . 0.0 108.953 175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.73 -18.66 14.76 Favored Glycine 0 N--CA 1.398 -3.887 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.604 ' HG3' ' OD1' ' A' ' 28' ' ' ASP . 78.1 mt-30 -71.66 135.3 46.82 Favored 'General case' 0 CA--C 1.452 -2.822 0 CA-C-O 122.375 1.083 . . . . 0.0 113.795 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.502 ' CG2' ' HA ' ' A' ' 56' ' ' LYS . 93.4 m -117.86 133.17 56.2 Favored 'General case' 0 C--N 1.259 -3.346 0 CA-C-N 112.962 -1.926 . . . . 0.0 109.019 177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' HB3' ' HB3' ' A' ' 37' ' ' ALA . 66.4 m-85 -131.26 162.33 30.27 Favored 'General case' 0 N--CA 1.38 -3.928 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.398 172.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.94 -25.11 63.62 Favored Glycine 0 C--N 1.294 -1.773 0 CA-C-N 113.386 -1.733 . . . . 0.0 113.362 -177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 34.7 p30 -158.99 168.21 27.34 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.07 -35.62 73.67 Favored 'General case' 0 CA--C 1.489 -1.38 0 CA-C-O 121.647 0.737 . . . . 0.0 111.571 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.692 ' CA ' ' HB2' ' A' ' 17' ' ' CYS . 0.0 OUTLIER -50.07 -52.67 32.67 Favored 'General case' 0 C--N 1.256 -3.499 0 CA-C-N 113.496 -1.684 . . . . 0.0 111.335 174.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 32' ' ' TYR . . . -66.33 -33.74 76.41 Favored 'General case' 0 C--N 1.265 -3.069 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.258 -174.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.635 ' CZ ' ' HA3' ' A' ' 26' ' ' GLY . 48.2 t80 -95.0 -2.11 51.04 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 115.351 -0.84 . . . . 0.0 113.127 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.832 ' O ' HG23 ' A' ' 43' ' ' VAL . 14.5 p -61.38 -43.85 98.16 Favored 'General case' 0 CA--C 1.439 -3.296 0 O-C-N 121.908 -0.495 . . . . 0.0 111.149 -172.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.603 ' HD2' ' N ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -57.26 -35.57 69.9 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 126.152 1.781 . . . . 0.0 114.496 -172.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 40' ' ' LYS . . . -68.59 -39.49 80.9 Favored 'General case' 1 C--N 1.229 -4.668 0 CA-C-N 112.4 -2.182 . . . . 0.0 108.665 179.626 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' A' ' 39' ' ' CYS . 34.9 mt -69.19 -48.12 70.43 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 CA-C-N 114.734 -1.121 . . . . 0.0 109.001 -177.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 39' ' ' CYS . 37.1 t -50.75 -50.63 22.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.574 0 CA-C-N 112.009 -2.359 . . . . 0.0 111.832 -176.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . 28.6 mmtm -78.73 -32.59 46.82 Favored 'General case' 0 C--N 1.277 -2.561 0 CA-C-N 114.55 -1.205 . . . . 0.0 112.87 -172.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.479 ' O ' ' HD2' ' A' ' 48' ' ' LYS . 16.3 m -80.55 4.21 19.2 Favored 'General case' 0 C--N 1.279 -2.494 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.017 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.45 19.05 46.7 Favored Glycine 1 N--CA 1.385 -4.706 0 N-CA-C 116.45 1.34 . . . . 0.0 116.45 171.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.05 -0.47 62.63 Favored Glycine 0 C--N 1.29 -2.012 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 45' ' ' SER . 38.7 mttp -71.77 -19.39 62.02 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 41.9 mt -79.83 140.99 15.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.435 -0.906 . . . . 0.0 108.645 174.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 27.8 m -121.08 -179.71 4.12 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.493 HD12 ' HA2' ' A' ' 26' ' ' GLY . 35.9 tp -90.16 141.06 29.07 Favored 'General case' 1 N--CA 1.324 -6.765 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 176.86 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.655 ' HD2' ' SG ' ' A' ' 57' ' ' CYS . 2.2 ttmp? -90.02 -54.59 3.97 Favored 'General case' 0 N--CA 1.385 -3.701 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.842 170.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 52' ' ' LYS . 58.9 m170 -139.38 137.16 18.55 Favored Pre-proline 0 C--N 1.283 -2.309 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.083 -173.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -76.62 109.83 2.93 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 N-CA-C 105.796 -2.424 . . . . 0.0 105.796 165.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.503 ' HA2' ' HB2' ' A' ' 23' ' ' PRO . . . 115.84 -177.22 16.96 Favored Glycine 0 C--N 1.284 -2.341 0 N-CA-C 107.867 -2.093 . . . . 0.0 107.867 -169.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.502 ' HA ' ' CG2' ' A' ' 31' ' ' THR . 14.2 pttp -79.21 173.35 12.67 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-O 121.901 0.857 . . . . 0.0 111.327 177.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.655 ' SG ' ' HD2' ' A' ' 52' ' ' LYS . 24.8 m . . . . . 0 C--N 1.281 -2.409 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 165.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 . . . . . 0 CA--C 1.507 -0.691 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.98 -138.79 24.14 Favored Glycine 0 C--O 1.24 0.485 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.411 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.28 91.35 0.73 Allowed Glycine 0 C--N 1.304 -1.204 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 177.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -101.16 165.06 11.49 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -175.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -84.88 174.23 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 -179.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' CYS . 15.0 t70 -129.94 133.16 46.65 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 171.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.472 ' C ' ' HB2' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -52.54 -156.84 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.5 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 166.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 7' ' ' CYS . . . 98.24 -65.73 0.78 Allowed Glycine 0 CA--C 1.462 -3.227 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -79.08 -17.43 55.2 Favored 'General case' 0 N--CA 1.407 -2.589 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 175.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.689 ' HB3' HG21 ' A' ' 15' ' ' VAL . 95.3 m-85 -114.74 81.02 1.49 Allowed 'General case' 1 N--CA 1.376 -4.142 0 CA-C-O 123.763 1.744 . . . . 0.0 110.075 -171.427 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.583 ' C ' HG13 ' A' ' 43' ' ' VAL . 65.5 mm-40 -45.0 -8.19 0.01 OUTLIER 'General case' 1 C--N 1.223 -4.892 2 C-N-CA 133.978 4.911 . . . . 0.0 114.725 173.826 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.536 ' CG ' ' HG2' ' A' ' 14' ' ' LYS . 45.5 t0 -98.35 134.6 41.13 Favored 'General case' 1 N--CA 1.371 -4.389 0 N-CA-C 106.058 -1.831 . . . . 0.0 106.058 174.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.9 t -79.12 6.19 10.18 Favored 'General case' 1 C--N 1.222 -4.956 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.787 -173.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.536 ' HG2' ' CG ' ' A' ' 12' ' ' ASP . 35.4 mmtm -81.85 -25.96 34.66 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 174.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.689 HG21 ' HB3' ' A' ' 10' ' ' PHE . 3.1 t -92.26 120.68 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.649 0 CA-C-N 113.195 -1.82 . . . . 0.0 109.072 -171.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.417 ' HA ' ' SG ' ' A' ' 7' ' ' CYS 0.402 59.6 m-85 -118.2 175.12 5.84 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 179.733 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.599 ' CB ' ' HA ' ' A' ' 36' ' ' CYS . 28.0 p -75.84 166.94 22.78 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 117.107 2.262 . . . . 0.0 117.107 -162.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.433 HG22 ' OD2' ' A' ' 6' ' ' ASP . 9.5 t -91.9 175.1 7.01 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 113.639 -1.618 . . . . 0.0 111.13 177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -91.05 -17.94 25.4 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 112.727 -2.033 . . . . 0.0 109.032 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -73.17 131.96 42.65 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.908 -1.042 . . . . 0.0 112.226 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.492 ' HA ' ' CB ' ' A' ' 34' ' ' ASN . 27.3 m -94.44 107.13 19.11 Favored 'General case' 0 N--CA 1.414 -2.257 0 CA-C-O 122.12 0.962 . . . . 0.0 111.077 177.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -110.75 100.44 45.88 Favored Pre-proline 0 C--N 1.276 -2.625 0 CA-C-N 113.161 -1.836 . . . . 0.0 109.554 -178.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 32' ' ' TYR . 6.8 Cg_exo -75.59 125.19 8.77 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.426 2.084 . . . . 0.0 111.267 179.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.405 ' HB2' ' CE2' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -151.53 129.32 11.62 Favored 'General case' 0 CA--C 1.488 -1.418 0 C-N-CA 125.236 1.415 . . . . 0.0 108.845 -174.547 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.2 t -92.61 106.73 18.66 Favored 'General case' 0 C--N 1.262 -3.226 0 N-CA-C 104.687 -2.338 . . . . 0.0 104.687 174.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -73.68 160.35 53.54 Favored Glycine 0 N--CA 1.401 -3.657 0 C-N-CA 119.907 -1.139 . . . . 0.0 111.349 -173.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.451 ' HA ' ' HG2' ' A' ' 52' ' ' LYS . 50.3 m -64.61 -7.37 10.23 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 121.854 0.835 . . . . 0.0 110.468 173.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -81.36 -10.48 59.53 Favored 'General case' 0 N--CA 1.432 -1.352 0 C-N-CA 126.763 2.025 . . . . 0.0 108.374 176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 93.49 -31.6 6.32 Favored Glycine 0 N--CA 1.426 -2.021 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . 0.266 26.1 mt-30 -74.72 130.08 38.85 Favored 'General case' 0 N--CA 1.396 -3.164 0 N-CA-C 115.71 1.745 . . . . 0.0 115.71 -177.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.626 HG21 ' HA ' ' A' ' 56' ' ' LYS . 89.9 m -98.81 126.04 44.35 Favored 'General case' 0 C--N 1.277 -2.545 0 CA-C-N 112.695 -2.048 . . . . 0.0 110.092 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . 30.1 p90 -106.99 133.03 52.24 Favored 'General case' 0 N--CA 1.39 -3.45 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.745 176.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -70.75 -42.51 61.55 Favored Glycine 0 CA--C 1.499 -0.912 0 CA-C-N 114.328 -1.306 . . . . 0.0 111.807 -179.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 21' ' ' SER . 32.6 p30 -128.72 168.78 15.34 Favored 'General case' 0 N--CA 1.41 -2.47 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' HG2' ' OD1' ' A' ' 6' ' ' ASP . 52.3 tttm -71.58 -35.47 70.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 121.733 0.777 . . . . 0.0 110.141 -173.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.599 ' HA ' ' CB ' ' A' ' 17' ' ' CYS . 49.6 t -48.26 -44.9 33.85 Favored 'General case' 0 C--N 1.263 -3.185 0 CA-C-N 112.814 -1.994 . . . . 0.0 112.755 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 32' ' ' TYR . . . -50.76 -42.99 58.21 Favored 'General case' 0 C--N 1.265 -3.094 0 CA-C-N 112.46 -2.155 . . . . 0.0 112.431 -177.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.5 ' HB2' ' HB3' ' A' ' 32' ' ' TYR . 8.8 t80 -127.53 -1.36 6.18 Favored 'General case' 0 C--O 1.201 -1.472 0 C-N-CA 117.492 -1.683 . . . . 0.0 114.186 -176.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.748 ' HA ' HD12 ' A' ' 42' ' ' ILE . 31.7 p -51.45 -55.35 19.25 Favored 'General case' 0 C--O 1.194 -1.861 0 C-N-CA 123.471 0.708 . . . . 0.0 111.38 -177.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.586 ' O ' ' HB ' ' A' ' 43' ' ' VAL . 0.0 OUTLIER -65.12 -24.38 67.4 Favored 'General case' 0 N--CA 1.409 -2.512 0 C-N-CA 127.045 2.138 . . . . 0.0 114.586 -177.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 38' ' ' PHE . . . -82.04 -28.73 32.32 Favored 'General case' 1 C--N 1.202 -5.816 0 CA-C-N 113.179 -1.828 . . . . 0.0 110.718 173.605 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.748 HD12 ' HA ' ' A' ' 39' ' ' CYS . 22.0 mt -66.99 -43.14 89.3 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.78 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 177.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 39' ' ' CYS . 46.7 t -50.34 -41.41 19.35 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 110.619 -2.991 . . . . 0.0 110.995 171.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 53.4 mttp -86.0 -29.46 23.48 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.853 -0.739 . . . . 0.0 112.464 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.51 ' HB3' ' HD3' ' A' ' 48' ' ' LYS . 64.3 m -86.85 12.96 9.77 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.43 174.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 90.36 3.48 72.15 Favored Glycine 0 N--CA 1.413 -2.895 0 N-CA-C 116.553 1.381 . . . . 0.0 116.553 172.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.68 14.12 82.83 Favored Glycine 0 N--CA 1.416 -2.638 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -173.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 45' ' ' SER . 4.5 pttm -64.74 -25.0 67.74 Favored 'General case' 0 C--N 1.367 1.348 0 CA-C-O 121.94 0.876 . . . . 0.0 109.671 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.681 HD13 ' HA ' ' A' ' 42' ' ' ILE . 4.1 mp -79.02 131.51 34.21 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 118.654 -1.218 . . . . 0.0 111.688 -179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 p -130.84 -177.82 4.53 Favored 'General case' 0 C--N 1.268 -2.942 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.438 ' HA ' HD12 ' A' ' 51' ' ' LEU . 27.8 tp -95.16 141.48 28.72 Favored 'General case' 1 N--CA 1.343 -5.806 0 N-CA-C 117.542 2.423 . . . . 0.0 117.542 -179.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.688 ' NZ ' ' HA ' ' A' ' 52' ' ' LYS . 0.0 OUTLIER -91.23 -54.95 3.72 Favored 'General case' 0 CA--C 1.461 -2.456 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.458 164.09 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 54' ' ' PRO . 25.1 t-80 -149.72 135.09 9.79 Favored Pre-proline 0 C--N 1.262 -3.219 0 CA-C-N 113.575 -1.648 . . . . 0.0 112.175 -167.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 53' ' ' HIS . 8.2 Cg_exo -73.8 110.3 3.05 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.965 1.776 . . . . 0.0 108.453 170.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.92 168.74 15.35 Favored Glycine 0 N--CA 1.422 -2.288 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -173.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.626 ' HA ' HG21 ' A' ' 31' ' ' THR . 12.3 mtpp -56.03 162.51 1.88 Allowed 'General case' 0 N--CA 1.425 -1.703 0 N-CA-C 118.071 2.619 . . . . 0.0 118.071 176.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m . . . . . 0 N--CA 1.413 -2.289 0 CA-C-N 109.435 -3.53 . . . . 0.0 101.817 158.292 . . . . . . . . 0 0 . 1 stop_ save_